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“Those worlds in space are as countless as all the grains of sand on all the 
beaches of the Earth. Each of those worlds is as real as ours. In every one of 
them, there's a succession of incidences, events, occurrences which influence its 
future. Countless worlds, numberless moments, an immensity of space and time. 
And our small planet, at this moment, here we face a critical branch-point in the 
history. What we do with our world, right now, will propagate down through the 
centuries and powerfully affect the destiny of our descendants. It is well within 
our power to destroy our civilization, and perhaps our species as well. If we 
capitulate to superstition, or greed, or stupidity we can plunge our world into a 
darkness deeper than the time between the collapse of classical civilization and 
the Italian Renaissance. But we are also capable of using our compassion and 
our intelligence, our technology and our wealth to make an abundant and 
meaningful life for every inhabitant of this planet. To enhance enormously our 






Dedicated to all great minds of past and present,  
on whose shoulders we may stand. 
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Introduction I: Ruthenium polypyridyl complexes as 






Light-sensitive ruthenium(II) polypyridyl complexes are classical tools in photochemistry 
that have recently been proposed as prodrugs for photoactivated chemotherapy (PACT). 
The use of light allows for excellent spatial and temporal control over prodrug activation 
so that the harmful systemic side-effects of chemotherapy are prevented. In this chapter, 
the topics of ruthenium anti-cancer drugs and photoactivated chemotherapy are 
introduced. Special attention is given to the mechanism of photosubstitution in 
ruthenium complexes, and examples are highlighted of ruthenium photosubstitution that 
are activated with visible light. Finally, it is addressed how the activation wavelength of 
PACT prodrugs can be shifted to the phototherapeutic window, in order to achieve a 




1.1 Anticancer transition metal complexes 
After the serendipitous discovery of cisplatin in 1969 and its clinical 
introduction in 1978 as the world’s first platinum anticancer drug, the 
scientific community was convinced that heavy metal coordination 
compounds, in particular based on platinum, could have potent anti-tumor 
activity.[1] The excitement of a new form of cancer therapy soon motivated 
researchers to look for similar compounds with enhanced toxicity against 
tumors and reduced side-effects.[2] The era of platinum-based chemotherapy 
began, in which thousands of cisplatin-analogues were tested in vitro and in 
animals, and nearly 40 of them were tested in clinical trials.[3] Although the 
exact mechanism of action of cisplatin remains elusive even today, it is 
generally accepted that the cytotoxic activity of platinum compounds is due to 
binding with the DNA, which prevents cell replication.[4] Despite the 
tremendous research efforts only two other compounds were ultimately 
approved for use in clinics worldwide: carboplatin and oxaliplatin (Figure 
1.1). It seemed that the discovery of cisplatin had been indeed a lucky shot, 
and it was realized that it had been a misconception that only compounds 
analogous to cisplatin are promising clinical anticancer candidates.[3] To break 
free from this “cisplatin-paradigm”, significant efforts have been undertaken 
towards the development of non-classical platinum complexes. Promising 
routes are targeted delivery, prodrug activation by light, intracellular prodrug 
reduction, among others.[4b, 5]  
Initially, research on coordination compounds with transition metals such as 
Ru, Au, Co, Fe, and Ni could not compete with the enormous enthusiasm for 
platinum chemistry. However, they have received increasing recognition as 
potent anticancer complexes in the last three decades.[2-3, 5] The leap from 
platinum to other metals is appealing: a wide variety in coordination 
geometry, binding preferences, oxidation states, redox activity, and ligand 
exchange kinetics may lead to a controlled mechanism of cytotoxicity that was 
previously unattainable with platinum compounds.[3] Of these metals, 
ruthenium appears to be one of the most promising.[2] As the research 
described in this thesis concerns the development of ruthenium-based 




Figure 1.1. Chemical structures of cisplatin, carboplatin, oxaliplatin, NAMI-A, KP1339, and RAPTA-
C. 
1.2 Ruthenium anticancer drugs 
Ruthenium is one of the transition metals most studied for the synthesis of 
anticancer coordination compounds, and is only surpassed in the number of 
reported studies by platinum.[6] The advantages of ruthenium complexes 
include:  
i. The preparative coordination chemistry is well-developed, reliable, 
and the chemical structures are predictable.[3, 7] The usual 
hexacoordinate octahedral geometry implies a very different reactivity 
compared to square-planar platinum(II) compounds.[3] 
ii. The ligand exchange rates are in the order of minutes to days and can 
be tuned so that the complexes are relatively kinetically inert under 
physiological conditions or can interact with physiological processes 
occurring on the same timescale.[2-3, 8] 
iii. The 2+, 3+, and 4+ oxidation states are accessible under physiological 
conditions,[2-3, 7] which allows the possibility of in situ redox-activation 
of substitutionally inert Ru(III) complexes to active Ru(II) complexes 
in the highly reductive environment of tumors.[2]  
iv. The photophysics and photochemistry of ruthenium complexes is well 
described and understood,[9] allowing for the smart design of in situ 
light-activatable anticancer compounds. 
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In the last decade, three major ruthenium-based anticancer drugs have been 
tested in (pre)clinical trials: KP1339, NAMI-A, and RAPTA-C, see Figure 1.1.[10] 
In preclinical studies, ruthenium chemotherapeutic drugs were shown to have 
better selectivity towards tumors and exhibit fewer side-effects than platinum 
drugs.[2] The activity of ruthenium anticancer drugs are still compared to that 
of cisplatin, even though they have little in common and each ruthenium 
compound appears to have a very distinct mode of action.[2-3, 7, 10-11] The 
cytotoxic effects of KP1339, NAMI-A, and RAPTA-C are mainly attributed to 
interactions with other biomolecules than nuclear DNA. Regardless, the 
binding of ruthenium anticancer drugs to DNA is a well-studied subject that is 
preferred over interaction studies with different biological targets.[12] Ru(II) 
and Ru(III) coordination compounds interact with DNA due to the relative 
softness of these ions, which lead to high binding affinities for nitrogen-rich 
DNA bases.[7] DNA intercalation, groove-bending, and other non-covalent 
interactions are also possible when the ruthenium compounds contain large 
planar aromatic ligands.[13] Upon interaction, the complex can either stay 
covalently or non-covalently bound and disrupt cell proliferation, or induce 
DNA damage.[7] However, it is important to realize that many Ru complexes do 
not end up in the nucleus and assert their toxicity through other interactions 
that are not yet well-explored. 
Ruthenium anticancer drugs can be roughly divided into five categories: 
i. Active Ru(II) complexes that easily hydrolyze and coordinate to their 
target biomolecule. 
ii. Ru(III) complexes that are activated upon reduction to the Ru(II) 
complex. 
iii. Substitutionally inert Ru(II) complexes that bind non-covalently to 
DNA or proteins by groove binding or intercalation.[14] 
iv. Complexes targeted to unconventional biomolecular targets, e.g. 
specific enzyme inhibitors.[2] 
v. Photoactivatable complexes that become toxic or have a toxic effect 
upon light irradiation  
The research described in this thesis focusses on the last category of 
compounds. They are potential compounds for photoactivated chemotherapy 
(PACT) and photodynamic therapy (PDT). These topics are introduced in the 
following sections. 
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1.3 Photoactivated chemotherapy 
Photoactivated chemotherapy (PACT) is a form of anticancer chemotherapy in 
which a non-toxic prodrug is systemically or dermally administered, and 
activated selectively at the tumor site by irradiation with visible light. This 
promising technique provides accurate spatial and temporal control over drug 
activation that may lead to selective tumor treatment with less side-effects.[9-
10, 15] The mechanisms of photoactivated chemotherapy fall into four broad 
categories: (i) photosensitization or singlet oxygen generation, also known as 
photodynamic therapy (PDT), (ii) photothermal reaction, (iii) photoinduced 
redox reactions, and (iv) photosubstitution.[9] In practice, it is difficult to 
distinguish the different pathways in the complex confinement of a cell. The 
different photoactivation pathways are often in competition with each other, 
and depend on solvent, oxygen level, possible reactants present, and the 
excitation wavelength.[9] The following sections focus on PDT and 
photosubstitution mechanisms. 
1.4 The phototherapeutic window 
The organic and metal-organic molecules used in PACT often only absorb 
considerably in the ultraviolet and blue wavelength region. Light with these 
wavelengths does not penetrate the body very well due to significant 
absorption by biomolecules such as melanin and hemoglobin (see Figure 
1.2).[16] Furthermore, spatial variations in refractive index within human 
tissue result in substantial scattering of light: higher energy light (blue region) 
is scattered more than low energy light (red region).[16] As a result of light 
scattering and absorption, wavelengths between 700 − 800 nm penetrate 
human tissue to about 1 cm, while wavelengths near 600 nm penetrate to only 
0.5 cm.[17] For blue and ultraviolet light, the penetration depth is a millimeter 
or less. Wavelengths above 950 nm are absorbed by the molecular vibrations 
of water. For these reasons, the wavelength domain between about 600 and 
950 nm has the optimum transmittance of light, and is therefore called the 
“phototherapeutic window”.[7, 10, 17-18] Moreover, a high dose of blue light itself 
is toxic for certain tissue types,[19] while red light does not damage tissues at 
light intensities relevant to PACT.I Overall, using red to near-infrared light 
                                                             
I Superficial PDT is usually executed with light intensities of 50 − 100 mW.cm−2.[20] In the case of 
internal irradiation using diffuser-tipped light-fibers, the intensity is expressed in terms of 
mW.cm−1 diffuser length. For example, the 630 nm light dose for photodynamic therapy with 
the clinically approved drug “photofrin” is prescribed as 270 mW.cm−1 for < 15 minutes.[21] 
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would lead to the simultaneous irradiation of a greater tumor volume, while 
not harming the healthy tissue around it. 
 
Figure 1.2: Optical absorption coefficients of the major human body chromophores. The 
phototherapeutic window in which light penetrates the body the deepest, lies between 600 and 
950 nm. Reprinted with permission from Vogel et al. [16] © (2003) American Chemical Society. 
1.5 Photodynamic therapy 
Photodynamic therapy (PDT) was developed as early as the 1900s, but was  
popularized in clinical therapy by Dougherty in the late 1970s and early 
1980s.[18c] Two types of PDT are known that both include strongly absorbing 
photosensitizer molecules such as porphyrins and phthalocyanins.[18c] In PDT 
type 1, the photosensitizer absorbs light and then reacts with biomolecules by 
means of an electron-transfer mechanism.[7] In PDT type 2, which is by far the 
most common, the photosensitizer is used to generate reactive oxygen species 
(ROS). Figure 1.3 schematically shows the most important photophysical 
pathways that are involved in this mechanism. Upon absorption of light the 
photosensitizer molecule reaches an excited singlet state, which is 
immediately followed by intersystem crossing (ISC) to a triplet state. Upon 
collision with ground-state molecular oxygen (3Σg state), which is also a triplet 
state, triplet-triplet annihilation (TTA) may occur. TTA causes the 
photosensitizer to relax to the singlet ground state, while dioxygen is 
promoted to a higher-energy singlet state (1Σg). After internal conversion to 
the 1Δg state, singlet dioxygen may either chemically react with other 
molecules, or relax back to the ground state non-radiatively or by emission of 
a 1270 nm photon. Reaction of singlet oxygen with cell constituents leads to 
the irreversible oxidation of DNA, lipids, amino-acids, cofactors, and proteins. 
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This damage triggers pathways towards programmed cell death (apoptosis), 
or cause instant cell death (necrosis).  
Although PDT is a promising and increasingly accepted therapy, a few issues 
need to be addressed.[18a] Firstly, many photosensitizers do not absorb 
strongly in the phototherapeutic window and rely on blue to green light for 
activation, leading to poor therapeutic efficiency. Furthermore, many 
photosensitizers suffer from photobleaching during treatment and poor water 
solubility, and are often retained in tissues which causes prolonged light-
sensitivity for the patient. Most importantly, many tumor tissues are poorly 
oxygenated (“hypoxic”) because of lack of angiogenesis, while the functioning 
of PDT relies on the presence of dioxygen.[22] It would therefore be beneficial 
to use PACT drugs that are activated by light but are toxic via an oxygen-
independent mechanism. 
 
Figure 1.3. Jablonski diagram of the foremost photophysical pathways in photodynamic therapy 
(type 2), involving a photosensitizer drug and molecular oxygen. Dashed arrows represent 
transitions in which photons are involved. Abbreviations: GS (ground state), A (Absorption), ES 
(excited state), ISC (intersystem crossing), P (phosphorescence), NR (non-radiative decay), TTA 
(triplet-triplet annihilation), IC (internal conversion). 
1.6 Photosubstitution 
A different PACT mechanism is based on photosubstitution, which relies on 
caging of a drug with a light-cleavable protective ligand. Upon light activation, 
the protective ligand dissociates and the active compound is released. Such a 
strategy does not rely on the presence of dioxygen and is therefore appealing 
for treatment of hypoxic tumors. Especially ruthenium complexes with 
heterocyclic N-donor ligands have been widely recognized as particularly 
attractive candidates for PACT, because of the near-unity intersystem crossing 
Chapter 1 
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efficiency to the triplet Metal-to-Ligand Charge Transfer state (3MLCT) state, 
long-lived excited states, highly tunable photochemical properties, and 
intensively studied properties in general.[7, 18a] The desirable features for such 
ruthenium photosubstitution anticancer drugs include: (i) solubility and 
stability in aqueous biological media, (ii) high cell uptake, (iii) negligible 
cytotoxicity in the dark and acute anticancer activity when irradiated, (iv) high 
quantum yield for photosubstitution, and (v) low influence of oxygen on the 
photophysical and photochemical properties.[9]  
 
Figure 1.4. Jablonski diagram of the foremost photophysical pathways of a typical 
photosubstitution Ru polypyridyl complex. Dashed arrows represent transitions in which photons 
are involved. Abbreviations: GS (ground state), A (Absorption), ISC (intersystem crossing), P 
(phosphorescence), NR (non-radiative decay), IC (internal conversion), MC (metal centered). 
Adapted from Göttle et al. [23] 
The mechanism of photosubstitution is well understood for ruthenium 
bipyridine and terpyridine complexes.[23-24] Figure 1.4 illustrates the 
photosubstitution mechanism for a typical Ru(II) complex with a photolabile 
ligand. After excitation to the singlet Metal-to-Ligand Charge Transfer state 
(1MLCT) state and intersystem crossing to the 3MLCT state, a dissociative 
triplet metal-centered state (3MC)  is within reach of (thermal) internal 
conversion. This 3MC state has dissociative character because the antibonding 
dσ* orbitals of the metal center become partially occupied, which weakens 
and elongates a metal-ligand bond. This weakening allows one of the ligands 
to be substituted by water, thereby giving rise to the potentially cytotoxic 
aqua derivative. In a biological setting, it is proposed that the aquated 
coordination site can be used for interactions with biomolecules.[18a, 25] 
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Figure 1.5. Representative examples of photosubstitution ruthenium polypyridyl complexes from 
the groups of Glazer (a),[26] Bonnet (b),[25d] and Turro (d).[27] 
Most Ru(II) polypyridyl complexes are actually quite photostable and the 
photosubstitution pathway is in competition with other processes such as 
phosphorescence and non-radiative relaxation.[9, 23a] The mechanism of 
photosubstitution is strongly dependent on the energy, shape, and position of 
the potential energy surfaces of the 3MLCT and 3MC states, which determine 
the accessibility of the 3MC state and hence the dissociation rate.[23a] 
Meanwhile, the energy gap between ground state and the 1MLCT state 
determines the maximum absorption wavelength. This means that, ideally, the 
1MLCT and 3MC states are both low in energy, so that the complex absorbs in 
the phototherapeutic window and the photosubstitution takes place 
efficiently.[23a, 28] In practice, a good trade-off between these two parameters is 




Figure 1.6. Representative examples of photosubstitutionally active ruthenium polypyridyl 
complexes that are activated with red, green, or yellow light from the groups of Glazer (a),[18a] 
Etchenique (b),[28] and Bonnet (c), respectively.[29] 
A viable strategy to optimize photochemical access to the 3MC state is to 
induce distortion of the octahedral symmetry around the Ru(II) center. Such 
distortion leads to smaller overlap between the nitrogen lone pairs and the 
orbitals of the ruthenium center, and consequently to a smaller ligand field 
splitting and lower energy of the dissociative triplet Metal-Centered state 
(3MC) state.[18a, 23b, 26] This makes the 3MC state more accessible from the 
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photochemically generated 3MLCT state. Popular strategies to induce such 
distortion include the use of bulky polypyridyl ligands that induce steric 
hindrance or use of the terpyridine ligand, which coordinates in a strained 
manner. However, lowering the 3MC state too much is known to cause 
complex instability in the dark, which is highly undesirable for 
phototherapeutic purposes.  
Some noteworthy examples of blue-light responsive photosubstitutionally 
active Ru(II) polypyridyl complexes as PACT compounds are given in Figure 
1.5. The group of Glazer reported that the strained complex 
[Ru(bpy)2(dmbpy)]2+ (bpy = bipyridine, dmbpy = 6,6’-dimethylbipyridine) 
ejects the dmbpy ligand upon >450 nm irradiation which causes a 2 order of 
magnitude increase in cytotoxicity.[26] The group of Turro reported the 
complex  cis-[Ru(bpy)2(CNU)2]2+ (CNU = 5-cyanouracil) that ejects two 
equivalents of CNU upon >395 nm irradiation.[27] Both the resulting ruthenium 
aqua species and the CNU potentially have a biological effect, but 
photocytotoxicity data on this complex have not been yet published. In recent 
years, our own research group has mainly focused on analogues of 
[Ru(tpy)(bpy)(SRR’)]2+ (tpy = terpyridine, SRR’ = thioether ligand) such as 
[Ru(tpy)(bpy)(N-acetyl-L-methionine)]2+, which selectively photoejects the 
thioether ligand upon 452 nm light irradiation.[23b, 25a, 25d]  
Examples of ruthenium complex activation with green or red light are much 
more rare. An interesting approach to achieve green light activation is 
demonstrated by the group of Etchenique with the complex [Ru(bpy)2(MAPN-
Rhod)Cl]+ (MAPN-Rhod = N-methylaminopropionitrile-rhodamine), see Figure 
1.6b.[28] The MAPN-Rhod ligand absorbs strongly around 532 nm, and is able 
to sensitize the GS→1MLCT transition of the ruthenium complex, which 
normally is not very sensitive for green light, by an intramolecular FRET 
mechanism (Förster Resonance Energy Transfer). Formally, this was 
designated to be a “reverse-FRET” mechanism, because in contrast to normal 
FRET, the maximum emission wavelength of the energy donor is lower in 
energy than the maximum absorption of the energy acceptor. 
Photosubstitution is then achieved by the same mechanism as explained 
above. A similar reverse-FRET strategy was pursued within our group with 
the complex [Ru(tpy-Rhod)(bpy)(2-methylthioethanol)]3+, see Figure 1.6c.[29] 
Due to the presence of the rhodamine ligand, it was found that the complex 
absorbed yellow light very strongly (ε570nm = 44 000 M−1.cm−1), while 
surprisingly, the photodissociation reaction was equally efficient with yellow 
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(570 nm) and blue light (452 nm). The group of Glazer prepared the strained 
complex [Ru(phen)2(biq)]2+ (phen = 1,10-phenanthroline, biq = 2,2’-
biquinoline), which ejects the biq ligand after light irradiation (Figure 
1.6a).[18a] Interestingly, this compound could be photoactivated with red and 
near-infrared light, which represents the first example of ruthenium based 
PACT in the phototherapeutic window. The phototoxicity index (PI, i.e. the 
EC50 in dark conditions divided by the EC50 in light conditions) with blue and 
infra-red light (both at a dose of 7 J.cm−2) was determined to have values of 44 
and 3, respectively, while the PI for the well-known PDT drug aminolevulinic 
acid was determined to be >18. The substantial absorbance up to 700 nm (ε at 
650 nm = 500 M−1.cm−1) was attributed to direct 1GS to 3MLCT absorption.[30]  
1.7 Photosubstitution in the phototherapeutic window 
Although some examples exist of photosubstitution ruthenium complexes that 
are activated with green to near-infrared light (see section 1.6), it remains 
challenging to realize high photosubstitution efficiency in the 
phototherapeutic window. Apart from molecular design and modification, 
other photochemical and photophysical strategies are under development to 
red-shift the activation wavelength. First of all, two-photon absorption (TPA) 
can be used, which is the quasi-simultaneous absorption of two photons of 
low energy to match the 1GS→1MLCT transition energy. Although this 
technique is effective in shifting the wavelength of activation, and has been 
used before for ruthenium polypyridyl complexes,[31] it requires high photon 
density light sources, and it is technically challenging to realize the irradiation 
of large volumes (e.g. a tumor). Secondly, photon upconversion can be used to 
combine multiple low energy photons into one higher energy photon. The 
most popular techniques to achieve photon upconversion in vitro are by use of 
lanthanoid-based upconverting nanoparticles (UCNP) and triplet-triplet 
annihilation upconversion (TTA-UC). The focus of the research described in 
this thesis is using TTA-UC for the activation of Ru polypyridyl compounds, 
and is further introduced in Chapter 2. 
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Light upconversion is the conversion of low-energy light to high-energy light, which can 
be exploited in applications such as bio-imaging and photoactivated chemotherapy. 
Among the various principles of light upconversion, triplet-triplet annihilation 
upconversion (TTA-UC) holds great promise because it can be realized at low excitation 
intensities and with high efficiency. In this chapter, the TTA-UC mechanism is outlined in 
detail and nanoparticle systems are discussed with which TTA-UC can be achieved in 
biological systems. Furthermore, one of the fundamental issues of the TTA-UC 
mechanism is the inherent oxygen sensitivity. Because solving this issue is of critical 
importance for the advancement of biological TTA-UC applications, this chapter also 
discusses in detail how the oxygen sensitivity can be overcome in biological systems. 
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2.1 The principle of light upconversion 
Light upconversion is the photophysical process in which light is converted 
from low energy (high wavelength, such as red light) to higher energy (low 
wavelength, such as blue light) by combining the energy of multiple photons. 
Light upconversion has been recognized to have great potential in biological 
applications such as bio-imaging and photoactivated chemotherapy (PACT). 
The advantages of upconversion bio-imaging are evident: first of all, in vitro 
upconversion bio-imaging with red to near-infrared excitation wavelengths 
reduces irradiation damage and allows a longer or more frequent observation. 
Secondly, because the emitted light has more energy than the excitation light, 
upconverted emission can be readily distinguished from autofluorescence so 
that an excellent imaging contrast can be achieved. Thirdly, red to near-
infrared excitation light is able to penetrate deeper in vivo so that deeper 
imaging can be performed.  
Besides bio-imaging, light upconversion can be used to activate PACT drugs, 
that are often only sensitive for UV to green light, with wavelengths in the 
phototherapeutic window (600 − 950 nm). This strategy is particularly suited 
for promising PACT drug classes such as blue-light sensitive ruthenium 
polypyridyl complexes (Chapter 1), Pt(IV) complexes that are activatable with 
UV to blue light,[1] light-cleavable organic moieties such as o-nitrobenzyl 
groups and coumarin derivatives that are activatable up to the green 
wavelength range,[2] and photo-isomerizing molecules such as azobenzenes.[3] 
Practically, this strategy involves red to near-infrared light being upconverted 
inside the tumor to blue light, which can then be used to activate a prodrug. 
Using red to near-infrared light instead of UV to green light would lead to a 
tumor treatment at greater tissue depth. Moreover, in contrast to UV to blue 
light, red to near-infrared light does not cause any tissue ablation at doses 
relevant to PACT (see Section 1.4). 
The three most relevant forms of light upconversion in combination with 
PACT are two-photon absorption (TPA), lanthanoid-based upconverting 
nanoparticles (UCNPs), and triplet-triplet annihilation upconversion (TTA-
UC). TPA relies on the simultaneous absorption of two low-energy photons by 
chromophores with high two-photon absorption cross sections, after which 
the combined energy of both photons can be used to trigger high-energy 
requiring photochemistry.[4] For example, this strategy has been explored with 
two-photon responsive Ru complexes[5] and for drug release from 
 
23 
photocleavable coumarin-derivatized vesicles.[6] Although appealing, the 
requirement that two photons must be simultaneously absorbed invokes the 
cumbersome and expensive use of high-power pulsed lasers. Moreover, the 
required high photon density (MW.cm−2 to GW.cm−2 irradiances)[7] are only 
obtained when the laser is focused to a microscopic irradiation volume. 
Obviously, treatment of a large tumor would be tedious and time-consuming. 
The alternative UCNPs are crystalline nano-sized particles that are made of 
low-phonon energy matrices, such as β-NaYF4, that can be advantageously 
used as upconversion platform and drug carrier in one.[8] The upconverting 
properties rely on the sequential absorption of infrared photons (808 or 980 
nm) by sensitizer lanthanoid ions such as Nd3+ or Yb3+ that transfer this 
energy multiple times to emitter ions such as Er3+, Tm3+, or Ho3+.[8e] The 
combined energy is ultimately released in the form of UV, blue, green, and/or 
red photons.[8e] UCNPs are enormously popular for bio-imaging and drug 
activation purposes,[9] despite that they suffer from low quantum yields of 
upconversion (typically << 0.5% in aqueous solution), low absorbance 
coefficients, and the need for high power excitation (> 1 W.cm−2) to achieve 
decent levels of prodrug activation.[10] Even in the NIR domain, high laser 
intensities (especially at 980 nm) leads to undesired tissue ablation.[11] In 
contrast, TTA-UC features much higher upconversion quantum yields (~5% in 
aqueous solution)[12] at much lower excitation intensities (typically < 0.2 
W.cm−2),[13] and features molecular chromophores with high molar absorption 
coefficients. Because of these advantages, the research described in this thesis 
explored the potential of combining TTA-UC and bio-imaging or PACT.  
2.2 Triplet-triplet annihilation upconversion 
TTA-UC was already demonstrated several times by Parker and Hatchard in 
the 1960s,[14] but in those days this phenomenon merely received recognition 
as photophysical curiosity. It was only in the 21st century that the principle 
was rediscovered and research on TTA-UC has since then received an 
exponentially growing amount of scientific interest.[15] Now, TTA-UC has 
become a powerful photophysical trick with promising applications such as 
oxygen sensing,[16] extending the action spectrum of photosynthetic 
organisms,[17] photocatalysis,[18] solar energy harvesting,[19] bio-imaging,[12, 20] 




Figure 2.1. Jablonski diagram of the photophysical processes involved in TTA-UC.  
TTA-UC is based on the photophysical interplay of photosensitizer (PS) and 
annihilator chromophores (A), see Figure 2.1.[4, 9f, 15a, 22] The photosensitizer 
absorbs low energy light (hν1), after which intersystem crossing (ISC) leads to 
a long-lived triplet state (Equation 2.1): 
𝑷𝑷 1 + ℎ𝜈1  
𝑟𝑎𝑎𝑎�⎯�  𝑷𝑷 1 ∗
𝑘𝐼𝐼𝐼�⎯�   𝑷𝑷∗ 3  Equation 2.1 
where rabs is the rate of light absorption by the photosensitizer (in mol.L−1.s−1), 
and kISC is the rate constant of ISC (in s−1). The triplet state energy of 3PS* is 
transferred to the annihilator by a Dexter-type energy transfer upon 
diffusional collision, called triplet-triplet energy transfer (TTET); a succession 
of TTET leads to a buildup of triplet state annihilator molecules due to a 
generally very long triplet state annihilator lifetime (Equation 2.2): 
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𝑷𝑷 3 ∗ + 𝑨 1
𝑘𝑇𝑇𝑇𝑇�⎯⎯� 𝑷𝑷 1 + 𝑨 3 ∗ Equation 2.2 
where kTTET is the second-order rate constant of TTET (in M−1.s−1). At this 
stage, triplet back transfer from annihilator to sensitizer is usually eliminated 
by keeping the sensitizer to annihilator molar ratio very low (typically 1:10 to 
1:200).[23] Then, two excited state triplet annihilator molecules produce an 
encounter-pair upon diffusional collision. The encounter-pair has either 
singlet, triplet, or quintet multiplicity, with 1/9, 3/9, and 5/9 chance of 
formation, respectively (discussed in more detail later). The singlet-state 
encounter-pair will result in triplet-triplet annihilation (TTA), where one 
molecule departs in a higher-energy singlet excited state while the other 
converts to the ground state (Equation 2.3): 
𝑨 3 ∗  + 𝑨∗ 3 →  (𝑨 − 𝑨)∗  → 1   𝑨∗ 1 +  𝑨 1  Equation 2.3 
where this overall TTA step is a bimolecular process and thus has a 
second-order rate constant, kTTA (in M−1.s−1). Note that TTA is only possible if 
the energy of the encounter pair exceeds the energy of the singlet excited 
annihilator. Finally, the singlet excited state returns to the ground state by 
fluorescent emission of a high energy photon (hν2), realizing light 
upconversion (Equation 2.4): 
  𝑨∗ 1
𝑘𝐹�  𝑨 1 + ℎ𝜈2 Equation 2.4 
where kF is the rate constant of annihilator fluorescence (in s−1). Due to the 
dependence on molecular contact in the TTET and TTA steps, the overall 
process heavily relies on the diffusion of sensitizer and/or annihilator 
chromophores. In case molecular diffusion is restricted, it may rely on 
diffusion of the triplet excitons through the material.[23] In systems that rely on 
molecular diffusion, it is often found that the TTA step is rate-limiting, i.e. the 
TTA-rate has values comparable to the rate of molecular diffusion.[23] In such 
systems, the TTA-UC mechanism is therefore very dependent on the viscosity 
of the host material or solution.[15a, 23-24] 
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The anti-stokes shift, i.e. the wavelength difference between excitation source 
and the lowest emission maximum, determines the maximum upconversion 
energy gain of TTA-UC (ΔEUC, in eV) that can be achieved. ΔEUC is limited to 
twice the energy of the incident photon, because TTA-UC is a two-photon 
process. However, this limit is in practice never reached, because of inevitable 
enthalpic energy losses during ISC (ΔH1 in eV), TTET (ΔH2 in eV), and TTA (ΔH3 
in eV). ΔEUC is therefore constrained by the sum of enthalpic losses, as 
described by Equation 2.5:[25] 
𝛥𝛥𝑈𝑈 = 2(ℎ𝜈1 − 𝛥𝐻1 − 𝛥𝐻2)− 𝛥𝐻3 Equation 2.5 
where hυ1 is the energy of the absorbed photons (in eV). Of these energy 
losses, ΔH2 is most easily reduced by carefully aligning sensitizer and 
annihilator excited state triplet levels. The highest ΔEUC thus far achieved is 
0.94 eV for a couple that is excited at 670 nm (hυ1 = 1.85 eV) and emits at 445 
nm (hυ2 = 2.79 eV). [25] 
The evolutions in time of the excited states in the TTA-UC scheme are 
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 Equation 2.6 
𝑑[ 𝑷𝑷 3 ∗]
𝑑𝑑
= 𝑘𝐼𝐼𝑈[ 𝑷𝑷 1 ∗]− 𝑘𝑝[ 𝑷𝑷 3 ∗]− 𝑘 𝑃𝐼 3 [ 𝑷𝑷 
3 ∗]
− 𝑘𝑇𝑇𝑇𝑇[ 𝑷𝑷 3 ∗][ 𝑨] 1  
Equation 2.7 
𝑑[ 𝑨 3 ∗]
𝑑𝑑
= 𝑘𝑇𝑇𝑇𝑇[ 𝑷𝑷 3 ∗][ 𝑨] 1 − 𝑘 𝐴 3 [ 𝑨 
3 ∗]− 𝑘𝑇𝑇𝐴[ 𝑨 3 ∗]2 Equation 2.8 
𝑑[ 𝑨 1 ∗]
𝑑𝑑
= 𝑘𝑇𝑇𝐴[ 𝑨 3 ∗]2 − 𝑘𝐹[ 𝑨 1 ∗] − 𝑘 𝐴 1 [ 𝑨 
1 ∗] Equation 2.9 
where φexc is the photon flux at the excitation wavelength (mol photons.s−1), 
𝐴𝜆𝑒𝑒𝑒is the absorbance at the excitation wavelength (assuming only PS 
absorbs at this wavelength), V is the irradiation volume (in L), kp is the rate 
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constant of sensitizer phosphorescence (in s−1),  𝑘 𝑃𝐼 3  is the non-radiative 
decay rate constant of 3PS* (in s−1), 𝑘 𝐴 3  is the decay rate constant of 3A* when 
no TTA occurs (in s−1; usually only non-radiative decay), , and 𝑘 𝐴 1  is the non-
radiative decay rate constant of 𝑨 1 ∗. Finally, note that the set of rate equations 
listed above described a rather simplified TTA-UC scheme: it does not account 
for (i) triplet back-transfer from 3A* to 1PS, (ii) hetero TTA between 3PS* and 
3A*, and (iii) homo TTA between pairs of 3PS*, which may become relevant at 
high [PS] and high excitation intensity.[7b, 22] 
From Equation 2.6 to Equation 2.9, the overall efficiency of TTA-UC (ΦUC) 
under stead-state conditions, defined as the number of upconverted photons 
per number of excited state photosensitizers upon illumination, is expressed 
by Equation 2.10:[23] 
𝛷𝑈𝑈 =
𝑛𝑛𝑛𝑛𝑛𝑟 𝑜𝑜 𝑛𝑢𝑢𝑜𝑛𝑢𝑛𝑟𝑑𝑛𝑑 𝑢ℎ𝑜𝑑𝑜𝑛𝑜








in which ΦISC is the quantum yield of intersystem crossing, ΦTTET the quantum 
yield of TTET, ΦTTA the quantum yield of triplet-triplet annihilation, and ΦF the 
quantum yield of fluorescence of the annihilator. The factor ½ accounts for the 
fact that two excited state photosensitizers maximally produce one excited 
singlet-state annihilator, i.e. the intrinsic maximum ΦUC is 50%. Overall, 
Equation 2.10 underlines that each step needs to be optimized for a high ΦUC. 
Usually, PS and A are chosen so that ΦISC and ΦF have values close to unity, and 
kISC and kF are generally very fast and thus not rate-limiting. Therefore, the 
overall efficiency is mainly governed by ΦTTET and ΦTTA. In the steady state 
(continuous wave excitation) ΦTTET is expressed as the ratio of the quenching 
rate of 3PS* (kTTET[1A][3PS*], in mol.L−1.s−1) and the total decay rate of 3PS* in 
presence of annihilator (Equation 2.11):[22] 
  𝛷𝑇𝑇𝑇𝑇 =  
𝑘𝑇𝑇𝑇𝑇[ 𝑨 1 ][ 𝑷𝑷 3 ∗]




𝑘𝑇𝑇𝑇𝑇[ 𝑨 1 ]





This expression states that higher annihilator concentrations lead to higher 
TTET efficiencies. For example, for a TTA-UC system in organic solution with a 
PS lifetime of 300 µs (i.e. 𝑘𝑝 + 𝑘 𝑃𝐼 3  = 3 × 104 s−1), 10 mM A, and realizing that 
triplet energy transfer in solution is usually diffusion limited (i.e. kTTET ≈ 
1 × 109 M−1.s−1),[22] the triplet quenching rate has a value of 107 s−1 and thus 
near unity energy transfer efficiencies are obtained. Next, ΦTTA can be 
expressed in the steady state (continuous wave excitation) as the ratio of the 
triplet-triplet annihilation rate (kTTA[3A*]2, in mol.L−1.s−1) and the total decay 
rate of the annihilator triplets (Equation 2.12):[22] 
  𝛷𝑇𝑇𝐴 =  𝑜 ×
𝑘𝑇𝑇𝐴[ 𝑨∗ 3 ]2
𝑘 𝐴 3 [ 𝑨∗ 3 ] + 𝑘𝑇𝑇𝐴[ 𝑨∗ 3 ]2
= 𝑜 ×
𝑘𝑇𝑇𝐴[ 𝑨∗ 3 ]
𝑘 𝐴 3 + 𝑘𝑇𝑇𝐴[ 𝑨∗ 3 ]
 Equation 2.12 
where f is the spin statistical factor. This factor f takes into account that the 
encounter-pair of the two triplet state annihilator molecules has either singlet, 
triplet, or quintet multiplicity, with 1/9, 3/9, or 5/9 probability, respectively; 
only the singlet state multiplicity leads to the desired high-energy excited 
singlet state. However, because quintet states are not energetically accessible 
and triplet state encounter-pairs are partially recycled into triplet excited 
state annihilator molecules, the probability can be increased to 40% (i.e. f = 
0.4).[15a, 23, 26] In some systems, f can be even further increased to approach 
unity.[7b] Furthermore, Equation 2.12 underlines that the TTA efficiency is 
directly dependent on the production of 3A* and approaches unity when 
𝑘 𝐴 3  << kTTA[3A*], also known as the “strong annihilation regime”. Usually, 
annihilators are chosen with metastable triplet states that feature lifetimes in 
the millisecond range (i.e. 𝑘 𝐴 3  ≈ 1 × 103).[22, 27] For instance, at a diffusion-
limited TTA rate (i.e. kTTA ≈ 1 × 109 M−1.s−1) this means that a triplet 
concentration of about 1 × 10−6 M would lead to a 50% TTA efficiency. 
Furthermore, it is important to realize that in the strong annihilation regime, 
ΦTTA becomes a constant and the overall TTA-UC process becomes only 
dependent on the rate of triplet production, i.e. light absorption, as described 
in more detail in recent kinetic treatments.[26] In other words: in the strong 
annihilation regime, the triplet state manifold is so well-populated that TTA is 
the predominant photophysical route and competing quenching processes are 
negligible.[23, 26c] This has the immediate consequence that in the “weak 
annihilation regime” (i.e. when 𝑘 𝐴 3  >> kTTA[3A*]) , the intensity variation of 
TTA-UC is quadratically dependent on the excitation intensity variation − as 
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would be expected for a two-photon process −, while in the strong 
annihilation regime this dependence becomes linear. Indeed, this 
phenomenon is systematically observed for TTA-UC systems, see Figure 2.2. 
The transition point at which this excitation intensity dependency shifts from 
quadratic to linear is called the intensity threshold (Ith), and is strictly defined 
as the intensity at which the value of ΦUC is half of the maximum.[7b] Monguzzi 
et al. have demonstrated that the value of Ith is proportional to (𝑘 𝐴 3 )
2 and is 
inversely proportional to kTTA, ΦTTET, and 𝐴𝜆𝑒𝑒𝑒 .[7b] Thus, in order to obtain high 
ΦUC at low excitation intensity, (i) annihilators with long lived triplet states are 
required, (ii) the absorbance of PS needs to be high (due to high [PS], high 
molar extinction coefficient, or both), (iii) the TTET step should occur with 
near-unity yield, and (iv) the TTA rate should be maximized. Typically, Ith has a 
value below 0.2 W.cm−2, while the lowest reported value thus far is 6 
µW.cm−2.[28] To put these values in perspective, the solar radiance at the earth 
surface (AM1.5) is about 0.1 W.cm−2 and the linear power regime for 
lanthanoid-based upconverting nanoparticles is only reached at excitation 
intensities above 150 W.cm−2.[10] 
 
Figure 2.2. Typical power dependency of upconversion emission in a TTA-UC scheme. As an 
example, data of a green-to-blue upconverting system is shown with an Ith of 0.05 W.cm−2 and a 
maximum ΦUC of 28%. (a) Upconversion emission intensity as a function of excitation intensity. 
The indicated slopes are obtained when the data is plotted on a double logarithmic scale. (b) 
Upconversion quantum yield (ΦUC) as a function of excitation intensity. Reprinted (adapted) with 
permission from Duan et al.[29] © American Chemical Society.  
The combined photophysical properties of photosensitizer and annihilator 
greatly influence ΦUC and ΔEUC, and only well-chosen combinations of 
photosensitizer and annihilator will lead to TTA-UC. The most important 
requirement for TTA-UC is the energy match between the triplet state energy 
levels of both molecules: ideally, the triplet energy level of the annihilator is 
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slightly lower in energy than the triplet energy level of the photosensitizer to 
accommodate favorable TTET. Besides this, the desirable characteristics of the 
photosensitizer include (i) high molar extinction coefficient, (ii) high ISC 
efficiency (ΦISC), (iii) long triplet lifetime (τT), and (iv) small singlet-triplet 
energy gap.[15a, 23, 30] These criteria are very well satisfied by palladium or 
platinum porphyrin complexes, which therefore have become benchmark 
photosensitizers in TTA-UC schemes. Typical examples are palladium tetra-
(di-tert-butyl)phenyltetraquinoxalino porphyrin (PdTPTQP), palladium 
tetraphenyltetrabenzoporphyrin (PdTPTBP), and platinum 
octaethylporphyrin (PtOEP), see Figure 2.3. Moreover, metalloporphyrins 
usually feature a large absorption gap between Q-bands and Soret bands, so 
that re-absorption of the upconverted light is mostly eliminated. For the 
annihilator the most important requirements are (i) high fluorescence 
quantum yield (ΦF), (ii) long triplet lifetime (τT), (iii) an excited singlet state 
with slightly less than twice the energy of the excited triplet state, and (iv) an 
excited singlet state with higher energy than the wavelength used to excite the 
photosensitizer.[15a, 23] Suitable annihilator molecules include anthracene, 
pyrene, perylene, rubrene, and diphenyl anthracene (DPA), see Figure 2.3.  
A few early examples of well-matching photosensitizer-annihilator 
combinations are given in Table 2.1; numerous other examples have been 
reviewed elsewhere.[4, 9f, 15a] All of these sensitizer-annihilator pairs exhibit 
very large anti-stokes shift from green/red to blue (0.72-0.94 eV shift), and 
their relevant energy levels satisfy the requirements discussed earlier. It is 
worthwhile to note that these early results have been acquired in 
deoxygenated apolar organic solvents to dissolve the highly lipophilic 
molecules and to prevent quenching by molecular oxygen, which is the most 
predominant quenching pathway in TTA-UC schemes. Since these early 
examples in organic solution, TTA-UC has been demonstrated in rubbery and 
glassy polymers,[15a, 23-24, 31] hydro-, organo- and ionogels,[32] and a variety of 
nano- and micro-sized particle systems.[12-13, 18b, 20, 28, 33] 
Table 2.1: Examples of photosensitizer-annihilator combination and their main TTA-UC properties. 









PdTPTQP perylene 670 445 0.94 0.6 [25] 
PdTPTBP 3-(4-tert-butylphenyl)perylene 635 450 0.81 6.6 [34] 
PtOEP DPA 536 410 0.72 19 [35] 
[Ru(dmbpy)3]2+ [a] anthracene 514.5 375 0.90 - [36] 




Figure 2.3. Chemical structures of frequently-used photosensitizers (top row) and annihilators 
(bottom row) in TTA-UC schemes. Approximate values for the highest absorption bands of 
photosensitizers and lowest emission peaks of annihilators are mentioned.[15a, 25]  
2.3 Overcoming the oxygen sensitivity of TTA-UC 
Whereas for some applications the oxygen sensitivity of TTA-UC can be 
exploited, for example to build an oxygen sensor,[16] for most other 
applications oxygen quenching leads to dysfunctional systems in which (i) 
upconversion does not work in air, and (ii) the highly reactive singlet oxygen 
that is generated by this quenching process leads to photodamage of the 
chromophores and the matrix (Figure 2.4). To counter these issues, several 
approaches have been developed in recent years. First of all, it has been 
shown that TTA-UC systems with very high TTET and TTA rates are less 
sensitive, because upconversion then successfully competes with the diffusion 
of oxygen. Especially promising are systems that feature supramolecular 
annihilator networks that support facile migration of triplet excitons. For 
example, the work of Kimizuka and coworkers shows that organogels or nano-
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MOFs are excellent host systems for TTA-UC: densely-packed annihilator 
networks resulted in triplet exciton diffusion rates that by far exceed the 
molecular diffusion rate of molecules in organic solvents.[28-29, 32b, 32c, 37] The 
second strategy involves using matrices that obstruct the diffusion of 
molecular oxygen, which has been exemplified with polymers that were 
covalently or non-covalently functionalized with sensitizer and annihilator.[31b, 
31h, 31i, 38] However, the low diffusion rate in these materials generally caused 
the upconversion efficiency to be low. An interesting solution to this problem 
was presented by Baluschev and Landfester et al., who encapsulated micron-
sized red-to-green upconverting oil-core nanocapsules in a cellulose matrix.[39] 
The cellulose acted as an oxygen barrier, so that TTA-UC was allowed to be 
efficient (ΦUC =  4.1%) and long lasting in air. In other work by the same 
authors in collaboration with Turshatov, similar nanocapsules of 100 − 140 
nm in diameter were embedded in electrospun polyvinyl alcohol (PVA) 
nanofibers with a diameter of 270 − 480 nm.[40] This nm-thick PVA wrapping 
successfully blocked diffusion of oxygen to the nanocapsules. These results 
show that it is possible to block oxygen with a nm-scale coating of an oxygen 
impermeable material.  
Finally, it has been realized that oxygen sensitivity can be eliminated by the 
use of (singlet) oxygen scavengers. The idea of ground-state oxygen 
scavenging is self-evident: a reducing agent is added to remove dissolved 
oxygen so that the solution is deoxygenated until depletion of the scavenger. 
For instance, sodium sulfite has been used to deoxygenate a green-to-blue 
upconverting oil-in-water micro-emulsion.[33i] In the case of singlet oxygen 
scavenging, oxygen is consumed only upon irradiation of the sensitizer (Figure 
2.4). Upon irradiation, singlet oxygen is produced which then reacts with the 
scavenger, causing a locally deoxygenated environment around the 
photosensitizer (micro-)environment. Once the oxygen concentration is low 
enough, TTA-UC is no longer restricted and upconverted light effectively 
appears upon further irradiation. Suitable scavengers that have been used for 
TTA-UC are alkene-terminated polyisobutylene, oleic acid, linoleic acid, and 
hyper-branched unsaturated polyphosphates.[12b, 12c, 13a, 31e, 33b, 33f] The former 
three examples rely on the reaction of the unsaturated bond with singlet 




Figure 2.4. Oxygen sensitivity of the TTA-UC mechanism: After the photosensitizer reaches the 
triplet excited state, instead of engaging in triplet-triplet energy transfer (TTET) to the 
annihilator, it is quenched by ground state molecular oxygen to produce singlet oxygen (a). 
Quenching of the triplet state annihilator by oxygen can also occur (not shown). To overcome this 
issue, sacrificial anti-oxidants can be added to the mixture which chemically react with singlet 
oxygen (b). Then, TTA-UC is no longer restricted when the oxygen concentration is (nearly) 
depleted. 
With biological TTA-UC applications in mind, quenching by molecular oxygen 
is also an especially important issue. For instance, using an oxygen-sensitive 
device for tumor imaging or treatment would surely lead to unreliable results, 
because oxygen concentrations vary drastically in the complex 
microenvironment of a tumor.[41] In the remaining sections of this chapter 
TTA-UC nanoparticles are described that have been used in bio-imaging or for 




Figure 2.5. Schematic representation of the combination of a supramolecular vehicle, TTA-UC, and 
PACT drugs for in vivo tumor treatment. The device is injected in the body, after which it 
accumulates at the tumor site and the tumor is irradiated with red light. The red light is then 
locally upconverted to blue light, which activates the PACT prodrug (blue) anchored to the 
vehicle’s surface or kept inside the vehicle. After irradiation the activated drug (red) dissociates 
from the vehicle and causes toxic interactions with biomolecules.  
2.4 TTA-UC in bio-imaging and PACT 
For biological TTA-UC applications, it is essential to combine sensitizer and 
annihilator in a supramolecular manner, so that they colocalize at the required 
site, and to facilitate molecular contact and migration of triplet states. 
Additionally, for PACT it is highly desirable to compartmentalize the light-
activatable prodrug together with the upconversion dye-pair, in order to 
utilize the upconverted light effectively (Figure 2.5). Meanwhile, 
supramolecular vehicles such as nanoparticles have emerged as extremely 
versatile tools in biomedical applications.[2, 42] Because the TTA-UC dye pairs 
are usually very lipophilic, supramolecular systems are preferred with very 
lipophilic compartments. So far, six systems have emerged in which water-
soluble nano-systems are combined with TTA-UC in a biological setting: silica-
coated Pluronic F127 micelles,[12a, 20b] polylactic acid-block-polyethylene glycol 
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(PLA-b-PEG) micelles,[33j] dye-modified cellulose templates,[20c] and a variety of 
oil-core nanocapsules,[12b, 12c, 20a, 20d] see Table 2.2. These systems will be 
further detailed in this section. Furthermore, in Chapter 8 and Chapter 9 we 
report the imaging of upconversion luminescence in cancer cells using 
liposomes and polymersomes as carrier systems. 
Green-to-blue upconverting silica-coated Pluronic F127 micelles were 
prepared in the group of Li.[12a] It was demonstrated that these micelles were 
non-toxic, had a high upconversion quantum yield, and could be used for in 
vitro upconversion imaging of cells and in vivo upconversion imaging of mouse 
lymph nodes. In a later publication,[12b]  it was reported that particles created 
with this experimental procedure, but functionalized with a red-to-green or 
red-to-yellow upconverting pair instead only resulted in very weak 
upconversion emission. In a similar strategy, polylactic acid-block-
polyethylene glycol was used to self-assemble green-to-blue upconverting 
micelles.[33j] The authors hypothesized that the upconverted blue emission 
was transferred via FRET to a blue-light responsive coumarin derivative, 
which induced photo-uncaging of a cell-binding peptide. However, control 
experiments in which the annihilator or sensitizer was omitted from the 
micelle formulation were not considered, so that it cannot be confirmed that 
uncaging of the peptide was indeed caused by TTA-UC. Regardless, after 
irradiation ex vivo with green light, and adding the nanoparticle suspension to 
cells, the nanoparticles showed a large increase in cell-binding. The 
functioning of this strategy in more biologically relevant conditions has yet to 
be demonstrated. The  group of Siegwart prepared 350 nm sized cellulose 
aggregates that were functionalized with an infrared-to-yellow upconverting 
TTA-UC pair.[20c] The aggregates were taken up by HeLa cells in 2D culture and 
after intratumoral injection in a xenograft mouse model. The topics of oxygen 
sensitivity, upconversion efficiency, particle morphology, and biocompatibility 
of the approach were unfortunately not addressed. 
Four types of oil-core nanocapsules with average hydrodynamic sizes from 
100 - 200 nm have been demonstrated to be excellent hosts for TTA-UC, and 
were successfully imaged in vitro and in vivo.[12b, 12c, 20a, 20d] The oily interior 
favors molecular diffusion and effectively dissolves large amounts of 
hydrophobic compounds in a small particle volume. The exact chemical 
composition of both core and shell greatly affected the upconverting 
capabilities of the particles in presence of oxygen. First of all, the group of 
Landfester and Turshatov demonstrated green-to-blue upconversion with 
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hexadecane-core PSAA-shell (PSAA = polystyrene-polyacrylic acid copolymer) 
nanocapsules.[20d] These particles only produced upconversion after 
deoxygenation, and only “in vitro” after fixation and sealing of the sample in a 
glove box. In a next paper, red-to-green upconverting 1-phenylhexadecane-
core PMMA-shell (PMMA = polymethyl methacrylate) were reported.[20a]  
Likewise, no upconversion in air could be established, which suggests that a 
nano-scale polymeric shell cannot safeguard the dyes inside the particles from 
quenching by oxygen. However, in living HeLa cells, some upconversion 
emission was in fact observed. Interestingly, upconversion brightened when 
the cells were treated with valinomycin, which stimulates mitochondria to 
enhance their oxygen consumption. This example demonstrates that ex vitro 
air stability is no definite prerequisite for obtaining upconversion in vitro. It is 
unclear why TTA-UC systems that do not work in air are capable of 
upconversion in living cells. We speculate that the presence of endogenous 
anti-oxidants are responsible for scavenging ground-state or singlet oxygen 
(see Section 2.3). Differences in oxygen concentration within each cell and 
differences between cells may also modify the ability of particles to perform 
TTA-UC. 
The group of Li prepared red-to-green and red-to-yellow upconverting soy 
bean oil-core BSA-dextran-shell nanocapsules (BSA = bovine serum 
albumin).[12b] This system was able to perform upconversion in air. It was for 
the first time realized that reductive compounds can facilitate TTA-UC: soy 
bean oil contains oleic acid and linoleic acid, which both are unsaturated fatty 
acids that react with singlet oxygen, see Section 2.3. As mentioned before, the 
underlying rationale is that in an oxygen-rich environment, the 
photosensitizer produces singlet oxygen that can react with a scavenger, 
resulting in a locally deoxygenated micro-environment. Apart from the 
“reducing oil core”, it was proposed that the BSA-shell participated in singlet 
oxygen scavenging, because BSA contains many tryptophan residues that are 
capable of reacting with singlet oxygen as well. Although the performance of 
the particles in 2D cell cultures was not established, the particles were 
successfully used for lymphatic imaging of living mice. Finally, the group of 
Kim prepared red-to-blue and red-to-green upconverting oleic acid-core silica 
shell nanocapsules.[12c] Here, pure oleic acid was chosen as scavenger to allow 
the particles to upconvert in air. From the article, it was not clear whether the 
particles were functional in 2D cell cultures, as the data showed fixated cells to 
which a commercial anti-fading reagent was added. Regardless, the particles 
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were successfully used in imaging of tumors in vivo with upconversion 
luminescence. Overall, from reviewing these published TTA-UC particle 
systems, it becomes clear that acquiring upconversion in vitro and in vivo has 
been a poorly explored subject so far.  
2.5 Emission stability of TTA-UC in a biological context 
A poorly addressed research topic is the emission stability in time of TTA-UC 
nanoparticles in a biological context. To the best of our knowledge, the 
emission stability has only been briefly discussed in the work of Li et al., who 
show that green-to-blue upconversion of silica-coated Pluronic F127 micelles 
in HeLa cells was completely stable for at least 10 minutes under continuous 
illumination (no exact excitation intensity given);[12a, 20b] no further 
explanation is given why the emission is so stable. Of course, the stability 
requirements depend greatly on the application. Long-term bio-imaging 
methods require stable emission for seconds to minutes under continuous 
irradiation, but for short-term experiments, the emission stability is not 
especially critical. For the combination of TTA-UC and PACT, high stabilities 
are required up to hours of irradiation time at high irradiances (up to ~1 
W.cm−2) in order to release enough biologically active species. For instance, in 
comparable work that combines lanthanoid-based upconverting nanoparticles 
and PACT/PDT, typical treatment durations vary from 20 min up to more than 
5 h.[43] Two critical questions are therefore: (i) how long-lasting is the 
upconversion emission in a biological context with current nanoparticle 
systems and (ii) how can the emission stability be improved? For instance, as 
mentioned before, many TTA-UC nanoparticles rely on the presence of 
endogenous or supplemental anti-oxidants in order to function in vitro or in 
vivo. However, after a certain time, the anti-oxidants may be depleted and 
oxygen can quench the TTA-UC process once again. Overall, the temporal 
stability of TTA-UC emission in a biological  context, and the enhancement of 
this stability with for example anti-oxidants, are important aspects that need 
to be considered in future work. We argue that it is simply not enough to only 
demonstrate that a given TTA-UC system functions in air-equilibrated 
solutions: it is of utmost importance to show the temporal stability at a given 
excitation intensity and a given oxygenation level in order to conclude on the 





Table 2.2. Summary of known TTA-UC nanoparticle systems that have been developed for bio-
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[a] Influence of oxygen not reported. [b] Values obtained in air. PLA-PEG = polylactic acid-
polyethylene glycol block copolymer, HD = hexadecane, 1-PHD = 1-phenylhexadecane, PiB-PEG-Me 
= polyisobutylene-polyethylene glycol block copolymer, PSAA = polystyrene-polyacrylic acid 
copolymer, PMMA = polymethyl methacrylate, BSA = bovine serum albumin 
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2.6 Thesis goal and outline 
In the research described in this thesis, the goal was to prepare an 
upconverting nano-device that is able to generate blue light inside living 
cancer cells with which a light-sensitive ruthenium anticancer prodrug can be 
activated in order to kill the cells. The device should only become toxic upon 
light irradiation in the phototherapeutic window. To achieve this goal, it is 
likely that the following requirements need to be met: 
i. high upconversion efficiency (ΦUC) at human body temperature (37 °C) 
ii. upconversion at low excitation intensity (i.e. a low Ith) so that use of 
high power lasers is prevented 
iii. a large upconversion energy gain (ΔEUC) to shift the activation 
wavelength to the phototherapeutic window (preferably red to near-
infrared light)  
iv. efficient energy transfer to the ruthenium prodrug 
v. low oxygen sensitivity 
vi. high temporal emission stability 
vii. low cytotoxicity of the nano-device in the dark 
viii. high cytotoxicity of the nano-device upon red to near-infrared light 
irradiation within a clinically relevant time span 
In Chapter 3, I will describe how efficient red-to-blue and green-to-blue 
upconversion can be obtained in a liposome drug carrier. The red-to-blue 
upconversion is used to trigger the photodissociation of a ruthenium 
polypyridyl complex that is anchored to another liposome. In Chapter 4, the 
ruthenium complex is this time attached to the same liposome as that 
containing photosensitizer and annihilator molecules, and it is shown that the 
upconversion energy is transferred non-radiatively from the annihilator to the 
ruthenium complex via Förster resonance energy transfer (FRET). In Chapter 
5 it is shown that red-to-blue upconversion is located in the lipid bilayer of the 
liposomes and that TTA-UC can be used to image the membrane of giant 
vesicles. Chapter 6 describes results of the investigation whether red-to-blue 
TTA-UC in liposomes is also efficient at human body temperature; I will 
describe how the upconversion efficiency is dependent on temperature in a 
variety of liposome compositions. Chapter 7 describes research that 
investigated whether a silica coating around the liposomes can protect the 
TTA-UC process from quenching by molecular oxygen. In Chapter 8 the in vitro 
applicability is addressed of liposomes that are functionalized with a red-to-
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blue upconverting dye couple and ruthenium polypyridyl complexes, and 
whether it is possible to trigger a cytotoxic effect upon red light irradiation. 
Furthermore, the effect is of supplemental anti-oxidants on the performance 
of this system is reported. In Chapter 9 I will describe how red-to-blue 
upconversion can be obtained in polymersomes, and that the upconversion 
luminescence can be imaged in living cancer cells. Furthermore, I will address 
whether anti-oxidants increase the upconversion luminescence in vitro. 
Finally, in Chapter 10 the thesis is concluded by summing up the advantages 
and limits of TTA-UC for pro-drug activation, and future research directions 
are proposed. 
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Activation of a photodissociative ruthenium complex by 
triplet-triplet annihilation upconversion in liposomes 
 
 
Liposomes capable of generating blue photons in situ by triplet-triplet annihilation 
upconversion of either green or red light, were prepared. The red-to-blue upconverting 
liposomes were capable of triggering the photodissociation of ruthenium polypyridyl 
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Light-sensitive ruthenium(II) polypyridyl compounds are classical tools in 
photochemistry that have recently been proposed as prodrugs for 
photoactivatable anticancer therapy (PACT).[1] As shown in classical 
photodynamic therapy (PDT), the use of light to treat cancer allows for 
spatially and temporally controlling the toxicity of an anticancer drug, which 
lowers side effects for cancer patients. Meanwhile, loading anticancer drugs 
into drug carriers such as liposomes helps targeting the compounds to tumor 
tissues. Especially sterically hindered liposomes, i.e., those grafted with 
polyethylene glycol chains, have been recognized as versatile and 
biocompatible drug carriers for the treatment of various diseases because of 
their long lifetime in the blood circulation. With such PEGylated liposomes 
uptake in tumors is enhanced due to the so-called enhanced permeability and 
retention (EPR) effect.[2] In PACT, activation of for example ruthenium-
functionalized liposomes could be realized after cell uptake using visible light. 
However, most ruthenium(II) polypyridyl compounds require activation with 
blue light (400 − 500 nm), i.e., outside the phototherapeutic window (600 − 
1000 nm), in which light permeates mammalian tissues optimally. In this 
work, in situ upconversion of red to blue light is realized using triplet-triplet 
annihilation upconversion (TTA-UC), and combined with ruthenium-
functionalized liposomes to trigger the activation of the ruthenium complex 
using a clinical grade PDT laser source. 
In TTA-UC, low energy photons are converted into higher energy photons by 
means of a bimolecular mechanism involving a sensitizer and two annihilator 
molecules.[3] The sensitizer absorbs the low-energy light, undergoes 
intersystem crossing (ISC) to a triplet state, and transfers its energy to an 
annihilator molecule via triplet-triplet energy transfer (TTET). Collision of two 
triplet annihilator molecules leads to triplet-triplet annihilation (TTA), 
whereby one molecule is promoted to the excited singlet state, while the other 
one falls back to the ground state. The singlet annihilator returns to the 
ground state by emission of a high-energy photon, thus realizing 
upconversion. TTA-UC with a range of molecule pairs has been realized in 
organic solvent,[3a, 3b, 3d] ionic liquid,[4] polymers,[3a, 3c, 5] and various water-
soluble nanoparticles.[6] In this communication, we demonstrate the first 
examples of TTA-UC in the lipid bilayer of neutral liposomes. 
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3.2 Results and discussion 
 
Figure 3.1. Chemical structures of platinum octaethylporphyrin (1), 9,10-diphenylanthracene (2), 
palladium tetraphenyltetrabenzoporphyrin (3), and perylene (4). 
Two well-investigated TTA-UC couples were considered for incorporation in 
liposomes: platinum octaethylporphyrin (1) and 9,10-diphenylanthracene (2) 
on the one hand, and palladium tetraphenyltetrabenzoporphyrin (3) and 
perylene (4) on the other hand (Figure 3.1). Obviously, when included in 
liposomes these highly apolar molecules favor the lipophilic interior of the 
lipid bilayer. Liposomes made of 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC) and containing 4 mol% of sodium N-(carbonyl-methoxypolyethylene 
glycol-2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE-MPEG-
2000), the sensitizer 1 or 3, and/or the annihilator 2 or 4, were prepared by 
extrusion in DPBS buffer solution (Table 3.1).  The diameters of the liposomes 
(130 − 170 nm) were measured by dynamic light scattering. UV-VIS 
absorption and luminescence spectra of liposomes containing either the 
sensitizer or the annihilator, i.e., of samples L1, L2, L3, and L4, were 
comparable to that of the corresponding compounds in toluene solution 
(Figure S.II.1). Thus, incorporation of any of the four molecules shown in 
Figure 3.1 into the DMPC bilayers did not change their spectroscopic 
properties.  
Although in liposome samples L1-2 and L3-4 both molecules of each 
upconverting couple were successfully inserted into the bilayer, it was initially 
uncertain whether their diffusion in the two-dimensions of the bilayer would 
be sufficient to allow TTA-UC to occur.[3a] After deoxygenation these samples 
were excited at either 532 nm or 630 nm, respectively, near the absorption 
maximum of the highest Q-band of 1 (λmax = 536 nm) or 3 (λmax = 628 nm), 
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respectively. A bright blue luminescence was observed in both cases (Figure 
3.2) after suppressing the scattered excitation light with notch and/or short 
pass filters. Under the same experimental conditions, no blue emission was 
observed for L1, L2, L3, or L4, thus proving that both components of each 
upconverting couple are necessary for the upconversion to occur. To the best 
of our knowledge, L1-2 and L3-4 are the first examples showing TTA-UC in 
liposomes. As both green-to-blue and red-to-blue upconversion was obtained, 
the use of liposomes appears to be a straightforward manner to solubilize 
TTA-UC couples in aqueous solution.  
Table 3.1. Overview of liposomal formulations used in this work. [DMPC], [PEG], [1], [2], [3], [4] 
and [5] represent the bulk concentrations in DMPC, DSPE-MPEG-2000, 1, 2, 3, 4 and 52+, 















L1-2 20 0.80 3.5 100 - - - 
L1 20 0.80 3.5 - - - - 
L2 20 0.80 - 100 - - - 
L3-4 20 0.80 - - 2.5 50 - 
L3 20 0.80 - - 2.5 - - 
L4 20 0.80 - - - 50 - 
L5 5.0 0.20 - - - - 0.20 
 
The luminescence spectra of L1-2 and L3-4 were measured at 298 K under 
argon (Figure 3.3). Upon excitation at 532 nm, L1-2 shows a structured 
upconversion band at 433 nm, corresponding to emission of 2 in toluene 
(Figure S.II.1b). A second band was present as well; its emission maximum 
(646 nm) was consistent with the phosphorescence of 1 in toluene (Figure 
S.II.1a). Similarly, for L3-4 excitation at 630 nm leads to an upconversion band 
at 473 nm, and a second band at 800 nm (Figure 3.3). The upconversion 
emission corresponds to emission of 4 in toluene (Figure S.II.1d), apart from 
the first peak at 447 nm that was filtered by the 633 nm notch filter used for 
rejecting the scattered excitation (Figure S.II.2). The peak at 800 nm in the 
emission spectrum of L3-4 corresponds to the phosphorescence of 3, as 
observed in toluene (Figure S.II.1c). In both samples, the phosphorescence 
band corresponds to a unimolecular event, i.e., emission from a 
photosensitizer molecule in the triplet state, whereas the upconversion band 





Figure 3.2. Digital photographs of L1-2 and L3-4 under irradiation at 532 nm and 630 nm, 
respectively, with 27 mW excitation power (for both systems) in a 2.6 mm diameter beam 
(intensity: 0.51 W.cm−2). (a) L1-2 without filter. (b) L1-2 with 533 nm notch filter and <575 nm 
short pass filter. (c) L3-4 without filter. (d) L3-4 with 633 nm notch filter. Samples were 
deoxygenated and maintained at 298 K. 
 
Figure 3.3. (a) Emission spectra of liposome sample L1-2 (black) and of a toluene solution 
containing 1 and 2 at the same bulk concentrations (red, [1] = 3.5 μM and [2] = 100 μM). (b) 
Emission spectra of the liposome sample L3-4 (black) and of a toluene solution containing 3 and 4 
at the same bulk concentrations (red, [3] = 2.5 μM and [4] = 50 μM). Asterisks indicate excitation 
(532 nm for L1-2 and 630 nm for L3-4). The samples were deoxygenated before measurement. 
Spectra acquired at 298 K, excitation power for both samples 27 mW, 2.6 mm diameter beam, 
intensity 0.51 W.cm−2. 
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The luminescence spectra of both upconverting couples were measured in 
toluene using the same bulk concentrations for the sensitizer and annihilator 
as for L1-2 and L3-4. The upconversion intensity for couple 1-2 was found to 
be four times weaker in liposomes than in toluene at 298 K, and for couple 3-4 
it was comparable for both sample types (Figure 3.3). Upon inserting the 
sensitizer and annihilator in the lipid bilayer two phenomena take place 
simultaneously. On the one hand, compartmentalization of the lipophilic 
molecules in the bilayer increases their local concentrations, which increases 
the probability of intermolecular collisions and therefore the rates of TTET 
and TTA. On the other hand, two-dimensional diffusion in a lipid bilayer is 
somewhat slower than in a non-viscous isotropic toluene solution, which may 
decrease TTA-UC efficiency in liposomes. Overall, our data show that the 
trade-off is excellent and that efficient TTA-UC occurs in PEGylated DMPC 
liposomes (at 298 K). 
Table 3.2. Upconversion quantum yield (Φuc) in liposomes and toluene at 293 K. 
 Φuc (%) 
TTA-UC Couple in PEGylated DMPC liposomes in toluene 
1-2[a] 2.3 (L1-2) 5.1[b] 
3-4[c] 0.5 (L3-4) 1.2[d] 
[a] 532 nm, 10 mW excitation power, 1.5 mm diameter beam (intensity 0.57 W.cm−2). [b] [1] = 3.5 
µM, [2] = 100 µM. [c] 630 nm, 10 mW excitation power, 2.5 mm diameter beam (intensity 0.20 
W.cm−2). [d] [3] = 2.5 µM, [4] = 50 µM. 
 
Measurements of upconversion quantum yields (Φuc) are usually done by 
relative actinometry.[3a] However, intense scattering in liposome samples 
would make any comparison with a reference compound in homogeneous 
solution challenging. For this reason, the upconversion quantum yields of L1-2 
and L3-4 were measured using an absolute method, i.e. with an integrating 
sphere and a calibrated spectrometer (Appendix I). The setup was similar to 
that used by Boyer et al. for determining the upconversion quantum yield of 
lanthanoid-based nanoparticles.[7] For L1-2, L3-4, and for their toluene 
analogues, Φuc was determined upon irradiation using a 10 mW continuous 
beam (Table 3.2). At 293 K Φuc in PEGylated DMPC liposomes was found 
roughly half of that in toluene for both couples, with values of 2.3% and 0.5% 
for L1-2 and L3-4, respectively, versus 5.1% and 1.2% in toluene. To the best 
of our knowledge, this is the first time that the quantum yield of TTA-UC has 




Figure 3.4. (a) Luminescence spectrum of L1-2 at 288 K (blue), 293 K (red) and at 298 K (black). 
(b) Time dependency of the upconversion at 436 nm (black) and of the phosphorescence at 646 nm 
(red) of L1-2 during three warming and cooling cycles from 288 to 298 K and from 298 to 288 K. 
(c) Luminescence spectrum of L3-4 at 288 K (blue), 293 K (red) and 298 K (black). (d) Time 
dependency of the upconversion at 473 nm (black) and of the phosphorescence at 800 nm (red) of 
L3-4 during three warming and cooling cycles from 288 to 298 K and from 298 to 288 K. Asterisks 
indicate excitation wavelengths (532 nm for L1-2 and 630 nm for L3-4. Samples were 
deoxygenated before measurement. Excitation power for both samples: 27 mW, 2.6 mm diameter 
beam, intensity 0.51 W.cm−2. 
The TTA-UC process is diffusion controlled, and therefore depends on 
temperature. For this reason, luminescence spectra were measured for L1-2 
and L3-4 at 288, 293, and 298 K (Figure 3.4a and Figure 3.4c). Upon warming, 
the sensitizer phosphorescence decreased for both samples, while the 
upconversion emission increased markedly. In contrast, for toluene samples at 
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the same bulk concentrations both the upconversion and phosphorescence 
intensities slightly decreased with increasing temperatures (Figure S.II.3) as a 
result of faster non-radiative decay. The liposome samples were subjected to 
three warming-cooling cycles while continuously monitoring their 
luminescence (Figure 3.4b and Figure 3.4d). The temperature dependence of 
the upconversion was found to be reversible, which advocates for a reversible, 
physical cause rather than an irreversible chemical evolution (such as 
aggregation or photoreactions of the chromophores). As the change of the 
upconversion vs. phosphorescence ratio occurs at a temperature that fits the 
gel-to-fluid phase transition temperature (Tm) of DMPC membranes (296.9 K), 
we interpret this change as a consequence of the much increased translational 
diffusion coefficient (DT) of membrane-embedded molecules above Tm, 
compared to that at temperatures below Tm.[8] TTET and TTA are both 
expected to occur much more frequent in the liquid phase of the membrane, 
i.e., above Tm, which would lead to an increase in the probability of 
upconversion (an intermolecular process) at the cost of phosphorescence (a 
monomolecular process). Similar observations were made for TTA-UC in 
rubbery polymer matrixes by Sing-Rachford and co-workers.[5e] 
In order to prove that in situ upconverted blue photons may be used to 
activate light-activatable prodrugs using red light, ruthenium-functionalized 
liposomes were mixed with the upconverting liposomes L3-4 (Figure 3.5b). 
The ruthenium complex [Ru(tpy)(bpy)(SRR’))]2+ (52+, see Figure 3.5a and 
experimental section) was selected because it has a single light-sensitive Ru-S 
bond. This kind of photoactivatable ruthenium compound shows stability in 
the dark but hydrolyzes to the aqua species [Ru(tpy)(bpy)(H2O)]2+ (62+) upon 
irradiation with blue light into its Metal-to-Ligand Charge Transfer state.[9] A 
thioether-cholesterol ligand (SRR’) can be used to anchor the complex to lipid 
bilayers, as has been demonstrated in our group.[9a, 9c] PEGylated DMPC 
liposomes bearing 3.7 mol% of complex 52+ were prepared (sample L5,Table 
3.1) and added in 1:1 volumetric ratio to the red-to-blue upconverting 
liposome sample L3-4. Both types of liposomes being grafted with sterically 
hindering polyethylene glycol (PEG) tails, fusion of the liposomes does not 
occur, and only radiative energy transfer between the upconverting liposomes 






Figure 3.5. (a) Chemical structures of 52+ and 62+ and the conversion of 52+ into 62+. (b) Cartoon 
illustrating the TTA-UC process in the lipid bilayer, using a photosensitizer (PS) and an annihilator 
(A). Radiative energy transfer from the annihilator to complex 52+, indicated with a blue arrow, 
triggers light-induced hydrolysis of 52+ to release 62+ in solution. 
The liposome mixture was deoxygenated and irradiated at 298 K for 2 hours 
with a 120 mW 630 nm laser light beam from a clinical grade Diomed PDT 
laser. The photoreaction was monitored by UV-vis spectroscopy at fixed 
intervals during irradiation (Figure 3.6). Although the absorbance of 4 
dominates the spectrum, the characteristic band of the hydrolyzed 
photoproduct (62+) could clearly be seen, rising between 450 and 550 nm as a 
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function of irradiation time. The isosbestic point at 457 nm showed that a 
single photochemical process was taking place. Monitoring the absorbance at 
490 nm allowed for quantitatively measuring the build-up of 62+ as a function 
of irradiation time, which reached a plateau after 3 hours irradiation (Figure 
3.6b). As a control experiment, a mixture of liposomes L4 and L5 was 
irradiated under the same experimental conditions as above. In liposomes L4 
the absence of sensitizer prevents upconversion from occurring, and the red 
photons can only excite the ruthenium complex by direct absorption in the tail 
of the 1MLCT band. The extinction coefficient of 52+ being very low at 630 nm 
(ε ≤ 100 M−1.cm−1), even under a strong photon flux the photoconversion to 62+ 
was much slower than in presence of L3-4 (Figure 3.6b), i.e., the upconverting 
liposomes achieve efficient sensitization of the photosubstitution reaction. A 
second control experiment showed that no photodissociation occurred in 
absence of light. Overall, these data are the first evidence that blue photons 
produced in situ by upconversion of PDT-compatible red photons, can be used 
to enhance the photodissociation rate of polypyridyl ruthenium complexes. 
 
Figure 3.6. (a) Absorption spectra, after baseline correction, of a 1:1 vol% mixture of liposome 
samples L3-4 and L5 (Table 3.1) during red light irradiation (630 nm). Blue line: spectrum at 
t = 0; red line: spectrum at t = 240 min; grey lines: spectra measured every 30 min. (b) Plot of the 
absorbance at 490 nm during red light irradiation (630 nm) of a 1:1 vol% mixture of L3-4 and L5 
(red dots), of a 1:1 vol% mixture of L4 and L5 (blue diamonds), and absorbance at 490 nm of a 1:1 
vol% mixture of L4 and L5 left in the dark (black triangles). Irradiation conditions: power 120 
mW, beam diameter 2.6 mm, intensity 2.3 W.cm−2, T = 298 K, sample volume 1 mL. 
3.3 Conclusion 
In conclusion, triplet-triplet annihilation upconversion was for the first time 
realized in PEGylated liposomes and characterized by absolute quantum yield 
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measurement. Red-to-blue upconverting liposomes L3-4, when mixed with 
ruthenium-functionalized, PEGylated liposomes L5 and irradiated with a 
clinical grade PDT laser at 630 nm, were able to trigger via radiative energy 
transfer the hydrolysis of the Ru-S bond and to release complex 62+. The 
upconverting liposomes transform two low-energy photons, which penetrate 
far in biological tissues but are poorly absorbed by the ruthenium complex, 
into one blue photon that does not need to travel into tissues and can directly 
promote the complex into its photoreactive excited state. Metal-ligand 
photodissociation mediated by upconverted light represents exciting 
perspectives for photoactivatable chemotherapy in oxygen-poor tissues such 
as hypoxic tumors. Obviously, the oxygen sensitivity of TTA-UC in liposomes 
needs to be addressed before concluding on the practical application of such 
systems in vivo. However, the high quantum yield of TTA-UC in liposomes and 
the excellent molar absorptivity of porphyrin sensitizers, for example 
compared to lanthanoid-based upconverting nanoparticles, may offer 
fascinating applications in bio-imaging, photoactivatable chemotherapy, and 
other applications where the in situ generation of blue light is required. 
3.4 Experimental section 
3.4.1 General 
Platinum octaethylporphyrin (1) and palladium tetraphenyl tetrabenzoporphyrin (3) were 
purchased from Frontier Scientific, Inc. (Logan, Utah, USA). Diphenyl anthracene (2) was 
purchased from Alfa Aesar GmbH & Co KG (Karlsruhe, Germany). Perylene (4) was purchased 
from Sigma-Aldrich Chemie BV (Zwijndrecht, The Netherlands). Sodium N-(carbonyl-
methoxypolyethylene glycol-2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE-
MPEG-2000) and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) were purchased from 
Lipoid GmbH (Ludwigshafen, Germany) and stored at −18 °C. Dulbecco’s phosphate buffered 
saline (DPBS) was purchased from Sigma Aldrich and had a formulation of 8 g.L−1 NaCl, 0.2 g.L−1 
KCl, 0.2 g.L−1 KH2PO4, and 1.15 g.L−1 K2HPO4 with a pH of 7.1-7.5. All chemicals were used as 
received. The syntheses of the thioether-cholesterol conjugate SRR’ and 
[Ru(terpy)(bpy)(Cl)](Cl) are described elsewhere.[9c, 11] 
Regular UV-Vis absorption spectra were taken on a Varian Cary 50 UV-Vis spectrometer. 
Emission spectra with excitation wavelengths 416 and 378 nm were taken on a Shimadzu RF-
5301PC spectrofluorimeter at ambient atmosphere. Emission spectra with excitation 
wavelengths 532 nm and 630 nm were measured in the same setup as for upconversion 
emission spectrometry, detailed below, and were always collected from deoxygenated samples 
that had been thoroughly bubbled with argon (Argon 4.6, LindeGas) for at least 30 minutes with 
a rate of ~2 bubbles per second. 
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3.4.2 Synthesis of 5(PF6)2 
 
Scheme 3.1. Synthesis of 5(PF6)2 
[Ru(tpy)(bpy)(Cl)](Cl) (100 mg, 0.18 mmol), ligand SRR’ (117 mg, 0.21 mmol), and AgBF4 (73 
mg, 0.37 mmol) were dissolved in acetone (30 mL). The reaction mixture was refluxed for 20 h 
in the dark. After cooling to room temperature it was filtered hot over Celite, and the solvent 
was removed by rotary evaporator under reduced pressure. The product was purified by 
column chromatography on silica gel (acetone/H2O/sat. aq. KPF6 100:10:1.5, Rf = 0.35). Acetone 
was evaporated under vacuum, upon which the product precipitated as an orange solid. 5(PF6)2 
was filtered, washed with water and dried under vacuum for 4 h. (124 mg, 52%). 1H NMR (300 
MHz, δ in CDCl3)  9.72 (d, J = 5.3 Hz, 1H, A6), 8.55 (m, J = 8.2 Hz, 3H, A3 + T3’), 8.41 (d, J = 7.9 Hz, 
2H, T3), 8.34 (d, J = 8.0 Hz, 1H, B3), 8.27 − 8.14 (m, 2H, A4 + T4’), 8.03 − 7.85 (m, 3H, A5 + T4), 
7.74 (t, 1H, B4), 7.68 (d, J = 5.0 Hz, 2H, T6), 7.36 (m, 2H, B5 + B6), 7.16 (m, 2H, T5), 5.30 (d, J = 
4.8 Hz, 1H, 6), 3.75 (t, J = 6.6 Hz, 2H, ζ ), 3.64 − 3.37 (m, 10H, α + β + γ + δ + ε), 3.13 (s, 1H, 3), 
2.40 − 0.75 (m, 47H), 0.67 (s, 3H). 13C NMR (75 MHz, δ in CDCl3) 157.67 + 157.01 + 156.31 + 
156.29 ( B2+ A2 + T2 + T2’), 153.18 (T6), 151.95 (A6), 149.80 (B6) , 140.86 (5),139.09 (T4), 
138.56 +138.37 (B4 + A4), 137.56 (T4’), 128.91 (T5), 128.35 (A5), 127.87 (B5), 125.16 (T3), 
124.85 (A3), 124.48 (T3’), 124.03 (B3), 121.86 (6), 79.56 (3), 70.88 + 70.35 + 70.30 + 67.52 + 
67.30 (α + β + γ + δ + ε), 56.86, 56.28, 50.26, 42.44, 39.88, 39.64, 39.22, 37.28, 36.97, 36.31, 
35.91, 34.47, 32.06, 32.01, 29.82, 28.35, 28.13, 24.42, 23.97, 22.95, 22.69, 21.19, 19.53, 18.85, 
15.04, 12.00. UV-Vis: λmax (ε in L.mol−1.cm−1) in CHCl3: 457 nm (6090).  ES MS m/z exp. (calc.):  
519.7 (519.4, [M−2PF6]2+). Elemental analysis for C59H79F12N5O3P2RuS: (calc.); C, 53.31; H, 5.99; 
N, 5.27; S, 2.41.  (Found); C, 53.34; H, 6.22; N, 5.15; S 2.41. 
3.4.3 Liposome preparation 
All liposome formulations were prepared by the classical hydration-extrusion method. As an 
example, the preparation of L1-2 is described here. Aliquots of chloroform stock solutions 
containing the liposome constituents were added together in a flask to obtain a solution with 20 
µmol DMPC, 0.8 µmol DSPE-MPEG-2000, 100 nmol 2, and 3.5 nmol 1. The organic solvent was 
removed by rotary evaporation and subsequently under high vacuum for at least 30 minutes to 
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create a lipid film. 1.0 mL DPBS buffer was added and the lipid film was hydrated by 5 cycles of 
freezing the flask in liquid nitrogen and thawing in warm water (50 °C). The resulting 
dispersion was extruded through a Whatman Nuclepore 0.2 μm polycarbonate filter at 40-50 °C 
at least 11 times using a mini-extruder from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA). 
The number of extrusions was always odd to prevent any unextruded material ending up in the 
final liposome sample. The extrusion filter remained colorless after extrusion, suggesting 
complete inclusion of the TTA-UC compounds in the lipid bilayer. Liposomes were stored in the 
dark at 4 °C and used within 7 days. The average liposome size and polydispersity index were 
measured with a Malvern Instruments Zetasizer Nano-S machine, operating with a wavelength 
of 632 nm. 
3.4.4 Setup for upconversion emission spectroscopy 
Upconversion emission spectra were measured with a custom-built setup, see Figure 3.7. All 
optical parts were connected with FC-UVxxx-2 (xxx = 200, 400, 600) optical fibers from Avantes 
(Apeldoorn, The Netherlands), with a diameter of 200-600 μm, respectively, and that were 
suitable for the UV-Vis range (200 − 800 nm). The excitation source was either a continuous 
wave Aries 150 532 nm portable DPSS laser from LaserGlow (Toronto, ON, Canada), or a clinical 
grade Diomed 630 nm PDT laser. The 630 nm light was filtered through a FB630-10, 630 nm 
band pass filter (Thorlabs, Dachau/Munich, Germany) put between the laser and the sample. 
The excitation power was controlled using a NDL-25C-4 variable neutral density filter 
(Thorlabs), and measured using either a PM20 optical power meter or a S310C thermal sensor 
connected to a PM100USB power meter (Thorlabs). Sample deoxygenation was performed in an 
external ice-cooled pear-shaped flask by bubbling argon for 30 minutes with a rate of 2 bubbles 
per second, after which the sample was transferred to the cuvette by cannulation under argon. 
The sample was held under argon in a 104F-QS or 104F-OS semi-micro fluorescence cuvette 
from Hellma GmbH & Co. KG (Müllheim, Germany) in a CUV-UV/VIS-TC temperature-controlled 
cuvette holder (Avantes), and was irradiated from the top with a collimated 2.6 mm diameter 
beam. Emission measurement was performed by means of a 2048L StarLine CCD spectrometer 
from Avantes under a 90° angle with respect to excitation. The excitation light was rejected 
using either a NF533-17 533 nm or NF633-25 633 nm notch filter from Thorlabs.  
 
Figure 3.7. Setup used for upconversion emission spectroscopy. Legend: (1) laser source, (2) optical fibers, (3) 
filter holder, (4) band pass filter that can be installed or removed, (5) variable neutral density filter that can be 
installed or removed, (6) temperature-controlled cuvette holder, (7) notch filter, (8) CCD spectrometer. 
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3.4.5 Photosubstitution experiments using red light 
 
Figure 3.8. Setup used for photosubstitution experiments using red light. Legend: (1) 630 nm laser source, (2) 
optical fibers, (3) filter holder, (4) 630 nm band pass filter, (5) variable neutral density filter that can be 
installed or removed, (6) halogen-deuterium light source for absorption measurements, (7) temperature 
controlled cuvette holder, (8) CCD spectrometer. 
Photosubstitution experiments using red light were performed with a custom build setup, see 
Figure 3.8. 1 mL of the liposome mixture, prepared as described in the main text, was 
deoxygenated by bubbling argon through the sample with a rate of ~2 bubbles per second for at 
least 30 minutes in an external ice-cooled pear-shaped flask, after which the sample was 
transferred by means of cannulation under argon to a 104F-QS or 104F-OS semi-micro 
fluorescence cuvette from Hellma GmbH & Co. KG (Müllheim, Germany) in a CUV-UV/VIS-TC 
temperature-controlled cuvette holder from Avantes. The sample was held under argon 
atmosphere at a constant temperature of 298 K and irradiated for 4 hours from the top with a 
120 mW 630 nm laser light beam from a clinical grade Diomed 630 nm PDT laser. The laser was 
collimated to a beam of 2.6 mm diameter to reach an intensity of 2.3 W.cm−2; in such conditions, 
a cylinder of approximately 0.13 cm3 was simultaneously excited by the laser. UV-Vis 
absorption spectra were measured using an Avalight DH-S-BAL halogen-deuterium lamp 
(Avantes) as light source and an 2048L StarLine spectrometer (Avantes) as detector, both 
connected to the cuvette holder at a 180° angle. A UV-Vis absorption spectrum was measured 
every 15 min; each time the laser was switched off, the halogen-deuterium lamp was turned on, 
a spectrum was recorded, the halogen-deuterium lamp was switched off, and the laser was 
switched on again. Each UV-Vis measurement took approximately 10 seconds in total. The 
baseline of each spectrum was corrected for Tyndall and Rayleigh scattering and drift of the 
halogen-deuterium light source, using Microsoft Excel 2010 and Origin 8.5 software. 
3.4.6 Beam profiling 
A beam profiler was used for measuring the beam diameters of the laser beams in the 
aforementioned setups. It consisted of a Trust Webcam Spotlight Pro, of which the front lens 
was pried off and replaced by NE510A (OD = 1) and NE520A (OD = 2) absorptive neutral 
density filters (Thorlabs). The laser beam was pointed directly on the photovoltaic chip of the 
webcam (4.8 mm wide and 3.6 mm high). Then, 1/e2 laser beam diameters in pixels were 
determined by Beams, an open source beam profiling software downloadable from 
http://ptomato.name/opensource/beams/beams.html. The beam diameter in millimeters was 
calculated by dividing the average beam diameter in pixels by the total number of horizontal 
pixels and multiplying this with the chip width in millimeters. For example, the diameter of the 
beam in Figure 3.9 was determined to be 339 px
640 px




Figure 3.9. Example output generated by the beam profiling setup in combination with the Beams software 
package. Axes represent chip width and height in pixels. 
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Triplet-triplet annihilation upconversion followed by FRET 
for the red light activation of a photodissociative 
ruthenium complex in liposomes 
 
Upconversion is a promising way to trigger high-energy photochemistry with low-energy 
photons. However, combining upconversion schemes with non-radiative energy transfer 
is challenging because bringing several photochemically active components in close 
proximity results in complex multi-component systems where quenching processes may 
deactivate the whole assembly. In this work, PEGylated liposomes were prepared that 
contained three photoactive components: a porphyrin dye absorbing red light, a 
perylene moiety emitting in the blue, and a light-activatable ruthenium prodrug 
sensitive to blue light. Time-dependent spectroscopic studies demonstrate that singlet 
perylene excited states are non-radiatively transferred to the nearby ruthenium complex 
by Förster Resonance Energy Transfer (FRET). Under red-light irradiation of the three-
component membranes, triplet-triplet annihilation upconversion (TTA-UC) occurs 
followed by FRET, which results in a more efficient activation of the ruthenium prodrug 
compared to a physical mixture of two-component upconverting liposomes and 
liposomes containing only the ruthenium complex. This work represents a rare example 
where TTA-UC and FRET are combined to achieve prodrug activation in the 
phototherapeutic window. 
This chapter was published as a full article: S. H. C. Askes, M. Kloz, G. Bruylants, J. T. 




Light-sensitive ruthenium(II) polypyridyl compounds are classical tools in 
photochemistry that have been recently proposed as prodrugs in 
photoactivatable anticancer therapy (PACT).[1] As shown in classical 
photodynamic therapy (PDT), the use of light to treat cancer allows for 
spatially and temporally controlling the release of a toxic species, which 
lowers side effects for cancer patients.[2] Whereas PDT drugs rely on the 
photocatalytic generation of singlet oxygen to kill cancer cells, PACT exerts 
cytotoxic activity mainly via an oxygen-independent mechanism, which makes 
them suitable for hypoxic tumors.[1c, 1d, 1g, 3] Meanwhile, loading anticancer 
drugs into drug carriers such as liposomes helps targeting the compounds to 
tumor tissues.[2a, 4] Especially sterically hindered liposomes, i.e., those grafted 
with polyethylene glycol chains, have been recognized as versatile and 
biocompatible drug carriers for the treatment of various diseases because of 
their long lifetime in the blood circulation. With such PEGylated liposomes 
tumor uptake is increased because of the so-called enhanced permeability and 
retention (EPR) effect.[5] In PACT, activation of, for example, ruthenium-
functionalized liposomes could be realized using visible light.[6] However, 
most ruthenium(II) polypyridyl compounds require activation with blue light 
(400 − 500 nm), which is outside the so-called “phototherapeutic window”, a 
range of wavelengths (600 − 1000 nm) that permeate mammalian tissues 
optimally. This drawback can be circumvented by using upconverting drug 
carriers: once in a tumor they locally convert red photons into blue photons 
that subsequently activate the phototherapeutic drug without having to travel 
over long distances in the tissue.  
Triplet-triplet annihilation upconversion (TTA-UC), a photophysical interplay 
of light and molecular dyes, is very promising for upconversion because it 
features strong red light absorption and high upconversion quantum yields at 
low irradiation power. In TTA-UC, low-energy photons are converted into 
higher-energy photons by means of a bimolecular mechanism involving a 
sensitizer and two annihilator molecules (Figure 4.1).[7] The sensitizer absorbs 
the low-energy light to generate a triplet state, which is transferred to an 
annihilator molecule by collisions. Further collision of two triplet annihilator 
molecules leads to triplet−triplet annihilation (TTA), whereby one annihilator 
molecule is promoted to the high energy-emitting singlet excited state, while 
the other falls back to the ground state. TTA-UC has been demonstrated in 
organic solvent,[7a, 7b, 7d] ionic liquid,[8] polymer matrix,[7a, 7c, 9] functionalized 
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polymer,[10] various water-soluble nanodevices,[1h, 11] and in a solvent-free 
liquid.[12] In all these systems further use of the upconverted light, for example 
to activate a prodrug,[1h] excite a quantum dot,[11h] control a soft actuator,[13], 
or power photoelectrochemistry,[14] relied exclusively on radiative energy 
transfer, because the molecule sensitive to high-energy light lies too far, at the 
nanoscale (>10 nm), from the annihilator. For example, Kwon et al. showed 
that TTA-UC in the core of oleic acid nanoparticles, encapsulated by a 12 nm 
thick silica layer, could trigger a photocatalytic reaction on CdS nanoparticles 
grafted on the silica shell, but that the shell was too thick to allow non-
radiative energy transfer.[11h] Non-radiative energy transfer would be by far 
preferable as it is more efficient; however, it also requires a close contact, at 
the nanoscale, between the annihilator molecule and the functional molecule 
to be photoactivated. 
In this work PEGylated liposomes were used as a supramolecular scaffold to 
put palladium tetraphenyltetrabenzoporphyrin (1) and perylene (2) in close 
proximity to the cytotoxic ruthenium complex [Ru(tpy)(bpy)(SRR’))]2+ (32+, 
see Figure 4.1a). When put together the red photosensitizer 1 and the blue 
emitter 2 are capable of red-to-blue TTA upconversion. On the other hand, 32+ 
dissociates, upon blue light irradiation, into the aqua species 
[Ru(tpy)(bpy)(H2O)]2+ (42+) and the free thioether ligand (Figure 4.1a).[1h, 6, 15] 
The cytotoxicity of 32+ and its modification by blue light irradiation is a 
complex matter that will be reported in a separate paper.[16] Here we realized 
that the Metal-to-Ligand Charge Transfer (MLCT) absorption band of 32+ 
ideally overlaps with the emission spectrum of 2 (Figure 4.2), a feature which 
maximizes the distance at which non-radiative energy transfer from 2 to 32+ 
may take place. In liposomes containing all three components 1, 2, and 32+, the 
average distance between photochemically active components becomes 
shorter than 5 − 8 nm, for which non-radiative energy transfer may take place 
(see Figure 4.1b).[17] However, such proximity might also open unwanted 
quenching routes, such as energy back-transfer from the complex to either 
photosensitizer or annihilator, hetero triplet-triplet annihilation between any 
pair of triplets present in the membrane, or phase separation of one of the 
molecules. In this chapter it is explored via steady-state and time-dependent 
spectroscopic studies how efficient non-radiative energy transfer from 
perylene to the ruthenium complex is, and whether the red-light triggered 
photosubstitution reaction in the three-component liposomes is more or less 
efficient than the (known) physical mixture of upconverting liposomes 
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(containing only 1 and 2) and ruthenium-functionalized liposomes 
(containing only 32+).9h  
 
Figure 4.1. a) Chemical structures of palladium tetraphenyltetrabenzoporphyrin (1), perylene (2), 
[Ru(tpy)(bpy)(SRR’)]2+ (32+), and [Ru(tpy)(bpy)(H2O)]2+ (42+), and the photochemical reaction 
from 32+ to 42+. b) Cartoon showing the sequence of photochemical events demonstrated in this 
work: red light is absorbed by compound 1, after which triplet-triplet annihilation upconversion 
(TTA-UC) occurs, followed by non-radiative energy transfer from 2 to 32+, and finally the 





Figure 4.2. Absorption spectrum of 32+ in chloroform (solid, left axis, εmax = 7700 at λmax = 456 nm) 
and area-normalized emission spectrum of compound 2 in PEGylated DMPC liposomes (dashed, 
right axis, λexc = 400 nm, 0.5 mol% of compound 2 with respect to the lipids). 
4.2 Results and Discussion 
4.2.1 Liposome preparation and characterization.  
PEGylated liposomes were prepared as shown in Table 4.1 from a mixture of 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 4 mol% sodium N-
(carbonyl-methoxypolyethylene glycol-2000)-1,2-distearoyl-sn-glycero-3-
phosphoethanolamine (DSPE-MPEG-2000), and compound 1, 2, and/or 
3(PF6)2, using a standard hydration-extrusion protocol in Dulbecco’s 
phosphate buffered saline (DPBS). PEGylation prevented liposomes fusion 
and/or aggregation that would interfere with the experiments. The true 
concentration of 32+ in all liposome samples was determined experimentally 
by inductively coupled plasma optical emission spectroscopy (ICP-OES) to be 
on average 89% of the expected value (Figure S.III.1). The average vesicle 
diameter and polydispersity index were determined by dynamic light 




Table 4.1. Lipid formulations of the PEGylated DMPC liposomes used in this work.  










L123 5.0 200 2.5 25 50 − 220[a] 
L12 5.0 200 2.5 25 - 
L23 5.0 200 - 25 10 − 290[a] 
L2 5.0 200 - 25 - 
L3 5.0 200 - - 200 
L0 5.0 200 - - - 
[a] The amount of 32+ used for L123 and L23 varied; hence a concentration range is given here. 
The true ruthenium concentrations were determined with ICP-OES. 
 
Because on the one hand, molecular diffusion plays an important role in TTA-
UC, and on the other hand, phase separation of one of the dyes could impair 
the efficiency of the system, the gel-to-liquid phase transition temperature of a 
series of PEGylated DMPC liposomes was determined by Differential Scanning 
Calorimetry (Figure S.III.2). The transition temperature for PEGylated DMPC 
liposomes without any chromophores (L0) is 25.2 °C, with a pretransition 
peak at 14 °C. Functionalizing these liposomes with 0.05 mol% 1 and 0.5 
mol% 2 (L12) caused a small decrease in the main transition peak height, but 
the main features of the thermogram remained, which indicates that the 
membrane was only slightly perturbed by the presence of the TTA-UC dyes 
and that the dyes are buried into the lipid bilayer. Next, a series of liposomes 
L123 was measured, which in addition to 0.05 mol% 1 and 0.5 mol% 2 also 
contained 1 to 4 mol% of the ruthenium complex. A progressive yet small 
decrease in the main transition temperature was observed compared to L12: 
from 25.1 °C for 0 mol% to 23.2 °C for 4 mol% 32+. Additionally, the main 
transition peak broadened and its intensity decreased upon increasing Ru 
concentration, while the pretransition peak disappeared already after 
inclusion of 1 mol% of the 32+ complex. These observations are compatible 
with the expected interaction of complex 32+ with the zwitterionic polar heads 
of the lipids. For this range of ruthenium concentrations however, no evidence 
was found that suggested phase separation of either 1, 2, or 32+. Overall, these 
DSC results show that at 20 °C and at 37 °C, all liposome formulations are in 
the gel phase and liquid crystalline phase, respectively. 
4.2.2 Photodissociation experiments using red light. 
Red-light irradiation experiments were first conducted to evaluate whether 
L123 liposomes, which contained both dyes for TTA-UC plus the ruthenium 
complex 32+, would achieve higher photodissociation rates than a mixture of 
L12 and L3, in which the upconversion and the photosubstitution on the 
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ruthenium complex are physically separated on two different liposomes.[1h] 
For all red light irradiation experiments the liposome samples were diluted 
with isotonic buffer so that the optical density due to the MLCT band of the Ru 
complex stayed low (A450-500 ≤ 0.25 with a 10 mm path length). Under such 
conditions, radiative energy transfer between the blue emitting perylene and 
the blue absorbing ruthenium complex is minimized, while the solution 
absorbance remains high enough for monitoring the experiments using UV-Vis 
absorption spectroscopy. The bulk concentrations of 1, of 2, and/or 32+ were 
kept equal in all experiments. Red light irradiation was realized for three 
hours at physiological temperature (310 K) and under anoxic conditions using 
a 630 nm clinical grade PDT laser set at low power (30, 60, or 120 mW, for an 
intensity of 0.24, 0.48, or 0.95 W.cm−2). UV-Vis absorption and luminescence 
emission spectra were measured during irradiation every 15 minutes.  
The UV-Vis absorption spectrum of a L123 sample containing 3.5 mol% of 32+ 
evolved during red light irradiation at 120 mW power as shown in Figure 4.3a. 
A band between 450 and 600 nm, typical of the aqua complex 42+, rises, while 
two isosbestic points are observed at 370 and 456 nm. The only 
photochemical reaction occurring in such conditions is thus the hydrolysis 
reaction of 32+ to 42+. The evolution of the absorbance at 490 nm (Figure 4.3c) 
clearly showed that the reaction was finished after two hours of irradiation. 
For comparison, a 1:1 volume mixture of L12 and L3 was irradiated under the 
same conditions, where only radiative energy transfer may occur. Slower 
photodissociation kinetics was observed (Figure 4.3c). Apparently, the optical 
density of the sample was high enough so that 32+ in L3 could reabsorb a 
significant amount of the blue photons upconverted by L12. When liposomes 
L23 were irradiated that contained only 2 and 32+, no TTA-UC could occur and 
very slow photodissociation was observed due to the low but non-zero molar 
absorption coefficient of 32+ at 630 nm (ε630 < 100 M−1.cm−1). Overall, our 
results clearly show that L123 achieved a higher photodissociation rate than a 




Figure 4.3. Absorption (a) and luminescence emission (b) spectra of L123 during red-light 
irradiation (630 nm) of liposomes functionalized with 32+. Dashed line: spectrum at t = 0; black 
solid line: spectrum at t = 180 minutes; grey lines: spectra measured every 15 minutes. c) 
Difference in absorbance at 490 nm, after baseline correction, during red-light irradiation (630 
nm) of L123 (black filled circles), a 1:1 volume mixture of L12 and L3 (dark-grey filled squares), 
and L23 (light-grey filled diamonds). Error bars represent standard deviation of three 
independent experiments. d) Integrated upconversion emission (400 - 600 nm, black filled circles) 
and integrated sensitizer emission (750 - 900 nm, open circles) during red-light irradiation of 
L123. Error bars represent standard deviation of three independent experiments. Irradiation 
conditions: power 120 mW, beam diameter 4  mm, intensity 0.95 W.cm−2, T = 310 K, sample volume 
1.5 ml, 8% of sample volume simultaneously irradiated.  Liposome dispersions used in these 
experiments were prepared as in Table 4.1, and then diluted with PBS buffer prior to measurement 
so that every time [1] = 0.25 µM, and [2] = 2.5 µM. The bulk concentration of 32+ was 
experimentally determined with ICP-OES and was 19 ± 1 µM, 21 ± 3 µM, and 20 ± 2 µM for L123, 
L23, and L3, respectively. 
When the red light-induced photodissociation reaction of L123 was followed 
by luminescence emission spectroscopy (Figure 4.3b), a peak at 800 nm, 
corresponding to the phosphorescence of 1, and a broad structured emission 
band ranging from 400 to 600 nm, corresponding to the upconverted emission 
of 2, could clearly be identified.[1h] Interestingly, the upconverted emission 
intensity evolved a lot during irradiation. It was initially very weak compared 
to the upconversion emission of L12 alone (Figure S.III.3), but increased 
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roughly 15-fold during the course of the reaction. No further evolution was 
observed after two hours of irradiation, which closely matches the reaction 
time observed by UV-Vis absorption spectroscopy. The low initial 
upconversion emission intensity, combined with the observation by UV-Vis 
spectroscopy that the photosubstitution clearly occurred, suggested that the 
upconverted energy may be transferred non-radiatively from 2 to 32+. As the 
reaction proceeded, and 32+ was progressively liberated from the membrane 
to diffuse in solution, non-radiative energy transfer from perylene to the 
ruthenium complex becomes less efficient, thus explaining the recovery of the 
blue emission when all ruthenium complex were detached from the 
membrane. To prove this hypothesis, we studied the non-radiative energy 
transfer between 2 and 32+ by direct excitation of perylene with violet or blue 
light, and studied the evolution of the system with time-dependent absorption 
and emission spectroscopy. 
4.2.3 Is there non-radiative energy transfer from 2 to 32+? 
Assuming that the same singlet excited state of 2 is reached by blue light 
excitation of 2 in absence of 1 and by red-light excitation of 1 in presence of 2, 
a series of L23 liposomes was prepared with a fixed amount of 2 (0.5 mol%), a 
varying amount (0.4 − 3.5 mol%) of 32+, but no red photosensitizer (1). The 
aim of this study was to determine with time-dependent spectroscopy 
whether the singlet excited state of 2 could transfer its energy non-radiatively 
to the ruthenium complex. Control liposomes were also prepared that 
contained only perylene (L2) or only 3.3 mol% of 32+ (L3). All liposomes were 
first studied by ultrafast transient absorption (TA) spectroscopy with 400 nm 
excitation (40 fs pulse duration, 20 − 60 nJ/pulse) while recording the 
transient absorption spectrum from 430 to 730 nm in the ps to ns range. The 
TA data were globally fitted using the software package Glotaran.[18] Full data 
set and analysis is detailed in Figure 4.4, Table 4.2, and in Appendix III. In 
short, the TA spectrum of L2 1.0 ns after a 400 nm excitation pulse (Figure 
S.III.4) closely matched literature reports for perylene in cyclohexane. It 
features negative signals from 430 to 550 nm due to ground state bleach and 
stimulated emission, and a strong positive band centered at 700 nm due to 
excited state absorption.[19] Global analysis using Glotaran gave an excited 
state lifetime of 6.00 ± 0.10 ns for 2 in L2, which also corresponds to literature 
values.[19-20] For L3 the transient absorption spectrum 1.0 ps after the 
excitation pulse at 400 nm showed a negative band ranging from 400 to 500 
nm and a weaker featureless positive band from 500 nm to 800 nm. The 
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former coincides with the MLCT absorption band in the steady state 
absorption spectrum (Figure 4.2) and can be attributed to ground state 
bleaching of the ruthenium complex. The latter is attributed to excited state 
absorption. The time evolution of the transient spectrum was best fitted with 
Glotaran to give an excited state lifetime of 0.52 ns for 32+. UV-VIS 
spectroscopy before and after the TA experiment showed that in such 
conditions negligible photodissociation occurred (see Appendix III). 
The TA data of liposomes L23 were qualitatively very similar to that of L2, and 
global fitting did not allow for detecting any feature reminiscent of 32+ as in 
L3. However, the average excited state lifetime (τ) of 2 decreased strongly as a 
function of the mol fraction of 32+ (Figure 4.4c and Table 4.2): from τ = 6.0 ns 
without any ruthenium complex in the membrane (L2) addition of up to 3.3 
mol% ruthenium complex (L23) lowered the lifetime of 2 down to 0.3 ns, 
which shows non-radiative quenching of the excited state of 2 by 32+. These 
results were confirmed by steady state fluorescence spectroscopy and time-
correlated single photon counting (TCSPC). Because 32+ is not emissive at all, 
2 is observed selectively using fluorescence techniques. The steady-state 
fluorescence spectra of the series of liposomes L23 clearly showed a decrease 
in fluorescence intensity of 2 with increasing concentration of 32+ in the 
membrane (Figure 4.4a). TCSPC was performed with 440 nm excitation (0.6 
pJ/pulse), while monitoring the emission at 474 nm on the nanosecond scale. 
The TCSPC results were very similar to TA data: the singlet excited state 
lifetime of 2 was found to be τ = 6.2 ns in absence of 32+, and decreased to 
τ = 0.9 ns in presence of 3.5 mol% of 32+ (see Figure 4.4b and Table 4.2). 
Clearly, the singlet state of 2 is quenched by the nearby ruthenium complex. 
Although no rising of a Ru-based excited state could be detected by TA 
spectroscopy in L23, probably due to its low and rather broad features as 
observed in L3, the increased rate of the photosubstitution reaction in 
liposomes L123 irradiated with red light, the recovery of the upconverted 
emission when the ruthenium aqua complex leaves the membrane, and the 
quenching of 2 by 32+ observed in L23, conclude to non-radiative energy 
transfer occurring from 2 to 32+ both in L23 and in L123. 
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Table 4.2. Best-fit average lifetimes (τ in ns) and energy transfer efficiencies (EET, calculated from 
Equation 4.1) at 293 K and 310 K for the excited state quenching of 2 by 32+ at different 32+ mol 
fractions in PEGylated (4 mol%) DMPC vesicles, as measured with transient absorption (TA) 
spectroscopy and time-correlated single photon counting (TCSPC). All liposomes had a fixed 
amount of compound 2 (0.5 mol%). Transient absorption spectroscopy data was globally fitted 
using the software package Glotaran.[18] Full datasets are given in Appendix III, as well as detailed 
information on data analysis.  
 molar percentage of 32+ in PEGylated DMPC liposomes 
 0.0 0.4 0.8 1.7 2.5 3.3 
TA spectroscopy at 
293 K 
            












EET 0% 50% 75% 83% 93% 95% 
 molar percentage of 32+ in PEGylated DMPC liposomes 
 0.0 0.5 0.9 1.7 2.4 3.5 
TCSPC at 293 K       
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From TA, steady-state fluorescence, and TCSPC data, the non-radiative energy 
transfer efficiency (EET) was calculated for each composition of the liposomes 
L23 following Equation 4.1 (see also Figure 4.4d, Table 4.2, and Appendix III): 






 Equation 4.1 
where τ and τ0 are the averaged lifetimes of 2 in presence and absence, 
respectively, of 32+ in the membrane, and I and I0 are the corresponding 
fluorescence intensities. A plot of EET as a function of the experimental mol 
fraction of 32+ in the membrane (Figure 4.4d) shows that the energy transfer 
efficiency rises up to 80% or more for concentration of the ruthenium 
complex above 2.5 mol%. Additionally, these data could be fitted with a 
modified Stern-Volmer curve (see Appendix III), and the rate of quenching of 
the singlet state of 2 by 32+ was determined to be 5.2 x 107 M−1.s−1. When 
performing TCSPC experiments at biological temperature (T = 310 K), at 
which the photodissociation experiments were conducted, the results were 
very similar (see Table 4.2): τ was found to be 5.7 ns when no ruthenium 
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complex was present, went down to 0.45 ns at 3.5 mol% of 32+ in the 
membrane, and EET increased to slightly higher values at all complex 
concentrations when compared to TCSPC data at 293 K. Overall, it is 
concluded that at human body temperature energy transfer from the singlet 
excited state of 2 to the ruthenium complex 32+ is very efficient above 2 - 2.5 
mol% of 32+ in the membrane, and is responsible for the efficient activation of 




Figure 4.4. Steady-state fluorescence spectra (a) and excited state time decays of 2 (b and c) for a 
series of PEGylated (4 mol%) DMPC liposomes containing a fixed amount of compound 2 (0.5 
mol%) and 0 to 4 mol% of compound 32+ at 293 K. a) Steady-state fluorescence spectra (λexc = 400 
nm, [2] = 1 μM). b) Fluorescence decay curves from time-correlated single photon counting (λexc = 
440 nm, λem = 474 nm, [2] = 1 μM). c) Normalized transient absorption kinetic traces at 700 nm. 
Best-fit curves drawn as solid lines for samples with addition of 32+ according to a three-
dimensional Förster decay model (see Appendix III). For the sample without addition of 32+, the fit 
curve represents a bi-exponential decay model. d) Energy transfer efficiency (EET) as a function of 
the mol fraction of 32+ at 293 K, calculated from time-correlated single photon counting data 
(empty squares), transient absorption data (grey filled circles), and steady state fluorescence 
spectroscopy (black filled diamonds). Best-fit curve according to a Stern-Volmer model (see 
Appendix III).  
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4.2.4 Does the aqua photoproduct quench the perylene excited state as 
well? 
Theoretically, when the ruthenium complex hydrolyses to the aqua species it 
is no longer attached to the cholesterol anchor and as the membrane is made 
of neutral lipids 42+ will diffuse away from the membrane.[6] After 
photodissociation 2 should thus regain its unquenched lifetime of ca. 6 ns. To 
probe this hypothesis, liposomes L23 with 4 mol% of 32+ (2.5 mM DMPC bulk 
concentration) were irradiated with blue light (420 nm) until full conversion 
of 32+ to 42+ was detected by UV-vis spectroscopy. No change in size or 
polydispersity of the liposomes was observed as judged by dynamic light 
scattering, indicating that the liposomes were unaffected by the light 
treatment. The lifetime of 2 was then measured with TA spectroscopy again, 
and indeed increased from 0.3 ns prior to irradiation to 3.9 ns after 
irradiation, owing to the decreased concentration of the energy acceptor 32+ in 
the membrane. However, the lifetime did not rise to the unquenched value of 
6.0 − 6.2 ns found in L2. To explain this observation, new L23 samples were 
prepared using the same relative composition of the membrane, but with an 8 
times higher lipid bulk concentration. In such concentrated liposomes the 
lifetime after the photoreaction rose to only 1.7 ns, which clearly 
demonstrated that the excited state lifetime of compound 2 depends on the 
bulk concentration of the aqua complex 42+. Our interpretation of this 
observation is that at higher concentrations the chance of finding 42+ in 
proximity of the membrane, and thus of 2, increases and that non-radiative 
energy transfer can occur to 42+ as well. Overall, the rise in the lifetime of 2 
upon blue light irradiation of the L23 samples confirms the results from the 
red light photodissociation experiments on L123: when the energy acceptor 
leaves the membrane, 2 no longer performs as much non-radiative energy 
transfer as when the complex is bound to the membrane, but instead loses its 
energy radiatively, which explains the increased blue emission at the end of 
the photoreaction (Figure 4.3b). 
4.2.5 What is the mechanism of energy transfer? 
In photochemistry, non-radiative energy transfer such as that between 2 and 
32+ is either described by a Dexter or to a Förster mechanism. The Förster 
mechanism relies on long-range dipole-dipole interactions and can be efficient 
up to a distance of 10 nm for spectrally well-matching donor-acceptor pairs. In 
the Dexter mechanism, direct orbital overlap is required between donor and 
acceptor, and energy transfer efficiency decays quickly beyond distances of 1 
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nm between the donor and the acceptor. For Dexter-type energy transfer, high 
mobility of both the donor and acceptor is imperative to realize energy 
transfer within the nanosecond timeframe in which 2 is in its singlet excited 
state. However, the DMPC bilayer at room temperature does not support such 
mobility: diffusion coefficients for fluorescent probes in DMPC membranes are 
typically 0.01 μm2.s−1 at 292 K,[21] which leads to a negligible displacement of 5 
x 10-3 Å2 in the 6 ns excited state lifetime of 2. In other words, in the timeframe 
in which 2 is in the singlet excited state the lipid bilayer is practically frozen. 
Also, there is no significant difference in quenching efficiency (vide supra) 
below (293 K) and above (310 K) the phase transition temperature at which 
the lipid bilayer transforms from a gel-like to liquid crystalline structure, 
which advocates for a diffusion-independent quenching mechanism. Finally, 2 
is located in the hydrophobic interior of the lipid bilayer, while the positively 
charged center of 32+, responsible for accepting the energy, is dangling at the 
bilayer-water interface.[22] Therefore, it is very unlikely that 2 and 32+ can 
come in close contact to realize orbital overlap. For these reasons, we 
conclude that the most likely mechanism of energy transfer is Förster 
Resonance Energy Transfer (FRET). Based on this assumption, and following 
the work of Holmes et al.,[23] the decay curves from TA and TCSPC data were 
satisfactorily fitted with a three-dimensional Förster decay function (see 
Appendix III). From the fitting parameters, the experimental Förster distance 
R0, for which FRET occurs with 50% efficiency, was calculated to be 29 Å. This 
value fits rather well the theoretical value (41 Å) that can be calculated from 
the spectra overlap shown in Figure 4.2 (see Appendix III). Both values also 
match the thickness of a DMPC lipid bilayer (36 Å),[21] which explains why 
FRET between 2 and 32+ is so efficient in this system. 
4.2.6 Overall efficiency of the sequential combination of TTA-UC and 
FRET 
Based on the evidence presented above, we propose that the enhanced 
photosubstitution rate when the three photoactive components 1, 2, and 32+ 
are present in the same membrane (L123) and irradiated with red light, 
results from the combination of TTA-UC between 1 and 2, and FRET from 2 to 
32+. To the best of our knowledge, this is one of the rare systems in which 
TTA-UC and FRET are combined to activate a photosensitive molecule.[24] 
Figure 4.5 shows a qualitative Jablonski diagram of this system: instead of 
realizing upconverted blue emission, the energy that is stored in the singlet 
excited perylene molecule is primarily transferred to the ruthenium complex 
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by FRET, to generate the singlet MLCT excited state. This excited state in turn 
leads to the selective substitution of the thioether ligand by a water molecule 
via the classical mechanism involving intersystem crossing to the 3MLCT state 
followed by thermal promotion of a triplet Metal-Centered state (3MC). In such 
a sequence, the photosubstitution quantum efficiency Etotal under red light 
irradiation, defined as the total number of photosubstitution reactions divided 
by the total number of red photons absorbed, is the product of the individual 
efficiencies, see Equation 4.2: 
𝛥𝑡𝑡𝑡𝑎𝑡 = 𝛷𝑈𝑈𝛥𝑇𝑇𝛷𝑅𝑅 Equation 4.2 
where 𝛷UC is the upconversion quantum yield (Appendix I), also defined as the 
quantum yield of generation of the singlet excited state of 2, EET is the 
efficiency of the non-radiative energy transfer (FRET) from 2 to 32+, and 𝛷Ru is 
the quantum yield of photosubstitution under blue light irradiation. This 
expression is only valid at the beginning of the reaction (t = 0), i.e. when the 
influence of radiative energy transfer is low and the non-radiative energy 
transfer efficiency is more or less constant. 𝛷UC was experimentally measured 
at 310 K in absence of 32+ and a value of 1.5% was found (see Appendix I). 
Note that such a measurement intrinsically takes into account any energy 
transfer from excited singlet 2 to ground state 1. 𝛷Ru has a value of 0.52%.[6] 
Estimating an energy transfer efficiency of 90 ± 5% at 3.5 mol% 32+, the 
theoretical value of Etotal should be 0.007%. Experimentally, a value can be 
determined directly from the UV-Vis spectroscopy data in Figure 4.3c, by 
taking the slope at t = 0 of a plot of the amount of moles of 32+ as a function of 
the amount of photons absorbed since t = 0 (see Figure S.III.9). Etotal was found 
to be 0.027%, which is in reasonable agreement with the theoretical value. 
The difference between theory and experiment is attributed to radiative 
energy transfer[1h] and direct absorption of the red light by 32+, which have 




Figure 4.5. Qualitative Jablonski diagram for a sequential combination of TTA-UC, FRET, and 
photosubstitution in liposomes L123 under red light irradiation. Abbreviations: intersystem 
crossing (ISC), triplet-triplet energy transfer (TTET), triplet-triplet annihilation (TTA), Förster 
Resonance Energy Transfer (FRET), metal-to-ligand charge transfer (MLCT) state, metal-centered 
(MC) state.  
In principle, at such power densities (~ 1 W.cm−2) the quantum efficiency of 
photodissociation reaction under red light irradiation should not depend on 
the photon flux. It was indeed shown that the TTA upconversion quantum 
yield does not depend on light intensity above a certain intensity threshold 
Ith.[25] For the 2-component liposomes L12 we demonstrated recently[26] that 
indeed the TTA-UC intensity linearly scales with irradiation intensity above 
Ith = 0.05 W.cm−2, while a quadratic dependence of the upconversion intensity 
on irradiation power is observed at lower intensities, i.e., between 50 and 8 
mW.cm−2 (see also Figure S.IV.4). When 3-component liposomes L123 were 
irradiated with 30, 60, or 120 mW power, i.e., 0.24, 0.48, and 0.95 W.cm−2, 
respectively, the increase in photosubstitution reaction rate was found almost 
proportional to light intensity (Figure S.III.10). In other words, at these 
intensities the overall efficiency of the photosubstitution reaction was indeed 
found, within experimental errors, independent on the red light intensity 
(Figure S.III.11). Clinical PDT frequently reports the use of light intensities of 1 
W.cm−2, and recent work even used intensities as high as 79 W.cm−2,[27] which 
underlines the biological applicability of TTA-UC in liposomes as a prodrug 
activation strategy. 
4.3 Conclusion 
This work is one of the first demonstrations that TTA-UC can be combined 
with FRET.[28] By putting the three photochemically active components 1, 2, 
and 32+ inside a single lipid bilayer highly efficient non-radiative energy 
transfer between the upconverted perylene excitation and the ground state of 
complex 32+ occurs. Under red light excitation from a commercial PDT laser 
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the photosubstitution reaction of 32+ to 42+ was much faster in the combined 
liposomes L123 than using radiative energy transfer, i.e., in a physical mixture 
of L12 and L3. In principle, this strategy can be generalized to any blue-light 
absorbing (pro)drug with good spectral overlap with the perylene emission. 
Light activation triggered by TTA-UC upconversion and FRET is especially 
attractive for the treatment of hypoxic tumors, in which classical PDT lose 
efficacy. For example, a system combining TTA-UC and PACT would function 
optimally. In the field of anticancer prodrug activation lanthanoid-doped 
upconverting nanoparticles have shown promising results,[3, 29] but the 
upconversion is poorly efficient in water and it requires laser powers in the 
multi-Watt regime that can be detrimental to cell viability.[30] Adding TTA-UC 
in the palette of the medicinal photochemist offers a significant alternative to 
the upconverting strategy: more light is absorbed, higher upconversion 
efficiencies are achieved at intensities as low as 10 mW.cm−2, and the 
molecular nature of the photoactive components allows for studying the 
mechanism of energy transfer in great detail. Recent work from our lab has 
shown that the problem of the sensitivity of TTA-upconversion schemes to 
dioxygen can be addressed using for example sodium sulfite.[26] These 
approaches may be combined to achieve red-to-blue TTA-upconversion and 
prodrug activation in vivo. 
4.4 Experimental section 
4.4.1 General 
Palladium tetraphenyltetrabenzoporphyrin (1) was purchased from Frontier Scientific, Inc. 
(Logan, Utah, USA). Perylene (2) was purchased from Sigma-Aldrich Chemie BV (Zwijndrecht, 
The Netherlands). Sodium N-(carbonyl-methoxypolyethylene glycol-2000)-1,2-distearoyl-sn-
glycero-3-phospho ethanolamine (DSPE-MPEG-2000), and 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) were purchased from Lipoid GmbH (Ludwigshafen, Germany) and 
stored at −18 °C. Dulbecco’s phosphate buffered saline (DPBS) was purchased from Sigma 
Aldrich and had a formulation of 8 g.L−1 NaCl, 0.2 g.L−1 KCl, 0.2 g.L−1 KH2PO4, and 1.15 g.L−1 
K2HPO4 with a pH of 7.1-7.5. All chemicals were used as received. The synthesis of 3[PF6]2 is 
described in Chapter 3.[1h] The concentration of 32+ in the liposome samples was measured with 
inductively coupled plasma optical emission spectroscopy (ICP-OES) after lysis of 100 − 500 μL 
of liposome suspension in 4 mL 65% nitric acid for 24 hours at 90 °C, and dilution to 10.0 mL. 
Regular UV-Vis absorption and emission spectra were recorded on a Varian Cary 50 UV-Vis 
spectrometer and a Shimadzu RF‐5301PC spectrofluorimeter, respectively. 
4.4.2 Liposome assembly 
All liposome formulations were prepared by the classical hydration-extrusion method. As an 
example, the preparation of L123 is described here. Aliquots of chloroform stock solutions 
containing the liposome constituents were added together in a flask to obtain a solution with 
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5.0 µmol DMPC, 0.20 µmol DSPE-MPEG-2000, 2.5 nmol 1, 25 nmol 2, and 0.20 µmol 3[PF6]2. The 
organic solvent was removed by rotary evaporation and subsequently under high vacuum for at 
least 30 minutes to create a lipid film. 1.0 mL DPBS buffer was added and the lipid film was 
hydrated by 4 cycles of freezing the flask in liquid nitrogen and thawing in warm water (50 °C). 
The resulting dispersion was extruded through a Whatman Nuclepore 0.2 μm polycarbonate 
filter at 40-50 °C at least 11 times using a mini-extruder from Avanti Polar Lipids, Inc. 
(Alabaster, Alabama, USA). The number of extrusions was always odd to prevent any 
unextruded material ending up in the final liposome sample. The extrusion filter remained 
practically colorless after extrusion, suggesting near-complete inclusion of the chromophoric 
compounds in the lipid bilayer. Liposomes were stored in the dark at 4 °C and used within 7 
days. The average liposome size and polydispersity index (PDI) were measured with a Malvern 
Instruments Zetasizer Nano-S machine, operating with a wavelength of 632 nm. The size and 
PDI were typically 130 − 170 nm and 0.05 − 0.20, respectively.  
4.4.3 Time-Correlated Single Photon Counting (TCSPC) 
For TCSPC experiments, a FluoTime 200 system from PicoQuant (Berlin, Germany) was used, 
operating with a PicoHarp 300 photon counting module, a PDL 800-B picosecond pulsed diode 
laser driver set at 10 MHz repetition rate, and a 440 nm LDH-P-C-440 laser diode. Samples were 
excited at 440 nm (6 μW laser power, 0.6 pJ/pulse) and detection was recorded at 474 nm. A 
111-QS cuvette from Hellma GmbH & Co. KG (Müllheim, Germany) was used and was 
thermostated in the holder at either 293 K or 310 K with a TC 125 temperature controller from 
Quantum Northwest (Seattle, WA, USA). Samples were always allowed a minimum of 7 minutes 
of thermal equilibration before measurement. The samples were greatly diluted so that in all 
cases, [2] = 1 μM and the absorption at excitation and emission wavelengths was below 0.1 (for 
10 mm path length). The data was fitted with Origin Pro 8.5 software.   
4.4.4 Transient Absorption (TA) Spectroscopy 
Transient absorption spectroscopy was performed on a femtosecond laser setup described in 
detail elsewhere.[31] A combined Libra and Legend laser system from Coherent produced pulses 
at 40 fs duration and 1 kHz repetition rate. Long delays were achieved by using two individual 
femtosecond amplifiers for pump and probe. Due to the shared source of seed pulses among the 
two lasers (the Legend was seeded from the Libra seed), femtosecond time resolution 
and arbitrary long pump probe delays were achieved. The pump laser was fed into an 
automated optical parametric amplifier that allowed conversion of the input pulse into any 
wavelength in the region 480 − 1600 nm while keeping the pulse duration. In this case, the 
samples were excited with 400 nm light (20 − 60 µW, 20 − 60 nJ/pulse). The laser driving the 
probe beam was focused on a calcium fluoride plate to generate a super continuum spanning 
from 360 − 1200 nm, which enabled spectrally resolved probing without the need for scanning. 
After passing through the sample, the probe beam was dispersed on a 256 element diode array, 
calculating pump-on pump-off difference signal on a shot to shot basis. The diode array was 
calibrated so that the spectrum was recorded from 430 to 730 nm. High concentration samples 
were used with [2] = 0.1 mM in a 110-QS cuvette from Hellma with a 1 mm optical path length 
so that A400 ≤ 0.6 (including sample scatter). The sample volume was 200 μL and the cuvette 
was mounted on a shaker to ensure mixing throughout the measurement. The acquisition time 
per sample was approximately 2 hours. It was confirmed with UV-Vis absorption spectroscopy 
before and after TA spectroscopy that the blue excitation did not cause any photochemical 
degradation of the samples within the measurement time. In TA experiments involving blue-
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light irradiated samples, 500 μl sample was irradiated with 10 mW 420 nm light (M420F2 fiber-
coupled high-power LED from Thorlabs) for a minimum of 2 hours. The reaction was monitored 
with UV-Vis spectroscopy to control the reaction time until all 32+ had converted to 42+, at 
which point the spectrum no longer evolved.  
4.4.5 Photodissociation experiments with red light 
Photodissociation experiments were conducted in a custom-built setup (Figure S.III.8). All 
optical parts were connected with FC-UVxxx-2 (xxx = 200, 400, 600) optical fibers from Avantes 
(Apeldoorn, The Netherlands), with a diameter of 200-600 μm, respectively, and that were 
suitable for the UV-Vis range (200 − 800 nm). 1.5 mL of the diluted liposome sample was 
deoxygenated by bubbling argon through the sample with a rate of ~2 bubbles per second for at 
least 30 minutes in an external ice-cooled pear-shaped flask. After this period, bubbling was 
stopped while maintaining the argon flow, and the sample was warmed in a water bath of 
approximately 40 °C for 10 minutes. Then, the sample was transferred by means of cannulation 
with argon pressure to a 111-OS macro fluorescence cuvette from Hellma in a CUV-UV/VIS-TC 
temperature-controlled cuvette holder from Avantes. The sample was allowed to equilibrate at 
310 K for an additional 10 minutes while stirring. The sample was held under argon 
atmosphere at a constant temperature of 310 K and irradiated for 4 hours from the side with a 
630 nm laser light beam from a clinical grade Diomed 630 nm PDT laser, set at a power of 30, 
60, or 120 mW. The 630 nm light was filtered through a FB630-10, 630 nm band pass filter 
(Thorlabs, Dachau/Munich, Germany) put between the laser and the sample. The excitation 
power was controlled using a NDL-25C-4 variable neutral density filter (Thorlabs), and 
measured using a S310C thermal sensor connected to a PM100USB power meter (Thorlabs). 
The laser was collimated to a beam of 4 mm diameter to reach an intensity of 0.24, 0.48, or 0.95 
W.cm−2; in such conditions, a cylinder of approximately 0.13 cm3 was simultaneously excited by 
the laser (8% of the total sample volume). UV-Vis absorption spectra were measured using an 
Avalight-DHc halogen-deuterium lamp (Avantes) as light source and a 2048L StarLine 
spectrometer (Avantes) as detector, both connected to the cuvette holder at a 180° angle and 
both at a 90° angle with respect to the red laser irradiation direction. The filter holder between 
cuvette holder and detector was in a position without a filter (Figure S.III.8, item 8). 
Luminescence emission spectra were measured using the same detector but with the UV-Vis 
light source switched off. To visualize the spectrum from 550 nm to 900 nm, while blocking the 
red excitation light, a Thorlabs NF-633 notch filter was used in the variable filter holder. To 
visualize the spectrum from 400 nm to 550 nm, an OD4 575 nm short pass filter (Edmund 
Optics, York, United Kingdom, part no. 84-709) was used. A UV-Vis absorption and two emission 
spectra (one for each filter) were measured every 15 min; each time the emission spectra were 
measured first by switching the filter holder to the appropriate position, then the laser was 
switched off, the halogen-deuterium lamp was turned on, the filter holder was switched to an 
open position, a UV-Vis absorption spectrum was recorded, the halogen-deuterium lamp was 
switched off, and the laser was switched on again. Each UV-Vis measurement took 
approximately 15 seconds in total. All spectra were recorded with Avasoft software from 
Avantes and further processed with Microsoft Office Excel 2010 and Origin Pro software. For 
each UV-Vis absorption spectrum, a baseline subtraction was performed followed by an 
evaporation correction to account for a slight loss of solvent as a result of the constant argon 
flow in the cuvette during the experiment. The emission spectra obtained from the two filters 
were stitched together at 550 nm to obtain a continuous spectrum from 400 to 900 nm. No 
correction was needed to seamlessly connect the spectra. 
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4.4.6 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) was performed on a TA Instruments (DE, USA) nano-
DSC III instrument in the range of 278 to 333 K with a scanning rate of 1 K.min−1 at 3 atm. The 
capillary cell (V = 300 µL) was filled with the liposome solution (lipid bulk concentration of 5 
mM) containing different concentrations of 1, 2 and 32+.  The reference cell was filled with the 
corresponding liposome-free buffer solution. A blank measurement was performed with PBS 
buffer. The liposome dispersions were degassed for 10 − 15 minutes prior to measurement on a 
Nalgene degassing station. For each sample, at least two cycles of heating and cooling were 
performed with 10 minutes of thermal equilibration between the ramps. The machine was 
cleaned beforehand with 50% formic acid and rinsed thoroughly with Milli-Q water. The 
thermograms were processed and analyzed using NanoAnalyze software from TA Instruments. 
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Imaging the lipid bilayer of giant unilamellar vesicles using 




Red-to-blue triplet-triplet annihilation upconversion was obtained in giant unilamellar 
vesicles. The upconverted light was homogeneously distributed across the membrane 
and could be utilized for the imaging of individual giant vesicles in three dimensions. 
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Upconversion luminescence (bio)imaging offers great advantages over 
conventional imaging. The absence of auto-fluorescence results in high 
contrast images, while photons of low energy, i.e. within the phototherapeutic 
window (600 − 1000 nm), afford higher tissue penetration and negligible 
irradiation damage. For these reasons lanthanoid-based upconverting 
nanoparticles (UCNPs), for example, have attracted much interest.[1] However, 
UCNPs suffer from several disadvantages, such as the need for high excitation 
power, the low absorption cross section of lanthanoid ions, and low 
upconversion efficiency in aqueous solution (typically ≤0.5%).[1b] In contrast, 
triplet-triplet annihilation upconversion (TTA-UC) requires low excitation 
intensity (<100 mW.cm−2), employs sensitizers having high extinction 
coefficients in the phototherapeutic window, and has achieved upconversion 
quantum yields up to 14% in aqueous solution.[1b, 2]  
In TTA-UC, low-energy photons are converted into higher-energy photons by 
means of a photophysical mechanism involving a couple of molecular dyes 
called the sensitizer and annihilator (see Chapter 2, Figure 2.1 for a qualitative 
Jablonski diagram).[3] The sensitizer absorbs the low-energy light, undergoes 
intersystem crossing (ISC) to a triplet state, and transfers its energy to the 
annihilator molecule by triplet−triplet energy transfer. Further collision of 
two triplet annihilator molecules leads to triplet−triplet annihilation (TTA), 
whereby one annihilator molecule is promoted to the excited singlet state, 
whereas the other one falls back to the ground state. The singlet annihilator 
returns to the ground state by emission of a high-energy photon, thus realizing 
upconversion. Most molecular dyes used in TTA-UC are highly lipophilic and 
require supramolecular strategies to be used in aqueous solution.[4] For 
example, sub-micrometer sized TTA-UC particles have been proposed for in 
vitro or in vivo imaging.[1b, 4c, 4d] We now demonstrate that TTA-UC can also be 
used for the imaging of lipid membranes.  
Giant Unilamellar Vesicles (GUVs) are classical tools in fluorescence imaging, 
as their large size (1−100 µm diameter) allows for direct observation of 
individual vesicles by optical microscopy techniques.[5] GUVs have for example 
been used for visualizing lipid rafts, membrane fusion, or ion transport.[6] In 
this study we functionalized PEGylated GUVs with palladium 
tetraphenyltetrabenzoporphyrin (1) as photosensitizer and perylene (2) as 
the annihilator (Figure 5.1a), and studied red-to-blue TTA-UC in the 
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membrane of the vesicles by optical microscopy. The aim of the study was to 
investigate the dye distributions across the membrane, the homogeneity of 
upconverted emission in the lipid bilayer, and the upconversion stability 
under imaging conditions. The growth of high-quality giant vesicles with a 
well-defined shape in physiologically relevant conditions, i.e., at high ionic 
strengths, was until recently considered as a challenge, but a new method was 
recently developed by some of us that is compatible with such conditions (up 
to 320 mOsm.kg−1).[7]  
5.2 Results and discussion 
Upconverting giant vesicles GUV12 were thus prepared from a lipid mixture 
of 95 mol% phospholipid (either 1,2-dimyristoyl-sn-glycero-3-
phosphocholine, i.e. DMPC, or 1,2-dioleoyl-sn-glycero-3-phosphocholine, i.e. 
DOPC), 4 mol% sodium N-(carbonyl-methoxypolyethylene glycol-2000)-1,2-
distearoyl-sn-glycero-3-phosphoethanolamine (DSPE-MPEG-2000), 0.5 mol% 
compound 2, and 0.02 mol% compound 1. The complete procedure is 
described in the experimental section. Briefly, the dye-containing lipid 
mixture in chloroform was deposited on a chemically cross-linked 
dextran−poly(ethylene glycol) hydrogel substrate, dried to form a lipid film, 
and then the film was re-hydrated with phosphate buffered saline (PBS) 
supplemented with 0.3 M sodium sulfite (Na2SO3) and 0.2 M sucrose at 293 − 
308 K. Transferring the solution onto a microscopy slide allowed for bright 
field imaging on a custom-build microscope based on an inverted microscopy 
setup. The images (Figure 5.1c) confirmed that for both lipid compositions 
(DMPC or DOPC) free-floating single vesicles were obtained, together with 
clusters of smaller vesicles. The images also show that the self-assembled 
vesicles were giant (diameter 1 − 100 μm), unilamellar, and spherical. The fact 
that almost identical procedures can be employed for preparing GUVs from 
lipids having a marked difference in their gel-to-liquid transition temperature 
(Tm = −17.3 °C and 23.9 °C for pure DOPC and DMPC, respectively)[8], 
demonstrates the flexibility of the GUV preparation method. For comparison, 
much smaller LUVs (samples LUV12) with an average diameter of ca. 150 nm 
were prepared from the same lipid mixture but using a standard hydration-





Figure 5.1. a) Chemical structures of palladium tetraphenyltetrabenzoporphyrin (1) and perylene 
(2). b) Emission spectra of DOPC upconverting GUVs with 30 mW 630 nm excitation (0.24 W.cm−2 
intensity) at 298 K in sulfite-supplemented (0.3 M) PBS buffer under air. c) Bright field 
micrographs of DOPC (left) and DMPC (right) upconverting giant vesicles at 298 K. 
Sodium sulfite was added in the buffer as an oxygen-scavenging agent. Since 
the triplet states involved in TTA-UC are readily quenched by molecular 
oxygen, it is common practice to deoxygenate samples before measuring 
upconverted emission. With LUVs de-oxygenation can be achieved by, for 
example, bubbling the solution with argon or N2. In the case of GUVs imaging 
however, bubbling an inert gas through the solution would at least impair 
visualization of single GUVs during a long time period of time due to 
convection, or even lead to damaging of the giant vesicles, so that 
supplementing the buffer with an oxygen scavenger is highly preferred. In a 
preliminary experiment, upconversion emission spectra of LUV12 samples 
deoxygenated by either argon bubbling for 30 minutes or by adding 0.3 M 
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sodium sulfite to the buffer, were compared (see Figure S.IV.2 and 
experimental section for details). When irradiated at 630 nm the emission 
spectrum of such LUVs at 298 K shows at 800 nm the phosphorescence band 
of 1, and between 450 and 600 nm the blue singlet emission from 2 (Figure 
S.IV.2). The spectra from both deoxygenation methods were found to be very 
similar. It was thus concluded that Na2SO3 does not interfere with the 
photophysical processes at the origin of upconversion, and that sulfite might 
be used for scavenging dioxygen in a GUV-containing sample as well.  
Indeed, even though addition of Na2SO3 significantly increased the ionic 
strength of the buffer (from 278 ± 1 mOsm.kg−1 for PBS buffer to 884 ± 11 
mOsm.kg−1 when supplemented with 0.3 M sodium sulfite), as explained above 
sodium sulfite did not prevent the assembly of DMPC or DOPC GUV12 using 
the hydrogel method. No differences in vesicle yield and morphology were 
observed in presence or absence of sodium sulfite in the buffer. This result 
demonstrates that the dextran−poly(ethylene glycol) hydrogel substrate is 
able to produce GUVs at high ionic strength, which is a significant advantage 
over alternative GUV preparation methods such as electroformation or gentle 
hydration, which often fail in such conditions. When irradiated at 630 nm 
under air, the emission spectrum of the DMPC or DOPC GUV12 samples 
prepared in a sulfite-supplemented buffer was identical to the emission 
spectrum of the corresponding LUV12 samples (Figure 5.1b and Figure 
S.IV.3), showing that the dyes 1 and 2 were indeed incorporated in the lipid 
bilayer.  
GUV12 samples were then visualized by emission microscopy at 298 K 
(Figure 5.2). When the vesicles were illuminated with violet light (405 nm), i.e. 
by direct excitation of perylene (2), fluorescence was clearly detected at the 
membrane (Figure 5.2b). To visualize upconversion, a 630 nm continuous 
wave PDT laser was coupled into the microscope and set at a power of a few 
milliwatts, resulting in the focal spot in an intensity of ~300 W.cm−2. All 
wavelengths other than 450 − 575 nm were strictly blocked by a combination 
of notch and short-pass filters (Appendix IV). High-quality images were 
obtained that were superimposable to the bright field images and to the 
fluorescence images recorded under white and violet light irradiation, 
respectively (Figure 5.2a-c). Control samples were prepared in which the 
porphyrin sensitizer 1 was omitted from the formulation (GUV2). Images 
recorded in identical conditions were black, i.e., no blue emission was 
observed (Figure S.IV.7). GUV12 samples prepared in absence of sulfite 
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oxygen scavenger and observed under air did not give any observable 
emission either (Figure S.IV.8). Altogether, these observations prove that the 
blue images recorded under 630 nm irradiation of GUV12 samples 
supplemented with sulfite comes from the TTA upconversion process and are 
not the result of sensitizer emission (at 800 nm) or of two-photon absorption. 
Overall, all data conclude that both dyes 1 and 2 co-localize in the membrane 
and result in TTA upconversion. At this scale of observation the upconverted 
emission is homogeneous across the membrane and no phase separation of 
the lipids or dyes was observed.  
Under the red-light irradiation conditions initially used in the microscopy 
setup (630 nm at an intensity of 320 W.cm−2), substantial bleaching of the 
upconverted emission of GUV12 samples was observed even in presence of 
0.3 M of sulfite. A plot of the averaged normalized pixel values as a function of 
red irradiation time shows that the upconverted emission is halved after less 
than 3 seconds (Figure 5.3). When the light intensity was lowered 60 times 
(i.e., down to 5.2 W.cm−2) clear upconversion images could still be recorded. In 
such conditions the bleaching rate was significantly lower (Figure 5.3), and 
the time necessary for halving the upconverted emission intensity of a pixel 
increased to approximately 15 seconds. The upconversion luminescence of 
LUV-12 in a spectroscopy setup could be observed for less than 8 mW.cm−2, 
with linear power dependency above 60 mW.cm−2 (Figure S.IV.4). Overall, 
these findings show that high power is not a requirement for the 




Figure 5.2. Imaging of DOPC (left) and DMPC (right) upconverting giant vesicles (GUV12) with a) 
bright field, b) 405 nm excitation and 450-500 nm detection, and c) 630 nm excitation and 450-
575 nm detection. d) Upconversion intensity profile plot following the arrows in the images 
directly above (c). At 630 nm: laser spot size diameter 39 μm, power 3.8 mW, intensity 320 W.cm−2. 
At 405 nm: laser spot size diameter 22 μm (power 1 mW, intensity 60 W.cm−2) for DOPC image or 
39 μm (power 1 mW, intensity 300 W.cm−2) for DMPC image. Images were acquired at 298 K in 








Figure 5.3 a) Averaged normalized pixel values as a function of red irradiation time during 
upconversion imaging of GUV12 samples in sulfite-supplemented PBS buffer (0.3 M). Conditions: 
630 nm excitation at 320 W.cm−2 (black filled circles) or 5.2 W.cm−2 (empty circles), detection in 
the 450−575 nm region, T = 298 K. Snapshots were taken with an exposure time of 0.2 s (320 
W.cm−2) or 1.0 s (5.2 W.cm−2). Error bars represent standard deviation based on six individual 
measurements. b) Upconversion emission microscopy images of GUV12 samples at t = 0 s (left) and 
at t = 10 s (right) at an illumination intensity of 320 W.cm−2 (top) and 5.2 W.cm−2 (bottom). 





Figure 5.4. 3D reconstructed image of a DMPC GUV12 sample, rotated counter-clockwise by 50° 
about the y-axis. Each z-slice was imaged at 298 K with 630 nm excitation (320 W.cm−2) and 
detection in the 450-575 nm region. The z-distance between slices was 1.0 µm. Video V1 
(http://www.rsc.org/suppdata/c5/cc/c5cc02197a/c5cc02197a2.mpeg) exhibits a 360° rotational 
view of this image and of four other individual DMPC GUV12. 
In optimized conditions, we realized that the upconverted emission was 
intense enough to be utilized for reconstructing in 3D the membrane of the 
giant vesicles. Z-stack upconversion image acquisition was indeed performed 
on both DMPC and DOPC GUV12 samples. The illumination intensity was 
deliberately chosen to be high (320 W.cm−2) to make sure that z-stack image 
acquisition was short (200 ms exposure time per slice, ca. 45 slices per stack, 
total acquisition time < 10 s). In such conditions, the slight lateral motion of 
the GUVs did not significantly affect the imaging process. From these stacks, 
3D reconstructions were made (e.g. Figure 5.4), of which a video was compiled 
(See Video V1 on-line at http://www.rsc.org/suppdata/c5/cc/c5cc02197a/ 
c5cc02197a2.mpeg). This reconstruction demonstrates that the TTA-
upconverted emission can be utilized for the three-dimensional 
reconstruction of an object that is 10 to 30 μm in size.  
5.3 Conclusion 
In conclusion, DOPC and DMPC giant vesicles capable of upconverting red light 
to blue light by means of triplet-triplet annihilation were prepared by lipid 
film hydration on a hydrogel substrate at high ionic strengths. The 
preparation method is facile and does not involve any specific equipment. 
Sodium sulfite added as an oxygen scavenger to the vesicle samples allows for 
observing upconversion even under air. According to optical microscopy, the 
upconverted emission allows for recording high quality images showing that 
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upconversion is homogeneously realized across the lipid bilayer. The quality 
and stability of the upconverted images enabled the 3D reconstruction of 
upconverting GUVs. These results show the great potential of TTA 
upconversion for imaging applications under anoxic conditions, and open a 
route towards cell membrane imaging with upconverted light. 
5.4 Experimental section 
5.4.1 General 
Palladium tetraphenyltetrabenzoporphyrin (1) was purchased from Frontier Scientific, Inc. 
(Logan, Utah, USA). Perylene (2) was purchased from Sigma-Aldrich Chemie BV (Zwijndrecht, 
The Netherlands). Sodium N-(carbonyl-methoxypolyethylene glycol-2000)-1,2-distearoyl-sn-
glycero-3-phospho ethanolamine (DSPE-MPEG-2000), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) were 
purchased from Lipoid GmbH (Ludwigshafen, Germany) and stored at −18 °C. Dulbecco’s 
phosphate buffered saline (PBS) was purchased from Sigma Aldrich and had a formulation of 8 
g.L−1 NaCl, 0.2 g.L−1 KCl, 0.2 g.L−1 KH2PO4, and 1.15 g.L−1 K2HPO4 with a pH of 7.1 − 7.5. All other 
chemicals were purchased from major chemical suppliers and used as received. Images and 
data were processed with Fiji ImageJ, Origin Pro, and Microsoft Excel software. 
5.4.2 GUV preparation  
All GUVs were prepared by lipid film re-hydration on dextran chemically cross-linked hydrogel 
substrates by a method described elsewhere.[7] The preparation of GUV12 is described here as 
an example. Glass microscopy slides were first incubated with 1:1 vol MeOH : HCl (37%) for 30 
min, then with 98% H2SO4  for 30 min, and then thiol-functionalized by incubating them for 1 h 
in a 2 wt.% solution of (3-mercaptopropyl)triethoxysilane in dry toluene under a nitrogen 
atmosphere, and washing them three times with toluene. Directly after, a homogeneous film of 
Dex-PEG hydrogel was formed on this surface by drop-casting 600 µL of a 1:1 volume mixture 
of 2 wt.% maleimide-functionalized dextran, with a substitution degree of 3 maleimide groups 
per 100 glucopyranose residues of dextran (synthesis and characterization detailed in ref. 2), in 
water and 2 wt.% α,ω-PEG dithiol (1500 g.mol−1) in water at room temperature. A homogenous 
hydrogel film was formed after 30 − 45 minutes at 40 °C. Then, 10 μL of lipid mixture stock 
solution in chloroform, containing 20 mM DMPC or DOPC, 0.8 mM DSPE-PEG-2K, 0.1 mM 
perylene (2), and 5 μM of compound 1, was deposited on the hydrogel surface. The organic 
solvent was evaporated for 30 minutes under a gentle stream of air followed by a period of at 
least 30 minutes in a 30 °C vacuum oven. The lipid film was then hydrated with 400 μL 
phosphate buffered saline (PBS) supplemented with 0.2 M sucrose, and when wanted 0.3 M 
sodium sulfite, for 1 - 2 hours at room temperature (ca. 293 K) in case of DOPC GUVs, or at 308 
K in case of DMPC GUVs. This recipe produced a solution containing free-floating vesicles that 
could be directly pipetted in a fluorescence cuvette for emission spectroscopy (see section 




5.4.3 Emission spectroscopy on GUVs 
For upconversion emission spectroscopy, approximately 700 μL of the above-mentioned 
solution of free-floating vesicles in buffer was transferred to a semi-micro cuvette and used as 
such in the setup detailed in section 5.4.6  
5.4.4 Preparation of a microscopy experiment with GUVs 
For optical microscopy imaging, 300 μL of the solution containing free-floating vesicles in buffer 
(section 5.4.2) was transferred to an Eppendorf tube containing 700 μL phosphate buffered 
saline supplemented with 0.3 M sodium sulfite and 0.2 M glucose to allow the sucrose-loaded 
giant vesicles to sink to the bottom of the tube. After one hour, 200 μL of this GUV suspension 
was transferred to a visualization microscopy chamber that had previously been coated with 
bovine serum albumin (BSA). As a result of surface treatment with BSA and of the greater 
density of the sucrose-loaded vesicles, the giant vesicles were immobilized on the glass surface 
of the chamber, which allowed for imaging with minimal diffusion during image recording. The 
rest of the chamber was filled with 100 μL PBS supplemented with 0.3 M sodium sulfite and 0.2 
M glucose. The vesicles were imaged within 24 hours. 
5.4.5 LUV preparation and characterization  
Upconverting LUVs, i.e. LUV12 samples, were prepared as described before as a reference.[4f] 
Aliquots of chloroform stock solutions containing the liposome constituents were added 
together in a flask to obtain a solution with 20 µmol DMPC, 0.8 µmol DSPE-MPEG-2000, 100 
nmol perylene (2), and 5 nmol of compound 1. The organic solvent was removed by rotary 
evaporation and subsequently under high vacuum for at least 30 minutes to create a lipid film. 
1.0 mL PBS buffer, optionally supplemented with 0.3 M Na2SO3, was added and the lipid film 
was hydrated by 5 cycles of freezing the flask in liquid nitrogen and thawing in warm water (50 
°C). The resulting dispersion was extruded through a Whatman Nuclepore 0.2 μm 
polycarbonate filter at 40-50 °C at least 11 times using a mini-extruder from Avanti Polar 
Lipids, Inc. (Alabaster, Alabama, USA). The number of extrusions was always odd to prevent any 
unextruded material ending up in the final liposome sample. The extrusion filter remained 
colorless after extrusion, suggesting complete inclusion of the sensitizer and annihilator in the 
lipid bilayer. LUVs were stored in the dark at 4 °C and used within 7 days. The LUVs had an 
average diameter of ca. 150 nm and a polydispersity index of 0.1, as determined from dynamic 
light scattering measurements with a Malvern Instruments Zetasizer Nano-S machine, 
operating at a wavelength of 632 nm. Additionally, cryo transmission electron microscopy was 
performed on DMPC LUV12 (see Figure S.IV.1) as described before.[9] 
5.4.6 Upconversion emission spectroscopy 
Upconversion emission spectroscopy was performed in a custom-built setup (Figure 5.5). All 
optical parts were connected with FC-UVxxx-2 (xxx = 200, 400, 600) optical fibers from Avantes 
(Apeldoorn, The Netherlands), with a diameter of 200-600 μm, respectively, and that were 
suitable for the UV-Vis range (200 − 800 nm). For LUV12 samples that were deoxygenated by 
argon bubbling: argon was bubbled through the sample (3.0 mL) with a rate of ~2 bubbles per 
second for at least 30 minutes in an external ice-cooled pear-shaped flask. After this period, 
bubbling was stopped while maintaining the argon flow, and the sample was warmed in a water 
bath of approximately 40 °C for 10 minutes. Then, the sample was transferred by means of 
cannulation with argon pressure to a 111-OS macro fluorescence cuvette from Hellma in a CUV-
UV/VIS-TC temperature-controlled cuvette holder from Avantes, while keeping the sample 
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under a constant flow of argon throughout the measurement. For LUV12 samples that were 
deoxygenated by addition of sodium sulfite, 3.0 mL of the sample was simply transferred to the 
cuvette and emission spectra were recorded under air. Likewise, GUV12 samples in sodium 
sulfite buffer (approximately 700 µL) were transferred to a 104F-QS or 104F-OS semi-micro 
cuvette from Hellma.  
 
Figure 5.5. Setup used for emission measurements under red light irradiation. Legend: (1) 630 nm laser source, 
(2) optical fibers, (3) filter holder, (4) 630 nm band pass filter, (5) variable neutral density filter, (6) 
temperature controlled cuvette holder, (7) variable filter holder, and (8) CCD spectrometer. 
The sample in the cuvette holder was allowed to equilibrate at 298 K for 10 minutes. The 
sample was irradiated from the side with a 30 mW 630 nm laser light beam from a clinical 
grade Diomed 630 nm PDT laser (4 mm beam, 0.24 W.cm−2). The 630 nm light was filtered 
through an FB630-10, 630 nm band pass filter (Thorlabs, Dachau/Munich, Germany) put 
between the laser and the sample. The excitation power was controlled using a NDL-25C-4 
variable neutral density filter (Thorlabs), and measured using a S310C thermal sensor 
connected to a PM100USB power meter (Thorlabs). Emission spectra were recorded at a 90° 
angle with respect to the excitation source using a 2048L StarLine CCD spectrometer from 
Avantes. To visualize the spectrum from 550 nm to 900 nm, while blocking the red excitation 
light, a Thorlabs NF-633 notch filter was used in a variable filter holder. To visualize the 
spectrum from 400 nm to 550 nm, an OD4 575 nm short pass filter (Edmund Optics, York, 
United Kingdom, part no. 84-709) was used. All spectra were recorded with Avasoft software 
from Avantes and further processed with Microsoft Office Excel 2010 and Origin Pro software. 
The emission spectra obtained with the two filters were stitched together at 550 nm to obtain a 
continuous spectrum from 400 to 900 nm. No correction was needed to seamlessly connect the 
spectra. 
5.4.7 Power dependency measurements 
Luminescence emission spectra of DMPC and DOPC LUV-12 were recorded at various excitation 
powers from 1 to 40 mW so that the excitation intensity (P) was 8 to 318 mW.cm−2 (4 mm laser 
beam diameter). The samples were placed in a Hellma 101-OS macro fluorescence cuvette (2.25 
mL, [lipid] = 1.0 mM) and thermally equilibrated at 298 K before measurement in the same 
fluorescence setup as described in Section 5.4.6. In this case, the spectrum was visualized with 
only a Thorlabs NF-633 notch filter in between the sample and the detector. The recorded 
spectra were integrated from 420 to 575 nm to obtain the integrated upconversion 
luminescence intensity (IUC), which was then plotted in a double logarithmic plot as a function 
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of the excitation intensity (Figure S.IV.4). The low power (≤ 40 mW.cm−2) and high power (≥ 
120 mW.cm−2) regimes were consistently fitted with slopes around 1 and 2, respectively, which 
shows the typical power dependency of TTA-UC.1 The intersection of these straight lines 
represents the intensity threshold (Ith) at which the power dependency changes from quadratic 
to linear. Ith was found to be 50 and 59 mW.cm−2 for the upconversion in DMPC and DOPC LUV-
12, respectively. Assuming no difference in power dependency between LUV-12 and GUV-12, 
these results indicate that all microscopy images with red light excitation (P ≥ 5.2 W.cm−2) were 
acquired in the linear power regime. 
5.4.8 Microscopy imaging 
Bright field and (upconversion) emission imaging was performed with a customized Zeiss 
Axiovert S100 TV Inverted Microscope setup (Figure 5.6), fitted with a Zeiss 100x Plan 
Apochromat 1.4 NA oil objective and an Orca Flash 4.0 V2 sCMOS camera from Hamamatsu, 
which together produced images with 65 nm pixel size. For direct perylene excitation, a 
CrystaLaser 50 mW 405 nm Solid State laser was used, combined with a ZT405/514/561rpc 
dichroic beam splitter (Chroma Technology Corporation) and ZET442/514/568m emission 
filter (Chroma Technology Corporation) (see Figure S.IV.5 for the transmission spectra of this 
set). For upconversion emission microscopy, a Diomed clinical grade 630 nm continuous wave 
PDT laser was used as excitation source. The light was filtered through a FB630-10 630 nm 
band pass filter (Thorlabs) put between the laser and the Chroma ZT405/532/635rpc dichroic 
beam splitter. To block everything except upconversion emission, a NF633-25 633 nm notch 
filter (Thorlabs) and a 575 nm short pass filter (Edmund Optics, part no. #84-709) were placed 
between the sample and the camera, resulting in OD >13 at 630 nm and OD>4 around 800 nm 
(i.e. at the phosphorescence emission of compound 1). The transmission curves of the filters 
and dichroic mirror are displayed in Figure S.IV.5 and Figure S.IV.6. The output power of the 
630 nm laser was typically 3.8 mW (39 μm spot size, 320 W.cm−2) at the sample. The typical 
camera exposure time was 200 ms, unless otherwise specified. 
 
Figure 5.6. Microscopy setups used for imaging GUVs with 630 nm (left) and 405 nm (right) excitation. Legend: 
(1) Thorlabs FB630-10 band pass filter, (2) Chroma ZT405/532/635rpc dichroic beam splitter, (3) Edmund 
Optics 575 nm OD4 short pass filter, 4) Thorlabs NF633-25 notch filter, (5) Chroma ZT405/514/561rpc 




5.4.9 Determination of bleaching curves 
Giant vesicles were first located in bright field mode and were subsequently irradiated for 60 
seconds at 630 nm with either 5.2 W.cm−2 (62 µW, laser spot size diameter 39 μm) or 320 
W.cm−2 (3.8 mW, laser spot size diameter 39 μm) illumination intensity while acquiring an 
image every 1.0 or 0.2 s, respectively. For each image, the pixel values (A.U.) of the brightest half 
of all the pixels was averaged and normalized to one. Six individual vesicles were measured per 
time point. The mean and standard deviation are plotted versus time (s) in order to obtain a 
bleaching curve. 
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Temperature dependence of  triplet-triplet annihilation 





Understanding the temperature dependency in photon-upconverting nano-systems is 
important to realize optimized upconversion applications. In this chapter, the 
temperature dependency of red-to-blue triplet-triplet annihilation upconversion in a 
variety of neutral PEGylated phospholipid membranes is reported. It appears that in 
these systems a delicate balance between lateral diffusion rate, annihilator aggregation, 
and sensitizer self-quenching and thermal deactivation leads to the maximization of the 
















Light upconversion is the generation of high-energy photons from low-energy 
photons, for example the conversion of red light to blue light. Generating 
upconverted light can be achieved through various mechanisms and in 
different materials, such as two-photon absorption dyes, energy upconversion 
processes in rare-earth doped materials or nanoparticles, and triplet-triplet 
annihilation (TTA-UC) in solution and solid state materials. Among these 
principles, TTA-UC offers many advantages: it can occur at low excitation 
power (in the best cases even lower than 1 mW.cm−2), it uses sensitizers 
having high molar absorptivity, and the obtained upconversion quantum 
yields may reach up to 14% in aqueous solution.[1] Since its popularization 
more than a decade ago,[2] TTA-UC has been used in many applications such as 
photocatalysis,[3] solar energy harvesting,[4] drug delivery and activation,[5] 
and luminescence bio-imaging.[1a, 6] 
TTA-UC is based on the photophysical interplay of photosensitizer and 
annihilator chromophores (see Chapter 2, Figure 2.1).[7] The photosensitizer 
absorbs low energy light, after which intersystem crossing leads to a long-
lived triplet state. The energy of this triplet state is transferred to the 
annihilator upon diffusional collision by means of triplet-triplet energy 
transfer (TTET); a succession of TTET leads to a concentration buildup of 
long-lived triplet-state annihilators. Two triplet state annihilators can then 
perform triplet-triplet annihilation upconversion, in which one of them 
departs with the energy of both to reach a high-energy singlet state. Finally, 
this singlet excited state returns to the ground state by emission of a high-
energy photon, thus realizing light upconversion. TTA-UC has been 
demonstrated in an extensive assortment of organic, inorganic, and/or 
supramolecular materials,[1c, 8] as well as in nano or micro-sized particles.[9]  
Among the various applications in the field of TTA-UC, there are some that are 
not operated at room temperature, such as bio-imaging and phototherapy. It is 
thus important to understand the temperature dependency of upconversion 
efficiency in order to optimize the use of TTA-UC. Because TTET and TTA 
occur via molecular contact, they are highly dependent on molecular diffusion;  
the efficiency of TTA-UC is generally greatly influenced by the fluidity and 
hence thermal responsiveness of the host material.[10] For many materials, a 
higher temperature leads to a higher fluidity, and therefore to higher TTA-UC 
efficiency. For example, green-to-blue TTA-UC in a rubbery polymer matrix 
 
97 
was only visible above the glass transition temperature of the material, above 
which the matrix becomes more fluid.[11] However, diffusion is not the only 
important factor. First of all, temperature-dependent chemical phenomena 
such as dye aggregation may affect upconversion as well: counter-intuitively, 
it was recently shown that at lower temperatures, mixed aggregation of 
sensitizer and annihilator molecules in diluted conditions resulted in higher 
TTA-UC efficiency.[12] It has also been shown that upconversion in gel matrices 
decreased at higher temperatures due to temperature-dependent disassembly 
of the host-material.[8c] Overall, understanding the temperature-dependence of 
all chemical and physical properties of a given medium, is necessary for 
optimizing upconversion.  
Our group recently demonstrated that green-to-blue and red-to-blue TTA-UC 
can be realized in the phospholipid membrane of neutral PEGylated liposomes 
composed of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). This 
knowledge was later used for the activation of photoactivatable 
chemotherapeutic agents in the photodynamic window.[5] In our initial studies 
it was reported that the upconversion intensity was reversibly affected by 
changes in temperature. [5b] Upon heating the sample from 15 to 25 °C the 
upconversion intensity increased significantly, which we interpreted as a 
consequence of the gel-to-liquid crystalline phase transition temperature (Tm) 
of the DMPC lipid bilayer. Upon raising the temperature above Tm the 
molecular diffusion of the dyes in the membrane is expected to increase 
greatly, which should lead to higher TTET and TTA rates, and thus higher 
TTA-UC efficiencies. In this work, we evaluate the general applicability of this 
hypothesis by systematically investigating the temperature dependency of 
TTA-UC in neutral PEGylated liposomes, using different lipids with different 
Tm. 
6.2 Results and discussion 
Neutral PEGylated liposome dispersions were prepared in phosphate buffered 
saline (PBS) by hydration and extrusion of lipid films containing five different 
neutral phosphatidylcholines, i.e. 1,2-dioleyl-sn-glycero-3-phosphocholine 
(DOPC), 1,2-dilaureyl-sn-glycero-3-phosphocholine (DLPC), 1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC), 1,2-dipentadecanoyl-sn-glycero-3-
phosphocholine (DPDPC), and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 




phosphoethanolamine (DSPE-MPEG-2000, see Figure 6.1). Addition of DSPE-
MPEG-2000 is a well-known strategy to prevent liposome aggregation and 
fusion. The lipid composition of liposome samples O, L, M, PD, and P is shown 
in Table 6.1. A well-investigated red-to-blue TTA-UC dye couple consisting of 
palladium tetraphenyltetrabenzoporphyrin (1) and perylene (2, see Figure 
6.1) was selected for incorporation in the liposomes. Samples containing these 
dyes, i.e. O12, L12, M12, PD12, and P12 (defined in Table 6.1), were prepared 
following an identical procedure. The hydrodynamic diameters (z-ave = 135 ± 
5 nm) and polydispersity indices (PDI = 0.09 ± 0.02), as measured by dynamic 
light scattering (DLS), were found to be very similar regardless of the lipid 
type or dye functionalization.  
 
Figure 6.1. Chemical structures of DOPC, DLPC, DMPC, DPDPC, DPPC, DSPE-MPEG-2000, palladium 
tetraphenyltetrabenzoporphyrin (1), and perylene (2).  
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Table 6.1. Lipid formulations of the PEGylated phosphatidylcholine liposomes used in this work, 
and their physical characterization by dynamic light scattering (with z-ave as hydrodynamic 
diameter and PDI as polydispersity index) and differential scanning calorimetry. DSC 
measurements were performed with a scanning rate of 1 °C.min−1 at 3 atm. pressure. 






PDI Tm (lit. value)[13] 
(°C)[b] 
ΔH (lit. value)[13] 
(kJ.mol−1)[b]  
O DOPC   139 0.11 - (−18.2) - (35.5) 
O1 DOPC 2.5      
O1’ DOPC 25      
O2 DOPC  25     
O12 DOPC 2.5 25 135 0.11 - - 
L DLPC   127 0.11 - (−2.1) - (7.5) 
L12 DLPC 2.5 25 134 0.12 - - 
M DMPC   132 0.07 25.0 (23.9) 27.7 (29.3) 
M1 DMPC 2.5      
M2 DMPC  25     
M12 DMPC 2.5 25 134 0.09 24.9 26.6 
PD DPDPC   132 0.09 34.9 (34.7) 33.6 (32.7) 
PD12 DPDPC 2.5 25 140 0.07 34.6 32.0 
P DPPC   140 0.08 42.4 (41.4) 40.1 (36.8) 
P12 DPPC 2.5 25 137 0.11 42.1 38.7 
[a] All liposomes were prepared with 5.0 mM lipid and 0.20 mM DSPE-mPEG-2000.[b] Tm is defined 
as the main transition temperature of the bilayer, and ΔH as the molar enthalpy change of the 
phase transition (the enthalpy change of the pretransition is included, in case there is one). 
Literature Tm and ΔH values given for the pure phospholipids. 
 
It is well known that phase changes of phospholipid membranes greatly 
influence the two-dimensional translational molecular diffusion coefficient (DT 
in µm2.s−1) of membrane solutes. Therefore, the gel-to-liquid phase transition 
temperature (Tm) and the total enthalpy change of the phase transition (ΔH) 
were measured for samples based on DMPC, DPDPC, and DPPC using 
differential scanning calorimetry (DSC, see Table 6.1 and Figure 6.2b). Tm and 
ΔH for dye-free PEGylated liposomes M, PD, and P were found to be very close 
to literature values for PEG-free liposomes, i.e. the PEG groups do not 
significantly influence the phase transition at these concentrations. Upon 
functionalization of the PEGylated liposomes with compounds 1 and 2, a small 
decrease in the main transition peak height was observed, but the main 
features of the thermogram remained. These results indicate that for liposome 
samples M12, PD12, and P12, compounds 1 and 2 were indeed buried in the 
lipid bilayer, and that their presence only minimally perturbed the physical 
properties of the membranes. No transitions were found between 5 and 50 °C 
for samples O, O12, L, and L12, because Tm for pure DOPC and DLPC are 
reported to be below the freezing point of water.[13] 
Next, UV-vis absorption and emission spectroscopy was performed on 
samples O12, L12, M12, PD12, and P12 at 20 °C in presence of 0.3 M sodium 
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sulfite for chemical deoxygenation, see Figure 6.2.[5a, 14] The absorption spectra 
show the superposition of the characteristic peaks of 1 at 440 and 630 nm and 
the vibronically structured band of 2 from 350 − 450 nm.[5b] Upon irradiation 
with 630 nm laser light (10 mW, 80 mW.cm−2), phosphorescence of 1 at 800 
nm and upconversion emission of 2 at 474 nm were observed for each sample. 
The emission stability at 20 °C was tested for each formulation by 
continuously irradiating for one hour and collecting emission spectra. All 
samples exhibited good emission stability during this period, see Figure S.V.1. 
 
Figure 6.2. (Photo)physical characterization of upconverting liposomes. a) Typical absorption 
(solid, left axis) and emission spectrum (dashed, right axis, λexc = 630 nm, intensity 80 mW.cm−2) of 
L12 liposomes ([DLPC] = 1.0 mM) at 20 °C in 0.3 M sodium sulfite PBS under air. b) Differential 
scanning calorimetry thermograms between 5 °C and 50 °C of liposomes with TTA-UC dyes (O12, 
L12, M12, PD12, and P12, solid) or without (O, L, M, PD, P, dashed). Arrows indicate Tm of the 
dyed liposomes, where applicable. Measurements were performed in heating mode with a scanning 
rate of 1 °C.min−1 at 3 atm. pressure. c & d) Temperature evolution of the upconversion intensity at 
474 nm (c) and of the phosphorescence intensity (d) of O12, L12, M12, PD12, and P12. Samples 
were heated from 5 °C to 50 °C at a rate of 0.3 °C.min−1 while continuously irradiated with 80 
mW.cm−2 630 nm light.  
To investigate the temperature dependency of TTA-UC in O12, L12, M12, 
PD12, and P12, these samples were heated from 5 °C to 50 °C at a rate of 0.3 
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°C.min−1 while stirring, and upconversion spectra were continuously recorded. 
A submerged thermocouple registered the accurate temperature inside the 
solution. Figure 6.2 shows the evolution of the luminescence intensities at 800 
nm (IP) and 474 nm (IUC) vs. temperature for each liposome formulation. For 
O12 and L12, both phosphorescence and upconversion intensity gradually 
decreased with increasing temperature. For M12, PD12, and P12, IUC 
increased up to 25, 35, and 42 °C, respectively, and then decreased gradually, 
whereas IP decreased steeply up to 25, 35, and 42 °C, respectively, and then 
continued to decrease, but less steeply. When the samples were brought back 
from 50 °C to 5 °C, the initial emission spectra at 5 °C were obtained again in 
all cases except for O12, showing that bleaching did not occur and that the 
thermo-photophysical evolution is reversible (Figure S.V.2). For O12, we 
attribute this relative instability to the presence of the unsaturated bond, 
which might participate in undesired photochemical reactions. Interestingly, 
for M12, PD12, and P12, the temperature values at which IUC maximizes and IP 
kinks are very close to the phase transition temperature of the bilayer (Tm) 
recorded with DSC.  
The increase of IUC when approaching Tm is easily explained: heating the 
liposomes above Tm greatly increases the membrane fluidity and thus 
increases the lateral diffusion coefficient (DT) of membrane dyes, which in 
turn causes an increase in TTA-UC efficiency. For instance, the DT for 
fluorescent probes in DMPC lipid bilayers has reported to increase from 0.01 
µm2.s−1 at 15 °C, to 6 µm2.s−1 at 30 °C to 13 µm2.s−1 at 50 °C.[13, 15] It is worth 
mentioning that for such DMPC bilayers, the foremost change in DT (a three-
order increase in magnitude) was found between 20 and 25 °C, and so the 
most considerable transition in TTA-UC efficiency was expected to occur in 
this temperature domain. This is indeed in accordance with our data for 
M12.[15] In absence of accurate literature data of DT in DPDPC and DPPC across 
the full temperature range, we assume that the same explanation holds for the 
results obtained with PD12 and P12. However, this rationale is clearly no 
longer valid above Tm: although DT continues to increase (vide supra), IUC 
decreased. Furthermore, for O12 and L12, in absence of a phase transition 
between 5 and 50 °C, IUC and IP both decrease across the whole temperature 
range. It is thus clear that other photophysical phenomena must play a role in 
the temperature dependence of TTA-UC in lipid bilayers. 
Therefore, the thermo-photophysical behavior of the isolated dyes was 
considered in DOPC, DMPC, and in toluene (Figure 6.3). First, the fluorescence 
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intensity of compound 2 (λexc = 420 nm, λem = 474 nm) was found to decrease 
by 10% in both DOPC liposomes and toluene when heated from 5 °C to 50 °C. 
This is most likely explained by a slightly increased thermal deactivation. In 
DMPC, the fluorescence intensity increased by 25% when heated from 5 °C to 
30 °C, with the most sharp increase around 25 °C, and then decreased slightly 
again up to 50 °C. This observation is in agreement with the work of Khan et 
al. who reported that perylene tends to form staggered aggregates in the 
tightly packed gel membrane below Tm, which break apart in the more loosely 
packed liquid-crystalline state above Tm.[16] Since the fluorescence intensity is 
lower in presence of such aggregates, the TTA-UC efficiency is lower below Tm. 
Overall, dissociation of perylene aggregates gives an additional explanation for 
the increase of upconversion intensity up to Tm.  
Secondly, the phosphorescence intensity of 1 (λexc = 630 nm, λem = 800 nm) 
was investigated under deoxygenated conditions. In toluene solution, roughly 
50% of the phosphorescence intensity is lost upon going from 5 °C to 50 °C 
due to increased thermal deactivation. When the dye was inserted into DOPC 
or DMPC liposomes (O1 and M1, respectively) about 70% phosphorescence 
intensity was lost upon going from 5 °C to 50 °C; the additional 20% loss of 
phosphorescence intensity with respect to the toluene sample may be due to 
increased dynamic self-quenching, because the molecules are much more 
confined in the lipid bilayer. The explanation of self-quenching is supported by 
the fact that for M1, the highest loss of phosphorescence is observed around 
the transition temperature, at which the fluidity of the membrane increases 
most rapidly and diffusion-based processes such as self-quenching are 
expected to have an increased effect. Overall, these results explain that the 
decrease of TTA-UC with rising temperature is most likely due to increased 
thermal deactivation and self-quenching of 1.  
Based on these data, we explain the typical maximization of IUC around Tm in 
lipid bilayers that have a transition temperature between 5 and 50 °C as 
follows. On the one hand, the increase in photosensitizer quenching as a 
function of temperature is rather linear (Figure 6.3). On the other hand, the 
temperature dependence of DT has been described in literature as sigmoidal, 
with three-orders of magnitude increase when approaching Tm, and flattening 
directly after Tm.[15] In other words, upon approaching Tm the membrane 
becomes fluid rather quickly, but once it reaches the liquid crystalline state 
the fluidity changes negligibly. Therefore, above Tm the effect of the only minor 
increase in lateral diffusion coefficient on the upconversion efficiency is 
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completely outcompeted by the increased quenching of the photosensitizer. 
Furthermore, the dissociation of annihilator aggregates results in a rather 
abrupt and significant increase in fluorescence around Tm as well (Figure 
6.3a). It is thus concluded that the combination of these three temperature-
dependent phenomena results in the maxima that were observed in the IUC 
versus temperature curve at 24, 34, and 40 °C for samples M12, PD12, and 
P12, respectively (Figure 6.2c).  
 
Figure 6.3. Temperature-dependent emission spectroscopy of compounds 2 or 1 in toluene, DMPC 
liposomes, or DOPC liposomes. a) Normalized fluorescence intensity at 474 nm of compound 2 in 
toluene (dashed, 20 µM), M2 liposomes (purple, [DMPC] = 1 mM), or O2 liposomes (black, 
[DOPC] = 1 mM) as a function of temperature. λexc = 420 nm, 0.7 mW (6 mW.cm−2). b) Temperature 
variation of the normalized phosphorescence intensity at 800 nm in 5 °C intervals for compound 1 
in toluene under argon (open circles) and for liposomes O1 (black triangles, [DOPC] = 1 mM) or 
M1 (purple squares, [DMPC] = 1 mM) prepared in PBS with 0.3 M sodium sulfite. λexc = 630 nm, 
10 mW (80 mW.cm−2).  
Finally, for the biological application of these upconverting liposomes in bio-
imaging or phototherapy, it would be beneficial to achieve the highest 
upconversion intensity at human body temperature (37 °C). From our results, 
it is evident that the systems O12, L12, and M12 achieve identical 
upconversion intensities at 37 °C, while PD12 and P12 exhibit inferior 
intensities. We cannot offer any explanation why IUC is lower in PD12 and P12. 
Altogether, the results suggest that even though IUC maximizes around Tm (for 
M12, PD12, and P12), choosing a lipid with a Tm near 37 °C does not result in 
an optimized upconverting liposome formulation. Finally, considering that 
little has been reported about the biocompatibility of DLPC,I  we conclude that 
                                                             
I In preliminary experiments, A549 lung carcinoma cells were incubated with L12 liposomes 
([DLPC] = 0.5 mM) for 4 h, which resulted in 100% cell death (data not shown). 
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O12 and M12 upconverting liposomes are the most promising for biological 
applications. 
6.3 Conclusion 
The temperature dependence of red-to-blue TTA-UC was studied in PEGylated 
liposomes with PC lipids with different lipophilic chain lengths and transition 
temperatures, and it was found that the upconversion intensity maximizes 
around Tm. Three major effects contribute to this temperature dependency: 
(1) an increase in lipid bilayer fluidity above Tm results in higher diffusion 
rates and thus higher rates of TTET and TTA, (2) dissociation of perylene 
aggregates when approaching Tm results in higher annihilator emission 
intensity, and (3) higher thermal deactivation and self-quenching rates of the 
photosensitizer at higher temperatures lead to a lower TTET rate and lower 
upconversion intensity beyond Tm. Measuring the point at which IUC maximizes 
may be exploited for probing the transition temperature of phospholipid 
membranes. Furthermore, for TTA-UC applications that require high 
performance at elevated temperatures, the results underline the importance 
of selecting photosensitizers that are minimally affected by temperature. 
Finally, all liposome formulations were efficient in upconversion at biological 
temperature, which underlines that liposomes are versatile platforms for 
upconversion bio-imaging and photopharmaceutical applications. The 
phospholipid can be freely chosen to further optimize the liposomal 
formulation in terms of medium stability, biocompatibility, clearance from the 
bloodstream, and surface functionalization. 
6.4 Experimental 
6.4.1 General 
Palladium tetraphenyltetrabenzoporphyrin (1) was purchased from Bio-Connect (Huissen, The 
Netherlands). Perylene (2) was purchased from Sigma-Aldrich Chemie BV (Zwijndrecht, The 
Netherlands). All lipids were purchased from either Lipoid GmbH (Ludwigshafen, Germany) or 
Avanti Polar Lipids (Alabaster, AL, USA) and stored at −18 °C. Dulbecco’s phosphate buffered 
saline (DPBS) was purchased from Sigma Aldrich and had a formulation of 8 g.L−1 NaCl, 0.2 g.L−1 
KCl, 0.2 g.L−1 KH2PO4, and 1.15 g.L−1 K2HPO4 with a pH of 7.1 − 7.5.  
6.4.2 Liposome assembly 
All liposome formulations were prepared by the classical hydration-extrusion method. As an 
example, the preparation of O12 is described here. Aliquots of chloroform stock solutions 
containing the liposome constituents were added together in a flask to obtain a solution with 
5.0 µmol DOPC, 0.20 µmol DSPE-MPEG-2000, 2.5 nmol compound 1, and 25 nmol compound 2. 
The organic solvent was removed by rotary evaporation and subsequently under high vacuum 
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for at least 30 minutes to create a lipid film. 1.0 mL DPBS buffer, with or without 0.3 M sodium 
sulfite, was added and the lipid film was hydrated by 4 cycles of freezing the flask in liquid 
nitrogen and thawing in warm water (50 °C). The resulting dispersion was extruded through a 
Whatman Nuclepore 0.2 μm polycarbonate filter at 40 − 50 °C at least 11 times using a mini-
extruder from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA). The number of extrusions 
was always odd to prevent any unextruded material ending up in the final liposome sample. The 
extrusion filter remained practically colorless after extrusion, suggesting near-complete 
inclusion of the chromophoric compounds in the lipid bilayer. Liposomes were stored in the 
dark at 4 °C and used within 7 days. The average liposome size and polydispersity index were 
measured with a Malvern Instruments Zetasizer Nano-S machine, operating with a wavelength 
of 632 nm. 
6.4.3 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) was performed on a TA Instruments (DE, USA) nano-
DSC III instrument in the range of 5 °C to 50 °C with a scanning rate of 1 °C.min−1 at 3 atm. The 
capillary cell (V = 300 µL) was filled with the liposome solution (lipid bulk concentration of 5 
mM), and the reference cell was filled with PBS buffer solution. A blank measurement was 
performed with PBS buffer. The liposome dispersions were degassed for 10 − 15 minutes prior 
to measurement on a Nalgene degassing station. For each sample, at least two cycles of heating 
and cooling were performed with 10 minutes of thermal equilibration between the ramps. The 
machine was cleaned beforehand with 50% formic acid and rinsed thoroughly with Milli-Q 
water. The thermograms were processed and analyzed using NanoAnalyze software from TA 
Instruments. 
6.4.4 Absorption and emission spectroscopy 
Absorption and emission spectroscopy was conducted in a custom-built setup (Figure S.V.3). All 
optical parts were connected with FC-UVxxx-2 (xxx = 200, 400, 600) optical fibers from Avantes 
(Apeldoorn, The Netherlands), with a diameter of 200-600 μm, respectively, and that were 
suitable for the UV-Vis range (200-800 nm). Typically, 2.25 mL of sample was placed in a 111-
OS macro fluorescence cuvette from Hellma in a CUV-UV/VIS-TC temperature-controlled 
cuvette holder with stirring from Avantes. Deoxygenated toluene samples were prepared in a 
glovebox in a sealed fluorescence cuvette. The cuvette holder temperature was controlled with 
a TC-125 controller and T-app computer software from Quantum Northwest (Liberty Lake, WA, 
USA), while the sample temperature was measured with an Omega RDXL4SD thermometer with 
a K-type probe submerged in the sample. The sample was excited with a collimated 630 nm 
laser light beam (4 mm beam diameter) from a Diomed 630 nm PDT laser. The 630 nm light 
was filtered through a FB630-10, 630 nm band pass filter (Thorlabs, Dachau/Munich, Germany) 
put between the laser and the sample. The excitation power was controlled using the laser 
control in combination with a NDL-25C-4 variable neutral density filter (Thorlabs), and 
measured using a S310C thermal sensor connected to a PM100USB power meter (Thorlabs). 
For regular measurements, the excitation power was set at a power of 10 mW (80 mW.cm−2). 
UV-Vis absorption spectra were measured using an Avalight-DHc halogen-deuterium lamp 
(Avantes) as light source and a 2048L StarLine spectrometer (Avantes) as detector, both 
connected to the cuvette holder at a 180° angle and both at a 90° angle with respect to the red 
laser irradiation direction. The filter holder between cuvette holder and detector was in a 
position without a filter (Figure S.V.3, item 8). Luminescence emission spectra were measured 
using the same detector but with the UV-Vis light source switched off. To visualize the spectrum 
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from 450 nm to 900 nm, while blocking the red excitation light, a Thorlabs NF-633 notch filter 
was used in the variable filter holder. All spectra were recorded with Avasoft software from 
Avantes and further processed with Microsoft Office Excel 2010 and Origin Pro software. 
Temperature dependent luminescence experiments were done with continuous irradiation and 
temperature ramping, except for phosphorescence measurements of compound 1 to prevent 
bleaching during the experiment. Instead, spectra were taken every 5 °C with 10 min thermal 
equilibration between temperature points. 
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Light upconversion by triplet-triplet annihilation (TTA-UC) in nanoparticles has received 
considerable research attention for bio-imaging and light activation of prodrugs. 
However, the mechanism of TTA-UC is inherently sensitive for quenching by molecular 
oxygen. A potential oxygen protection strategy is the coating of TTA-UC nanoparticles 
with a layer of oxygen impermeable material. In this work, we explore if (organo)silica 
can fulfill this role. Three synthesis routes are described for obtaining monodispersed 
(organo)silica-coated red-to-blue upconverting liposomes; their upconversion properties 
are investigated in solution and in A549 lung carcinoma cells. Although it was found that 
the silica offered no protection from oxygen in solution and after uptake in A549 cancer 
cells, upon drying of the silica-coated liposome dispersion in an excess of (organo)silica 
precursor, interesting liposome-silica nanocomposite materials were obtained that were 
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Photon upconversion is defined as the generation of high energy light (e.g. 
blue) from low energy light (e.g. red). Among the wide variety of applications, 
light upconversion has received substantial interest in upconversion bio-
imaging and as method to shift the activation wavelength of photoactivatable 
anticancer prodrugs towards the phototherapeutic window.[1] One mechanism 
of light upconversion is triplet-triplet annihilation upconversion (TTA-UC), 
which is based on the photophysical interplay of photosensitizer and 
annihilator chromophores (see Chapter 2, Figure 2.1).[2] The photosensitizer 
absorbs low energy light, after which a long lived triplet excited state is 
reached via intersystem crossing. The energy of this triplet state is transferred 
to the annihilator upon diffusional collision by means of triplet-triplet energy 
transfer (TTET); a succession of TTET leads to a buildup of long lived triplet 
state annihilators. Two triplet state annihilators can then perform triplet-
triplet annihilation upconversion, in which one of them departs with all the 
energy and reaches a high energy singlet excited state. Finally, this singlet 
excited state returns to the ground state by fluorescent emission of a high 
energy photon, realizing light upconversion. TTA-UC has been demonstrated 
in an extensive assortment of organic, inorganic, and/or supramolecular 
materials,[3] as well as in nano- or micro-sized particles,[4] and has been used 
for applications in photocatalysis,[5] solar energy harvesting,[6] drug delivery 
and activation,[1a, 1b] and bio-imaging.[7]  
Evidently, for biological application of TTA-UC, supramolecular assemblies are 
required to co-localize photosensitizer and annihilator. Furthermore, for the 
biological application in anticancer applications, such an assembly is required 
to support efficient TTA-UC, have selective uptake in tumors, and cause 
minimal toxicity for healthy tissues. Meanwhile, liposomes functionalized with 
PEGylated lipids have emerged since decades as supramolecular tools in drug 
delivery. Liposomes have high biocompatibility and low toxicity, and 
accumulate selectively in tumors because of the enhanced permeability and 
retention effect (EPR).[8] Our group recently combined liposomes with TTA-
UC: red-to-blue upconversion was demonstrated in the lipid bilayer of neutral 
PEGylated DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) liposomes.[1a, 
1b] These upconverting liposomes were further functionalized with a blue-light 
activatable Ru(II) polypyridyl complex. Upon red light irradiation of this 
combined system, the upconverted light was efficiently transferred to the Ru-
complex via FRET, which triggered the release of the photoactivated 
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compound. This mechanism may be exploited in photoactivated cancer 
therapy to release a cytotoxic compound in tumors. 
However, no upconversion could be observed in air, because molecular 
oxygen quenches the triplet states of sensitizer and annihilator. In other 
words, the upconverting drug carrier did not function in oxygen-rich 
conditions, and the use of this system in vitro would lead to unreliable 
performance, because oxygen concentrations vary drastically in the complex 
microenvironment of a tumor.[9] Oxygen sensitivity can be reduced by 
developing upconversion systems that either (i) feature very fast TTA UC so 
that upconversion takes place on a shorter timescale than physical quenching 
by molecular oxygen, (ii) have built-in functionality for the consumption of 
molecular oxygen to create a locally oxygen-depleted microenvironment, or 
(iii) are protected by a nanoscale oxygen-impenetrable barrier. Most 
noteworthy examples of the latter strategy include upconverting oil-core 
nanocapsules embedded in an oxygen protective cellulose material or 
polyvinyl alcohol nanofibers,[3f, 10] and upconversion in hyperbrached 
unsaturated polyphosphoesters.[11] However, there are no examples yet where 
a nanoscale oxygen-barrier is used to protect TTA-UC in a drug delivery 
system. In this work, we attempt to coat upconverting liposomes with 
(organo)silica I  as potential oxygen barrier and investigate the oxygen 
protection potential of such a silica barrier. 
Using silica has several advantages. First of all, silica has been widely 
recognized as a chemically inert, biocompatible, pH insensitive, and 
transparent material.[12] Secondly, the silica surface can be modified to attach 
molecules such as PEG, biotin, or Ru(II)-complexes.[13] Finally, it has been 
demonstrated that nm-thick silica layers can act as an oxygen barrier in silica-
coated polymer films,[14] and it has been suggested that silica protects oxygen-
sensitive chromophores such as [Ru(bpy)3]2+ and [Ru(phen)3]2+ in doped silica 
nanoparticles.[15] Silica-coating of liposomes has been described before;[16] for 
example, Bégu et al. described the application of a silica-coating to DPPC 
liposomes (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) by sequential 
hydrolysis and condensation of tetraethylorthosilicate (TEOS) as silica 
precursor.[16a, 16b, 17] It was suggested that the deposition of silica on the 
membrane was controlled by hydrogen-bonding interactions between the 
                                                             
I Organosilica is defined as silica containing organic groups as integral part of its structure 
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phosphate groups of the lipids, interfacial water, and silanol groups of the 
silica. Furthermore, nitrogen adsorption isotherms suggested that the dried 
particles were non-porous. However, most of the published articles do not 
explicitly discuss whether the particles are stable and monodispersed in 
aqueous buffer, which is a important criterion for a drug delivery device. 
 
Figure 7.1. Schematic representation of (organo)silica-coated liposomes containing 
photosensitizer (PS; PdTPTBP) and annihilator chromophores (A; perylene or TBP). PdTPTBP = 
palladium tetraphenyltetrabenzoporphyrin, TBP = 3,5,8,11-tetra(tert-butyl)perylene 
This chapter describes three synthetic routes for obtaining monodispersed 
(organo)silica-coated DMPC liposomes containing a red-to-blue upconverting 
couple, i.e. palladium tetraphenyltetrabenzoporphyrin (PdTPTBP) and 
perylene (Figure 7.1). In a second step, the upconverting properties of silica-
coated liposomes are investigated in order to assess whether silica can act as 
an oxygen-barrier to allow upconversion in air. Furthermore, the uptake of 
these particles and their ability to perform upconversion in vitro will be 
evaluated. Finally, the silica-coated liposomes are dried in presence of an 
excess of (organo)silica precursor and the upconversion properties of the 
resulting nanocomposite materials are investigated. 
7.2 Results and Discussion 
7.2.1 Preparation of upconverting liposomes 
Preliminary attempts to reproduce the work of Bégu et al., who described the 
synthesis of silica-coated liposomes based on direct addition of 
tetraethylorthosilicate (TEOS) to non-PEGylated DPPC liposomes were 
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unsuccessful.[16b] In our hands, these experiments inevitably led to the 
formation of silica nanoparticles, gelation of the reaction mixture, and/or 
aggregation of the silica-coated liposomes. Also, silica-coating experiments 
with 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) liposomes were 
unsuccessful. Therefore, only DMPC-based liposomes were further considered 
for preparing silica-coated liposomes. Three synthetic routes, called methods 
A, B, and C, were developed to apply an (organo)silica-coating to upconverting 
DMPC liposomes and obtain monodispersed particles (Figure 7.2). 
First of all, upconverting DMPC liposomes (from now on called UL) were 
prepared according to a literature procedure.[1a] Briefly, a mixture of 5 mM 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 4 mol% sodium N-
(carbonyl-methoxypolyethylene glycol-2000)-1,2-distearoyl-sn-glycero-3-
phosphoethanolamine (DSPE-mPEG-2000) was used to prepare liposomes via 
a hydration-extrusion method in phosphate buffered saline (PBS). A red-to-
blue upconverting TTA-UC couple was selected for incorporation in the 
liposomes, consisting of palladium(II) tetraphenyltetrabenzoporphyrin 
(PdTPTBP, 0.05 mol%) and perylene (0.5 mol%). Dynamic light scattering 
(DLS) measurements reported a reproducible average hydrodynamic 
diameter (z-ave) of around 150 nm and a polydispersity index (PDI) of 0.1 
(Table 7.1). The UV-vis absorption spectrum (Figure 7.3) of UL shows the 
characteristic absorption peaks of perylene (390, 414, 440 nm) and  PdTPTBP 
(440, 630 nm). The emission spectrum (λexc = 630 nm, 80 mW.cm−2) of UL in 
50 mM sodium sulfite in PBS shows both the phosphorescence of PdTPTBP 
and the perylene-based emission, characteristic of upconversion with this dye 
couple (Figure 7.3a).[1a] In Figure 7.3b, the temperature dependence is shown 
of the upconversion emission and phosphorescence. The upconversion first 
increases up to 25 °C, and then decreases slightly, while the phosphorescence 
decreases steeply up to 25 °C, and then continues to decrease, but less steeply. 
The rise in upconversion up to 25 °C is explained by the fact that the DMPC 
membrane changes its phase from gel to liquid crystalline at 24 °C;[18] in the 
liquid crystalline phase the fluidity of the membrane is increased, and 
collision-dependent processes such as TTET and TTA become more 
efficient.[1a] A detailed discussion of this phenomenon is described in Chapter 
6. Here, this thermo-photophysical phenomenon is used to verify the integrity 




Figure 7.2. Three different synthesis methods to obtain silica-coated upconverting PEGylated 
liposomes. Conditions per eq. DMPC: (i) 25 eq. APTES, 16 h; (ii) 8 eq. TEOS, 1 M HCl, 30 min (iii) 8 




Figure 7.3. a) Absorption spectrum (red) and emission spectrum (blue) of UL under 10 mW 630 nm 
irradiation (80 mW.cm−2) at 20 °C in 50 mM Na2SO3 PBS in air. b) Temperature dependency of 
upconversion (at 474 nm) and phosphorescence (at 800 nm) of UL in 50 mM Na2SO3 PBS in air. 
Table 7.1. Physical characterization of liposomes UL and (organo)silica-coated liposomes A-UL, 
pT-UL, pTA-UL, ApT-UL and T-UL by Dynamic Light Scattering (DLS) and zeta-potentiometry, 
with reported average hydrodynamic diameter (z-ave), polydispersity index (PDI) and  zeta 
potential at the given pH.  
[a] Standard deviation based on N ≥ 3 samples. [b] Standard deviation based on 3 measurements 
of the same sample 
 
Figure 7.4. TEM micrographs (a/b) and particle diameter distribution (c, N = 324 particles) of 
A-UL. d) An A-UL particle dries out over time during TEM, leaving behind an organosilica shell. 
Sample z-ave (nm)[a] PDI[a] zeta potential[b] 
(mV) 
pH 
UL 148 ± 4 0.09 ± 0.01 −16 ± 0 7.1 
A-UL (unwashed) 171 ± 5 0.14 ± 0.02   
A-UL  128 ± 1 0.10 ± 0.02 −40 ± 5 6.8 
ApT-UL 145 ± 1 0.15 ± 0.01 −20 ± 0 7.0 
pT-UL   −19 ± 1 6.9 
pTA-UL 167 ± 1 0.15 ± 0.01 −17 ± 1 7.2 
T-UL   −33 ± 1 6.7 
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7.2.2 Preparation of silica-coated liposomes − method A 
UL were subsequently used for silica-coating experiments. In the first silica-
coating method (method A),  UL were first coated with 
(3-aminopropyl)triethoxysilane (APTES) to make organosilica-coated 
liposomes named A-UL, followed by additional coating with pre-hydrolyzed 
TEOS, making ApT-UL. APTES was chosen as initial layer because it has been 
suggested in the literature that the protonated amino group of APTES (pKa = 
10.4) associates with the negatively charged phospholipid head groups of the 
liposome membrane;[16d, 16e, 19] in other words, the liposome membrane acts as 
a template on which APTES hydrolyses and condenses. After the first reaction 
step and before purification, DLS measurements showed an increase of 20 nm 
in hydrodynamic size of A-UL with respect to UL (Table 7.1), suggesting the 
deposition of an organosilica layer on the membrane of about 10 nm in 
thickness. As a control, UL were kept in the same reaction conditions, without 
adding APTES. The DLS values of UL remained unchanged during these 16 h, 
which excludes that this change in size was caused by instability of the UL. 
Note that in absence of the liposomes, APTES is likely to form five- or six-
membered organosilicate rings in aqueous solution, which suppresses 
nanoparticle formation.[20] Therefore, APTES alone cannot result in changes in 
DLS measurements.  
To visually confirm the deposition of an APTES layer, A-UL were imaged by 
transmission electron microscopy (TEM), see Figure 7.4. The micrographs 
show individual particles in various polygonal shapes. No other nanoparticles 
were observed. Interestingly, when these particles were irradiated by an 
intense electron beam in the vacuum of the TEM, the liquid inside the particles 
visibly boiled and leaked out of the particles, leaving behind electron dense 
shells (Figure 7.4d). This observation suggested that the particles indeed 
consist of organosilica-coated liposomes. Surprisingly, the particles collapsed 
only upon high electron irradiation and the particles withstood the high 
vacuum of the TEM (~ 10-5 bar) at low irradiance, which is evidence that the 
organosilica layer greatly fortifies the outer shell of a liposome. The average 
particle diameter from TEM (176 nm, Figure 7.4c) is consistent with the 
hydrodynamic size observed by DLS (171 nm, Table 7.1). The observed 
particles with a diameter of around 400 nm are likely to have been individual 
particles that merged during drying of the TEM grid, because these were 
absent in DLS measurements. Zeta potentiometry on A-UL gave a zeta-
potential of −30 mV at pH 6.8 (Table 7.1). Such a negative surface charge was 
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unexpected, given that the amino-groups of the organosilica layer are likely to 
be protonated at neutral pH.  
 
Figure 7.5. TEM micrographs (a/b) and particle diameter distribution (c, N = 142 particles) of 
ApT-UL. d) An ApT-UL particle dries out over time during TEM, leaving behind an (organo)silica 
shell. 
The second synthesis step, to make ApT-UL, involved coating of A-UL with 
pre-hydrolyzed TEOS, i.e. TEOS that had been hydrolyzed for 24 h prior to 
addition.[17a] This pre-hydrolysis step was found to be essential in acquiring 
monodispersed silica-coated liposomes: instead of hydrophobic TEOS, that 
may enter the liposome membrane and disrupt its structure, hydrolyzed TEOS 
(i.e. Si(OH)4 and small condensed oligomers) only condenses in solution. 
Without pre-hydrolysis the silica-coated liposomes aggregated quickly during 
the application of the coating. When TEOS was pre-hydrolyzed before addition 
to A-UL, DLS measurement of ApT-UL (before washing) showed that the 
resulting coated liposomes were monodisperse with an increase in 
hydrodynamic size of 17 nm with respect to the purified A-UL (Table 7.1), 
indicating that an additional layer of silica was deposited on A-UL. The DLS 
values did not change significantly for at least one week after preparation. 
TEM images showed single particles with an average particle diameter of 163 
nm, together with smaller clustered particles, which are probably silica 
nanoparticles (Figure 7.5). Similar to previous observations with A-UL, the 
particles dried out under intense electron irradiation in the vacuum of the 
TEM (Figure 7.5d), which allowed direct visualization of the solid silica shell 
around the liposome. Overall, method A successfully produced (organo)silica-
coated liposomes that were mono-dispersed and stable in aqueous solution.  
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7.2.3 Preparation of silica-coated liposomes − method B 
Method B involved the silica-coating of UL with TEOS under acidic catalytic 
conditions to make T-UL. Similar methods have previously been used for the 
silica-coating of micelles.[7a, 7b] Literature suggests that the use of acid catalysis 
results in more extensive condensation of the silica network,[12b] which might 
in turn reduce the porosity of the silica layer and improve protection against 
oxygen. The synthesis method yielded clear solutions that did not aggregate 
visibly within one week, but an accurate size distribution by DLS could not be 
obtained (PDI = 1.00). The zeta potential of T-UL was found to be negative 
(−33.4 mV). TEM imaging showed that T-UL consists of single dispersed 
particles with a rather broad size distribution (Figure 7.6). Much smaller 
particles (< 10 nm) were also present, which are probably silica nanoparticles 
originating from TEOS condensation in solution instead of on the liposome 
surface. Interestingly, compared to A-UL and ApT-UL these particles show 
only little drying out under intense electron irradiation in the TEM. This may 
indicate that the silica network in these particles is indeed more condensed 
than in A-UL and ApT-UL. Overall, our results demonstrate that using method 
B resulted in successful silica-coating of liposomes, albeit with a poorly 
defined particle diameter and poor particle purity. 
 
Figure 7.6. TEM micrographs (a/b) and particle diameter distribution (c, N = 57 particles) of T-UL. 
 
 




7.2.4 Preparation of silica-coated liposomes − method C 
Method C involved silica-coating of UL with pre-hydrolyzed TEOS to make pT-
UL, after which the product was additionally coated with APTES to make pTA-
UL. The zeta-potential of pT-UL and pTA-UL had similar negative values 
(−18.8 and −17.0 mV, respectively). Aqueous samples containing pTA-UL 
were not very stable over time; aggregated particles were observed after a few 
days at room temperature. Freshly prepared pTA-UL had an average 
hydrodynamic size of 167 nm. TEM imaging showed polygonal particles 
similar to ApT-UL, with an average particle diameter of 137 nm. In conclusion, 
although singly dispersed silica-coated liposomes were produced with method 
C, the particles were of lower quality than ApT-UL from method A in terms of 
aggregation over time. Overall, these results suggest that an initial APTES 
“template” layer, such as applied in method A, is beneficial for producing 
stable silica-coated liposome dispersions.  
7.2.5 Spectroscopic properties of silica-coated liposomes in solution 
To evaluate whether the silica-coated liposome solutions produced 
upconversion, samples A-UL, ApT-UL, T-UL, and PtA-UL were investigated 
with UV-vis absorption and emission spectroscopy (λexc = 630 nm, 10 mW, 80 
mW.cm−2), see Figure 7.8. All absorption spectra matched the absorption 
spectrum of UL (Figure 7.3),[1a] which means that the silica-coating did not 
affect the molecular dyes. Emission spectra were first taken in air, after which 
sodium sulfite (Na2SO3, 50 mM) was added to scavenge ground-state oxygen 
and the emission spectra were recorded again. Without sulfite, for all 
solutions only very weak phosphorescence of PdTPTBP (λem = 800 nm) was 
observed in comparison with UL in presence of sulfite (Figure 7.3). However, 
upon addition of sulfite, all samples directly exhibited much more intense 
phosphorescence of PdTPTBP and intense upconverted emission of perylene 
at 474 nm. In a second experiment, to ascertain that the silica-coating had not 
destroyed the lipid bilayer, the temperature dependence of phosphorescence 
and upconversion was recorded between 10 and 35 °C in presence of sulfite 
(Figure S.VI.1). If the lipid bilayer would still be intact, a steep increase in 
upconversion and decrease of phosphorescence around the lipid bilayer main 
transition temperature (Tm ≈ 25 °C) would be expected, just as was observed 
for UL (Figure 7.3). Indeed, in all cases, the thermo-photophysical behavior 
was similar to UL, confirming that the lipid bilayer was still intact. Overall, 
despite the lipid bilayer being intact inside the particles, it is clear that none of 
the (organo)silica layers around the liposomes were capable of blocking 
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oxygen. This must mean that the organo(silica) coating is either porous to 
oxygen or incomplete, because the capability of upconversion, which takes 
place inside the particles, is affected by the sodium sulfite added to the 
solution outside the particles. This result can only be explained if oxygen is 
able to diffuse freely across the organosilica-coating or across the patches that 
have remained uncoated.  
 
 
Figure 7.8. Absorption (red, left axes), and emission spectra in air (black, right axes) and in air in 
50 mM Na2SO3 PBS (blue, right axes) of A-UL (a), ApT-UL (b), T-UL (c), and pTA-UL (d) with 10 
mW 630 nm (80 mW.cm−2) at 20 °C. 
Other silica-coated hybrid systems for TTA-UC have been reported. For 
example, Liu et al. described acid-catalyzed silica-coating of TTA-UC dye-
loaded Pluronic F-127 micelles with TEOS (similar to method B).[7a, 7b] They 
showed that the water-soluble particles performed upconversion, but did not 
mention oxygen quenching of the process at all. In fact, Wang and coworkers 
used identical particles that were functionalized with two dyes for ratiometric 
oxygen sensing in cells.[21] Obviously, such particles must be oxygen 
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permeable if they are used for oxygen sensing. Kwon et al. discussed the 
oxygen sensitivity of an upconverting oleic acid-core silica-shell nanocapsules, 
with a silica shell thickness of 12 − 23 nm.[5b] While the system was capable of 
upconversion in air, it was not the relatively thick silica shell that protected 
the dyes from oxygen, but the oleic acid that is able to scavenge oxygen; 
without oleic acid, no upconversion was observed. Thus, so far, in all TTA-UC 
systems with nm-thick silica shells, silica offers no protection from oxygen. 
Our results seem to be yet another example that nano-size silica layers, made 
by various methods, is not able to block the diffusion of molecular oxygen in 
aqueous solution. 
7.2.6 Upconversion with silica-coated liposomes in cells 
Although TTA-UC in liposomes or (organo)silica-coated liposomes in solution 
is too oxygen-sensitive, it would be incorrect to assume that they do not 
function in biological systems. Indeed, TTA-UC has been shown before to 
occur in vitro and in vivo with nanoparticle systems that are oxygen sensitive 
as well.[22] Up to now, a reasonable explanation has not yet been provided in 
the literature why such particles are able to produce upconversion in 
biological systems. Possibly, TTA-UC is facilitated by the presence of 
endogenous anti-oxidants that are able to lower the local oxygen 
concentration by consuming ground state oxygen or singlet oxygen (see 
Chapter 8 and Chapter 9). Furthermore, the silica shell may actually offer 
protection from oxygen in a biological situation in which oxygen is present at a 
lower concentration than in an aqueous dispersion. With this in mind, A549 
lung carcinoma cells were treated with UL, A-UL, ApT-UL, or pTA-UL and 
then imaged with (upconversion) luminescence microscopy. For these 
experiments, perylene was substituted by 2,5,8,11-tetra(tert-butyl)perylene 
(TBP, Figure 7.1) to prevent the annihilator from escaping the liposomes, 
which is known to occur for perylene.[23] First of all, uptake of the particles 
was investigated after 24 h incubation by regular fluorescence microscopy 
(20x magnification) to image the emission of TBP (λexc = 377 nm), see Figure 
S.VI.2. For both liposomes and silica-coated liposomes, the appearance of blue 
fluorescence throughout the cytosol confirmed the cellular uptake of the 
particles. The differences in zeta-potential and the presence of the 
(organo)silica-coating did not seem to affect the particle uptake significantly. 
Furthermore, no signs of particle toxicity were observed. In a second 
experiment, the cells were incubated with either UL or ApT-UL for 24 h and 
then imaged at 100x magnification with 405 nm and 639 nm excitation under 
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poorly oxygenated conditions (1% O2), see Figure 7.9. For both UL and ApT-
UL, under 405 nm excitation, bright fluorescent spots were observed, marking 
the locations of the TBP dye. Given that the usual uptake mechanism of 
liposomes is endocytosis, we assign these spots to be endo- and lysosomes. 
Interestingly, upon 639 nm excitation and observing between 450 to 575 nm, 
upconverted emission was observed at the same locations as that observed for 
TBP fluorescence upon 405 nm excitation (Figure 7.9). Comparable 
upconversion was observed in vitro for both UL and ApT-UL. It was noticed 
that the upconversion intensity varied significantly from cell to cell, which 
possibly reflects differences in oxygenation levels and concentration of 
endogenous anti-oxidants. Overall, UL and ApT-UL performed upconversion 
in A549 cells, but silica-coating of the liposomes improved neither uptake nor 




Figure 7.9. a) Microscopy imaging in bright field mode at 100x magnification and with 405 or 639 
nm (26 W.cm−2) excitation of living A549 cells treated with either medium only (“no particles”), 
UL, or ApT-UL at 1% O2, 7% CO2, and 37 °C. b) Intensity profiles of luminescence observed with 
405 and 639 nm along the red arrows given in (a), for samples UL (left) and ApT-UL (right). 
7.2.7 Dried upconverting silica-coated liposomes 
One of the reasons why the silica-coating does not act as an oxygen barrier 
may be the coating thickness. How thick should the silica-coating be to 
become a barrier for oxygen? Attempts were undertaken to grow extra layers 
of silica on ApT-UL, but this led inevitably to aggregation of the particles in 
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solution. As an alternative, it was decided to prepare a solid silica-liposome 
composite material by drying unpurified A-UL and ApT-UL samples, i.e. 
without removing the excess of APTES or preTEOS, in an oven at 50 °C 
overnight. The new samples were called A-UL-D and ApT-UL-D, respectively. 
As silica-free control, liposomes UL were freeze-dried (sample UL-F). For A-
UL-D and ApT-UL-D, heat-drying drives the condensation equilibrium of the 
(organo)silica network to the fully condensed species by the removal of H2O 
and EtOH, making a dense silica material. 
The solids were characterized with Scanning Electron Microscopy (SEM) and 
29Si-NMR. Figure 7.10 shows SEM images of the solids. A-UL-D consisted of a 
mesh of spherical-polygonal particles within the same size range as the water 
dispersed A-UL particles observed by TEM. The 29Si-NMR spectrum (Figure 
S.VI.3) shows a broad peak at −68 ppm, corresponding to the fully condensed 
(T3) organosilica product of APTES.[20a, 24]II In comparison, ApT-UL-D had a 
more coarse structure, and individual particles could not be distinguished. 
This is consistent with the hypothesis that ApT-UL particles are embedded in 
a matrix of amorphous silica. The 29Si-NMR spectrum of this material showed 
two peaks at −106  and −96 ppm, corresponding to the triple-condensed (Q3) 
and double-condensed (Q2) silica products of TEOS (Figure S.VI.3). Thus, the 
silica matrix of ApT-UL-D is not fully condensed. No signals originating from 
condensed APTES were detected, which emphasizes that the silica vs. 
organosilica ratio is very high. In contrast, SEM images of UL-F suggested that 
this sticky solid consisted of a network of broken lipid bilayers, which 
underlines that the silica shell around the liposomes is necessary to conserve 
the nanostructure of the silica-coated liposomes inside the dried composite 
materials.  
To investigate the integrity of the liposomes inside the material, 
thermogravimetric analysis (TGA) was performed of all solid samples. If the 
liposomes would be intact, i.e. defined as a lipid bilayer surrounding an 
aqueous interior, it was expected that first water would escape from ~100 °C 
onwards, followed by thermal decomposition of the phospholipids at a higher 
temperature. Figure 7.11 shows the TGA curves of freeze-dried liposomes UL-
F, and heat-dried (organo)silica-coated liposomes A-UL-D and ApT-UL-D. The 
                                                             
II 29Si-NMR peak designations are coded by the number of bonded oxygen atoms (T = 3, Q = 4) 
and by the number of siloxane (Si-O-Si) bonds (subscript 0 − 4).[20a] 
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mass of UL-F reduces by 75% between 230 and 350 °C, indicating the 
expected thermal decomposition of the phospholipids. The curve for ApT-UL-
D is very similar to UL-F, but with a 40% mass reduction between 230 and 
350 °C. The higher residual mass is attributed to the empty residual silica 
shells, which evidently do not decompose at this temperature. No mass 
decrease was observed between 30 and 230 °C, indicating the absence of 
water and thus the absence of intact liposomes inside this material. The TGA 
curve for A-UL-D shows a gradual mass reduction of 13% between 100 and 
200 °C, and again a second mass reduction from 230 °C onwards. The mass 
reductions between 100 and 200 °C suggest the loss of water. However, the 
theoretical percentage of water mass, assuming 100% synthesis yield and 130 
nm diameter liposomes, would amount to 50 − 60%. Therefore, these data 
indicate that only a relatively small part of A-UL-D consist of intact liposomes 
and that the (organo)silica matrix around the liposomes was not able to 
prevent drying out of the aqueous interior of the liposomes. 
 
Figure 7.10. SEM micrographs of dried (organo)silica-coated liposomes A-UL-D and ApT-UL-D, 
and freeze-dried liposomes UL-F. 
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Regardless of the fact that the water inside the material is lost, the residual 
fragments of dye-doped lipid bilayer inside the solid may still be able to 
perform upconversion. As an initial test, A-UL-D powder was irradiated with 
630 nm in air, and surprisingly, blue luminescence was clearly visible after 
blocking the excitation light (Figure 7.12a). Emission spectroscopy (λexc = 630 
nm, 30 mW, 0.66 W.cm−2) confirmed that A-UL-D and ApT-UL-D were indeed 
producing upconverted luminescence under red light irradiation (Figure 
7.12b). In contrast, no upconversion in air was detected for freeze-dried 
liposomes UL-F (Figure S.VI.4). These results indicate that (organo)silica can 
indeed offer protection from oxygen in TTA-UC materials. To offer such 
protection, however, it is clear that a much thicker layer is necessary than the 
nano-thick shells applied to water-dispersible silica-coated liposomes. The 
upconversion emission in A-UL-D and ApT-UL-D was not very durable; 
bleaching occurred within minutes at 0.66 W.cm−2 irradiance (Figure 7.12c). 
Time-traces of the upconversion intensity revealed that the emission was 
more long-lasting for A-UL-D.  Whereas all upconversion luminescence had 
bleached within 2 min for ApT-UL-D, 40% of the start intensity still remained 
for A-UL-D. This difference may be caused by the greater amount of primary 
amine groups in A-UL-D, which are known to chemically quench singlet 
oxygen. Such a chemical reaction consumes dioxygen and therefore may 
contribute to an oxygen-low environment inside the material upon 
irradiation.[25] Nonetheless, the relative instability of the upconversion 
emission underlines that even in such bulk materials, (organo)silica does not 
completely obstruct the diffusion of oxygen. Finally, it must be emphasized 
that these results are rather preliminary and that the preparation method for 
obtaining these silica-coated materials can be greatly improved. We foresee 
that an optimized drying procedure would yield solids with higher degree of 
silica condensation and in which all the water inside the liposomes remains 
trapped. Then, the addition of water soluble anti-oxidants to the aqueous 
interior of the liposomes before silicification and drying, which would end up 
inside the material, would greatly enhance the upconversion quantum yield 
and stability in air (see Chapter 8 and Chapter 9). Such highly tunable nano-
composite materials, consisting of silica, phospholipids, and water, would 





Figure 7.11. Thermogravimetric analysis plots from 30 to 500 °C (10 °C.min−1 in air) of freeze-
dried liposomes UL-F, and heat-dried (organo)silica-coated liposomes A-UL-D and ApT-UL-D. 
 
Figure 7.12. Upconversion with heat-dried silica-coated liposomes. a) Photographs of heat-dried 
organosilica-coated liposomes A-UL-D in ambient light (left) and irradiated with red light and 
photographed with a 575 nm short pass filter in front of the camera (right). b) Emission spectra of 
A-UL-D (solid) and ApT-UL-D (dashed) under 630 nm irradiation, normalized at 800 nm. c) 
Typical time-traces of the normalized upconversion intensity (IUC) at 474 nm of A-UL-D (solid) and 
ApT-UL-D (dashed) under continuous 630 nm irradiation. All experiments were performed at 20 




Monodisperse (organo)silica-coated liposomes were prepared that can be 
used to upconvert red light to blue light by means of triplet-triplet 
annihilation upconversion. The silica-coating did not prevent the 
upconversion to be quenched by molecular oxygen in solution. Furthermore, 
the upconverted blue light could be imaged in living A549 cells in hypoxic 
conditions without causing cytotoxicity, but the luminescence was not more 
intense than in control cells that had been treated with uncoated upconverting 
liposomes. However, when the (organo)silica-coated liposomes were heat-
dried in presence of excess (organo)silica precursor, solids were obtained that 
could perform upconversion in air. Our results suggest that the (organo)silica 
shell of the silica-coated liposomes in solution needs to be much thicker 
and/or compact to protect the upconversion from oxygen in a biological 
setting. This work represents noteworthy examples of the combination of 
phospholipids, water, and silica for the construction of tunable upconverting 
nanoparticles and materials. Such hybrid systems combine the favorable 
properties of their constituents, and may eventually be used in applications 
such as drug delivery, cell imaging, photocatalysis, and solar energy 
harvesting. 
7.4  Experimental Section 
7.4.1 General 
1,2-dilaureyl-sn-glycero-3-phosphocholine (DLPC), 1,2-dimyristoyl-sn-glycero-3-phospho 
choline (DMPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), and sodium N-(carbonyl-
methoxypolyethylene glycol-2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE-
mPEG-2000) were purchased from Lipoid GmbH (Ludwigshafen, Germany) and stored at −18 
°C. Palladium tetraphenyltetrabenzoporphyrin (PdTPTBP) was purchased from Bio-Connect 
(Huissen, The Netherlands). Perylene was purchased from Sigma-Aldrich Chemie BV 
(Zwijndrecht, The Netherlands). The synthesis of 2,5,8,11-tetra(tert-butyl)perylene (TBPe) is 
described in Chapter 9. Dulbecco’s phosphate buffered saline (DPBS) was purchased 
from Sigma Aldrich and had a formulation of 8 g.L−1 NaCl, 0.2 g.L−1 KCl, 0.2 g.L−1 KH2PO4, and 
1.15 g.L−1 K2HPO4 with a pH of 7.1 − 7.5. All other chemicals were obtained from the major 
companies and used as received. 
7.4.2 Instrumentation 
Ultracentrifugation was done with a Beckman-Coulter Optima L-90K ultracentrifuge, equipped 
with a 70.1 Ti rotor, at 50K rpm (230,000 g) for 30 min. Freeze-dried samples were prepared 
with a Christ Alpha 1-2 LDPlus machine, operating at <0.03 mbar. Liposome or silica-coated 
liposome samples were placed in 50 mL round bottom flasks, frozen in liquid nitrogen while 
gently swirling, and attached to the freeze-dryer. Dynamic Light Scattering (DLS) 
measurements were performed on undiluted samples ([DMPC] = 10 mM) using a Zetasizer nano 
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S (Malvern Instruments) operating at 633 nm, with 3 measurements of 12 runs each time. Zeta-
potential measurements were performed on a Zetasizer nano ZS (Malvern Instruments), at 
25 °C with 3 measurements and 10 − 100 automatic runs. Samples were diluted 20x in MilliQ in 
a DTS1070 cell, at a known pH, so that [DMPC] = 0.5 mM. Fourier Transform Infrared (FT-IR) 
spectra were recorded on a Perkin-Elmer Paragon 1000. Transmission Electron Microscopy 
(TEM) imaging was performed on a JEOL 1010 TEM using accelerating voltages of 60.0 or 
80.0 kV, iTEM software and a Olympus Megaview G2 camera. Samples were loaded onto 
Formvar-coated carbon grids (Van Loenen instruments, Netherlands) by depositing a grid on 
top of a sample droplet for about 30 minutes. CP-MAS 29Si Nuclear Magnetic Resonance (NMR) 
spectroscopy was performed on a Bruker AV400 using a relaxation delay of 60 seconds and 
pulse duration of 3 µsec. Scanning Electron Microscopy (SEM) was performed on a Nova 
NanoSEM (FEI) using accelerating voltages of 15.0 kV. Powder samples were deposited on 
conducting tape. Thermogravimetric Analysis (TGA) measurements were performed on a 
Netzsch STA with a DSC/TG Al2O3 pan crucible, with a temperature increasing from 30 to 500 °C  
at 10 °C.min−1, and a gas flow of 40 mL.min−1.  
7.4.3 Preparation of upconverting liposomes 
Aliquots of stock solutions in chloroform were added together in a round bottom flask to obtain 
a mixture of DMPC lipid (5 mM in CHCl3, 10 mL, 50 µmol), DSPE-mPEG-2000 (0.2 mM in CHCl3, 
10 mL, 2 µmol), PdTPTBP (10 µM in CHCl3, 2.5 mL, 25 nmol) and perylene (0.2 mM in CHCl3, 
1.25 mL, 250 nmol). For liposomes used in cell treatment, the perylene dye was replaced by 
TBPe in the same amount. The solvent was removed by rotary evaporation at 50 °C under 
reduced pressure and then under high vacuum for at least 15 minutes. PBS buffer (5 mL) was 
added to the lipid film to obtain a final DMPC lipid concentration of 10 mM. The flask was then 
freeze-thawed using liquid nitrogen and a water bath at 50 °C for 3 cycles, and the suspension 
was subsequently extruded using a 200 nm Nuclepore polycarbonate filter and a mini-extruder 
(Avanti Polar Lipids, Inc.) at 55 °C, for at least 11 times. All dyes were incorporated into the 
liposomes with minimal losses, as indicated by the lack of color on the filter after the extrusion. 
The resulting liposome suspension was analyzed by DLS before use in further synthesis steps. 
Optionally, an oxygen scavenger was added in a given concentration to the PBS buffer. After 
extrusion, the oxygen scavenger-loaded liposomes were purified using an Illustra NAP-25 size 
exclusion column with Sephadex G25 packing (GE Healthcare). Typically, liposomes were 
loaded on the column in 1 mL portions, and eluted with 2 mL PBS. Fractions of about 0.4 mL 
were collected; fractions 6 − 10 contained the liposomes as judged by the green-yellow color, 
fractions 12 and above contained the oxygen scavenger, as judged by the addition of 
2,6-dichlorophenolindophenol (DCPIP; 1.0 mM in PBS, 200 µL, 200 nmol) to each fraction. The 
fractions containing the liposomes (~ 2 mL, i.e. [lipid] ≈ 5 mM) were combined and used for 
further synthesis.  
7.4.4 Silica-coating of upconverting liposomes 
Silica-coated liposomes were prepared according to a modified literature procedure.[16a, 17a, 17b]  
Method A - APTES-preTEOS coating 
(3-Aminopropyl)triethoxysilane (APTES, 293 µL, 1.25 mmol) was added to the liposome 
solution (section 7.4.3, 5 mL, [DMPC] ≈ 5 mM) and the mixture was stirred for 16 h. At this 
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point, the pH was 10.7. To remove unreacted and unassociated APTES, the sample was 
ultracentrifuged and resuspended in 5 mL PBS twice, which neutralized the pH. This washing 
procedure did not affect the particle size distribution and shape, as judged by TEM (data not 
shown). Meanwhile, tetraethylorthosilicate (TEOS) was pre-hydrolyzed in PBS (typically 50 mM 
TEOS) for 24 h at 40 °C, creating a solution of 50 mM pre-hydrolyzed TEOS called “preTEOS”. 
Preliminary experiments determined that a pre-hydrolysis time of 24 hours was optimal for 50 
mM TEOS in PBS. A longer time resulted in the formation of non-desired silica nanoparticles 
(observed by DLS), and a shorter time resulted in sample aggregation during liposome coating. 
Higher TEOS concentrations resulted in formation of silica nanoparticles as well. Thus, 8 mL 
preTEOS (50 mM, 400 µmol) was added to the APTES-coated liposome suspension (5 mL) and 
the mixture was stirred for 24 h at 20 °C. The final APTES-preTEOS coated liposomes were 
purified by ultracentrifugation and redispersion in 5 mL MilliQ or PBS (once).  
Method B − Acid-catalyzed TEOS coating 
Liposomes were prepared as mentioned in Section 7.4.3, but instead of PBS, 1 M HCl in PBS was 
used to hydrate the lipid film. The liposome assembly under such acidic conditions produced 
high quality liposomes (z-ave 134 nm, 0.1 PDI). After liposome assembly, TEOS (36 µL, 160 
µmol) was added to 2 mL of the liposome solution ([DMPC] ≈ 5 mM) and stirred for 30 minutes. 
Then, the solution was transferred to a dialysis bag (Servapor, MW cutoff 12 − 14 KDa; SERVA 
Electrophoresis GmbH) and dialyzed against demineralized water (1 L) for 24 h, during which 
time the water was refreshed twice. 
Method C − PreTEOS-APTES coating 
First, TEOS was pre-hydrolyzed in PBS (typically 50 mM TEOS) for 24 hours at 40 °C, creating a 
solution of 50 mM pre-hydrolyzed TEOS called “preTEOS”. 8 mL PreTEOS (400 µmol) was then 
added to the liposome suspension (Section 7.4.3, 5 mL, [DMPC] ≈ 5 mM) and stirred for 24 h at 
20 °C. These TEOS-coated liposomes were ultracentrifuged and redispersed in 5 mL PBS twice 
to remove unreacted and unassociated TEOS. APTES (293 µL, 1.25 mmol) was added to the 
coated liposome solution (5 mL) and the solution was stirred overnight for 16 h. The final 
preTEOS-APTES coated liposomes were purified by ultracentrifugation and redispersion in 5 
mL MilliQ or PBS (once). 
7.4.5 Preparation of (silica-coated) liposome solids 
Freeze-dried liposome solids were prepared by freeze-drying at ≤ 0.03 mbar (section 7.4.2). 
Oven-dried silica-coated liposome solids were prepared by depositing unpurified silica-coated 
liposomes A-UL or ApT-UL (i.e. including excess APTES and/or preTEOS) in 5 mL portions on 
watch glasses and drying overnight at 50 °C.  
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7.4.6 UV-Vis absorption and emission spectroscopy 
 
Figure 7.13 Setup used for emission spectroscopy on samples in solution using red light irradiation. Legend: (1) 
630 nm laser source, (2) optical fibers, (3) filter holder, (4) 630 nm band pass filter, (5) variable neutral density 
filter, (6) temperature controlled cuvette holder, (7) variable filter holder with a 633 nm notch filter, and (8) 
CCD spectrometer. 
Absorption and emission spectroscopy was performed with a custom-built setup (Figure 7.13). 
Typically, a 2 mL sample was transferred in a 111-OS macro fluorescence cuvette from Hellma 
and placed in a CUV-UV/VIS-TC temperature-controlled cuvette holder from Avantes 
(Apeldoorn, The Netherlands). Every time the temperature was changed, the sample was 
allowed to equilibrate for 5 minutes. The samples were irradiated from the side with a 10 mW 
630 nm laser light beam from a clinical grade Diomed 630 nm PDT laser (4 mm beam, 80 
mW.cm−2). The 630 nm light was filtered through a FB630-10, 630 nm band pass filter 
(Thorlabs, Dachau/Munich, Germany) put between the laser and the sample. The excitation 
power was controlled using a NDL-25C-4 variable neutral density filter (Thorlabs), and 
measured using a S310C thermal sensor connected to a PM100USB power meter (Thorlabs). An 
Avantes 2048L StarLine CCD spectrometer was connected at 90° angle with respect to the 
excitation source. A Thorlabs NF-633 notch filter placed between the cuvette holder and the 
spectrometer was used to block the excitation light. To make the emission spectra of the 
different samples in solution comparable, the samples were diluted in PBS so that A630 = 0.20. 
Optionally, Na2SO3 (1 mL, 100 mM in PBS, pH = 7.4) was freshly added to 1 mL samples so that 
50 mM Na2SO3 was present for oxygen scavenging during spectroscopy. 
7.4.7 Solid state emission spectroscopy 
 
Figure 7.14. Setup used for emission spectroscopy on powders using red light irradiation. Legend: (1) 630 nm 
laser source, (2) optical fibers, (3) filter holder, (4) 630 nm band pass filter, (5) variable neutral density filter, 
(6) temperature controlled cuvette holder, (7) bifurcated optical fiber, (8) variable filter holder with a 633 nm 
notch filter, and (9) CCD spectrometer. 
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Solid state emission spectroscopy was done in a slightly different setup than for liquid samples 
(Figure 7.14). A bifurcated fiber (FCB UVIR 400-2, Avantes) was connected to the top of the 
cuvette holder, in which a lens (Avantes COL-UV/VIS lens, f = 8.7 mm) was fitted that 
simultaneously transmitted excitation light and captured the emission. 7.1 mg solid sample was 
deposited on the bottom of a semi-micro cuvette. Samples were irradiated with 30 mW 630 nm 
light (2.4 mm beam, 0.66 W.cm−2).  
7.4.8 General cell culturing 
A549 human lung carcinoma cells were cultured in 25 cm2 flasks in 8 mL Dulbecco’s Modified 
Eagle Medium with phenol red (DMEM; Sigma Life Science, USA), supplemented with 8.2% v/v 
fetal calf serum (FCS; Hyclone), 200 mg.L−1 penicillin and streptomycin (P/S; Duchefa), and 1.8 
mM glutamine S (GM; Gibco, USA), under standard culturing conditions (humidified, 37 °C 
atmosphere containing 7.0% CO2). The cells were split approximately once per week upon 
reaching 70 − 80% confluency, using seeding densities of 2 × 105 cells, and the medium was 
refreshed once per week. Cells were passaged for 4 − 8 weeks.  
7.4.9 Regular fluorescence microscopy 
For regular fluorescence microscopy experiments, cells were seeded into 6-well plates, 200K 
cells per well. Meanwhile, the liposome- or silica-coated liposome-samples at a 2.5 mM lipid 
concentration were filtered through a 0.45 µm filter and further brought to a 1 mM final lipid 
concentration with OptiMEM (Life Technologies, USA), supplemented with 2.5% FCS, 200 mg/L 
P/S, and 1.8 mM GM (“OptiMEM complete”). 24 h after cell seeding, 3 mL of liposome mixture 
was added to each well, and the cells were incubated for another 24 hours. Then, the liposomes 
were removed and the cells were washed once with PBS and supplied with 1 mL OptiMEM. The 
cells were imaged in bright field mode (250 ms exposure) and with 377 nm excitation (1000 ms 
exposure) using a Leica SPE confocal microscope at 20x magnification and Cell^M software. 
7.4.10 Upconversion luminescence microscopy 
For upconversion microscopy experiments, cells were seeded at 30K on 25 mm diameter 
microscopy coverslips (VWR, thickness no. 1) in 6-well plates. Meanwhile, the liposome- or 
silica-coated liposome-samples at a 2.5 mM lipid concentration were filtered through a 0.45 µm 
pore filter and further brought to a 1 mM final lipid concentration with OptiMEM complete. 24 h 
after seeding, 3 mL liposome-medium mixture was added to each well and incubated for 24 h. 
Then, the liposomes were washed once with PBS and supplied with 1 mL OptiMEM. The 
coverslips were transferred to custom-made coverslip holders, which in turn were put in a 
stage-top miniature incubator (Tokai Hit, INUBG2ETFP-WSKM) fitted with a GM-8000 gas 
controller. The cells were incubated for 30 minutes at 1% O2, 7% CO2, and 37 °C before imaging. 
Imaging was performed with a customized Zeiss Axiovert S100 Inverted Microscope setup, 
fitted with a Zeiss 100x Plan Apochromat 1.4 NA oil objective, and an Orca Flash 4.0 V2 sCMOS 
camera from Hamamatsu, which together produced images with pixel size of 69 nm (for 100x). 
The typical camera exposure time was 1000 ms. Excitation at 405 nm was performed with a 
CrystaLaser DL405-050 diode laser, in combination with a Chroma zet442/514/568m emission 
filter and Chroma zt405/514/561rpc dichroic mirror. The output power of the 405 nm laser at 
the sample was typically 62 µW at 100 x magnification (60 μm spot diameter, intensity 2.2 
W.cm−2). Excitation at 639 nm was performed with a Power Technology 1Q1A30(639-35B)G3 
diode laser, in combination with a 575 nm short pass filter (Edmund Optics, part no. #84-709) 
and Chroma zt405/532/635rpc dichroic mirror. The output power of the 639 nm laser at the 
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sample was typically 1.0 mW at 100 x magnification (70 μm spot diameter, 26 W.cm−2 
intensity). 
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Activation of liposome-bound Ru(II) prodrugs using red-





Light upconversion by means of triplet-triplet annihilation upconversion (TTA-UC) is 
a promising photochemical approach to shift the activation wavelength of 
photodissociative ruthenium(II) prodrugs to the phototherapeutic window. In this 
chapter, the biological application of liposomes doped with red-to-blue upconverting 
TTA-UC dyes and blue-light responsive Ru-prodrugs is addressed. The oxygen-
sensitivity of TTA-UC in liposomes was effectively reduced by the addition of water-
soluble and biocompatible anti-oxidants. This strategy also resulted in greatly 
enhanced upconversion emission in living cells. To demonstrate the in vivo 
applicability of upconversion mediated Ru-prodrug release, it was shown that red-to-
blue TTA-UC could be generated at a depth of 12 mm in chicken and pork fillet, and 
that Ru prodrugs could be activated by red-to-blue TTA-UC at a depth of 7 mm in pork 
fillet under irradiation of a medical grade 630 nm PDT laser. Finally, the 
photocytotoxicity of the liposomes in combination with red light irradiation was 
investigated in A549, MCF7, and MRC5 cells. Unfortunately, neither irradiation of Ru-
bound prodrugs with blue light (direct activation) nor with red light (mediated by 
TTA-UC) resulted in high toxicity compared to experiments conducted in the dark, due 
to the poor overall toxicity of the here-studied Ru complexes. Altogether, the results 
presented in this chapter provide valuable insights in which requirements need to be 
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Light-activatable ruthenium polypyridyl complexes have received 
considerable attention as promising anticancer pro-drugs in photoactivated 
chemotherapy (PACT).[1] It is proposed that upon excitation with visible light, 
they are transformed from the non-toxic “caged” compound to the cytotoxic 
species. With such compounds, undesired side-effects for patients can be 
greatly reduced by the excellent spatio-temporal control over activation. Also, 
the toxicity does not depend on the presence of oxygen, as opposed to 
photodynamic therapy (PDT) that functions by generating highly reactive 
oxygen species (ROS). Thus, using light-activatable Ru-complexes may be 
suitable for hypoxic tumor tissues for which PDT is not effective. Furthermore, 
non-covalent binding of ruthenium polypyridyl complexes to PEGylated 
liposomes by means of a lipophilic anchor-ligand may help targeting these 
compounds towards tumor tissues by making use of the leaky vasculature of 
tumors, i.e. the enhanced permeability and retention effect .[2] 
 
Figure 8.1. Chemical structures of palladium(II) tetraphenyltetrabenzoporphyrin (1), perylene (2), 
and 2,5,8,11-tetra(tert-butyl)perylene (3). 
However, most Ru-complexes are only activatable with blue or green light, 
while those wavelengths do not penetrate human tissue very well. Shifting the 
excitation wavelength of ruthenium complexes to the phototherapeutic 
window (600 − 950 nm) by molecular design remains very challenging.[3] To 
circumvent this problem, upconversion of light can be used to locally 
“upgrade” red to near-infrared photons to blue or green photons, with which 
the pro-drug can be activated. Especially the combination of red-to-blue 
triplet-triplet annihilation upconversion (TTA-UC) and light-sensitive 
ruthenium complexes on liposomal drug carriers is very promising, as 
demonstrated in Chapter 3 and Chapter 4.[4] A red-to-blue TTA-UC dye couple 
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consisting of  palladium(II) tetraphenyltetrabenzoporphyrin (1) and perylene 
(2, see Figure 8.1) was doped in PEGylated liposomes and used for effectively 
triggering the photodissociation reaction of [Ru(tpy)(bpy)(thioether-
cholesterol)]2+ (42+, see Figure 8.2) to [Ru(tpy)(bpy)(H2O)]2+ (82+). In further 
experiments (Chapter 4), lifetime and steady-state spectroscopy experiments 
revealed that the upconverted blue light of 2 was transferred with ~90% 
efficiency to 42+ via a Förster resonance energy-transfer (FRET) mechanism 
when all three molecules were doped in the same liposome membrane. 
 
Figure 8.2. Chemical structures of ruthenium polypyridyl complexes 42+, 52+, 62+, and 72+ and their 




Figure 8.3. Schematic representation of the three liposome systems (System A, B, and C) studied in 
this chapter. Compound 42+ features as an example of a Ru-complex which can be anchored to 
liposome membrane. 
However, the biological application of these upconverting liposomes doped 
with Ru-prodrugs is not straightforward. Especially the biocompatibility and 
toxicity of the system, the oxygen sensitivity of the TTA-UC mechanism, and 
the photoactivation with red light in biological systems have not been 
addressed so far. Moreover, the (photo)cytotoxicity of Ru-prodrug doped 
liposomes with blue light irradiation (i.e. without upconversion) has not yet 
been investigated as well. In this chapter, three major types of liposomes will 
be prepared, called System A, B, and C (Figure 8.3), and their photochemical 
properties and (photo)cytotoxicity will be evaluated. System A consists of 
liposomes doped with upconverting dyes 1 and 2 or 1 and 3; System B 
consists of liposomes doped with only Ru-complex 42+, 52+, 62+, or 72+; System 
C consists of liposomes doped with upconverting dyes 1 and 3 and Ru-
complex 62+. The following research questions will be addressed: 
i. Are red-to-blue upconverting liposomes able to produce upconversion 




ii. Are upconverting liposomes cytotoxic in the dark and what becomes 
their cytotoxicity under red-light irradiation?  (System A) 
iii. How are upconverting liposomes digested after uptake? (System A) 
iv. Up to which depth can TTA-UC with red-to-blue upconverting 
liposomes be generated in a model of healthy human tissue? 
(System A) 
v. Is it really advantageous to use red light instead of blue light? Does the 
greater penetration depth of red light with respect to blue light result 
in a greater degree of prodrug activation? (System C) 
vi. Are liposomes doped with ruthenium complexes (photo)cytotoxic 
under dark and blue light irradiated conditions? (System B) 
vii. Can ruthenium prodrugs on liposomes be activated by red-to-blue 
TTA-UC in vitro in hypoxic conditions? (System C) 
8.2 Results and discussion 
8.2.1 Liposome preparation 
Neutral PEGylated liposomes were prepared by a standard hydration-
extrusion protocol in phosphate buffered saline (PBS) as described before 
(Chapter 3 − Chapter 7). Where applicable, before addition to the lipid film,  
PBS was supplemented with a known concentration of L-ascorbic acid (L-Asc) 
and/or glutathione (GSH), and neutralized to pH 7.0 − 7.6 with NaOH. The 
major component of all liposomes was a neutral phospholipid, i.e. either 1,2-
dilauroyl-sn-glycero-3-phosphocholine (DLPC, liposomes denoted with L in 
Table 8.1) or 1,2-dimyristoyl-sn-glycero-3-phosphocholine was used (DMPC, 
liposomes denoted with M). The liposomes were PEGylated with 4 mol% 
sodium N-(carbonyl-methoxy polyethyleneglycol-2000)-1,2-distearoyl-sn- 
glycero-3-phospho ethanolamine (DSPE-mPEG-2000), which is known to 
prevent aggregation and prolong the blood-circulation lifetime of liposomes.[2] 
Finally, the liposomes were doped with either the TTA-UC dye couple 
(System A; 0.05 mol% 1, 0.5 mol% 2 or 3), or Ru-complex (System B; 4 mol% 
42+, 52+, 62+, or 72+), or all three components (System C; 0.05 mol% 1, 1 mol% 
3, and 4 mol% 62+); see Figure 8.3 for a schematic representation of systems A, 
B, and C and Table 8.1 for the exact liposome formulations and the codes used 
to name all liposomes. Incorporation of all dopants in the final samples was 
complete, as the extrusion filter during liposome preparation remained almost 
colorless. Dynamic light scattering (DLS) experiments revealed that the 
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hydrodynamic size (z-ave) of all liposomes varied from 130 − 170 nm with an 
average polydispersity index (PDI) of 0.1.  
Table 8.1. Summary of liposome formulations used in this chapter. Liposomes with designation L 
or M are made with DLPC or DMPC as main lipid, respectively. 
System Code [DMPC]  [DLPC] [PEG][a] [1]  [2]  [3]   [42+]  [52+]  [62+] [72+] 
  mM mM mM μM μM μM μM μM μM μM 
A 
L1-2  5.0 0.20 2.5 25      
M1 5.0  0.20 2.5       
M2 5.0  0.20  25      
M3 5.0  0.20   25     
M1-3 5.0  0.20 2.5  25     
B 
M4 5.0  0.20    200    
M5 5.0  0.20     200   
M6 5.0  0.20      200  
M7 5.0  0.20       200 
C 
L1-3-6  5.0 0.20 2.5  50   200  
M1-3-6 5.0  0.20 2.5  50   200  
M3-6 5.0  0.20   50   200  
[a] PEG = DSPE-mPEG-2000 
8.2.2 Anti-oxidants protect TTA-UC in DLPC liposomes in air in solution 
One strategy of reducing the oxygen-sensitivity of TTA-UC in liposomes is the 
addition of water soluble anti-oxidants that react with ground state or singlet 
state oxygen to chemically deoxygenate the solution. To evaluate the influence 
of water-soluble anti-oxidants on TTA-UC, red-to-blue upconverting 
PEGylated DLPC liposomes (L1-2) were mixed with various amounts of L-Asc 
or GSH. Here, DLPC was used as main lipid, because red-to-blue TTA-UC was 
found to be much more efficient at room temperature in DLPC than DMPC 
liposomes (Chapter 6). The UV-vis absorbance spectrum of L1-2 in presence 
of 5 mM L-Asc shows the typical absorption peaks of 2 between 375 and 450 
nm, and the absorption peaks of 1 at 440 and 630 nm (Figure 8.4a). A small 
band below 400 nm was attributed to absorption of L-Asc and oxidized 
ascorbate products. When the sample was irradiated with 10 mW 630 nm 
light (80 mW.cm−2), emission spectra (recorded every 3 s) after switching on 
the laser initially showed only weak phosphorescence of 1 at 800 nm and no 
upconversion emission (Figure 8.4a, inset). However, after 1 min of red light 
irradiation, the phosphorescence at 800 nm suddenly intensified and intense 
upconversion emission at 474 nm was observed. We define the progressed 
time until this time-point as the “lag-time” (see Figure 8.4a, inset). After 2 min, 
the emission spectrum had stabilized in time and it was identical to that 
observed under deoxygenated conditions (see Chapter 6, Figure 6.2). No 
upconversion was observed in air in absence of L-Asc (data not shown). To 
explain this observation, it was hypothesized that upon irradiation compound 
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1 first reacted with ground-state oxygen to make singlet oxygen, that in turn 
reacted with L-Asc. This photoreaction was repeated until all ground-state 
oxygen present in the irradiated solution was depleted. When the oxygen 
concentration becomes low enough, triplet-state photosensitizer and 
annihilator are no longer quenched, leading to efficient TTA-UC and increased 
phosphorescence of 1.  
 
Figure 8.4. Emission spectroscopy in air of L1-2 liposomes PBS supplemented with L-Asc or GSH. a) 
Absorption (solid) and emission spectra (dotted: t = 0; dashed: t = 5 min) of L1-2 liposomes in PBS 
supplemented with 5 mM L-Asc. Inset shows the upconversion intensity (IUC at 474 nm) for the first 
5 min of irradiation with 3 s intervals. b) Time trace of the upconversion intensity (IUC at 474 nm, 
blue), phosphorescence intensity (Ip at 800 nm, red), and dissolved oxygen concentration (black) 
during red light irradiation of L1-2 liposomes in PBS supplemented with 5 mM L-Asc. The laser was 
turned on after 74 min in the dark, as indicated by the arrow. c/d) Lag-time as a function of [L-Asc] 
(c) or [GSH] (d). Exp. conditions: [DLPC] = 1 mM, [1] = 0.5 µM, [2] = 5 µM, 2.25 mL sample, T = 20 
°C 10 mW 630 nm laser excitation (80 mW.cm−2) with approximately 8% of the volume 
simultaneously irradiated, pH 7.0 − 7.6.  
To confirm this hypothesis, the experiment was repeated while measuring the 
dissolved oxygen concentration using a NeoFox oxygen probe dipped in the 
solution (Figure 8.4b). In the first 74 min the sample was left in the dark and 
the oxygen concentration remained close to the initial value, showing that 
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ground state O2 quenching is very slow with L-Asc. When the laser was turned 
on however, rapid consumption of all the oxygen in the cuvette was observed 
within 5 min while intense upconversion emission was observed after 1 min 
of continuous irradiation. The upconversion was stable for the next 45 min 
after which the experiment was stopped. Overall, these results demonstrate 
that the addition of L-Asc to a dispersion of upconverting liposomes allows 
efficient and stable upconversion to occur in air due to singlet-oxygen 
consumption upon irradiation. 
To study whether the lag-time varies with anti-oxidant concentration, the 
experiment was repeated with [L-Asc] ranging from 0.25 to 50 mM and the 
lag-time was measured in each situation (Figure 8.4c). Noteworthy a 
concentration of 0.25 mM did not give rise to any upconversion, presumably 
because the concentration of oxygen in air-equilibrated water has about the 
same value (9 ppm; ~0.25 mM). Upon increasing [L-Asc] from 0.5 mM to 5.0 
mM, the lag-time strongly decreased from 8 min to 1 min and had a value of 
ca. 0.5 min at a concentration of 50 mM. The same experiments were 
performed with GSH as anti-oxidant at 1 − 20 mM concentrations (Figure 
8.4d), which is close to physiological concentrations of this biological anti-
oxidant (0.5 − 10 mM).[5] For all concentrations, intense upconversion was 
also observed after a certain lag-time, but the lag-times were significantly 
longer than with L-Asc. Finally, a combination of 1 mM L-Asc and 5 mM GSH 
was used as anti-oxidant “cocktail”. Stable upconversion was observed after 
1.1 min, which is significantly faster than either of the anti-oxidants alone (3.2 
min for [L-Asc] at 1 mM; 13 min for [GSH] at 5 mM). This result suggests that 
using a combination of L-Asc and GSH synergistically minimizes the lag-time. 
For this reason, in further experiments a combination of these two anti-
oxidants was used. In conclusion, it was demonstrated that the addition of 
biologically relevant concentrations of biological anti-oxidants to 
upconverting liposomes results in stable TTA-UC in air-equilibrated solutions. 
Unfortunately, L1-2 liposomes were found to be unsuitable for in-vitro 
experiments, due to high cytotoxicity of the PEGylated DLPC liposomes in 
preliminary experiments: when A549 lung carcinoma cells were incubated 
with L1-2 liposomes ([DLPC] = 0.5 mM) for 4 h, 100% cell death was observed 
(data not shown). In contrast, DMPC liposomes were much less toxic and 
selected for the in vitro experiments (see below). 
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8.2.3 Anti-oxidants protect TTA-UC for DMPC liposomes in vitro  
To investigate whether the addition of anti-oxidants would also enhance 
TTA-UC in cells, A549 lung carcinoma cells were grown in vitro and incubated 
with upconverting DMPC liposomes M1-3 for 24 h with or without an anti-
oxidant “cocktail” composed of 2 mM L-Asc and 2 mM GSH. Perylene 
(compound 2) was replaced by 2,5,8,11-tetra(tert-butyl)perylene (compound 
3) to avoid partitioning of the annihilator to the water phase, which is known 
to occur for normal perylene.[6] Indeed, it was found that tert-butylation 
prevented liposomal escape of 3  (see Appendix VII for data and discussion). 
These experiments also confirmed that compound 1 does not escape from 
liposomes. After 24 h incubation and removing the excess of liposomes, the 
cells were imaged in bright field mode, with 405 nm, and with 639 nm 
excitation (2.7 and 26 W.cm−2 intensity, respectively). Additionally, a 1% 
oxygen atmosphere was used to mimic median tumor oxygen partial 
pressures, which generally range from 0.5% to 4% (pO2 = 5 − 30 mm Hg).[7] 
Using 405 nm excitation compound 3 was excited directly, leading to normal 
fluorescence. In this mode numerous fluorescent spots were observed 
throughout the cell cytoplasm, indicating that the liposomes had been 
successfully taken up. The presence of anti-oxidants did not influence the 
uptake of the vesicles. In absence of anti-oxidants, 639 nm excitation did not 
lead to significant upconversion luminescence, indicating that the liposomes 
were not capable of producing upconversion. However, when the cells were 
co-incubated with the anti-oxidant cocktail, bright upconversion was observed 
at the same sites as that of the fluorescence observed under 405 nm 
excitation. This result indicates that at these locations, both dyes were present 
simultaneously, thus suggesting that the liposomes were intact and functional. 
Note that under these conditions the upconversion luminescence was not very 
stable: it quickly faded and disappeared within a few seconds. Overall, these 
results demonstrate that co-treatment of cells with biologically relevant 
amounts of  anti-oxidants can significantly boost upconversion of M1-3 




Figure 8.5. In vitro upconversion imaging of M1-3 upconverting liposomes in living A549 lung 
carcinoma cells in bright field mode (left column), with λexc = 405 nm and λem = 450 – 525 nm 
(middle column), and with λexc = 635 nm and λem = 450 – 525 nm (right column) at 100x 
magnification. Cells were incubated for 24 h with medium only (top row), with M1-3 liposomes 
(middle row, [DMPC] = 1 mM), or M1-3 liposomes with addition of 2 mM L-Asc and 2 mM GSH 
(bottom row, [DMPC] = 1 mM). Imaging conditions: T = 37 °C, 7.0% CO2, 1.0% O2, 75 µW 405 nm 
laser power (60 µm spot diameter, 2.7 W.cm−2 intensity), 1.0 mW 639 nm laser power (70 µm spot 
diameter, 26 W.cm−2 intensity). For comparability, the images are identically colored for λexc = 405 
nm from 100 − 2500 pixel values (black blue white) , and for λexc = 635 nm from 100 − 200 
pixel values (black blue white), as indicated by the calibration bars in the top row. 
To investigate the exact location of M1-3 liposomes, the cells were 
additionally stained with LysoTracker Red DND-99 to label acidic organelles 
such as late endosomes and lysosomes. This probe is not excited with either 
405 or 639 nm (Figure S.VII.2), and therefore does not interfere with the 
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fluorescence and upconversion luminescence imaging. Although live-cell 
colocalization was challenging due to the rapid movement of some of the 
fluorescent sites, images were successfully acquired in bright field mode, and 
with 405, 561, and 639 nm excitation when excitation sources were quickly 
changed (Figure 8.6). It was found that prompt fluorescence of compound 3 
(λexc = 405 nm), upconversion luminescence (λexc = 639 nm), and LysoTracker 
Red fluorescence (λexc = 561 nm) all co-localized centrally in the cytosol. This 
colocalization indicates that the upconverting liposomes are present in acidic 
vesicles inside the cell.  Therefore, M1-3 liposomes are probably taken up by 
endocytosis and accumulate in late endosomes and lysosomes.  
 
Figure 8.6. In vitro imaging of M1-3 liposomes in living A549 cells that were additionally stained 
with LysoTracker Red DND 99  in bright field mode, with λexc = 405 nm (to excite compound 3), 
with λexc = 561 nm (to excite LysoTracker), and with λexc = 639 nm to generate TTA-UC (λem = 
450 − 525 nm) at 1 % O2. The cells had been incubated for 24 h with M1-3 and anti-oxidants prior 




Curiously, upconversion was not observed at all locations where fluorescence 
of compound 3 was observed (Figure 8.5 and Figure 8.6). Whereas 
upconversion luminescence was especially located around the nucleus, the 
peripheral sites showing fluorescence of 3 did not produce any detectable 
upconversion. The peripheral fluorescence sites were found to be strongly 
clustered, strongly contrasting in bright-field mode, and not stained by 
LysoTracker Red (Figure 8.6). Furthermore, their size and location closely 
resemble that of lipid dropletsI in HeLa and A549 cells.[8] We thus propose that 
compound 3 accumulates in lipid droplets after the digestion of the liposomes 
in lysosomes. The fact that the lipid droplets do not produce upconversion 
may be due to separation of 1 and 3 after liposome digestion, or because the 
local oxygen concentration in the lipid droplets is higher compared to endo- 
and lysosomes and TTA-UC is quenched. To investigate the latter hypothesis, 
cells were first treated with liposomes in absence of anti-oxidants. Then, 
instead of using singlet-oxygen scavengers, the cells were imaged in presence 
of 100 mM sodium sulfite (neutralized to pH 7) as ground-state oxygen to 
effectively deoxygenate the entire medium. Although many cells did not 
survive this treatment because of the dramatic increase in osmotic pressure, 
some cells could be successfully imaged before their death (Figure 8.7). The 
images strongly resemble the situation where the cells were co-treated with L-
Asc and GSH: both the acidic organelles and the lipid droplets exhibit 
fluorescence of 3 (λexc = 405 nm), but upconverted emission (λexc = 639 nm) 
was only observed centrally in the cell. This result indicates that upconversion 
cannot be realized at any oxygenation level in the lipid droplets, and that 
compounds 1 and 3 must be physically separated and/or that compound 1 is 
degraded during digestion of the liposomes. 
                                                             




Figure 8.7. In vitro imaging of M1-3 liposomes in living A549 cells in bright field mode (left), with 
λexc = 405 (middle), and with λexc = 639 nm (right). After 24 h incubation with M1-3 liposomes, the 
medium was refreshed, and the cells were imaged at 37 °C, 20% O2 and 7% CO2. Just before 
recording these images, 100 mM Na2SO3 in PBS (pH 7) was added to deoxygenate the medium. 
Other imaging conditions as in Figure 8.5. 
8.2.4 Cytotoxicity of upconverting DMPC liposomes with red light 
irradiation 
It has been reported that photosensitizer 1 generates singlet oxygen upon red-
light irradiation,[9] which is a highly cytotoxic species. In fact, singlet-oxygen 
generating photosensitizers are frequently used in photodynamic therapy 
(PDT) type II to kill cancer cells. Thus, it was anticipated that irradiation of 
M1-3 liposomes inside living cells may lead to cell death. Therefore, the 
toxicity of upconverting DMPC liposomes was evaluated in the dark and upon 
red-light irradiation by treating three cell lines with M1-3 liposomes 
according to a recently published (photo)cytotoxicity protocol developed in 
our group.[10] The cell lines used for this study were A549 (human lung 
carcinoma), MCF7 (human breast adenocarcinoma) and MRC5 (normal human 
lung) cells. As controls, M1 (doped with only the photosensitizer) and M3 
(doped with only the annihilator) liposomes were used. In short, the 
photocytotoxicity protocol involved incubation of the cells with the liposomes 
for 24 h, after which the medium was refreshed and the cells were either 
irradiated in normoxic conditions (7% CO2, 20% O2, 37 °C) with high-power 
red light (628 nm, 23.0 ± 1.5 mW, 15 min,  20.7 J.cm−2) or kept in the dark in 
otherwise identical conditions. The viability of the cells 48 h after irradiation 
was quantified with a sulforhodamine B staining assay. Prior to these 
experiments, the uptake of M3 and M1-3 liposomes after 24 h incubation was 
verified by imaging the fluorescence of 3 in the cells by fluorescence 
microscopy (λexc = 377 nm, Figure S.VII.3 and Figure S.VII.4). Because 
compound 1 is not emissive under these conditions, the uptake of M1 
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liposomes could not be visualized and we assumed that the uptake of M1 is 
similar to the uptake of M3.  
Figure 8.8 shows the evolution of cell viability as a function of the liposome 
concentration, expressed as the bulk concentration of DMPC (in mM) or 
compound 1 (in nM). In dark conditions, the data showed a limited decrease in 
cell viability of A549 and MCF7 cells treated with increasing liposome 
concentration, while the MRC5 cells were unaffected at any liposome 
concentration tested. This dark cytotoxicity can be explained by a lipid 
overdose at higher concentrations (> 100 µM). However, such high liposome 
concentrations are probably not clinically relevantII and it can thus be 
concluded that upconverting liposomes M1-3 are non-toxic in the dark. 
Following red light irradiation, the dose-response curves were found to be 
very similar to those obtained in dark conditions. This result is surprising, as 
the experiments were carried out in a 20% O2 atmosphere where PDT effects 
were expected. Apparently, the amount of singlet oxygen generated is too low 
to induce a cytotoxic effect. We attribute the low amount of singlet oxygen 
generation to the much lower photosensitizer dye doping (~0.05 mol% with 
respect to the lipid) compared to published liposomal PDT studies. For 
instance, one study reports M5076 ovarian sarcoma cells incubated with 
photofrin-loaded liposomes (8 mol% photofrin with respect to lipid) for 1 hIII 
and exposed to 2 J.cm−2 630 nm light;[13] this treatment caused approximately 
50% cell death at a photofrin bulk concentration of 9 nM. Other explanations 
for the absent PDT effect may be: (i) the amount of endocytosed liposomes is 
too low to import enough photosensitizer; (ii) singlet oxygen that is generated 
in endo- and lysosomes may be less harmful compared to other cellular 
targets such as the mitochondria;[14] (iii) or the photosensitizer may be 
bleached before a significant amount of singlet oxygen is produced. Overall, 
our results clearly show that M1-3 liposomes are not (photo)cytotoxic below 
                                                             
II Two clinically used liposomal anti-cancer drug formulations are Lipoplatin™ (9:91 w/w% 
cisplatin/lipid) and Doxil (11:89 w/w% doxorubicin/lipid).[11] The recommended dose of 
Lipoplatin™ is 200 mg.m−2 body surface area per 14 days. Given an average human body surface 
of 1.7 m2, this leads to a dose of 309 mg lipids. At about 5 L of blood volume, the lipid in blood 
concentration would be 62 mg.L−1 (~ 85 µM). The recommended dose of Doxil is 50 mg/m2 
doxorubicin. Using the same figures, the lipid in blood concentration directly after 
administration would be 0.17 mM. These calculations suggest that lipid concentrations higher 
than ~0.1 mM, for which M1-3 starts to become toxic, are probably not relevant for clinical 
application. Furthermore, liposome uptake studies in mice from the late 1980s and early 1990s 
report concentrations of 0.1 – 0.7 mM (in blood circulation directly after injection).[12]  
III The authors do not mention refreshment of the medium before irradiation. 
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0.1 mM [DMPC] in the dark and under a high dose of red-light irradiation (20.7 
J.cm−2) in both cancer cells and healthy cells. 
 
Figure 8.8. Cell viability of A549 (top row), MCF7 (middle row) and MRC5 cells (bottom row) 
treated with M1 (left column), M3 (middle column), or M1-3 liposomes (right column) and left in 
the dark (black data points) or irradiated for 15 min with 628 nm light (red data points, 20.7 
J.cm−2 light dose) as a function of [DMPC] (bottom axes) or [1] (top axes). Solid lines represent Hill-
slope fit curves to the same color data points. Error bars represent the standard deviation of the 
mean cell viability value from three individual biological experiments. 
8.2.5 Anchoring amphiphilic Ru-complexes to DMPC liposomes 
After establishing the photophysical properties and low cytotoxicity of the 
upconverting liposomes (System A), the photocytotoxicity of Ru-complex 
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functionalized liposomes (System B) irradiated with blue light in absence of 
upconversion was considered. Four Ru-complexes were investigated for use in 
System B: compounds 42+, 52+, 62+, and 72+ (Figure 8.2). These compounds all 
dissolve poorly in water, and feature a cationic Ru2+ compound functionalized 
with a lipophilic ligand (cholesterol-thioether in 42+, alkyl-thioether in 52+ and 
62+, and double alkyl-tailed neocuproine in 72+). Each of these compounds is 
non-emissive (Φem << 1%) and photodissociative: upon blue-light irradiation 
in water, compounds 42+ and 52+ react to mono-aqua product 
[Ru(tpy)(bpy)(H2O)]2+ (compound 82+),[15] and compounds 62+ and 72+ react to 
bis-aqua product [Ru(bpy)2(H2O)2]2+ (compound 92+; see Figure S.VII.6 to 
Figure S.VII.8). In presence of liposomes, these compounds insert in the 
membrane and upon blue-light irradiation the photoproduct dissociates from 
the membrane as illustrated in Figure 8.9a.[16] Thus, PEGylated DMPC 
liposomes were functionalized with 4 mol% 42+, 52+, 62+, or 72+ (M4, M5, M6, 
and M7 respectively). In spite of the lipophilic anchor ligands it was initially 
uncertain whether the Ru complexes were adequately anchored and would 
not escape the membrane over time in the dark. In an in vivo situation, such 
“hopping” would mean that in the dark the Ru-complex would escape the 
liposome drug carrier and insert in biological membranes, i.e. before the 
tumor site is reached, leading to poor selectivity and to potential side-effects.  
To investigate whether or not hopping of the complexes from one membrane 
to another occurs, a simple but effective assay was developed, illustrated in 
Figure 8.9b. In short, M4, M5, M6, or M7 liposomes were added to a stirred 
solution of M3 liposomes while measuring the fluorescence intensity of 3 (λexc 
= 420 nm, λem = 486 nm). As discussed in Appendix VII, 3 does not hop from 
membrane to membrane. Compounds 42+, 52+, 62+, and 72+ all have substantial 
absorbance overlap with the emission of 3 (Figure S.VII.5), so that FRET 
occurs if the Ru complexes come in close proximity of 3, as was reported in 
Chapter 4.[4b] Also, fusion of the liposomes does not spontaneously occur (no 
changes in DLS were observed upon mixing), and close liposomal proximity is 






Figure 8.9. Fluorescence assay to determine “hopping” of Ru-complexes 42+, 52+, 62+, and 72+ from 
liposome to liposome. a) Cartoon illustrating the photodissociation reaction of a Ru complex that 
is anchored to a liposome with a lipophilic ligand: upon irradiation the photoproduct dissociates 
while the anchor remains (here 42+ reacts to 82+). b) Cartoon of the hopping process. c/d) 
Fluorescence emission intensity of 3 at 486 nm (λexc = 420 nm, 240 µW.cm−2 intensity) as a function 
of time after mixing liposomes M3 with M4, M5, M6, or M7 for the first 45 min (c) and for 24 h and 
48 h after mixing (d). In part (c), the Ru-doped liposomes were added at t = 2 min. Conditions: 2 
mL volume in a stirred macro cuvette at 20 °C, [DMPC] = 50 µM of each liposome formulation, [3] 
= 0.25 µM.  
In Figure 8.9 the fluorescence intensity of 3 as a function of time after mixing 
is shown. While the fluorescence intensity in the mixtures of M3 and M5, M3 
and M6, or M3 and M7 stayed relatively stable with time, the fluorescence 
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intensity of 3 in the mixture of M3 and M4 rapidly decreased within the first 
20 minutes after mixing and was quenched by 95% after 45 min. Negligible 
reduction in fluorescence was observed for M3 without any addition. It is thus 
very clear that 42+ is inadequately trapped in M4 liposomes and readily 
equilibrates with the membrane of M3 within the first 45 minutes of mixing. 
The other Ru complexes seem to be tightly anchored to the liposomes, at least 
during the first 45 min. In a further experiment, the fluorescence of 3 in these 
mixtures was measured 24 and 48 h after mixing (Figure 8.9b). The 
fluorescence intensity of 3 in the mixtures of M3 and M5, and M3 and M6 was 
again very stable, but it decreased greatly for the mixture of M3 and M7 
(~90% quenching after 48 h). Thus, 72+ also hops from membrane to 
membrane, but slower than 42+. These results imply that it is not 
straightforward to synthesize a lipophilic anchor to trap an inorganic Ru-
complex to a liposome. For 32+ we attribute the escape to the PEG3-cholesterol 
moiety of 32+ being not lipophilic enough. However, it was surprising to find 
that a double-tail alkyl ligand (72+) is not a strong anchor, while a single-tail 
alkyl ligand is. Overall, it was found that under these conditions, complexes 52+ 
and 62+ are well-trapped in the lipid bilayer of M5 and M6, so that these 
complexes were considered as suitable candidates for further biological 
experiments. Complexes 42+ and 72+ were excluded from biological 
experiments. 
8.2.6 Photo(cytotoxicity) of Ru-complex doped liposomes under blue 
light irradiation 
As introduced earlier, the purpose of Ru-complex doped liposomes (System B) 
is to transport the Ru-complex inside the cell, after which the complex can be 
activated with blue light to produce a toxic aqua species (complex 82+ or 92+, 
see Figure 8.2). To test this hypothesis, the (photo)cytotoxicity of M5 and M6 
liposomes was evaluated in A549, MCF7, and MRC5 cells according to the 
same protocol that was used before for M1-3 liposomes (Section 8.2.4). 
However, instead of using red light the cells were this time irradiated for 10 
minutes with a 454 nm LED-array (7.0 ± 0.8 mW.cm−2 intensity, 4.2 J.cm−2 
dose) under 7% CO2 and 20% O2. It was previously found that a longer 
irradiation time may cause significant cell death.[17] As complexes 52+ and 62+ 
are not emissive the uptake of the liposomes could not be confirmed by 
fluorescence microscopy. Furthermore, the activation half-time to convert 52+ 
to 82+ and 62+ to 92+ was estimated to be 3 min (see Appendix VII for 
calculation), so that in such conditions it was anticipated that 10 min 
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irradiation would nearly convert all of the complex to the aqua species. The 
evolution of cell viability as a function of concentration is shown in Figure 
8.10, and the 50% effective concentration values (EC50) and photo-indices (PI, 
calculated by 𝑃𝐼 = 𝛥𝐶50𝑑𝑎𝑟𝑘  𝛥𝐶50
𝑡𝑙𝑙ℎ𝑡� ) are reported in Table 8.2. 
 
Figure 8.10. Cell viability of A549 (top row), MCF7 (middle row) and MRC5 cells (bottom row) 
treated with M5 (left column), or M6 (right column) liposomes and left in the dark (black circles) 
or irradiated for 10 min with 454 nm light (blue diamonds, 4.2 J.cm−2 light dose) as a function of 
[DMPC] (bottom axes) or [Ru] (top axes). Solid lines represent Hill-slope fit curves to the same 
color data points. Error bars represent the standard deviation of the mean cell viability value from 
three individual biological experiments. 
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Table 8.2. EC50 values (expressed in µM [Ru]; [Ru] = 0.04 × [DMPC]) and photo-indices (PI) of M5 
and M6 liposomes after irradiation with 454 nm light (10 min, 7.0 ± 0.8 mW.cm−2 intensity, 4.2 
J.cm−2) and in the dark in A549, MCF7 and MRC5 cells. Confidence intervals (CI) are given in µM. 




CI (µM) PI EC50 CI (µM) PI 
 - +   - +  
A549 + 6.0 1.1 1.4 1.0 2.1 0.2 0.2 1.1 - 5.9 0.8 0.9 2.4 0.3 0.4 
MCF7 + 7.8 0.6 0.6 1.3 2.4 0.3 0.4 1.5 - 10 1.3 1.5 3.6 0.8 1.0 
MRC5 + 93 76 410 3.0 8.9 2.8 4.0 4.8 - 270 270 15E3  43 13 20  
 
The data show that both M5 and M6 liposomes are toxic for A549 cells in the 
dark with EC50 values of 5.9 and 2.4 µM [Ru], respectively. In both cases 
irradiation with blue light marginally affected the values. In MCF7 cells, M5 
and M6 had EC50 values of 10 and 3.6 µM [Ru]; light irradiation slightly 
lowered these values to 7.8 and 2.4 µM [Ru], respectively. Finally, in MRC5 
cells, M5 and M6 liposomes had EC50 values of 270 and 43 mM [Ru], 
respectively, which shows that the liposomes barely affect MRC5 cells in the 
dark. However, light irradiation lowered the EC50 values to 93 and 8.9 µM [Ru], 
respectively, which is statistically significant. Unfortunately the photo-indices 
of both liposome-bound complexes were rather low. Overall, the data show 
that M5 and M6 are more toxic in the dark than M1-3 liposomes (compare 
Figure 8.10 to Figure 8.8), clearly indicating that 52+ and 62+ are toxic in the 
dark. What is the origin of this toxicity? Since the surface of the liposomes is 
sterically hindered with PEG groups, the interaction of the membrane-bound 
complex with biomolecules of the cell is hindered. Another possibility is that 
toxic interactions arise after digestion of the liposomes, after which 52+ or 62+ 
is liberated. In such a scenario, even though 52+ and 62+ are not 
photoactivated, their amphiphilicity may in fact cause significant toxicity. For 
instance, it has recently been shown that complex 42+ in absence of liposomes 
and in the dark is significantly toxic in A549 and MCF7 cells with a EC50 value 
of 5 µM, comparable to the data of M5 and M6.[18] If liposome digestion is 
indeed the cause of the dark toxicity, drug carriers with higher resistance 
towards digestion may be needed to lower the dark toxicity. Interestingly, the 
data also show that M5 and M6 are more toxic for cancerous cells (A549 and 
MCF7) than for healthy cells (MRC5). This observation may indicate a 
selectivity of liposome-bound complexes 52+ and 62+ for cancer cell lines. Thus, 
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blue light irradiation can generally cause more cell death, but that this effect is 
highly cell-dependent. In the rest of this chapter, complex 62+ is used as Ru 
prodrug, because it exhibits the greatest photo-index.  
8.2.7 Activation of a photodissociative ruthenium complex using 
upconverting DMPC liposomes in air 
As introduced earlier, the photoreaction of 62+ can only be executed efficiently 
using blue light. In Chapter 4 it was demonstrated that in liposomes that were 
doped with compounds 1, 2, and 42+, the upconverted light was efficiently 
transferred to the ruthenium complex via FRET and triggered the 
photodissociation of the complex. However, those experiments were 
performed under deoxygenated conditions (by bubbling the solution with 
argon) and the red light activation did not work in air, which clearly limited 
the biological applicability of System C liposomes. On the other hand, as 
demonstrated in sections 8.2.2 and 8.2.3, anti-oxidants such as L-Asc and GSH 
protect TTA-UC against oxygen. An obvious step forward was thus to add anti-
oxidants to System C liposomes in order to protect TTA-UC and trigger the 
photodissociation with red light in air. In such a mixture of anti-oxidants and 
TTA-UC-Ru liposomes, it is important to consider that the anti-oxidants may in 
fact interfere with the photosubstitution reaction of 62+ to 92+: for instance, 
anti-oxidants may react with ground or excited-state 62+ and cause unwanted 
side-reactions, or the thiol of GSH may substitute water in 92+ to form a GSH-
Ru adduct. Thus, the influence of anti-oxidants on a TTA-UC-photodissociation 
reaction cascade had to be evaluated.  
For this purpose, M1-3-6 liposomes were prepared at 1 mM [DMPC] that 
contained red-to-blue TTA-UC compounds 1 and 3 and photodissociative Ru-
compound 62+. The photodissociation reaction with red light irradiation was 
performed in either deoxygenated conditions by bubbling argon for 30 min, or 
in air-equilibrated conditions and in presence of 10 mM L-Asc and 10 mM GSH. 
Both samples were irradiated at human body temperature (37 °C) with 630 
nm light (150 mW, 1.2 W.cm−2) for 2.5 h while recording UV-vis absorbance 
(Figure 8.11a and b) and emission spectra every 15 min. The UV-vis spectrum 
at t = 0 shows the characteristic absorption bands of 1 at 440 and 630 nm, of 3 
between 375 and 450 nm, while the absorbance of 62+ (Figure S.VII.7) is 
hidden under the bands of 1 and 3. Under argon, in absence of anti-oxidants, 
the absorption band of the photoproduct 92+ evolves to completion in the first 
hour of irradiation, just as observed for complex 62+ in water upon blue light 
irradiation (Figure S.VII.7). By plotting the absorbance at 490 nm versus time 
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(Figure 8.11c), it is clear that the photoreaction was completed after about 45 
min of irradiation. While the photoreaction was progressing, the upconversion 
emission at 486 nm increased (Figure 8.11d), because complex 92+ dissociates 
into solution and no longer quenches the emission of 3 via FRET (see Chapter 
4). After 60 – 90 min of irradiation, both the absorption and emission spectra 
completely stabilized. When the experiment was conducted in air and in 
presence of anti-oxidants, the same absorption band between 460 and 600 nm 
appeared in the first 30 min of irradiation (Figure 8.11b), which strongly 
resembled the absorption band of 92+. After that time-point, this absorption 
band slowly disappeared, indicating that the photoproduct was not stable 
upon prolonged irradiation or further reacts with L-Asc and/or GSH. Also the 
upconversion emission intensity increased in the first two hours of 
irradiation, similar to the previous experiment. As control, the irradiation 
experiment under argon was repeated with M3-6 liposomes, which did not 
contain photosensitizer 1 and hence could not produce TTA-UC. A slow 
evolution of the absorbance at 490 was observed, which is attributed to direct 
absorption of the red light by 62+. These results demonstrate that TTA-UC 
greatly amplified the rate of photodissociation upon red light irradiation. At 
these irradiation conditions, 45 min were necessary to activate 40 µmol 
ruthenium prodrug. 
Is the same photoproduct obtained under argon and in air in presence of anti-
oxidants? To answer this question, the irradiation experiments were repeated, 
but stopped after 60 min; the liposomes were removed from the solution 
using a centrifugal filtration, and UV-vis absorption spectra of the filtrates 
were recorded. In case of irradiation under argon, the UV-vis absorption 
spectrum of the filtrate was identical to the absorption spectrum of 92+ (Figure 
S.VII.7 and Figure S.VII.9), thereby confirming the photodissociation reaction 
of 62+ to 92+. In the presence of anti-oxidants, the resulting absorption 
spectrum was very similar, suggesting that the same (or a similar) Ru-complex 
had been formed. As control, no absorption was detected for filtered solutions 
of non-irradiated M1-3-6 liposomes under argon or in presence of anti-
oxidants. Finally, the same irradiation experiments were repeated at higher 
concentration (20 mM DMPC), and mass spectra were recorded after 
centrifugal filtration, lyophilisation of the filtrate, and redissolving the residue 
in acetone (Figure S.VII.10). In case of irradiation under argon, the mass 
spectrum confirmed that 92+ had indeed formed during irradiation (main 
peaks 490.1 and 507.1 m/z belonging to [Ru(bpy)2(OH2)(OH)]+(MeCN) and 
 
157 
[Ru(bpy)2(OH2)(OH)]+(acetone), respectively). In case of irradiation in air in 
presence of anti-oxidants, the sample only dissolved in methanol, which 
suggests that another Ru-complex had been formed. The mass spectrum 
showed 481.1 and 490.0 m/z, belonging to [Ru(bpy)2(OH2)2]2+(MeO-) and 
[Ru(bpy)2(OH2)(OH)]+(MeCN), see Figure S.VII.11. Although no signals were 
detected from a GSH complex, for example expected at m/z 738.1 for 
[Ru(bpy)2(GS)(H2O)]+, it is still plausible that compound 92+ and products such 
as GSH adducts co-exist in the reaction mixture. Overall, the results 
demonstrate that GSH and L-Asc facilitated the photoactivation cascade of 
TTA-UC, FRET, and Ru-photodissociation in air while minimally interfering 
with the photochemistry. These findings may thus be used to investigate Ru-
prodrug activation using TTA-UC in vitro. 
 
Figure 8.11. a/b) UV-vis absorption spectroscopy in 15 min intervals (blue to red gradient) during 
red-light irradiation of M1-3-6 liposomes under argon (a) and in air in presence of 10 mM L-Asc 
and GSH (b). c/d) Absorbance at 490 nm (c) and upconversion emission at 486 nm (d) as a 
function of time for the experiment under argon (blue squares) and in air in presence of anti-
oxidants (red circles). As control, M3-6 liposomes were irradiated under the same conditions 
under argon (c, black diamonds). Conditions: 2 mL sample with 1 mM DMPC, irradiated at 37 °C 
with 150 mW 630 nm light (1.2 W.cm−2). 
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8.2.8 Inducing TTA-UC and drug activation through meat with DLPC 
liposomes 
The main reason to use red-to-blue light upconversion in PACT is the 
increased excitation penetration depth of red light in tissues. To study the 
activation of a ruthenium prodrug using red-to-blue TTA-UC in liposomes, a 
two-fold investigation was performed. First, the depth at which TTA-UC can be 
generated through biological tissues was measured for L1-2 liposomes by 
placing layers of fresh meat (chicken or pig) between the excitation source 
and the sample. Secondly, the photodissociation of 62+ to 92+ with red light and 
L1-3-6 liposomes was attempted through a layer of pork to simulate 
operation conditions. 
In order to measure the depth at which red-to-blue upconversion can be 
generated through biological tissues, first an upconverting gel was prepared 
by mixing L1-2 liposomes ([DLPC] = 10 mM) with 0.5 wt.% agarose and 5 mM 
L-Asc and GSH in PBS and was deposited as a thin disk between two 
microscopy slide. The gel was then covered with a variable stack of meat 
slices, a 630 nm laser beam (0.57 W.cm−2) was directed through the meat at 
the upconverting gel, and the emission spectrum was measured of the sample 
in a custom-made cage spectroscopy setup (see experimental section, Figure 
8.16). Raw chicken breast fillet and pork fillet were selected to mimic human 
tissue of different color and structure, and were thinly sliced with 1 – 2 mm 
thickness.  
The emission spectra for both meat types showed the typical 
phosphorescence of 1  at 800 nm and upconversion emission of 2 at 474 nm 
identical to the emission spectra shown in section 8.2.2 (Figure 8.12a and c). 
As could be expected, the intensity of the entire spectrum decreased as a 
function of meat thickness due to filtering and scattering of the excitation 
source by the meat. In a typical experiment, upconversion was still observable 
for 12.8 mm thick chicken and for 11.6 mm thick pork. Figure 8.12c and d 
show the upconversion intensity (IUC), the phosphorescence of 1 (Ip), and their 
ratio as a function of meat thickness. It can be clearly seen that from the third 
meat layer onwards, IUC decreases relatively faster than Ip; i.e. IUC/Ip decreases. 
This can be rationalized by the fact that TTA-UC is quadratically dependent on 
the excitation intensity below the intensity threshold for efficient 
upconversion (Ith), while the phosphorescence is linearly dependent. Ith was 
previously determined to be 0.05 W.cm−2 for very similar red-to-blue TTA-UC 
in DOPC liposomes (Chapter 5). Considering that IUC/Ip changes for the first 
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time after 3 layers of meat, this must mean that the excitation intensity after 3 
layers of meat has decreased from 0.57 W.cm−2 to approximately 
0.05 W.cm−2). Overall, the results show that upconversion was generated even 
beyond 1 cm penetration depth, but that beyond 5 to 6 mm meat depth the 
TTA-UC efficiency decreased quickly. Naturally, the depth at which the 
excitation intensity equals Ith depends on the initial excitation intensity, so it 
was decided that a higher irradiance was needed to activate Ru-prodrugs 
through meat (see below). Finally, the results also suggest that upconverting 
drug carriers should have a low Ith value, so that their performance would be 
minimally dependent on the excitation intensity. 
 
Figure 8.12. Emission spectroscopy of an upconverting liposome gel through layers of chicken 
breast or pork fillet. a/c) Emission spectra of gellified L1-2 liposomes through layers of meat at 
room temperature as a function of chicken breast (a) or pork fillet thickness (c). b/d) 
Upconversion intensity (IUC, at 474 nm), phosphorescence intensity of compound 1 (Ip) and the 
ratio of IUC and Ip as a function of chicken breast (b) or pork fillet (d) thickness. Conditions: 20 µL 
sample in a 25 µm × 25 mm diameter disk of L1-2 liposomes ([DLPC] = 10 mM) in 0.5% wt.% 
agarose gel, 5 mM L-Asc, and 5 mM GSH in PBS at room temperature, irradiated with 30 mW (3 
mm spot, 0.57 W.cm−2) 630 nm light through a variable number of meat slices. The spectra are cut 
off between 575 nm and 675 nm to omit the large excitation scatter peak. 
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The second set of experiments involved Ru-complex activation through a layer 
of meat. For this, a 2 mm thick cuvette was filled with 400 µL L1-3-6 
liposomes ([DLPC] = 10 mM) in anti-oxidant PBS (10 mM L-Asc and GSH), 
buried under a layer of pork fillet (7 ± 0.5 mm), and irradiated from the top 
with either red or blue light for 2 h, as shown in Figure 8.13a. The light dose 
was equal for both experiments (110 mW laser light, 3 mm spot size, 1.6 
W.cm−2, 11.2 kJ.cm−2); higher intensity blue light could not be realized in our 
experimental setup. The UV-vis absorption spectrum of the cuvette (without 
meat) was measured before and after irradiation (Figure 8.13b). The 
absorption band that appeared between 460 and 600 nm indicated the 
formation of a small quantity of the aqua species 92+ (compare Figure 8.11a 
and Figure 8.13b). The amount of activated Ru-complex was similar for both 
excitation wavelengths.  
This result can be interpreted by considering the two different photochemical 
pathways of activation. In the case of blue light, the light does not penetrate 
the meat far, but the photons that do reach the sample have a high chance of 
being absorbed due to the high absorbance of 62+ at 450 nm (ε450 ≈ 6000 
M−1.cm−1, [62+] = 0.40 mM; 𝐴450𝟔
2+≈ 0.5 for 2 mm path length). Upon blue light 
absorption, the complex is directly activated without intervention of the TTA-
UC process, i.e. the chance is high that a blue photon causes photodissociation 
of 62+. In the case of red light, the light penetrates much further, i.e. more light 
reaches the cuvette, but the overall activation efficiency is the product of 
upconversion quantum yield (ΦUC), energy transfer efficiency from annihilator 
3 to Ru-complex 62+ (EET), and photodissociation quantum yield (ΦRu; see 
Chapter 4),[4b] leading to a ~20 times lower overall activation efficiency. Also, 
the absorbance of compound 1 at 630 nm was comparatively low (𝐴630𝟏  = 
0.15), leading to less use of the light that permeates through the meat. Finally, 
at 1.6 W.cm−2 630 nm excitation intensity, it is likely that ΦUC is lower than its 
maximum value, because the excitation intensity likely drops to Ith or below 
(~0.05 W.cm−2). Thus, even though L1-3-6 liposomes are clearly more 
responsive to blue light, the data show that the overall activation with red 
light was approximately just as efficient as with blue light. Improvements in 
red-light absorbance and upconversion efficiency may eventually lead to a 





Figure 8.13. Irradiation of L1-3-6 liposomes through a thick slice of pork fillet. a) Photographs of 
the experimental setup used for red and blue light irradiation. The 2 mm cuvette holding 400 µL 
L1-3-6 ([DLPC] = 10 mM) is covered with 7 mm pork fillet and irradiated for 2 h from above with a 
collimated 110 mW 630 or 450 nm beam (3 mm spot size, 1.6 W.cm−2 intensity, 11.2 kJ.cm−2 light 
dose). b) UV-vis absorbance spectra of the sample before (black) and after irradiation with 450 nm 
(blue) or 630 nm light (red). c) Photographs of the pork fillet after red (left) or blue light 
irradiation (right). Upon blue light irradiation, a clear “burn mark” was observed, as indicated 
with the arrow. d/e) UV-vis absorbance spectra (d) and the absorbance difference at 490 nm (e) as 
a function of irradiation time for L1-3-6 liposomes irradiated through 7 mm pork fillet with 300 
mW.cm−2 630 nm light (4.2 W.cm−2).  
Apart from investigating the sample after irradiation, the meat was also 
visually inspected after the 2 h irradiation. While red light had caused no 
damage at all, blue light had burned the meat considerably at the irradiation 
spot (Figure 8.13c). This result is consistent with data of our group that blue 
light is much more harmful for cells than green or red light.[10] Red light is thus 
much more favorable for drug activation than blue light. Tissue ablation is also 
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a great issue in the biological application of lanthanoid-based upconversion 
nanoparticles (UCNPs): for instance, it has been shown by Wu et al. that 
irradiation of chicken meat with 980 nm laser light for 20 min at ≥ 5 W.cm−2 
intensity causes significant burn marks. In the case of red-to-blue TTA-UC, our 
data show that upconversion-mediated drug activation is possible at relatively 
low power without any tissue ablation. 
Finally, the irradiation experiment was repeated with higher intensity red 
light (300 mW, 4.2 W.cm−2 intensity) and the absorption spectrum was 
measured every 30 min (Figure 8.13d and e). The evolution of the absorption 
band of 92+ between 460 and 600 nm reached completion after approximately 
2 h of irradiation, which indicates that a higher irradiation intensity indeed 
leads to more activation. Again, no visible signs of irradiation damage of the 
tissue were observed. In conclusion, the data show that activation of complex 
62+ by red light in combination with red-to-blue TTA-UC could be realized 
through a 7 mm thick slice of pork fillet. Furthermore, the results demonstrate 
that TTA-UC mediated photoactivation of photo-pharmacological compounds 
such as Ru-compounds is a promising and feasible strategy that may lead to 
treatment of tumors without tissue ablation. 
8.2.9 Testing in vitro toxicity of M1-3-6 liposomes in hypoxic conditions 
with red light irradiation 
The photocytotoxicity under high power red light was evaluated of M1-3-6 
liposomes that contained TTA-UC dyes 1 and 3, and Ru-complex 62+ in A549 
and MRC5 cells. The same experimental protocol was used as in Section 8.2.6, 
but with a few important adaptations. The liposomes were tested only at 0.1 
mM concentration, because M1-3 liposomes were not toxic at this 
concentration. To enhance the amount of upconverted photons, (i) the cells 
were co-treated with 5 mM L-Asc and GSH, (ii) the irradiation was performed 
with a much higher light intensity and dose than before (1.1 W.cm−2 intensity, 
5 min irradiation, 320 J.cm−2 dose), (iii) the irradiation was performed under 
hypoxic conditions (1% O2), and (iv) another plate design was used (Figure 
8.18). As controls, liposomes were used that contained only the TTA-UC dyes 
(M1-3), and liposomes deprived of photosensitizer (M3-6). As always, all 
experiments were also performed without irradiation in the dark. In order to 
reach the higher light intensity, instead of using LED arrays, which cannot 
reach such intensities, a PDT laser with collimating lens was fitted underneath 
the plate. As a consequence, not all wells could be irradiated at the same time, 
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the irradiation time per well needed to be short, the total irradiation time was 
higher (2 h in total), and the statistical error on the data was higher. 
 
Figure 8.14. Cell viability of A549 (left) and MRC5 cells (right) that were treated with M1-3, M3-6, 
and M1-3-6 liposomes ([DMPC] = 0.1 mM), co-treated with 5 mM L-Asc and GSH, and irradiated 
with 1.1 W.cm−2 630 nm light for 5 min (320 J.cm−2) at 1% O2 (red) or left in the dark under the 
same conditions (black). Error bars represent standard deviation of three individual wells. The 
experiment was conducted once. 
 
Figure 8.15. Cell viability of A549 (left) and MRC5 cells (right) that were treated with M1-3, M3-6, 
and M1-3-6 liposomes ([DMPC] = 0.1 mM), co-treated with 5 mM L-Asc and GSH, and irradiated 
with 1.1 W.cm−2 630 nm light for 5 min (320 J.cm−2) at 1% O2 (red) or left in the dark under the 
same conditions (black). In this experiment, the medium was not refreshed either before or after 
irradiation, so that the liposomes and anti-oxidants were present during the last 72 h of the 





In Figure 8.14, the cell viability of A549 and MRC5 cells is reported after 
treatment with M1-3, M3-6, and M1-3-6 liposomes that were irradiated or 
left in the dark. For both cell lines, M1-3 liposomes were not found to be 
significantly toxic in dark and light conditions, consistent with the results 
discussed in Section 8.2.4. In dark conditions, M3-6 liposomes were found to 
be more toxic in A549 cells than M1-3 liposomes, but were not toxic in MRC5 
cells. Red-light irradiation did not significantly influence the toxicity. Finally, 
in dark conditions, M1-3-6 liposomes were found to be equally toxic as M3-6 
liposomes in both cell lines. Again, irradiation did not significantly influence 
the toxicity. To summarize: MRC5 cells were unaffected by any treatment, 
while a mild toxicity regardless of irradiation was observed for M3-6 or M1-3-
6 liposomes in A549 cells. Because the toxicity of M3-6 and M1-3-6 liposomes 
is equal, the toxicity is most probably caused by the dark toxicity of compound 
62+ (see Section 8.2.6). Furthermore, the result that light irradiation did not 
change the toxicity of M1-3-6 liposomes in A549 cells was expected based on 
the results of M6 liposomes (Section 8.2.6), which showed that the conversion 
of 62+ to 92+ upon irradiation does not cause more toxicity in A549 cells. In 
contrast, blue light irradiation of M6 in MRC5 cells caused a decrease in cell 
viability at 0.1 mM from 82% in the dark to 55% in light conditions (Figure 
8.10). Thus, the fact that M1-3-6 liposomes are not toxic in MRC5 cells upon 5 
min red light irradiation may indicate that upconversion was not effective in 
triggering the photodissociation reaction of 62+ to 92+. Most probably, 5 min of 
red light irradiation is simply not enough to release enough toxic 92+. For 
instance, in the preceding experiments discussed in Section 8.2.7, conducted 
in ideal, deoxygenated conditions, 30 – 60 min was needed to convert all 62+ to 
92+ at similar light intensity. Furthermore, it is uncertain to what extent the 
toxicity of 92+ is affected by the presence of L-Asc and GSH, as it is known for 
example that GSH greatly decreases the toxicity of metallodrugs such as 
cisplatin.[19]  
As a final experiment the cell treatment was repeated without removing the 
liposomes and anti-oxidants from the cell medium; the liposomes and anti-
oxidants were present during the last 72 h of the photocytotoxicity assay. 
During irradiation stable upconversion emission was detected in the whole 
well volume when the plate was viewed with red-light blocking laser goggles. 
The cell viability of the A549 and MRC5 cells after treatment is plotted in 
Figure 8.15. Apart from the great decrease in viability in all wells, attributed to 
the continuous presence of liposomes and anti-oxidants, only minor 
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differences in cytotoxicity were observed in A549 cells that had been treated 
with M1-3, M3-6, or M1-3-6 liposomes. Thus, under these conditions the 
toxicity of red-light irradiated M1-3-6 liposomes is not substantial. Much 
further work is necessary to elucidate the conditions at which the activation of 
Ru-prodrugs using TTA-UC causes significant photocytotoxicity in cancer cells. 
For instance, Ru-complexes with a better photo-index are needed so that the 
upconversion strategy may be better tested in vitro. Also, longer irradiation 
times are required to release enough Ru-complex to induce a potentially toxic 
effect. 
8.3 Conclusion 
In this chapter, the biological applicability of three liposome systems was 
addressed: upconverting liposomes (System A), Ru-prodrug doped liposomes 
(System B), and liposomes doped with both upconverting dyes and Ru-
prodrugs (System C). First of all, it was found that the biocompatible anti-
oxidants L-Asc and GSH at biologically relevant concentrations greatly 
enhanced TTA-UC for L1-2 liposomes in solution and in M1-3 liposomes in 
cancer cells (System A). Then, it was established that M1-3 liposomes are not 
(photo)cytotoxic in A549, MCF7, and MRC5 cell lines in the dark in and in red-
light irradiated conditions; no PDT effect was observed, even at relatively high 
red light dose. Photocytotoxicity studies with Ru-prodrug functionalized 
liposomes M5 and M6 (System B) showed that both liposome formulations 
were considerably toxic in the dark, and that blue light irradiation enhanced 
their toxicity only slightly. Furthermore, it was demonstrated that 
photoactivation of Ru-prodrugs in liposomes mediated by red-to-blue TTA-UC 
(System C) could be obtained in air by adding biologically relevant 
concentrations of L-Asc and GSH. The same reaction could be triggered when a 
thick slice of pork fillet was placed between the laser and the sample, which 
illustrates the practical applicability of upconverting liposomes. Finally, the 
photocytotoxicity of M1-3-6 liposomes was investigated under high power 
red light irradiation. Unfortunately, no significant cytotoxic effect was 
observed, which may be due to a low overall activation efficiency or to the 
poor cytotoxicity of the activated Ru-drug 92+. Overall, our results pave the 
way for photoactivation of Ru-complexes by TTA-UC in vitro, and give 
important insights in what requirements need to be fulfilled in order to make 
the activation-by-upconversion strategy perform well in a biological context: 
important optimization parameters that need to be considered include 
nanoparticle design, excitation wavelength and intensity, local oxygen 
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concentration and presence of anti-oxidants, TTA-UC emission stability, light 
dose, tissue thickness, and photo-index of Ru-prodrugs.  
8.4 Experimental section 
8.4.1 General 
Palladium tetraphenyltetrabenzoporphyrin (1) was purchased from Frontier Scientific, Inc. 
(Logan, Utah, USA). Perylene (2) was purchased from Sigma-Aldrich Chemie BV (Zwijndrecht, 
The Netherlands). The synthesis of 2,5,8,11-tetra(tert-butyl)perylene (compound 3) is 
described in Chapter 9. The synthesis of 4(PF6)2 is described in section 3.4.2. The synthesis of 
[Ru(tpy)(bpy)(Cl)](Cl) is described elsewhere.[20] Compounds 5(PF6)2 was synthesized by 
Lucien Lameijer. Compounds 10, 11, 12, 6(PF6)2, and 7(PF6)2 were synthesized by Michael 
Meijer. Sodium N-(carbonyl-methoxypolyethylene glycol-2000)-1,2-distearoyl-sn-glycero-3-
phospho ethanolamine (DSPE-mPEG-2000), 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), 
and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) were purchased from Lipoid GmbH 
(Ludwigshafen, Germany) and stored at −18 °C. Dulbecco’s phosphate buffered saline (PBS) was 
purchased from Sigma Aldrich and had a formulation of 8 g.L−1 NaCl, 0.2 g.L−1 KCl, 0.2 g.L−1 
KH2PO4, and 1.15 g.L−1 K2HPO4 with a pH of 7.1 − 7.5. Anti-oxidant supplemented PBS was 
prepared by dissolving L-ascorbic acid and/or glutathione in PBS and neutralizing with sodium 
hydroxide to pH 7.0 − 7.6. Other chemicals were purchased from major chemical suppliers and 
used as received. Images and data were processed with Fiji ImageJ, Origin Pro, and Microsoft 
Excel software. Emission and absorption spectroscopy, and photodissociation experiments 
using red light were performed in experimental setups reported in other chapters (see Sections 
4.4.5 and 6.4.4). Photodissociation experiments using blue light were recorded in a Cary 50 
Varian spectrometer equipped with a Cary Single Cell Peltier for temperature control. 
8.4.2 Synthesis of 5(PF6)2 
To a suspension of [Ru(tpy)(bpy)Cl]Cl (202 mg, 0.360 mmol) in acetone/H2O (9:1, 40 mL) were 
added dodecyl(methyl)sulfide (1.17 g, 5.41 mmol) and AgPF6 (200 mg, 0.791 mmol). This 
mixture was heated at 55° C for 24 hours under argon, after which the solvent was removed by 
rotary evaporation. The residue was dissolved in a minimal amount of acetone and precipitated 
by the addition of Et2O. Collection by filtration and washing with Et2O (3×) afforded 
[Ru(tpy)(bpy)(dodecyl(methyl)sulfide)](PF6)2 (compound 5(PF6)2) as a red-brown precipitate 
(250 mg, 0.251 mmol, 70%). TLC: Rf = 0.64 (100/10/2 acetone/water/sat. KPF6).1H NMR (400 
MHz, CD3OD) δ = 9.79 (d, J = 6.3 Hz, 1H, Ha), 8.82 (d, J = 7.7 Hz, 1H, HA), 8.78 (d, J = 8.2 Hz, 2H, 
HD+HG), 8.63 (d, J = 8.0 Hz, 2H, HE+HH), 8.59 (d, J = 7.0 Hz, 1H, HK), 8.40 (t, J = 8.0 Hz, 2H, HB+HF), 
8.15 – 8.00 (m, 4H, HI+HJ+Hb)), 7.92 (t, J = 7.8 Hz, 1H, Hc), 7.81 (d, J = 6.4 Hz, 2H, Hd+He), 7.50 – 
7.39 (m, 2H, HC+Hf), 7.28 (d, J = 5.0 Hz, 1H, Hh), 7.27 – 7.18 (m, 1H, Hg), 1.65 (dd, J = 8.4, 6.5 Hz, 
2H, H2), 1.36 (s, 3H, H1), 1.34 – 1.11 (m, 16H, H3 – H10), 1.09 – 1.00 (m, 4H, H11+H12), 0.93 – 0.84 
(m, 3H, H13). 13C NMR (100 MHz, CD3OD) δ = 158.1 (Quat. Arom.), 157.4 (Quat. Arom.), 156.7 
(Quat. Arom.), 153.0 (Cd+Ce), 151.83 (Quat. Arom.), 151.7 (Ca), 151.6 (Quat. Arom.), 149.4 (Ch), 
138.8 (CI+CJ), 138.2 (Cc), 138.0 (CB), 136.9 (CF), 128.4 (CC+Cf), 127.8 (Cb), 127.1 (Ch), 124.9 
(CE+CH), 124.6 (CK), 124.1 (CD+CG) 123.8 (CA), 33.5 (C2), 31.7 (C10), 29.4 (C9), 29.3 (C8), 29.1 (C7), 
28.6 (C6), 28.0 (C5), 26.4 (C4), 22.4 (C3), 19.0 (C2), 13.2 (C1+C13). ESI-MS m/z exp. (calcd.): 261.7 
(261.5, [M-2PF6-H2O+MeOH]2+); 353.5 (353.6, [M-2PF6]2+); 522.0 (522.1, [M-2PF6-H2O+MeO]+); 
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852.2 (852.2, [M-PF6]+). UV-Vis: λmax in H2O: 452 nm (ε = 6300 M−1.cm−1). Photosubstitution 
quantum yield = 0.0070 in H2O (λexc = 452 nm), as determined with a literature procedure.[21] 
 
Scheme 8.1. Synthesis of compound 5(PF6)2 from [Ru(tpy)(bpy)Cl]Cl and dodecyl(methyl)sulfide. 
8.4.3 Synthesis of 1,3-bis(methylthio)-2-dodecyloxypropane – compound 10 
To a stirred suspension of NaH (222 mg, 5.55 mmol) in dry and deoxygenated THF (5 mL) 
under Ar atmosphere was added 1,3-bis(methylthio)-2-propanol (0.25 mL, 1.85 mmol). The 
mixture was stirred at RT for 10 min, after which 1-bromododecane (0.5 mL, 2.13 mmol) was 
added dropwise, resulting in a light-brown suspension. The reaction mixture was heated to 
reflux for 20 h. Hereafter, the mixture was concentrated to 1 – 2 mL, Et2O (40 mL) was added, 
and the resulting mixture was washed with brine (40 mL), 1 M aq. NH4Cl (2 × 40 mL) and brine 
(40 mL). The organic layer was dried with MgSO4 and the solvent was removed by rotary 
evaporation. After column chromatography (SiO2, petroleum ether 40-60: DCM (2:1) to neat 
DCM) the title compound was obtained as a light-yellow oil (250 mg, 0.78 mmol, 42%). TLC: Rf = 
0.9 (DCM). 1H NMR (300 MHz, δ in CDCl3): 3.58 (p, J = 5.8 Hz, 1H, H3), 3.51 (t, J = 6.6 Hz, 2H, 
H1’), 2.74 (ddd, J = 18.9, 13.6, 5.8 Hz, 4H, H2+H4), 2.16 (s, 6H, H1+H5), 1.65 – 1.51 (m, 2H, H2’), 
1.42 – 1.18 (m, 18H, H3’-H11’), 0.88 (t, J = 6.5 Hz, 3H, H12’); 13C NMR (75 MHz, δ in CDCl3): 79.3, 
70.3, 37.7, 32.1, 30.2, 29.8, 29.8, 29.8, 29.7, 29.6, 29.5, 26.3, 22.8, 16.9, 14.3; ESI-MS m/z exp. 
(calcd.): 135.1 (135.0, [M-C12H25O]+), 208.0 (208.2, [C12H25O+Na]+), 321.2 (321.2, [M+H]+). 
 
Scheme 8.2. Synthesis of compound 10 from 1,3-bis(methylthio)-2-propanol and 1-bromododecane. 
8.4.4 Synthesis of  6(PF6)2  
A mixture of compound 10 (66 mg, 0.206 mmol) and cis-Λ/Δ-[Ru(bpy)2Cl2] (50 mg, 0.103 
mmol) under Ar atmosphere was dissolved in a 1:1 mixture of EtOH and H2O (10 mL) and 
heated to reflux in the dark for 20 h. Hereafter, the reaction mixture was cooled to room 
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temperature, and the solvent was removed in vacuo. The reaction mixture was poured onto 30 
mL of sat. aq. KPF6, extracted with DCM (4 × 20 mL), and concentrated by rotary evaporation. 
Removal of the excess ligand was done by centrifugal washing with diethyl ether (2 × 12 mL, 
2800 g). cis-Λ/Δ-[Ru(bpy)2(10)](PF6)2 (compound 6(PF6)2) was obtained as an orange powder 
in 45% yield (47 mg, 0.046 mmol). 1H NMR (400 MHz, δ in CD3CN): 9.62 (d, J = 5.3 Hz, 1H, HH), 
9.17 (d, J = 5.3 Hz, 1H, Hh), 8.52 (t, J = 8.7 Hz, 2H, He+HE), 8.38 (dd, J = 8.2, 2.8 Hz, 2H, Hd+HD), 
8.33 – 8.24 (m, 2H, Hf+HF), 8.03 – 7.96 (m, 2H, Hc+HC), 7.93 – 7.85 (m, 2H, Hg+HG), 7.49 (d, J = 5.1 
Hz, 1H, HA), 7.43 (d, J = 5.1 Hz, 1H, Ha), 7.36 – 7.26 (m, 2H, Hb+HB), 4.37 (s, 1H, H3), 3.67 (dt, J = 
9.2, 6.5 Hz, 1H, H1’), 3.49 (dt, J = 9.2, 6.5 Hz, 1H, H1’), 3.20 (dd, J = 13.2, 6.2 Hz, 1H, H4), 3.12 (dd, 
J = 13.9, 2.7 Hz, 1H, H2), 2.95 (s, 1H, H2), 2.61 (dd, J = 13.1, 1.6 Hz, 1H, H4), 1.66 – 1.54 (m, 2H, 
H2’), 1.43 (s, 3H, H1), 1.40 – 1.21 (m, 18H, H3’-11’), 1.08 (s, 3H, H5), 0.88 (d, J = 6.8 Hz, 3H, 
H12’); 13C NMR (100 MHz, δ in CD3CN): 158.6 (Cq), 158.5 (Cq), 157.3 (Cq), 157.2 (Cq), 154.6 (Ch), 
153.9 (CH), 152.2 (Ca), 151.9 (CA), 139.8 (Cc+CC+Cf+CF), 129.7 (Cg), 128.7 (Cb+CB), 128.6 (CG), 
125.9 (Ce), 125.8 (CE), 125.2 (Cd), 125.1 (CD), 74.2 (C3), 70.4 (C1’), 38.0 (C4), 37.2 (C2), 32.6, 
30.5, 30.3, 30.3, 30.0, 26.8, 23.4, 20.9 (all C2’-11’), 18.5 (C1), 16.0 (C5), 14.4 (C12’); HR-MS m/z 
exp. (calcd.): 367.1310 (367.1312, [M-2PF6]2+); UV-Vis: λmax (ε in L.mol-1.cm-1) in CH3CN: 415 nm 
(6172); Elemental analysis for C37H52F12N4OP2RuS2: (calcd.): C, 43.40; H, 5.12; N, 5.47; (exp.): C, 
43.38; H, 5.15; N, 5.49. 
 
Scheme 8.3. Synthesis of 6(PF6)2 from compound 10 and cis-Λ/Δ-[Ru(bpy)2Cl2].  
 
8.4.5 Synthesis of 2,9-dimethyl-1,10-phenanthroline-5,6-dione – compound 11 
According to literature procedure.[22] 11 was obtained as ocher yellow needles in 59% yield 
(2.03 g, 8.53 mmol). 1H NMR (300 MHz, δ in CDCl3): 8.38 (d, J = 8.0 Hz, 2H, H4+H7), 7.42 (d, J = 
8.0 Hz, 2H, H3+H8), 2.86 (s, 6H, H2+H9); Spectrum matches literature data.[22] ESI-MS m/z exp. 




Scheme 8.4. Synthesis of compound 11. 
8.4.6 Synthesis of 5,6-bis(dodecyloxy)-2,9-dimethyl-1,10-phenanthroline – compound 12 
Compound 11 (500 mg, 2.10 mmol) was dissolved in a 1:1 mixture of H2O and THF (20 mL), and 
placed under Ar atmosphere, followed by the addition of tetrabutylammonium bromide (451 
mg, 1.40 mmol), sodium dithionite (2.19 g, 12.6 mmol) and 1-bromododecane (1.66 mL, 6.93 
mmol). To the resulting yellow suspension was slowly added a solution of KOH (1.77 g, 31.5 
mmol) in H2O (10 mL), leading to a dark brown suspension. The reaction mixture was stirred at 
40 °C for 3 days, during which the color lightened to yellow-brown. After dilution with H2O (50 
mL), the mixture was extracted with EtOAc (3 x 75 mL). The combined organic layers were 
washed with H2O (100 mL), dried over MgSO4 and the solvent was removed by rotary 
evaporation. Column chromatography (SiO2, EtOAc) yielded the title compound in 59% yield as 
a beige powder (720 mg, 1.25 mmol). TLC: Rf = 0.8 (EtOAc). 1H NMR (300 MHz, δ in CDCl3): 8.45 
(d, J = 8.4 Hz, 2H, H4+H7), 7.49 (d, J = 8.4 Hz, 2H, H3+H8), 4.21 (t, J = 6.7 Hz, 4H, H1’), 2.93 (s, 6H, 
H2+H9), 1.88 (p, J = 6.7 Hz, 4H, H2’), 1.61 – 1.48 (m, 4H, H3’), 1.45 – 1.20 (m, 32H, H4’-H11’), 
0.88 (t, J = 6.9 Hz, 6H, H12’); 13C NMR (75 MHz, δ in CDCl3): 158.2, 141.9, 131.0, 124.4, 123.7, 
74.1, 32.1, 30.6, 29.8, 29.8, 29.7, 29.5, 26.4, 25.7, 22.9, 14.3; HR-MS m/z exp. (calcd.): 577.4721 
(577.4728, [M+H]+). 
 
Scheme 8.5. Synthesis of compound 12 from 1-bromododecane and compound 11. 
8.4.7 Synthesis of 7(PF6)2 
A mixture of 12 (100 mg, 0.172 mmol) and cis-Λ/Δ-[Ru(bpy)2Cl2] (100 mg, 0.206 mmol) was 
placed in a 25-mL Teflon-lined stainless steel reaction vessel. Ethylene glycol (8 mL) was added, 
and the closed vessel was heated to 200 °C for 6 h. The red solution obtained was poured onto 
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water (50 mL) and an orange precipitate was produced by adding sat. aq. KPF6 (5 mL). After 
cooling the mixture to 4 °C, the precipitate was collected by filtration, washed with cold water 
and cold Et2O, and purified by column chromatography (SiO2, acetone to acetone:H2O:sat. aq. 
KPF6 (100:10:2)). Further purification using size exclusion chromatography (Sephadex LH20, 
acetone) yielded cis-Λ/Δ-[Ru(bpy)2(12)](PF6)2 (compound 7(PF6)2) as a red powder (29 mg, 
0.023 mmol, 13%). 1H NMR (300 MHz, δ in CD3CN): 8.63 (d, J = 8.5 Hz, 2H, H4+H7), 8.49 (d, J = 
8.1 Hz, 2H, He), 8.43 (d, J = 8.1 Hz, 2H, Hd), 8.02 (td, J = 8.0, 1.5 Hz, 2H, Hf), 7.97 (td, J = 8.0, 1.5 Hz, 
2H, Hc), 7.68 (d, J = 5.3 Hz, 2H, Ha), 7.61 (d, J = 5.1 Hz, 2H, Hh), 7.56 (d, J = 8.5 Hz, 2H, H3+H8), 
7.27 (dd, J = 5.7, 1.0 Hz, 2H, Hg), 7.23 (dd, J = 5.7, 1.1 Hz, 2H, Hb), 4.38 – 4.18 (m, 4H, H1’), 1.91 – 
1.83 (m, 10H, H2+H9+H2’), 1.54 (p, J = 7.1 Hz, 4H, H3’), 1.41 – 1.21 (m, 32H, H4’-H11’), 0.88 (t, J 
= 6.5 Hz, 6H, H12’); 13C NMR (75 MHz, δ in CD3CN): 166.6, 153.8 (Ch), 152.9 (Ca), 138.8 (Cc), 
138.6 (Cf), 133.1 (C4+C7), 128.3 (C3+C8+Cb+Cg), 125.4 (Cd+Ce), 75.4 (C1’), 32.7 (C2’), 30.8, 30.4, 
30.3, 30.1, 26.8 (all C3’-C10’), 26.0 (C2+C9), 23.4 (C11’), 14.4 (C12’); HR-MS m/z exp. (calcd.): 
495.2534 (495.2539, [M-2PF6]2+); UV-Vis: λmax (ε in L.mol−1.cm−1) in CH3CN: 452 nm (13730); 
Elemental analysis for C58H76F12N6O2P2Ru: (calcd.): C, 54.41; H, 5.98; N, 6.56; (exp.): C, 54.94; H, 
5.23; N, 6.58. 
 
Scheme 8.6. Synthesis of compound 7(PF6)2 from cis-Λ/Δ-[Ru(bpy)2Cl2] and compound 12.  
8.4.8 Liposome preparation 
All liposome formulations were prepared by the classical hydration-extrusion method. As an 
example, the preparation of  M1-3-6 is described here. Aliquots of chloroform stock solutions 
containing the liposome constituents were added together in a flask to obtain a solution with 
5.0 µmol DMPC, 0.20 µmol DSPE-mPEG-2000, 2.5 nmol 1, 25 nmol 3, and 0.20 µmol 6[PF6]2. The 
organic solvent was removed by rotary evaporation and subsequently under high vacuum for at 
least 30 minutes to create a lipid film. 1.0 mL PBS buffer (with or without L-ascorbic acid and/or 
glutathione) was added and the lipid film was hydrated by 4 cycles of freezing the flask in liquid 
nitrogen and thawing in warm water (50 °C). The resulting dispersion was extruded through a 
Whatman Nuclepore 0.2 μm polycarbonate filter at 40-50 °C at least 11 times using a mini-
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extruder from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA). The number of extrusions 
was always odd to prevent any unextruded material ending up in the final liposome sample. The 
extrusion filter remained practically colorless after extrusion, suggesting near-complete 
inclusion of the chromophoric compounds in the lipid bilayer. Liposomes were stored in the 
dark at 4 °C and used within 7 days. The average hydrodynamic liposome size and 
polydispersity index (PDI) were measured with a Malvern Instruments Zetasizer Nano-S 
machine, operating with a wavelength of 632 nm. The size and PDI were typically 130 − 170 nm 
and 0.1, respectively. 
8.4.9 Upconversion emission spectroscopy with L1-2 liposomes and meat 
 
Figure 8.16. Experimental setup used for spectroscopy through meat. a) Schematic representation of the setup: 
630 nm laser (1); optical fibers (2); filter holder (3) for 630 nm band pass filter (4) and variable neutral density 
filter (5); cage system (6) with two oppositely facing cage plates, both fitted with a collimating lens (8), and a 
central sample-holding plate; microscopy slide holding the liposome gel and meat on top (7); filter holder (9) 
for a 630 nm notch filter (10) for blocking the excitation source; spectrometer (11). b) Photographs of the cage 
system with the upconverting liposome gel only (bottom) and with 1 layer of pork fillet on top (top). Both 
photographs were taken with a 575 nm OD 4 short pass filter in front of the camera to block the excitation 
source. 
L1-2 liposomes were prepared according to Section 8.4.8 ([DLPC] = 20.0 mM). To prepare a 
liposome hydrogel and to allow upconversion in air, this solution was heated to 55 °C and 1:1 
v/v mixed with a solution at 55 °C containing 1 wt.% agarose, 10 mM sodium L-ascorbate and 
10 mM sodium glutathionate (pH 7.3). 20 µL of this mixture was pipetted with a warm pipet on 
a warm 1 mm thick microscopy slide (Menzel-Gläser Superfrost, 76 x 26 mm) and immediately 
covered with a round 25 mm diameter microscopy coverslip (VWR, thickness no. 1). Upon 
cooling to room temperature, this procedure produced a thin gel slice with ~25 µm thickness. 
On top of the coverslips, thin slices of chicken breast fillet or pork fillet were layered (1 – 2 mm 
thick each, measured for each slice with a caliper) up to ~13 mm thick. The entire sample 
construct was allowed to reach room temperature (20 °C) before measurement in a custom-
build spectroscopy setup (Figure 8.16). A cage with an open sample space was constructed with 
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single collimating lenses (Avantes COL-UV/VIS) on both sides for excitation (from the top) and 
detection (from the bottom) connected with FC-UVxxx-2 (xxx = 400, 600) optical fibers 
(Avantes). The excitation lens was connected to a clinical grade Diomed 630 nm PDT laser set to 
30 mW (3 mm beam, 0.42 W.cm−2) using a PM100 USB power meter and S310C detector 
(Thorlabs). Between the laser and the excitation lens, a filter holder was placed with a FB630-
10 band pass filter and a NDL-25C-4 variable neutral density filter (Thorlabs). The detection 
lens was connected to a 2048L StarLine spectrometer (Avantes); between the spectrometer and 
detection lens, a filter holder with a NF-633 notch filter was placed. For each meat layer 
thickness, the spectrum was taken at 5 different sample locations, and the spectrum was 
averaged. Then, a new layer of meat was carefully placed on top and the measurements were 
repeated until a thickness of ~13 mm was achieved. 
8.4.10 Photodissociation experiments with meat 
For photodissociation experiments with L1-3-6 liposomes and meat, the sample was prepared 
as described in Section 8.4.8 ([DLPC] = 10 mM). 400 µL sample was placed in a 2 mm thick 
cuvette and sandwiched between a 5 × 5 cm glass plate and a 5 × 5 cm slice of pork fillet (Albert 
Heijn; “AH Filetlapjes à la minute naturel”), 7 ± 0.5 mm thick. This meat-sample construct was 
placed in the same cage setup as described in Section 8.4.9, but the laser was now directly 
coupled to the excitation lens and the FB630-10 band pass filter was now placed directly 
between the excitation lens and the sample (see Figure 8.13). The detection lens and 
spectrometer were left out. To compare blue and light irradiation, the meat-sample construct 
was irradiated from the top with either 110 mW 450 nm or 630 nm laser light in a 3 mm 
collimated beam (1.6 W.cm−2). Also, the experiment was repeated with 300 mW 630 nm light 
(4.2 W.cm−2). 
8.4.11 General cell culturing 
A549 human lung carcinoma cells were cultured in 25 cm2 flasks in 8 mL Dulbecco’s Modified 
Eagle Medium with phenol red (DMEM; Sigma Life Science, USA), supplemented with 8.2% v/v 
fetal calf serum (FCS; Hyclone), 200 mg.L−1 penicillin and streptomycin (P/S; Duchefa), and 1.8 
mM glutamine-S (GM; Gibco, USA), under standard culturing conditions (humidified, 37 °C 
atmosphere containing 7.0% CO2). The cells were split approximately once per week upon 
reaching 70 − 80% confluency, using seeding densities of 2 × 105 cells, and the medium was 
refreshed once per week. Cells were passaged for 4 − 8 weeks. 
8.4.12 Live cell imaging with M1-3 liposomes  - preparation 
After cell splitting, the cells were suspended in OptiMEM (Life Technologies, USA), 
supplemented with 2.5% FCS, 200 mg/L P/S, and 1.8 mM GM at 3 × 105 cells per mL. 100 µL of 
this suspension was placed in a droplet on round 25 mm diameter microscopy coverslips (VWR, 
thickness no. 1) in a 6-well plate. After 5 min of sedimentation, 3 mL OptiMEM was carefully 
added to each well, and the cells were incubated for 24 h. Meanwhile, M1-3 liposome samples 
were prepared as before ([DMPC] = 2.5 mM, 2 mL volume). Optionally, this solution contained 5 
mM sodium L-ascorbate and 5 mM sodium glutathionate. The solution was sterilized with a 0.2 
µm filter and from this a 3:5 v/v liposomes/Opti-MEM solution was prepared ([DMPC] = 1 mM). 
3 mL of this solution was added to the desired wells, and the cells were incubated for 24 h. 
Then, the cells were washed once with PBS, and resupplied with 1 mL Opti-MEM before 
imaging. Optionally, the cells were incubated with 50 nM LysoTracker Red DND-99 in Opti-MEM 
for 30 min, after which the cells were washed once with PBS, and resupplied with 1 mL Opti-
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MEM before imaging. Finally, the coverslips were transferred to a custom-made sample holder 
for round 25 mm coverslips, and supplied with 500 µL Opti-MEM.  
8.4.13 Live cell imaging with M1-3 liposomes  - microscopy 
Bright field and (upconversion) emission imaging was performed with a customized Zeiss 
Axiovert S100 Inverted Microscope setup, fitted with a Zeiss 100× Plan Apochromat 1.4 NA oil 
objective, and an Orca Flash 4.0 V2 sCMOS camera from Hamamatsu, which together produced 
4.2 megapixel images with pixel size of 69 nm. The typical camera exposure time was 1000 ms. 
Samples were loaded in a temperature and atmosphere controlled stage-top mini-incubator 
(Tokai Hit, Japan) set at 37 °C with 1% O2 and 7% CO2 in which samples were incubated for 30 
min before imaging. For direct excitation and fluorescence imaging of 2, a CrystaLaser 
DL-405-050 405 nm solid state laser was used, combined with a ZT405/514/561rpc dichroic 
beam splitter (Chroma Technology Corporation) and ZET442/514/568m emission filter 
(Chroma Technology Corporation). The output power of the 405 nm laser at the sample was 
typically 75 µW (60 μm spot diameter, intensity 2.7 W.cm−2). For upconversion emission 
microscopy, a Power Technology 1Q1A30(639-35B)G3 639 nm diode laser was used as 
excitation source, combined with a Chroma ZT405/532/635rpc dichroic beam splitter. To block 
everything except upconversion emission, a 575 nm short pass filter (Edmund Optics, part no. 
#84-709) was placed between the sample and the camera, resulting in OD > 5 at 639 nm and 
800 nm (i.e. the excitation source and the phosphorescence of 1 were completely blocked). The 
output power of the 639 nm laser at the sample was typically 1.0 mW (70 μm spot diameter, 
intensity 26 W.cm−2). All laser beam spots had a Gaussian intensity profile; spot diameters are 
reported as Full Width at Half Maximum (FWHM) values.  
8.4.14 Photocytotoxicity assay of liposomes with red and  blue light 
The phototoxicity of upconverting liposomes and liposomes doped with Ru-complexes was 
determined according to a photocytotoxicity protocol that was recently developed in our 
group.[10] MCF7, A549, or MRC5 cells were seeded in the central 60 wells of a 96 well plate at 
8 K, 5 K, and 6 K cells respectively in 100 µL Opti-MEM. 100 µL Opti-MEM was added to the 
outer wells. The plate was incubated for 24 h. Meanwhile, liposomes were prepared as before 
([DMPC] = 5.0 mM) and sterilized by extruding through a 0.2 µm filter. This procedure did not 
change the DLS values of the liposomes. The sterilized solution was used to prepare a dilution 
series of liposomes in 8-chamber reservoirs, and 100 µL of each diluted mixture was added to 
the wells according to the plate-design, see Figure 8.18a. The outer wells and control wells were 
mock-treated with 100 µL Opti-MEM only. The plates were incubated for 24 h, after which the 
cells were washed once with 200 µL Opti-MEM and resupplied with 200 µL Opti-MEM. The well-
plate was placed in a temperature and atmosphere controlled stage-top mini-incubator (Tokai 
Hit, Japan) set at 37 °C, 20% O2, and 7% CO2 in which samples were incubated for 10 min before 
irradiation. Then, the plate was irradiated with either 15 min of 628 nm light (23.0 ± 1.5 
mW.cm−2 intensity, 20.7 J.cm−2 dose) or 10 min of 454 nm light (7.0 ± 0.8 mW.cm−2 intensity, 4.2 
J.cm−2 dose) using a custom-build array of 96 LED lights that fitted exactly on top of the mini-
incubator, which have been characterized by our group recently.[10] The irradiation intensities 
were determined with a custom build spectroscopy setup, detailed in Section 8.4.15. Control 
plates were treated in the same way, but not irradiated. After irradiation, the plate was 
incubated for 48 h at 37 °C, 7% CO2 and 20% O2. Then, the cells were fixed by adding 100 µL 
10% w/w trichloroacetic acid (TCA) in H2O to each well and the plate was placed in a 
refrigerator at 4 °C for 60 h. The TCA was removed by rinsing the plate gently with H2O five 
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times and the plate was dried overnight. Then, the inner 60 wells of the plate were stained with 
100 µL sulforhodamine B (SRB, 0.6 w% in 1 v% acetic acid) for 30 min, after which the plate 
was washed five times in 1 v% acetic acid. Once the plate was dry (± 3 h), the SRB stain was 
dissolved in 200 µL 10 mM tris-base solution and the plate was placed on an orbital shaker for 
30 min. Finally, the absorbance at 510 nm was measured with a plate reader (Tecan Infinite 
M1000 Pro) and the absorbance was converted to relative cell-viabilities using Microsoft Excel 
2010 and GraphPad Prism 7 software. In case of M1-3, M1, and M3 liposomes, the experiment 
was performed three times (three biological replicates); in case of M5 and M6, the experiment 
was performed twice (two biological replicates). 
8.4.15 Characterization of red and blue LED arrays in mini-incubator irradiation setup 
The light power density of the LED arrays was measured using a custom-built spectroscopy 
setup consisting of an integrating sphere, which was positioned underneath the 96-well plate to 
simulate the irradiation conditions during cell experiments (Figure 8.17). The integrating 
sphere was mounted in a custom-made holder that mimicked the height of the mini-incubator 
while allowing the integrating sphere to be aligned exactly with a single 6 mm diameter well of 
a 96-well plate. On top of the holder, the lid of the mini-incubator was positioned, and on top of 
that, the LED array just like during cell irradiation. The integrating sphere position was 
diagonally adjustable over ten wells in order to individually measure a representative set of 
wells (B2, C3, C7, D4, D8, E5, E9, F6, F10, and G11). The integrating sphere was connected via an 
optical fiber to an Avantes CCD spectrometer, which were together spectrally calibrated just 
before measurement using a NIST-traceable calibration lamp (Avantes) to report the spectrum 
in spectral irradiance units (µW.cm−2.nm−1), where the surface here refers to that of the 
aperture of the integrating sphere. The light averaged intensity at the bottom of each well in 
mW.cm−2 was then determined by spectrally integrating the spectrum for each well with 
OriginPro software and averaging these values over the different wells. Analysis of the 
spectrum also provided the intensity maximum and full-width-half-maximum (FWHM) 
bandwidth of each LED array. For the 454 nm LED array had a FWHM of 23 nm and an intensity 
of 7.0 ± 0.8 mW.cm−2. The 628 nm LED array had a FWHM of 19 nm and an intensity of 23.0 ± 
1.5 mW.cm−2. 
 
Figure 8.17. Photographs of the setup used for characterization of LED arrays, consisting of (from top to 
bottom) 96-LED array (1), mini-incubator lid (2), mini-incubator mimicking plate holder (3), 96-well plate (4), 
bottom of the plate holder (5), and integrating sphere fitting directly underneath the 96-well plate (6). 
8.4.16 Photocytotoxicity assay of liposomes with high intensity red light 
For photocytotoxicity assays using high intensity red light, a different procedure was followed; 
the differences are reported here. Instead of using all 60 central wells of a 96 well plate, only 24 
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of them were used according to the plate design in Figure 8.18b. Wells between the test-wells 
were intentionally left empty to avoid unintentional irradiation of neighboring wells. For this 
experiment, the diluted liposome solution (0.20 mM DMPC in Opti-MEM) was mixed 1:1 v/v 
with 10 mM sodium L-ascorbate and sodium glutathionate in PBS to make a 100 µM DMPC and 
5 mM anti-oxidant solution. Additionally, the experiment was performed under hypoxic 
conditions by adjusting the O2 level in the mini-incubator to 1%. Single wells were irradiated for 
5 min with a 630 nm Diomed 630 PDT laser, fiber-coupled with a 600 µm fiber (Avantes) to a 
collimating lens (Omicron Laserprodukte GmbH, DE) fitted underneath the well plate (Figure 
8.19). Together, these produced a 6 mm collimated beam (300 mW power, 1.1 W.cm−2 intensity, 
320 J.cm−2 dose for 5 min irradiation) that illuminated an entire well surface area exactly. In 
these experiments, the well plate was moved every 5 min with an automated stage (MLS203-1, 
Thorlabs) so that each well was irradiated consecutively (2 h total irradiation time). This 
experiment was performed only once. 
 
Figure 8.18. Plate design for photocytotoxicity assays. a) Plate design for an experiment using the inner 60 
wells with a control column and three liposome formulations.[10] Each liposome formulation at each 
concentration is added to three different wells (technical triplicate). b) Plate design for an experiment using 
high intensity red light irradiation with three control wells (C) and three liposome formulations (indicated 
with 1, 2, and 3). The white wells have been left empty to avoid unintentional irradiation of neighboring wells. 




Figure 8.19. Photographs of setup used for irradiation experiments with high intensity red light, consisting of a 
mini-incubator (1; for clarity here without 96-well plate), motorized XY-translation stage (2), and collimating 
lens fitted underneath the mini-incubator (3), connected to a fiber-coupled laser (not shown). 
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Imaging upconverting polymersomes in cancer cells: 
biocompatible anti-oxidants brighten triplet-triplet 
annihilation upconversion 
 
Light upconversion is a powerful tool in bio-imaging as it can abolish autofluorescence, 
increase imaging contrast, reduce irradiation damage, and increase excitation 
penetration depth in vivo. Among the various principles of light upconversion, triplet-
triplet annihilation upconversion (TTA-UC) in nanoparticles holds great promise, due to 
the high efficiency at low excitation power. However, the TTA UC mechanism is 
inherently obstructed by molecular oxygen, leading to drug delivery systems and nano 
devices that do not function in air. In this work, we demonstrate that sacrificial anti-
oxidants can be used to protect TTA-UC in polymersomes by photochemically depleting 
the local oxygen concentration. Red-to-blue upconverting polymersomes were prepared, 
which did not upconvert significantly in air, but did produce bright upconversion upon 
addition of 10 mM of L-ascorbate, glutathionate, L-histidine, sulfite, or trolox. Most 
importantly, this strategy also succeeded in living cells: A549 lung cancer cells were co-
treated with upconverting polymersomes and 5 mM L-ascorbate and glutathionate, 
resulting in an order of magnitude brighter upconversion than without anti-oxidants. 
These results demonstrate a simple chemical solution to the issue of oxygen sensitivity of 
TTA-UC, which is of paramount importance for the technological advancement of this 
technique in biology. 
This chapter was published as a full article: Sven H.C. Askes, Wim Pomp, Samantha L. 




Upconversion of light is the generation of high-energy photons from 
low-energy photons, for example the conversion of red light to blue light. In 
biological systems, upconversion imaging is characterized by negligible 
auto-fluorescence, increased imaging contrast, reduced irradiation damage, 
and increased excitation penetration depth in vivo. Because of these 
advantages, lanthanoid-based upconverting nanoparticles (UCNPs), for 
example, have attracted extensive interest.[1] However, UCNPs suffer from 
several disadvantages, such as the need for high excitation intensities or the 
low upconversion efficiencies observed in aqueous solution (typically ≤ 0.5%), 
which results from the low absorption cross section of lanthanoid ions and 
luminescence quenching by water at their surface.[2] In contrast, triplet-triplet 
annihilation upconversion (TTA-UC) requires low excitation intensity (down 
to 1 mW.cm−2), employs sensitizers having high molar absorptivity in the 
phototherapeutic window, resulting in upconversion quantum yields up to 
14% in aqueous solution.[2-3] TTA-UC is based on the photophysical interplay 
of photosensitizer and annihilator chromophores (see Chapter 2, Figure 
2.1).[1b, 4] The photosensitizer absorbs low energy light, after which 
intersystem crossing leads to a long-lived triplet state. This triplet state is 
transferred to the annihilator upon diffusional collision by means of 
triplet-triplet energy transfer (TTET); a succession of TTET leads to a 
concentration buildup of long-lived triplet state annihilators molecules. Two 
triplet state annihilator molecules interact resulting in  triplet-triplet 
annihilation upconversion, in which one of them departs with all the energy of 
the pair, thus reaching a high-energy singlet excited state. Finally, this singlet 
excited state returns to the ground state by fluorescent emission of a high-
energy photon, thereby realizing upconversion. TTA-UC has been 
demonstrated in an extensive assortment of organic, inorganic, and/or 
supramolecular materials,[3b, 5] as well as in nano- or micro-sized particles.[6] It 
has been used for applications in photocatalysis,[7] solar energy harvesting,[8] 
drug delivery and drug activation,[9] or bio-imaging. In particular bio-imaging 
using TTA-UC has been demonstrated, often in fixed cells, using silica-coated 
micelles,[2, 10] dye-modified cellulose templates,[11] PMMA nanocapsules,[12] or 
soybean oil or oleic acid core nanocapsules.[13]  
Although many published studies focusing on biological application of TTA-UC 
avoid discussing the sensitivity of their system to oxygen, TTA-UC inherently 
suffers from physical quenching of the sensitizer and/or annihilator triplet 
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excited states by O2. Such quenching leads to the formation of undesirable, 
cytotoxic singlet oxygen and concomitant loss of upconversion in the nano-
devices. For example, the TTA-UC liposome system initially described by our 
group for the activation of a blue-light sensitive prodrug[9] functioned only 
under inert atmosphere. Other groups showed that TTA-UC bio-imaging of 
PMMA nanocapsules in HeLa cells also suffered from oxygen sensitivity; 
upconversion was shown to be enhanced upon addition of valinomycin, which 
stimulates mitochondrial oxygen consumption.[12a] Here we argue that 
addressing the issue of oxygen sensitivity is of paramount importance for the 
technological advancement of TTA-UC in biology. Using TTA-UC 
polymersomes we demonstrate that it is possible to dramatically reduce the 
oxygen sensitivity of TTA-UC nano-sized systems by the addition of 
antioxidants thereby creating a locally oxygen-depleted environment. 
Interestingly, this strategy can be applied to cell cultures as exemplified by the 
imaging of TTA-UC polymersomes inside living cancer cells. 
The polymersomes used in this study belong to a large family of vesicles that 
have attracted significant attention in the fields of drug delivery and 
bio-imaging research.[14] Polymersomes are typically composed of synthetic 
amphiphilic block copolymers that, similar to liposomes, self-assemble into 
spherical bilayer membranes surrounding an aqueous interior. Analogous to 
liposomes, the hydrophobic membrane of polymersomes can be doped with 
hydrophobic dyes such as palladium(II) tetraphenyl tetrabenzoporphyrin (1) 
and 2,5,8,11-tetra(tert-butyl)perylene (2, see Figure 9.1). When combined 
these dyes form a TTA-UC couple that is capable of upconverting red light into 
blue light. Polymersomes have many advantages compared to lipid-based 
liposomes. Notably, the membrane thickness, rigidity, fluidity, plasticity, 
permeability, and surface functionalization, can be tuned by choosing the 
appropriate copolymer. In addition, polymersomes typically feature high 
retention of encapsulates, high stability in aqueous media, and can be very 
cheap to make.[14a-d] In this study poly-isobutylene (PiB, Mw ~ 1.0 kg.mol−1) 
and poly-ethylene glycol (PEG, MW ~ 0.35 or 0.75 kg.mol−1) were chosen here 
as the hydrophobic and hydrophilic polymer blocks respectively.[15] PiB is a 
well-known polymer with low permeability to small molecules such as 
dioxygen; it has a high chemical and thermal resistance and a high 
biocompatibility.[16] PEG is a biocompatible polymer that has become an 
established standard for the surface functionalization of drug delivery and 
bio-imaging systems. In this article we describe the synthesis and 
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characterization of upconverting PiB-PEG polymersomes, study the stability of 
red-to-blue TTA-UC in aqueous solution in presence of a range of bio-
compatible antioxidants, and demonstrate the enhanced TTA-UC imaging of 




Figure 9.1. a) Chemical structures of the red photosensitizer palladium(II) tetraphenyl 
tetrabenzoporphyrin (1), of the blue emitter 2,5,8,11-tetra(tert-butyl)perylene (2), and of the 
polyisobutylene-block-monomethyl polyethylene glycol (PiB1000-b-PEGx-Me, x = 350 or 750) 
amphiphilic block copolymers used in this study, with PiB molecular weight of 1.0 kg.mol−1 and 
PEG block molecular weights of 0.35 kg.mol−1 (3) and 0.75 kg.mol−1 (4). b) Schematic illustration 
of a polymersome composed of 3 or 4, and doped with compounds 1 and 2. 
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9.2 Results and discussion 
9.2.1 Synthesis and characterization of TTA-upconverting polymersomes 
In order to acquire a vesicle morphology, an amphiphilic block copolymer 
needs to have a hydrophilic block volume fraction of 0.25 to 0.45.[14b] Hence, 
two amphiphilic block copolymers (compounds 3 and 4) were synthesized by 
condensation of polyisobutylene succinic anhydride (PiB-SA, MW ~ 1.0 
kg.mol−1) and mono-methoxy polyethylene glycol (MW ~ 0.35 kg.mol−1 for 3 
and 0.75 kg.mol−1 for 4).[17] The products were characterized using NMR 
spectroscopy, IR spectroscopy, and gel-permeation chromatography (see 
experimental section and Appendix VIII). Nanoparticle dispersions called P3 
and P4 were produced with polymers 3 and 4, respectively, using a 
freeze-thaw-extrusion protocol in phosphate buffered saline at a 
concentration of 10 mg/mL polymer. P3 and P4 were clear solutions that 
exhibited a typical nanoparticle scatter (Figure S.VIII.10). Sample P3 was 
more opaque than P4, indicating a larger particle size. The hydrodynamic 
diameter (z-average) and polydispersity index (PDI) of the particles was 
measured using dynamic light scattering (DLS), revealing typical particle 
diameters of ~150 and 80 nm for P3 and P4, respectively, and PDI’s ranging 
from 0.1 to 0.3 (Table 9.1). The nanoparticle dispersions were stable over time 
and the hydrodynamic radius did not change over a period of at least two 
months. The ζ-potentials were found to be −42.0 and −24.0 mV for P3 and P4, 
respectively. The negative surface charge originates from the carboxylic acid 
groups in the polymer junction, which are deprotonated at neutral pH. The 
less negative charge of P4 can be explained by the larger PEG-brush on its 
surface, which is known to decrease the observed surface charge due to an 
increased hydrodynamic drag.[18] 
To examine the particle morphology and measure the particle diameter 
distribution, the samples were examined with transmission electron 
microscopy (TEM, see Figure 9.2). The micrographs show that P3 and P4 
consisted of particles of 156 ± 90 nm (bimodal distribution) and 95 ± 49 nm 
(unimodal distribution), respectively. The size populations as determined 
with TEM were in good agreement with the DLS values. For both P3 and P4, 
upon high-intensity exposure to the electron beam of the TEM microscope, the 
particle shell collapsed, liquid visibly leaked from the interior, and the 
particles became more and more translucent for electrons. After this 
transformation was complete, only an empty collapsed shell remained (Figure 
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S.VIII.7). Surprisingly, the particles did not burst at low electron beam 
exposures, indicating that the shell successfully tolerated the high vacuum in 
the TEM chamber. Overall, these observations are consistent with vesicular 
nanoparticles composed of rubbery membranes surrounding an aqueous 
interior, i.e. polymersomes.  
Table 9.1. Sample composition of all studied polymersome samples, and their typical particle sizes 
and surface charges;  hydrodynamic particle diameters (z-average), polydispersity index (PDI), 
ζ-potential, and particle diameters from transmission electron microscopy (TEM). ζ-potentials 
















P3 10 - - - 149 0.120 −42.0 ± 7.5 156 ± 90  
P3-1 10 - 10 - 152 0.136   
P3-2 10 - - 200 154 0.154   
P3-1-2 10 - 10 200 146 0.189   
P4 - 10 - - 83 0.263 −24.0 ± 10.7 95 ± 49 
P4-1 - 10 10  83 0.277   
P4-2 - 10 - 200 86 0.267   
P4-1-2 - 10 10 200 77 0.263   
 
 
Figure 9.2. Transmission electron micrographs of P3 (a) and P4 (c) vesicles and their respective 
measured particle diameter distributions (b and d). The mean diameters and standard deviations 
were determined from a population (N) of 773 and 643 individual particles for P3 and P4, 
respectively. 
The TTA-UC dyes that were selected for incorporation in the polymersome 
membrane were palladium(II) tetraphenyl tetrabenzoporphyrin (1) as the red 
light-absorbing photosensitizer, and 2,5,8,11-tetra(tert-butyl)perylene (2) as 
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the blue light-emitting annihilator. Instead of using perylene, the benchmark 
annihilator in many TTA-UC systems,[1b] four-fold tert-butylated perylene was 
used to prevent aromatic stacking and thereby enhance solubility of the 
molecule in the hydrophobic environment of the membrane.[19] Preliminary 
experiments indeed indicated that the greater lipophilicity of 2 prevented the 
molecule from partitioning with the water phase in amphiphilic dispersions, 
whereas unsubstituted perylene shuttles between different membranes (data 
not shown).[20] With respect to perylene, the fluorescence maximum of 2 is 
reported to be bathochromically shifted by only about 15 nm while the 
fluorescence lifetime and quantum yield are very similar.[19, 21] Indeed this 
tetrasubstitution of perylene did not significantly alter the ability of this blue 
emitter to serve as an annihilator for red-to-blue TTA-UC. Bright red-to-blue 
TTA-UC was achieved in air by dissolving 1 and 2 in a 3:1 mixture of 
chloroform and oleic acid and illuminating with 50 mW 630 nm excitation (0.4 
W.cm−2), without deoxygenation (Figure S.VIII.8). Next, 1 and/or 2 were 
incorporated in polymersomes P3 and P4 resulting in dye-loaded 
polymersomes, denoted as P3-1, P3-2, P3-1-2, P4-1, P4-2, and P4-1-2 (see 
Table 9.1 for the membrane composition, and Figure 9.3 and Figure S.VIII.10 
for photographs of the samples). Both dyes were incorporated quantitatively 
in the vesicle membrane, and dye doping had no effect on particle size or 
stability (Table 9.1 and Figure 9.2). UV-Vis absorption and emission 
spectroscopy on P3-1, P3-2, P4-1, and P4-2 confirmed that both dyes were 
incorporated, with the dye absorbance and emission spectra being identical to 
those of the isotropic chloroform solutions (compare Figure S.VIII.9 with 
Figure S.VIII.10).  
To demonstrate TTA-UC, polymersomes P3-1-2 and P4-1-2 were first 
examined using UV-Vis absorption and emission spectroscopy under aerobic 
conditions in the presence of 50 to 75 mM sodium sulfite (Figure 9.3). Sulfite 
is a known scavenger of ground-state molecular oxygen.[9a, 22] The UV-Vis 
absorption spectrum shows the characteristic absorption bands of 1 (around 
630 nm) and 2 (350 − 450 nm). At 20 °C and under red light excitation (at 630 
nm, 50 mW, 0.4 W.cm−2) the emission spectrum of both samples showed the 
typical phosphorescence band of 1 at 800 nm and the structured emission 
band of 2 at 460 nm (Figure 9.3c). These results represent the first example of 
TTA-UC in polymersomes. The upconversion emission was intense and could 
easily be viewed by the naked eye when the red excitation source was blocked 
with a 575 nm short-pass filter (Figure 9.3b). To study the location of TTA-UC, 
Chapter 9 
186 
giant polymersomes GP3-1-2 with a diameter of 5 − 10 µm diameter were 
assembled using the same constituents as in P3-1-2. Imaging using an optical 
microscope setup with 635 nm excitation and visualized from 450 to 575 nm 
confirmed that TTA-UC was indeed located in the polymer membrane (Figure 
S.VIII.12). The absolute quantum yield of upconversion (ΦUC) in the 
polymersomes, measured using an integrating sphere setup (see experimental 
section), amounted to 0.002 at 20 °C for both P3-1-2 and P4-1-2 (see Table 
9.2).  
To investigate TTA-UC at human body temperature (37 °C), upconversion and 
phosphorescence were measured as a function of temperature between 5 and 
50 °C (Figure S.VIII.13). Upon elevating the temperature, the upconversion 
emission gradually intensified (ΦUC at 37 °C = 0.005) while the 
phosphorescence intensity decreased. This trend is beneficial for bio-imaging 
at 37 °C. We attribute the higher TTA-UC efficiency at higher temperatures to 
the higher mobility of 1 and 2 in the PiB membrane, as the translational 
diffusion rate of polyaromatic hydrocarbons in polyisobutylene materials is 
usually positively correlated to temperature.[23] The upconversion efficiency of 
P3-1-2 and P4-1-2 are in the same order of magnitude compared to 
red-to-blue TTA-UC in phospholipid-based liposomes measured in similar 
conditions (ΦUC at 37 °C = 0.015% using perylene as annihilator).[9a] Finally, 
the intensity threshold (Ith) at which the power dependency of upconversion 
changes from quadratic to linear was determined, as it is regarded as a 
benchmark parameter for the efficiency of TTA-UC.[3b, 24] The red laser 
excitation power was varied between 16 and 510 mW.cm−2 while measuring 
the upconversion intensity at both 20 and 37 °C (Figure S.VIII.14). From the 
double logarithmic plot of upconversion intensity (IUC) vs. excitation intensity 
(P), a value of ca. 200 mW.cm−2 was determined for Ith (Table 9.2). At 37 °C, Ith 
decreased down to 20 − 50 mW.cm−2, owing to the greater TTA-UC efficiency 
at this temperature. Note that excitation intensities above 200 mW.cm−2 can 
easily be reached in common laser microscopy setups. In summary, TTA-UC in 
polymersomes was established for the first time, and the photophysical 




Figure 9.3. Visual and photophysical characterization of TTA-UC in P3-1-2 and P4-1-2. a) 
Photographs of 10 mg/mL dispersions of P3-1-2 (left) and P4-1-2 (right). b) Photographs of a 7.5 
mg/mL P3-1-2 dispersion irradiated with a 50 mW 4 mm diameter red laser beam from the left 
side in presence of 75 mM sodium sulfite. In the right picture, the excitation source is blocked with 
a 575 nm short pass filter. c) UV-Vis absorbance (black) and emission (red/blue) spectroscopy of 
P4-1-2 vesicles (0.5 mg/mL compound 4) at 20 °C. Emission spectrum taken under red light 
irradiation (630 nm, 50 mW, 0.4 W.cm−2) in presence of 50 mM sodium sulfite. For clarity, the blue 
curve is the red curve multiplied by 10. d) IUC at 486 nm under red light irradiation (630 nm, 50 
mW, 0.4 W.cm−2, 4 mm excitation path length) of samples P3-1-2 and P4-1-2. [3] = 10, 7.5, and 5.0 
mg/mL (dashed black, blue, and red, respectively), and [4] = 10, 8.8, and 7.5 mg/mL (solid black, 
blue, and red, respectively). Conditions: 600 µL sample in a non-stirred semi-micro cuvette at 20 
°C. No oxygen scavenger was added here. 
Table 9.2. Photophysical characteristics of P3-1-2 and P4-1-2 in presence of 50 mM sodium sulfite: 
absolute quantum yield of upconversion (ΦUC) at 20 °C, ratio of upconversion emission intensity at 
37 °C and 20 °C, estimation of ΦUC at 37 °C calculated from multiplying the intensity ratio IUC,37°C / 
IUC,20°C with ΦUC at 20 °C, and the intensity threshold (Ith) for efficient TTA-UC at 20 °C and 37 °C.  




  Est. ΦUC at 
37 °C (%) 
Ith at 20 °C 
(mW.cm−2) 
Ith at 37 °C 
(mW.cm−2) 
P3-1-2 0.20 2.7 0.54 256 204 
P4-1-2 0.21 2.4 0.50 220 197 
 
9.2.2 Do these polymersome dispersions produce upconversion in air? 
In phospholipid-based liposomes TTA-UC is inhibited by the presence of 
molecular oxygen, which physically quenches triplet excited states and results 
in the photocatalytic production of singlet oxygen. To investigate whether P3-
1-2 and P4-1-2 were capable of producing upconversion under aerobic 
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conditions polymersome samples were prepared without the oxygen 
scavenger sulfite at different copolymer bulk concentrations, and irradiated 
for 30 minutes while monitoring IUC (Figure 9.3d, see Figure S.VIII.15 and 
Figure S.VIII.17 for full datasets). At a concentration of 10 mg/mL polymer 3, 
no upconversion was observed at t = 0, but after 7 minutes of red light 
irradiation the band of upconverted blue light appeared and IUC reached a 
maximum after ~15 minutes irradiation. Comparison of the UV-Vis 
absorbance spectra before and after irradiation showed significant bleaching 
of both dyes 1 and 2 (Figure S.VIII.15). No difference in DLS values were found 
before and after the experiment, indicating that red light irradiation did not 
damage the polymersomes’ integrity. At a concentration of 7.5 mg/mL 
polymer 3, qualitatively identical observations were made but IUC maximized 
at a lower value, whereas at 5 mg/mL no upconversion was observed at all 
after 30 min irradiation. As a control, a 7.5 mg/mL P3-1-2 sample prepared in 
presence of 75 mM sodium sulfite exhibited a 1000-fold more intense 
upconversion band that was very stable over 30 min (Figure S.VIII.16). The 
results with P4-1-2 vesicles were very similar: upconversion did not occur at 
polymer concentrations lower than 8.8 mg/mL. These results clearly indicated 
that in air TTA-UC in polymersomes is concentration-dependent. We interpret 
this result by the fact that the block-copolymers contain a C=C double bond 
that is known to be able to chemically quench singlet oxygen via a perepoxide 
mechanism.[25] We hypothesize that such chemical quenching results in the 
local consumption of oxygen during initial red light irradiation, up to the point 
where the oxygen concentration is low enough to allow TTA-UC to occur. 
Similar observations have been reported by Kim et al., who have used 
polyisobutylene as the liquid core in TTA-UC nanocapsules.[3a, 26] At lower 
polymer concentrations, oxygen diffusion outcompeted its photochemical 
consumption, so that no upconversion was observed. To confirm this 
hypothesis, we repeated the experiment in a stirred macro cuvette with an 
oxygen sensor probing the oxygen concentration in solution (Figure S.VIII.18; 
[3] = [4] = 10 mg/mL). During red light irradiation a gradual decrease in 
dissolved oxygen was indeed observed while upconversion first appeared 
after 15 min for P3-1-2 and after 60 min for P4-1-2, i.e., when the bulk oxygen 
concentration was below 1−2 ppm. Overall, these results show that 
upconversion in polymersomes can indeed occur in air and in absence of 
sulfite, most likely due to singlet oxygen scavenging by the unsaturated 
polymer itself. However, under diluted conditions and thus reduced singlet 
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oxygen scavenging capacity, upconversion in air does not occur anymore 
unless sulfite is added. 
 
Figure 9.4. Emission (red/blue) and oxygen concentration (black) time traces of polymersome P4-
1-2 samples in air under red light irradiation (630 nm, 50 mW, 0.4 W.cm−2) irradiation with 
addition of 10 mM sodium glutathionate, sodium sulfite, sodium L-ascorbate, L-histidine, sodium 
azide, hydroquinone, trolox, or 1:19 v/v mixed with opti-MEM cell culture medium (see 
formulation in exp. section). Red and blue line represent Iphosphorescence (at 800 nm) and IUC (at 486 
nm, multiplied by 10 for clarity), respectively. Conditions: [4] = 0.5 mg/mL, [1] = 0.5 µM, [2] = 10 
µM, T = 20 °C, pH = 7.0-7.3 (pH for the trolox experiment was 7.6 to dissolve the compound 
completely), with a 2 mL sample volume in a stirred macro cuvette. Laser was turned on at t = 0.  
9.2.3 Addition of other water-soluble oxygen scavengers to P4-1-2 
Encouraged by these results, and realizing that TTA-UC in air can occur by 
chemical scavenging of ground state oxygen (sulfite) or singlet oxygen 
(copolymer alkene function), P4-1-2 vesicles were mixed with a selection of 
known anti-oxidants and irradiated with red light while continuously 
measuring oxygen concentration, the phosphorescence intensity Iphosphorescence 
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(at 800 nm), and the upconversion intensity IUC (at 486 nm, see Figure 9.4). 
The bulk copolymer concentration was fixed at 0.5 mg.ml−1, so that there 
would be no TTA-UC in air without anti-oxidants (see previous section). The 
anti-oxidants chosen were sodium sulfite, sodium L-ascorbate, sodium 
glutathionate, L-histidine, hydroquinone, and trolox, i.e., the water-soluble 
derivative of vitamin E. The anti-oxidant concentration was kept constant (10 
mM at pH 7.0 − 7.6) to mimic cellular concentrations of glutathione (0.5 − 10 
mM)[27] and so that there was an excess of the anti-oxidants with respect to 
the dissolved oxygen concentration in an air-saturated aqueous solution at 
room temperature (~9 ppm; 2.5 mM). In each of these experiments, as soon as 
the laser was switched on, a clear consumption of oxygen was observed, which 
decreased from ~8 to 0 ppm in 15 − 25 min. In all cases, except for L-histidine, 
oxygen was already consumed in the dark, but illumination clearly accelerated 
the process, probably due to the higher redox potential of the 1O2/O2•− couple 
(E0 = +0.65 V at pH 7) compared to the 3O2/O2•− couple (E0 = −0.33 V at pH 
7).[28] More importantly, the time evolution of emission showed a steep rise 
both for IUC and Iphosphorescence, signifying the stabilization of the triplet excited 
states at sufficiently low oxygen concentrations. Strong TTA-UC was observed 
instantaneously (within 30 seconds) for sodium sulfite, sodium L-ascorbate, 
L-histidine, and trolox. For sodium glutathionate, upconversion was first 
observed after 2 min. Upconversion was not observed in mixtures with 
hydroquinone, even at 0 ppm oxygen concentrations. We explain this result by 
the fact that the reaction of hydroquinone and oxygen produces 
benzoquinone, which is known to quench the triplet excited states of aromatic 
hydrocarbons due to charge-transfer interactions.[29] As control experiments, 
irradiation at identical conditions was repeated without oxygen scavengers, 
and without oxygen scavengers in the dark (Figure S.VIII.19). As expected, no 
oxygen consumption or upconversion were observed. Additionally, a physical 
quencher of singlet oxygen, i.e., sodium azide,[30] was tested as well. In 
presence of 10 mM NaN3 however (Figure 9.4), no UC and only weak 
phosphorescence were observed, which confirmed that chemical quenching is 
required for obtaining TTA-UC, rather than physical quenching. Finally, 
upconversion in P4-1-2 vesicles was also tested in a 1:19 v/v mixture of 
vesicles and opti-MEM cell medium, which also contains biocompatible anti-
oxidants (see formulation in experimental section). Upconversion was first 
detected after 6 min irradiation and dissolved oxygen was depleted within 20 
min irradiation, which confirmed the presence of chemical quenchers of 
singlet oxygen in the medium (probably sodium pyruvate and bovine serum 
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albumin from fetal calf serum).[31] Overall, these results clearly demonstrate 
that the addition of a biologically realistic concentration of anti-oxidants is a 
potent strategy to obtain TTA-UC in air. The local O2 concentration is depleted 
by chemically consuming either ground-state oxygen (sulfite) or the 
photocatalytically generated singlet oxygen (histidine, etc.), until an oxygen 
concentration threshold is reached where TTA-UC becomes possible. 
9.2.4 Anti-oxidants brighten TTA-UC in cancer cell cultures 
To see whether our concept is also valid in cell culture conditions using live 
cells, human lung carcinoma A549 cells were incubated with P4-1-2 for 4 h, in 
the absence or presence of a mixture of 5 mM sodium L-ascorbate and sodium 
glutathionate as anti-oxidant “cocktail”. After refreshing the medium and 
staining the nuclei with Hoechst 33342, the cells were visualized with optical 
microscopy at 37 °C, 7% CO2, and 1% O2 (Figure 9.5). An atmosphere with a 
low oxygen concentration was chosen to mimic median tumor oxygen partial 
pressures, which generally range from 0.5% to 4% (pO2 = 5 − 30 mm Hg).[32] In 
absence of anti-oxidants and under 405 nm excitation, fluorescent spots were 
detected in the cytosol that correspond to singlet emission of 2 in the 
polymersomes. Under the hypothesis that nanoparticles are usually 
endocytosed,[33] we tentatively assigned these spots to be endosomes, 
lysosomes, and/or multi-vesicular bodies containing the polymersomes. 
Attempts were undertaken to demonstrate the co-localization of these spots 
and endo- or lysosomes using LysoTracker Red, but the rapid motion of these 
fluorescent spots during imaging prevented a conclusive outcome. Under 635 
nm excitation, upconverted emission was detected in locations that closely 
matched the emission detected under 405 nm irradiation (Figure S.VIII.20). 
Considering that upconversion only occurs when 1 and 2 are co-located in the 
same membrane, this observation indicates that the polymersomes were still 
intact and located where upconversion was detected. However, the 
upconversion emission intensity was rather weak and sometimes difficult to 
detect at all. 
In contrast, when the cells where incubated with the anti-oxidants cocktail 
described above, very similar images for the bright field and 405 nm 
excitation were obtained. However, a much brighter image was obtained upon 
635 nm excitation. Imaging was also performed at 19% O2 and 7% CO2 (i.e. 
pO2 far exceeding any in vivo tissue oxygenation level), but no upconversion 
emission was detected at all under these conditions (data not shown). To 
quantify the emission at 1% O2, 30 individual image sets with 40x 
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magnification were acquired in the presence and absence of anti-oxidants (10 
− 20 cells per image, see experimental section and Figure S.VIII.21), and the 
emission was quantified by calculating the mean pixel value of each image 
(Figure 9.6). While the emission intensity with λexc = 405 nm, and thus the 
uptake of polymersomes, was not influenced by the addition of anti-oxidants, 
the upconversion emission (λexc = 635 nm) was found to be an order of 
magnitude more intense in presence of the anti-oxidant cocktail. The mean 
signal to background ratio (S/B, see experimental section for definition) 
increased from 0.2 (without anti-oxidant) to 2.6 (with antioxidant, see Figure 
9.6b). By contrast, the S/B ratio for λexc = 405 nm remained low (~1) due to 
substantial autofluorescence of the cells, and it was not influenced by the 
presence of the antioxidant cocktail (Figure 9.6a). These exciting results 
demonstrate the potential of TTA-UC polymersomes in bio-imaging 
applications. Indeed, the in vitro data mirror the data obtained in 
homogeneous solution, demonstrating that co-treatment with cell-compatible 
anti-oxidants, at oxygen concentration that are realistic for tumor 




Figure 9.5. In vitro upconversion imaging of P4-1-2 upconverting polymersomes in living A549 
lung carcinoma cells in bright field mode (left column), with λexc = 405 nm (middle column), and 
with λexc = 635 nm (right column) with 100x magnification. Cells were incubated for 4 h with 
Opti-MEM only (top row),with 1:1 v/v mixture of Opti-MEM and P4-1-2 vesicles (middle row, 
[4]  = 0.5 mg/mL), or with 1:1 v/v mixture of Opti-MEM and P4-1-2 vesicles ([4] = 0.5 mg/mL) and 
addition of 5 mM sodium L-ascorbate and 5 mM sodium glutathionate (bottom row). The cell 
nuclei were stained with Hoechst 33342 prior to imaging. Imaging conditions: T = 37 °C, 7.0% CO2, 
1.0% O2, 62 µW 405 nm laser power (60 µm spot diameter, 2.2 W.cm−2 intensity), 13 mW 635 nm 
laser power (50 µm spot diameter, 640 W.cm−2 intensity). For comparison, the image histograms 
for λexc = 405 nm are scaled from 0 − 8000 pixel values, and for λexc = 635 nm are scaled from 




Figure 9.6. Quantified fluorescence emission under 405 nm (a) and 635 nm (b) excitation. The 
emission was quantified as the mean pixel value, based on 30 individual images at 40x 
magnification for each experiment, without nuclear stain, see experimental section and Figure 
S.VIII.21. Mean signal to background ratios (S/B) are given for both 405 and 635 nm excitation as 
the ratio of the mean luminescence intensity and the mean background intensity (i.e. the “No 
vesicles” dataset). 
9.3 Conclusion 
TTA-UC polymersomes were constructed in aqueous buffers by self-assembly 
of polyisobutylene-b-monomethoxy polyethylene glycol block-copolymers 
(PiB-b-PEG-Me, 3 or 4), a red-light absorbing porphyrin photosensitizer 1, and 
a blue-light emitting tert-butylated perylene annihilator 2. Only weak red-to-
blue upconversion was observed in concentrated dispersions in air, and 
dilution completely abolished upconversion emission. However, upon the 
addition of chemical antioxidants such as sulfite, L-ascorbate, glutathionate, 
L-histidine, or trolox, intense and stable upconversion was observed in air 
(21% O2). Scavenging of reactive oxygen species by the sacrificial anti-oxidant 
led to an oxygen-depleted environment in the illuminated area where TTA-UC 
can occur efficiently. The biocompatibility of this strategy was demonstrated 
by incubating these polymersomes in vitro in the absence or presence of a 
mixture of L-ascorbate and glutathionate. The upconversion luminescence was 
an order of magnitude more intense when the cells were co-treated with the 
anti-oxidants cocktail.  These results clearly demonstrate that biocompatible 
anti-oxidants brighten TTA-UC in aqueous solution but also in living cancer 
cells. These results reinforce the applicability of TTA-UC nanoparticles in bio-






Polyisobutylene succinic anhydride (PiB1000-SA, Dovermulse H1000) with a saponification 
number of 58.1 mg KOH/g was kindly provided by DoverChem (Dover, OH, USA) and was 
purified by silica flash chromatography in pure DCM before use. Palladium 
tetraphenyltetrabenzoporphyrin (1) was purchased from Bio-Connect (Huissen, The 
Netherlands). Dulbecco’s phosphate buffered saline (DPBS) was purchased from Sigma Aldrich 
and had a formulation of 8 g.L−1 NaCl, 0.2 g.L−1 KCl, 0.2 g.L−1 KH2PO4, and 1.15 g.L−1 K2HPO4 with 
a pH of 7.1 − 7.5. All other chemicals were purchased from major chemical suppliers and used as 
received. 
The average polymersome diameter, polydispersity index, and zeta-potential were measured 
using a Malvern Instruments Zetasizer Nano-S machine, operating with a wavelength of 632 nm. 
The zeta-potential measurement was carried out in a DTS1070 folded capillary cell. 
Transmission electron microscopy was done on a Jeol 1010 with an acceleration voltage of 80 
kV. Images were collected with an Olympus Megaview G2 camera, and Olympus iTEM software. 
Samples were loaded on Formvar/Carbon film on Copper 400 mesh TEM grids (FC400Cu100; 
van Loenen Instruments, Zaandam, The Netherlands). Oxygen measurements were done with 
an Ocean Optics NeoFox Foxy oxygen probe that was calibrated with 1 M Na2SO3 as the 
zero-oxygen point. Images and data were processed using Fiji ImageJ,[34] Origin Pro, and/or 
Microsoft Excel software. 
9.4.2 Synthesis of 2,5,8,11-tetra(tert-butyl)perylene (compound 2) 
Adapted from literature procedures.[35] Perylene (0.50 g, 1.98 mmol) was added to 50 mL dry 
tert-butyl chloride under Schlenck conditions. Anhydrous aluminium trichloride (1.0 g, 7.5 
mmol) was added and the mixture was refluxed for 6 h, after which an additional 30 mL 
tert-butyl chloride was added and the mixture was further refluxed overnight. Then, 20 mL 
tert-butyl chloride and 1.0 g anhydrous aluminium trichloride were added and reflux was 
continued for another 24 h. The mixture was allowed to cool to room temperature and 
extracted with 100 mL brine in a separatory funnel. The aqueous layer was separated and 
extracted with three 50 mL portions of DCM. The DCM fractions were combined with the 
previously obtained organic fraction and dried with anhydrous sodium sulfate. The dried 
organic layer was filtered and rotary-evaporated at 80 °C until a concentrate remained, which 
was baked in a petri-dish on a hot plate at 170 °C for 30 h, at which point smoke ceased to 
evolve. The remaining dark brown solid was dissolved in a 2:1 mixture of petroleum ether and 
chloroform and purified with silica column chromatography (gradient of pure PE to 2:1 
PE:CHCl3 mixture, Rf = 0.93 in PE:CHCl3) to afford 0.72 g of orange crystalline product (1.51 
mmol, 76%). An aliquot of the product was recrystallized from 50:50 DCM:MeOH for use in 
photophysical experiments. 1H NMR (300 MHz, CDCl3) δ (ppm) 8.24 (d, J = 1.7 Hz, 4 H), 7.63 (d, 
J = 1.6 Hz, 4 H), 1.50 (s, 36 H). 13C NMR (75 MHz, CDCl3) δ (ppm) 148.8, 135.0, 130.9, 125.9, 
123.4, 117.8, 35.0, 31.5. NMR spectra match literature data.[36] 
9.4.3 Synthesis of PiB1000-b-PEG350-Me (compound 3) 
Adapted from literature procedure, see Scheme S.VIII.1.[17] 3.66 g PiB1000-SA (3.79 mmol) and 
1.32 g mono-methoxy PEG350 (3.77 mmol) were heated to 80 °C, blanketed with argon by  three 
cycles of evacuation and argon purging, and then stirred overnight at 110 − 120 °C. The mixture 
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was allowed to cool to room temperature, after which it was purified by silica column 
chromatography (DCM:MeOH gradient from 99:1 to 95:5; Rf = 0.37 for 95:5 DCM:MeOH) to yield 
2.89 g of product (2.08 mmol, 55%). 1H NMR (400 MHz, CDCl3) δ (ppm) 4.9 − 4.8 (1 H, C=C of 
PiB), 4.3 − 4.1 (2 H, alpha protons of the ester), 3.8 − 3.5 (30 H, PEG) 3.4 (3 H, O-CH3 of PEG-Me), 
3.1 − 2.9; 2.8 − 2.4; 2.3 − 2.1; 2.1 − 0.8 (111 H, methyl and methylene of PiB). IR spectroscopy 
(cm−1):   3467 (OH), 2949, 2883 (C-H), 1734 (C=O), 1638 (C=C), 1470, 1389, 1366, 1231 (PiB 
skeleton), and 1104 (C-O of PEG). NMR and IR spectra given in Figure S.VIII.3 and Figure 
S.VIII.5, respectively, both corresponding to literature data.[17] Gel permeation chromatogram 
given in Figure S.VIII.1. MALDI-TOF mass spectrometry did not yield a usable spectrum. 
9.4.4 Synthesis of PiB1000-b-PEG750-Me (compound 4) 
Identical procedure as for PiB1000-PEG350-Me. Used 1.87 g PiB1000-SA (1.81 mmol) and 1.29 g 
mono-methoxy PEG750 (1.72 mmol). 1.79 g product obtained (1.00 mmol, 59%). Rf = 0.29 for 
95:5 DCM:MeOH. 1H NMR (400 MHz, CDCl3) δ (ppm) 4.9 − 4.8 (1 H, C=C of PiB), 4.3 − 4.1 (2 H, 
alpha protons of the ester), 3.8 − 3.5 (71 H, PEG) 3.4 (3 H, O-CH3 of PEG-Me), 3.1 − 2.9; 2.8 − 2.4; 
2.3 − 2.1; 2.1 − 0.8 (169 H, methyl and methylene of PiB). IR spectroscopy (cm−1): 3487 (OH), 
2949, 2878 (C-H), 1737 (C=O), 1636 (C=C), 1470, 1388, 1366, 1230 (PiB skeleton), and 1107 
(C-O of PEG). NMR and IR spectra given in Figure S.VIII.4 and Figure S.VIII.6, respectively, both 
corresponding to literature data.[17] Gel permeation chromatogram given in Figure S.VIII.2. 
MALDI-TOF mass spectrometry did not yield a usable spectrum. 
9.4.5 Preparation of upconverting polymersomes 
Polymersomes and dye-doped polymersomes were prepared according to a 
hydration-extrusion protocol. As an example, the preparation of P4-1-2 is described here. 
Aliquots of chloroform stock solutions containing the polymersome constituents were added 
together in a glass tube to obtain a solution with 10 mg PiB1000-PEG750-Me, 10 nmol palladium 
tetraphenyltetrabenzoporphyrin (1), and 200 nmol 2,5,8,11-tetra(tert-butyl)perylene (2). The 
organic solvent was removed by rotary evaporation and subsequently under high vacuum for at 
least 15 minutes to create a polymer film. 1.0 mL DPBS buffer was added and the polymer film 
was hydrated by 3 cycles of freezing the flask in liquid nitrogen and thawing in warm water (50 
°C). The resulting dispersion was extruded through a Whatman Nuclepore 0.1 μm 
polycarbonate filter at room temperature at least 11 times using a mini-extruder from Avanti 
Polar Lipids, Inc. (Alabaster, Alabama, USA). The number of extrusions was always odd to 
prevent any unextruded material ending up in the final liposome sample. The extrusion filter 
remained completely colorless after extrusion, suggesting full inclusion of the chromophoric 
compounds in the polymer membrane. Polymersomes were stored at room temperature and 
were typically used for further experiments within 24 h. The polymersomes were characterized 
with dynamic light scattering (DLS), zeta potentiometry, and (cryo) transmission electron 
microscopy. 
9.4.6 Preparation of giant polymersomes 
All giant polymersomes were prepared by lipid film re-hydration on dextran chemically 
cross-linked hydrogel substrates by a method described elsewhere.[22a, 37] The preparation of 
GP3-1-2 is described here as an example. Glass microscopy slides were first incubated with 1:1 
vol MeOH:HCl (37%) for 30 min, then with 98% H2SO4  for 30 min, and then thiol-functionalized 
by incubating them for 1 h in a 2 wt% solution of (3-mercaptopropyl)triethoxysilane in dry 
toluene under a nitrogen atmosphere, and washing them three times with toluene. Directly 
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after, a homogeneous film of Dex-PEG hydrogel was formed on this surface by drop-casting 600 
µL of a 1:1 volume mixture of 2 wt.% maleimide-functionalized dextran, with a substitution 
degree of 3 maleimide groups per 100 glucopyranose residues of dextran (synthesis and 
characterization detailed in ref. 2), in water and 2 wt.% α,ω-PEG dithiol (1500 g.mol−1) in water 
at room temperature. A homogenous hydrogel film was formed after 30 − 45 min at 40 °C. Then, 
10 μL of polymer mixture stock solution in chloroform, containing 10 mg/mL 3, 0.8 mM 
DSPE-PEG-2K, 0.20 mM 2, and 10 μM 1, was deposited on the hydrogel surface. The organic 
solvent dried within 1 min, after which the slide was dried further for at least 20 min under 
vacuum at room temperature. The polymer film was then hydrated with 400 μL 0.2 M sucrose 
in phosphate buffered saline for 1 h at 50 °C, creating a buffered solution containing 
free-floating vesicles. For optical microscopy imaging, 300 μL of this solution was transferred to 
an Eppendorf tube containing 700 μL 0.2 M glucose in PBS to allow the sucrose-loaded giant 
vesicles to sink to the bottom of the tube. After one hour, 300 μL of this GUV sediment was 
transferred to a visualization microscopy chamber, and the rest of the chamber was filled with 
100 μL 0.2 M glucose PBS. Finally, to chemically deoxygenate the chamber, 100 µL 0.5 M sodium 
sulfite in PBS was added. The vesicles were imaged within 24 hours with a modified 
epifluorescence microscope setup, see below. 
9.4.7 Emission spectroscopy 
Emission spectroscopy was conducted in a custom-built setup (Figure S.VIII.22). All optical 
parts were connected with FC-UVxxx-2 (xxx = 200, 400, 600) optical fibers from Avantes 
(Apeldoorn, The Netherlands), with a diameter of 200 − 600 μm, respectively, and that were 
suitable for the UV-Vis range (200 − 800 nm). Typically, 2.0 mL of sample was placed in a 
111-OS macro fluorescence cuvette from Hellma in a CUV-UV/VIS-TC temperature-controlled 
cuvette holder with stirring from Avantes. The cuvette holder temperature was controlled with 
a TC-125 controller and T-app computer software from Quantum Northwest (Liberty Lake, WA, 
USA), while the sample temperature was measured with an Omega RDXL4SD thermometer with 
a K-type probe submerged in the sample. The sample was excited with a collimated 630 nm 
laser light beam (4 mm beam diameter) from a clinical grade Diomed 630 nm PDT laser. The 
630 nm light was filtered through a FB630-10, 630 nm band pass filter (Thorlabs, 
Dachau/Munich, Germany) put between the laser and the sample. The excitation power was 
controlled using the laser control in combination with a NDL-25C-4 variable neutral density 
filter (Thorlabs), and measured using a S310C thermal sensor connected to a PM100USB power 
meter (Thorlabs). For regular measurements, the excitation power was set at a power of 50 mW 
(0.4 W.cm−2). UV-Vis absorption spectra were measured using an Avalight-DHc 
halogen-deuterium lamp (Avantes) as light source and a 2048L StarLine spectrometer 
(Avantes) as detector, both connected to the cuvette holder at a 180° angle and both at a 90° 
angle with respect to the red laser irradiation direction. The filter holder between cuvette 
holder and detector was in a position without a filter (Figure S.VIII.22, item 8). Luminescence 
emission spectra were measured using the same detector but with the UV-Vis light source 
switched off. To visualize the spectrum from 550 nm to 900 nm, while blocking the red 
excitation light, a Thorlabs NF-633 notch filter was used in the variable filter holder. To 
visualize the spectrum from 400 nm to 550 nm, an OD4 575 nm short pass filter (Edmund 
Optics, York, United Kingdom, part no. 84-709) was used. All spectra were recorded with 
Avasoft software from Avantes and further processed with Microsoft Office Excel 2010 and 
Origin Pro software. The emission spectra obtained from the two filters were stitched together 
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at 550 nm to obtain a continuous spectrum from 400 to 900 nm. No correction was needed to 
seamlessly connect the spectra. 
9.4.8 Determination of the quantum yield of upconversion 
The quantum yield of upconversion was determined absolutely by means of an integrating 
sphere setup. The setup and measurement procedure are discussed in depth in Appendix I.  
9.4.9 General cell culturing 
A549 human lung carcinoma cells were cultured in 25 cm2 flasks in 8 mL Dulbecco’s Modified 
Eagle Medium with phenol red (DMEM; Sigma Life Science, USA), supplemented with 8.2% v/v 
fetal calf serum (FCS; Hyclone), 200 mg.L−1 penicillin and streptomycin (P/S; Duchefa), and 1.8 
mM glutamine-S (GM; Gibco, USA), under standard culturing conditions (humidified, 37 °C 
atmosphere containing 7.0% CO2). The cells were split approximately once per week upon 
reaching 70 − 80% confluency, using seeding densities of 2 × 105 cells, and the medium was 
refreshed once per week. Cells were passaged for 4 − 8 weeks. 
9.4.10 Cell imaging preparation 
After cell splitting, the cells were suspended in OptiMEM (Life Technologies, USA), 
supplemented with 2.5% FCS, 200 mg/L P/S, and 1.8 mM GM at 3 × 105 cells per mL. For 
imaging at 100× magnification, 100 µL of this suspension was placed in a droplet on round 25 
mm diameter microscopy coverslips (VWR, thickness no. 1) in a 6-well plate. After 5 min of 
sedimentation, 3 mL OptiMEM was carefully added to each well, and the cells were incubated 
for 24 h. For imaging at 40× magnification, cells were seeded in a glass-bottom 24-well plate 
(Greiner Bio-One International, Germany, item no. 662892) at 50k cells per well and incubated 
for 24 h.  Meanwhile, P4-1-2 polymersome samples were prepared as before ([4] = 10 mg/mL, 
1 mL volume), and then purified by size exclusion chromatography (NAP-25 columns from GE 
healthcare, PBS as eluens) by collecting only the green eluting band (~ 2 mL), and diluting this 
elute further to a volume of 10.0 mL with PBS. Optionally, this final PBS solution contained 20 
mM sodium L-ascorbate and 20 mM sodium glutathionate. Then, the solution was sterilized with 
a 0.2 µm filter and diluted with 10 mL Opti-MEM ([4] = 0.5 mg/mL). 3 mL of this solution was 
added to each well of the 6-well plate, and the cells were incubated for 4 h. Then, the cells were 
washed once with PBS, and resupplied with 1 mL Opti-MEM before imaging. Optionally, the 
cells were incubated with 1 µg/mL Hoechst 33342 in PBS for 20 min at 37 °C to stain the cell 
nuclei.  
9.4.11 Cell and giant polymersome imaging 
Bright field and (upconversion) emission imaging was performed with a customized Zeiss 
Axiovert S100 Inverted Microscope setup, fitted with a Zeiss 100× Plan Apochromat 1.4 NA oil 
objective or a Zeiss 40× EC Plan Neofluar 1.3 NA oil objective, and an Orca Flash 4.0 V2 sCMOS 
camera from Hamamatsu, which together produced 4.2 megapixel images with pixel size of 69 
nm (for 100x) or 173 nm (for 40x). The typical camera exposure time was 1000 ms. Samples 
were loaded in a temperature and atmosphere controlled stage-top mini-incubator (Tokai Hit, 
Japan) set at 37 °C with 1% O2 and 7% CO2 in which samples were incubated for 30 min before 
imaging. For imaging at 100× magnification, a custom-made sample holder for round 25 mm 
cover slips was used. For direct excitation and fluorescence imaging of 2, a CrystaLaser 
DL-405-050 405 nm solid state laser was used, combined with a ZT405/514/561rpc dichroic 
beam splitter (Chroma Technology Corporation) and ZET442/514/568m emission filter 
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(Chroma Technology Corporation). The output power of the 405 nm laser at the sample was 
typically 62 µW at 100× magnification (60 μm spot diameter, intensity 2.2 W.cm−2) and 76 µW 
at 40× magnification (150 µm spot diameter, intensity 0.44 W.cm−2). For upconversion emission 
microscopy, a LRD-0635-PFR-00200-01 LabSpec 635 nm Collimated Diode Laser (Laserglow 
Technologies, Toronto, Canada) was used as excitation source, combined with a Chroma 
ZT405/532/635rpc dichroic beam splitter. To block everything except upconversion emission, 
a 575 nm short pass filter (Edmund Optics, part no. #84-709) was placed between the sample 
and the camera, resulting in OD > 5 at 635 nm and 800 nm (i.e. the excitation source and the 
phosphorescence of 1 were completely blocked). The output power of the 635 nm laser at the 
sample was typically 12.6 mW at 100× magnification (50 μm spot diameter, intensity 640 
W.cm−2) and 13.1 mW at 40× magnification (131 µm spot diameter, intensity 97 W.cm−2). All 
laser beam spots had a Gaussian intensity profile; spot diameters are reported as Full Width at 
Half Maximum (FWHM) values.  
9.4.12 Quantification of luminescence 
The mean total signal (ST) of the images was defined as 
𝑃𝑇 = 𝐵𝐵 + 𝐿 Equation 9.1 
where BG is the mean background signal and L is the mean luminescence signal. BG was 
measured in absence of P4-12 (i.e. L = 0). ST was calculated in mean pixel value by taking the 
sum of all pixel values (V) in the region of interest (ROI), containing a certain amount of pixels 




 Equation 9.2 
The same ROI was used for all images with a 1200 px diameter, closely encircling the 
illumination spot, see Figure S.VIII.21. The cell confluency in the illumination spot was always 
70 − 100%, amounting to 10 − 20 cells located in the ROI. ST was calculated for 30 individual 
images of each experiment (300 to 600 individual cells) by measuring the mean pixel value 
within the ROI with Fiji ImageJ software.[34] The mean signal to background ratio (S/B) was then 
calculated from the ST and BG values: 
𝑃/𝐵 =  
𝐿
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SUMMARY, CONCLUSIONS, AND OUTLOOK 
 
10.1 TTA-UC nanovesicles in solution and in living cells 
As described in Chapter 3, PEGylated DMPC liposomes were successfully 
prepared that were capable of generating blue photons by triplet-triplet 
annihilation upconversion of either green or red light with two distinct 
molecular chromophore pairs (Figure 10.1). The upconversion intensity in 
liposomes was found to be comparable to that in toluene solution at 20 °C and 
was linearly dependent on excitation intensity above only 0.05 W.cm−2 
(Chapter 5). To investigate the location where upconversion took place, red-
to-blue upconverting giant vesicles (GUVs) were prepared and imaged with 
upconversion luminescence microscopy, as reported in Chapter 5. The results 
demonstrated that TTA-UC was occurring in the lipid bilayer of the giant 
vesicles, and the high quality and stability of the upconverted images enabled 
the 3D reconstruction of upconverting GUVs. Because TTA-UC in liposomes 
would have to be performed at human body temperature (37 °C), the 
temperature dependency of TTA-UC was investigated in a series of neutral 
PEGylated phospholipid liposomes, of which the results are reported in 
Chapter 6. It was found that for phospholipids with a gel-to-liquid phase 
transition, the TTA-UC intensity maximized near the main transition 
temperature (Tm). This result was explained by the fact that molecular 
diffusion of dyes, and thus TTA-UC efficiency, increases towards Tm, while 
thermal quenching of the photosensitizer as a function of temperature 
decreases the TTA-UC efficiency above Tm. The TTA-UC efficiency in DOPC, 
DLPC, and DMPC liposomes were very similar at 37 °C. Thus, TTA-UC in 
liposomes can be generally realized and the phospholipid can be freely chosen 
to further optimize the liposomal formulation in terms of medium stability, 
biocompatibility, clearance from the bloodstream, and surface 
functionalization. 
Building further on these results, it was important to establish whether TTA-
UC upconversion in vesicles can take place in living cells. Indeed, in Chapter 7 
and Chapter 8 it is described that upconverting liposomes were endocytosed 
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by cancer cells and that the red-to-blue upconversion luminescence could be 
imaged under hypoxic conditions. The liposomes were localized in endosomes 
and lysosomes, and were degraded by the cells within 24 h after uptake. 
However, the upconversion luminescence bleached rapidly (within a couple of 
seconds) and the intensity was rather low due to quenching by molecular 
oxygen in the cells. As described in Chapter 8, the oxygen sensitivity was 
improved by co-treating the cells with a biologically relevant concentration of 
glutathione and L-ascorbic acid, which greatly improved the upconversion 
luminescence inside the cells. Furthermore, the upconverting liposomes were 
found to be non-cytotoxic in the dark and under high-power red light 
irradiation; no PDT effect was observed, probably because of the low 
photosensitizer concentration in the membrane that results in very low 
singlet oxygen production. 
 
Figure 10.1. Red-to-blue TTA-UC in nanovesicles with a photosensitizer (PS) and annihilator (A) 
dye. 
Besides liposomes, red-to-blue TTA-UC was also realized in the membrane of 
polymersomes, which were self-assembled from polyisobutylene-
polyethylene glycol block copolymers, as described in Chapter 9. Although 
red-to-blue upconversion was somewhat less efficient in polymersomes than 
in liposomes, the polymersomes were much more quickly internalized by 
living cells. The upconverting polymersomes were then successfully imaged in 
living cells, while the addition of glutathione and L-ascorbic acid greatly 
boosted  their performance in vitro. Compared to liposomes, the strong 
rubbery membrane of polymersomes may be more resistant towards 
digestion in cells or in the digestive tract of mammals, which opens up 
possibilities in drug delivery. Altogether, TTA-UC in liposomes and 
polymersomes represents exciting opportunities for luminescence bio-
 
205 
imaging, because auto-fluorescence and irradiation damage to the cells or 
tissue are effectively eliminated. 
10.2 Overcoming the oxygen sensitivity of TTA-UC 
The TTA-UC mechanism relies heavily on triplet-state chromophores, which 
are readily quenched by molecular oxygen. This quenching event usually leads 
to severely compromised TTA-UC efficiencies in air; an issue that is poorly 
resolved in literature. Indeed, in the initial work described in Chapter 3 it was 
realized that the upconversion was only observed when the liposome 
solutions were deoxygenated by bubbling with argon. To counter the issue of 
oxygen sensitivity in TTA-UC nanosystems, three strategies were pursued in 
this research (Figure 10.2). The first strategy was applying a potentially 
oxygen-impermeable coating to the nanoparticle. Chapter 7 describes how a 
nanometer-thick (organo)silica coating was applied to upconverting DMPC 
liposomes. Although these nanocomposites were readily taken up by cancer 
cells, unfortunately the silica coating did not decrease the quenching by 
oxygen (neither in solution nor in cells), most probably because of the 
porosity of the silica coating. However, upon drying of the silica-coated 
liposome dispersion in an excess of (organo)silica precursor, interesting lipid-
silica nanocomposite materials were obtained that were capable of TTA-UC in 
air, thereby confirming that in certain conditions (organo)silica can act as 
oxygen barrier for TTA-UC systems. These results represent intriguing 
examples of the combination of phospholipids, water, and silica for the 
construction of tunable upconverting nanoparticles and materials. 
In a second approach, it was realized that physical deoxygenation methods 
such as bubbling with argon could be replaced by adding a ground-state 
molecular oxygen scavenger to the liposomes, such as sodium sulfite, as 
described in Chapter 5. Sulfite depletes the oxygen dissolved in solution, 
thereby allowing efficient and stable TTA-UC to occur in air (Figure 10.2b). 
However, many ground-state oxygen scavengers are incompatible with 
biological systems (e.g. hydrazine), and they slowly deplete over time when 
oxygen leaks into the sample. To improve on this approach, the third strategy 
(Chapter 8) involved addition of a singlet-oxygen scavenger (“anti-oxidants”) 
such as L-ascorbic acid or glutathione. Instead of reacting with ground state 
oxygen, such anti-oxidants only react with excited-state singlet oxygen: Upon 
continuous irradiation of the TTA-UC system, the photosensitizer produces 
singlet oxygen, which is then scavenged by the anti-oxidant until all oxygen is 
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consumed (Figure 10.2c). This strategy was very efficient in allowing intense 
and stable TTA-UC in air (>80% stability during the first hour of continuous 
irradiation). As described in Chapter 9, the role of anti-oxidant can also be 
fulfilled by histidine, trolox, or the anti-oxidants present in cell medium (e.g. 
bovine serum albumin or  pyruvate). Thus, the anti-oxidant approach is a 
rather general and powerful strategy that can be applied to virtually any 
existing TTA-UC system. 
 
Figure 10.2. Cartoon illustrating the three different oxygen protection strategies pursued in this 
thesis. a) Coating the upconverting liposomes with an oxygen impermeable barrier. b) Chemical 
deoxygenation with a ground-state oxygen scavenger, i.e. anti-oxidant (A.O.), leading to an 
oxidized anti-oxidant (Ox. A.O.). c) Singlet-state oxygen scavenging: upon irradiation, the 
photosensitizer generates singlet oxygen, which then reacts with an anti-oxidant to form the 




Figure 10.3. Cartoon illustrating the combination of TTA-UC in liposomes and light-activatable, 
membrane-anchored Ru-polypyridyl complexes. a) TTA-UC and Ru complex are physically 
separated on two different liposomes: the generated blue light from TTA-UC is transferred to the 
Ru complex via radiative energy transfer (Chapter 3). b) TTA-UC and Ru complex are located on 
the same liposome: the generated blue light from TTA-UC is transferred to the Ru complex via 
FRET (Chapter 4), after which the activated Ru-aqua complex dissociates from the membrane. PS: 
photosensitizer; A: annihilator; FRET: Förster Resonance Energy Transfer. 
10.3 Activation of Ru(II) prodrugs by TTA-UC 
The aim of this thesis was to activate Ru(II) prodrugs with red light by means 
of an upconverting drug carrier. This goal was first met in Chapter 3, where it 
was described how the photodissociation reaction of a Ru(II) polypyridyl 
complex from liposomes could be triggered by upconverting liposomes in a 
physical mixture of red-to-blue upconverting liposomes and Ru complex-
doped liposomes. In this initial work, the blue upconverted light was 
transferred to the Ru-complex by radiative energy transfer, i.e. by emission of 
blue light and reabsorption of this light by the Ru-complex. When the 
upconverting dyes and the Ru-complex were doped in the same liposome 
membrane, as described in  Chapter 4, it was found that the upconverted light 
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was transferred to the Ru-complex by Förster Resonance Energy Transfer 
(FRET) with more than 85% efficiency for moderate Ru-complex molar 
doping amounts (4 mol% with respect to the phospholipids). These studies 
supported the potential of Ru-prodrug activation by red-to-blue TTA-UC, but 
unfortunately the experiments did not succeed yet in air due to quenching of 
TTA-UC by oxygen. To allow the system to function in air, the photoreaction 
was successfully performed in presence of L-ascorbate and glutathione, as 
described in Chapter 8. It was also attempted to test liposomes doped with 
TTA-UC dyes and Ru-prodrugs in vitro. However, the Ru-complexes that were 
used exhibited high cytotoxicity without irradiation as well, and did not 
become significantly more toxic upon irradiation; for these reasons, activation 
by red-to-blue TTA-UC did not lead to a pronounced photochemotherapeutic 
effect, and the feasibility of the approach remains uncertain. At this point, 
more research efforts are necessary for the design of membrane-anchored Ru-
prodrugs with high photo-indices and low toxicity in the dark before the 
feasibility of the activation-by-upconversion approach can be validated in 
biological systems.  
10.4 General remarks 
The results described in this thesis provide valuable insights for developing 
biological applications of TTA-UC. Liposomes and polymersomes were 
successfully used as multifunctional red-to-blue TTA-UC platform for bio-
imaging and activation of light-activatable Ru prodrugs. It is clearly 
demonstrated that blue-light sensitive Ru-polypyridyl complexes, that 
normally do not respond well to light in the phototherapeutic window, can be 
activated by red light by means of TTA-UC. The biological evaluation of this 
activation-by-upconversion strategy requires more research attention to 
elucidate which parameters need optimization, such as nanoparticle design, 
TTA-UC stability, oxygen sensitivity and presence of anti-oxidants, light dose, 
amount of nanoparticle dopants (dyes and drug), and photo-index of the Ru 
prodrugs. We expect that the results of this thesis will lead to exciting 
applications in photoactivation chemotherapy that provide an alternative for 
photodynamic therapy in hypoxic tumors.  
The red-to-blue upconversion quantum yield was found to be high at human 
body temperature (1.5% at 37 °C) and maximized at much lower excitation 
intensities (~0.1 W.cm−2) compared to lanthanoid-based upconversion 
nanoparticles (UCNPs), which typically achieve upconversion quantum yields 
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in water much lower than 0.5% at much greater excitation intensities (>1 
W.cm−2). In contrast to TTA-UC nanovesicles, UCNPs also suffer from low 
absorption, poorly reproducible synthesis routes and poor stability in aqueous 
solution, cell growing medium, or serum. Naturally, TTA-UC systems also have 
disadvantages, such as the oxygen sensitivity and photostability. However, in 
recent years, it has been successfully shown that oxygen sensitivity is a hurdle 
that can be overcome with creative approaches and continuous research 
efforts.[1] As a contribution to this, in this thesis it was successfully 
demonstrated that the oxygen sensitivity of TTA-UC nanovesicles can be 
greatly reduced (even in vitro!) when biocompatible anti-oxidants were 
added. Of course, still much work is required in designing and synthesizing 
new types of TTA-UC nanoparticle systems with much lower intrinsic oxygen 
sensitivity, higher temporal stability in vitro, higher upconversion efficiencies, 
while maximizing biocompatibility and biostability. Overall, in our opinion 
TTA-UC nanoparticles outperform UCNPs in many ways. Yet curiously, the 
field of biological TTA-UC research receives much less attention than the field 
of UCNPs: a quick search on SciFinder (August 2016) with keywords “triplet-
triplet annihilation upconversion” produces 365 results (of which ~10 are 
biology-oriented), while “upconversion nanoparticles” produces 2318 results, 
of which most are aimed towards biological application of UCNPs. We expect 
that the results described in this thesis reinforce the applicability of TTA-UC 
nanoparticles in biology and hope that they will convince the scientific 
community that this research field deserves more attention.  
10.5 Outlook 
10.5.1 Oxygen sensitivity 
Although substantial work in this thesis was dedicated towards the reduction 
of the oxygen sensitivity of TTA-UC nanoparticle systems in combination with 
PACT, a number of improvements can be made. In the future design and 
preparation of TTA-UC nanoparticle systems, the oxygen sensitivity must first 
be minimized in the design, and then characterized in air-equilibrated 
solutions and in biological systems. As outlined in this thesis, it has become 
apparent that oxygen sensitivity can be minimized by using anti-oxidants that 
scavenge ground state or singlet state oxygen. It may be also possible to use 
nanoparticles with built-in anti-oxidants. For example, in a vesicle design the 
aqueous interior may be filled with a high concentration of water-soluble anti-
oxidants; alternatively the membrane can be functionalized with oxygen-
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scavenging moieties such as unsaturated carbon-carbon bonds or lipophilic 
anti-oxidants such as β-carotenes (Figure 10.4). Regardless of which anti-
oxidant is used and at which location, it is important to evaluate their toxicity. 
It may also be important to separate anti-oxidants from TTA-UC dyes and Ru 
prodrugs, because: 
i. Some anti-oxidants or anti-oxidant products quench triplet state dyes, 
for example α-tocopherol or hydroquinone.[2] 
ii. Anti-oxidants such as glutathione may cause photo-reduction of dyes 
and/or Ru prodrugs 
iii. An anti-oxidant such as glutathione or histidine may coordinate to 
heavy metal photosensitizers or to the activated Ru complex.  
iv. Oxidized anti-oxidant products may react further with upconversion 
dyes and degrade them, such as in the case of peroxidized carbon-
carbon bonds.  
 
Figure 10.4. Upconversion polymersomes with built-in anti-oxidants, either in the hydrophilic 
interior or inside the hydrophobic membrane. 
To illustrate this built-in anti-oxidant strategy, during the work described in 
this thesis a red-to-blue upconverting polymersome formulation was 
prepared with a polybutadiene-polyethylene glycol block copolymer (kindly 
provided by Prof. dr. Jan van Hest, Radboud University, Figure 10.5a) and 
investigated with emission spectroscopy without any further addition of anti-
oxidants (Figure 10.5c). The polymer and TTA-UC dyes concentration (5 
mg/mL, 5 µM PdTPTBP, 100 µM 2,5,8,11-tetra(t-butyl)perylene), and 
irradiation conditions (0.4 W.cm−2 630 nm excitation) were identical to those 
used for Figure 9.3d (Chapter 9). In this case the upconversion was observed 
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instantaneously and at lower polymer concentration (still observable at 1.6 
mg/mL polymer), suggesting that the unsaturated bonds of polybutadiene 
were more effective in scavenging singlet oxygen than polyisobutylene. 
Curiously, in a preliminary experiment upconversion could not yet be realized 
in living cells. 
 
Figure 10.5. Upconverting polymersomes based on polybutadiene-block-monomethylpolyethylene 
glycol copolymer (PBd-b-PEG-Me), prepared according to Georgieva et al.[3] with [PBd-b-PEG-Me] 
= 9.8 mg/mL, [PdTPTBP] = 10 µM, and [2,5,8,11-tetra(t-butyl)perylene] = 0.20 mM. a) Molecular 
structure of PBd5600-b-PEG1000-Me block copolymer with PBd MW ~5600 g/mol and PEG MW 1000 
g/mol, received from Prof. dr. Jan van Hest (Radboud University). b) TEM micrographs of the 
polymersomes. Hydrodynamic particle size according to DLS: 120 nm, 0.1 polydispersity index. c) 
Time traces of upconversion emission at 486 nm (blue, left axis) and phosphorescence of PdTPTBP 
at 800 nm (red, right axis) during 630 nm irradiation (50 mW, 0.4 W.cm−2, 4 mm excitation path 
length) of upconverting PBd-b-PEG-Me polymersomes at 4.9 mg.mL−1 concentration. Conditions: 
600 µL sample in a non-stirred semi-micro cuvette at 20 °C. No oxygen scavenger was added. 
Directly comparable with data from Chapter 9, see Figure 9.3d. 
An alternative strategy to improve the oxygen sensitivity of TTA-UC is the 
design of supramolecular assemblies that feature tight networks of annihilator 
molecules. Such networks support fast diffusion of triplet excitons and greatly 
enhance the rates of TTET and TTA. In this way, TTA-UC is competitive with 
quenching by molecular oxygen and becomes appreciably efficient in air. A 
number of studies by the group of Kimizuka represent sophisticated examples 
of this strategy, which are expected to greatly impact the field of TTA-UC and 
might lead to highly efficient, oxygen-independent TTA-UC nanoparticles.[4]  
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10.5.2 Biocompatibility of TTA-UC dyes 
In the research described in Chapter 8, it was found that the annihilator dye, 
2,5,8,11-tetra(t-butyl)perylene, accumulated in lipid droplets in A549 cells 
after digestion of the liposomes by the cell. This suggested that this dye could 
not be digested by the cell, and it raises concern on the long-term toxicity and 
mutagenicity. Thus, for real-world biological TTA-UC applications it is 
necessary to evaluate the mutagenicity and carcinogenicity of TTA-UC dyes. 
10.5.3 Shifting the activation wavelength further to the NIR 
In this thesis it was chosen to use red-to-blue TTA-UC to shift the prodrug 
activation wavelength into the phototherapeutic window (630 nm). However, 
the highest tissue transparency while minimizing absorption by water is 
achieved in the NIR region between 700 and 900 nm.[5] In order to further 
shift the wavelength from 630 nm towards this region, other photosensitizer-
annihilator pairs may be used that can be excited with 700 – 850 nm and emit 
in the green, yellow, or red.[6] Since it was already demonstrated in Chapter 3 
that liposomes can accommodate a diverse selection of lipophilic TTA-UC 
dyes, we expect that incorporation of a NIR sensitive photosensitizer and 
visible-range emitting annihilator in the liposomes is straightforward. 
However, it must be kept in mind that in order to further use the 
upconversion emission to achieve prodrug activation, the emission 
wavelength must overlap well with the prodrug absorption. Therefore, in the 
case of Ru polypyridyl complexes, NIR-to-green TTA-UC would be best suited 
for this approach.[6e]  
10.5.4 Nanoparticle-bound Ru-prodrugs  
More research is necessary for the design of nanoparticle-anchored 
photoactivatable Ru prodrugs with high toxicity when irradiated and low 
toxicity in the dark. In the research described in Chapter 8, it was found that 
irradiation did not affect the cytotoxicity of certain Ru-prodrugs anchored to 
DMPC liposomes, while a relatively high toxicity was found in the dark. It was 
hypothesized that the degradation of Ru-doped liposomes was the cause of the 
observed dark toxicity. Thus, two key steps are needed to find a good PACT 
candidate to combine with a TTA-UC activation route: (i) it must be 
established that the activated complex is toxic once it is released inside the 
cell, and (ii) it is important to affirm that the complex is anchored and remains 
anchored to the nanoparticle throughout the entire treatment procedure. In 
this context, it may be beneficial if Ru-complexes are doped in more rigid 
nanoparticles such as polymersomes or silica nanoparticles. However, our 
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results are rather preliminary, and substantially more research must be 
performed in this area.  
 
Figure 10.6. Photoactivation of Pt(IV) prodrugs with upconverting liposomes. a) Molecular 
structure of complex Pt-1, received from Prof. dr. Bednarski (Universität Greifswald) and the 
proposed conversion to the aquated Pt(II) species upon irradiation in water.[7] b) Absorption 
spectroscopy before and after irradiation of Pt-1 in PBS (0.13 mM) with 450 nm (arbitrary 
power). c) Absorption spectroscopy during red light irradiation (120 mW 630 nm; 1 W.cm−2 
intensity) of a mixture of Pt-1 (0.25 mM) and upconverting liposomes (1.25 mM DMPC, 0.25 mM 
DSPE-mPEG-2000, 0.6 µM PdTPTBP, 6 µM perylene) at 37 °C; the inset shows the absorbance at 
400 nm as a function of irradiation time. The sample was deoxygenated prior to irradiation by 
bubbling argon for 30 min. 
10.5.5 Activation-by-upconversion of other prodrugs 
The general applicability of TTA-UC for the activation of other prodrugs than 
Ru-compounds deserves more attention in future work. During the work 
described in this thesis an experiment was conducted in collaboration with 
Prof. dr. Bednarski (Universität Greifswald) to examine whether compound 
Pt-1 could be activated with red-to-blue upconverting liposomes (Figure 
10.6). In water, in absence of upconverting liposomes, it is proposed that upon 
UV to blue light irradiation Pt-1 converts to the aquated Pt(II) species,[7] 
which can be observed by UV-vis absorption spectroscopy as a decrease of the 
LMCT absorption band (Figure 10.6b). Upon 630 nm irradiation of a mixture 
of upconverting liposomes and Pt-1, the same decrease in LMCT band was 
observed, suggesting successful conversion of Pt-1 to the aquated Pt(II) 
species. Thus, upconverting liposomes may also be suitable for red-light 
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activation of Pt(IV) compounds. This preliminary experiment demonstrates 
that the strategy of combining PACT drugs with TTA-UC in nanoparticles can 
be easily extended to other (inorganic) prodrugs such as Pt(IV) compounds, 
CO or NO releasing molecules, and photocleavable coumarin derivatives.  
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APPENDIX I: DETERMINATION OF QUANTUM 
YIELD OF UPCONVERSION 
 
I.1. Experimental setup 
 
Figure S.I.1. Setup used for absolute quantum yield measurements. a) Schematic representation; 
(1) 532 nm or 630 nm laser source, (2) collimating lens, 630 nm band pass filter, and mechanical 
iris − these parts were only used in case of 630 nm excitation (3) power meter adjustable in 
position, (4) integrating sphere with sample tube in the center, (5) filter holder, (6) notch filter or 
short pass filter that can be installed or removed, (7) variable neutral density filter that can be 
installed or removed, (8) CCD spectrometer, (9) optical fibers. b) Picture of the integrating sphere 
while irradiating a red-to-blue upconverting sample with 630 nm light. A 630 nm notch filter was 
held in front of the camera to block the red-light scatter. The blue light originates from the 
upconversion in the sample. 
An integrating sphere setup was used for determining the quantum yield of 
upconversion (Figure S.I.1). For green-to-blue upconversion quantum yield 
determinations, the excitation source was a 532 nm continuous wave Aries 
150 portable DPSS laser from LaserGlow (Toronto, ON, Canada) with a beam 
diameter of 1.5 mm. For red-to-blue upconversion, the excitation source was a 
fiber-coupled clinical grade Diomed 630 nm PDT laser. The optical fiber was 
connected to a collimating lens, after which the light passed a 630 nm band 
pass filter (Thorlabs, Dachau/Munich, Germany, part no. FB630-10) and a 
mechanical iris to produce a ca. 2 mm beam. The excitation power was 
measured using a S310C thermal sensor connected to a PM100USB power 
meter (Thorlabs). An AvaSphere-30-IRRAD integrating sphere, customized 
with a sample holder and an extra aperture, and an AvaSpec-ULS2048L 
StarLine CCD spectrometer were purchased from Avantes (Apeldoorn, The 
Netherlands). The integrating sphere and spectrometer were calibrated 
together using a Avalight-HAL-CAL-ISP30 NIST traceable calibration lamp 
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from Avantes, so that the observed intensities are expressed with the 
dimension of a photon flux (mol of photons.s−1.nm−1). The filter holder was 
fabricated by our own mechanical department, and held a NDL-25C-4 variable 
neutral density filter (Thorlabs), or a NF533-17 notch filter (Thorlabs) in case 
of excitation with 532 nm light, or an OD4 575 nm short pass filter (Edmund 
Optics, York, United Kingdom, part no. 84-709) in case of excitation with 630 
nm light. The FC-UVxxx-2 (xxx = 200, 400, 600) optical fibers with 200-600 
μm diameter were purchased from Avantes and were suitable for the UV-Vis 
range (200-800 nm). Spectra were recorded with Avasoft software from 
Avantes and further processed with Microsoft Office Excel 2010 and Origin 
Pro software.  
I.2. Procedure for determining the quantum yield of 
upconversion 
The quantum yield of upconversion (Φuc) is defined by Equation S.I.1: 
𝛷𝑈𝑈 =
𝑛𝑛𝑛𝑛𝑛𝑟 𝑜𝑜 𝑛𝑢𝑢𝑜𝑛𝑢𝑛𝑟𝑑𝑛𝑑 𝑢ℎ𝑜𝑑𝑜𝑛𝑜








where qp-em is the emission photon flux of the singlet annihilator species (in 
photons.s−1) and qp-abs is the photon flux absorbed by the sensitizer species (in 
photons.s−1).  
Note that for TTA-UC quantum yields, it is common to multiply Φuc by 2, because 
TTA-UC intrinsically has a maximum quantum yield of 50% and thus must be 
scaled to attain a maximum value of 100%. This was only applied in Chapter 3, 
as it was later realized that this factor is rather confusing. 






 Equation S.I.2 
where Iannihilator(λ) is the spectral luminescence intensity (in photons.s−1.nm−1) 
of the annihilator species, λ1 and λ2 are the low- and high-wavelength 
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boundaries, respectively, of the upconverted annihilator emission spectrum. 
qp‐abs is determined by subtracting the spectral light intensity of the excitation 
source that has passed through the sample (Iexc‐sample, in photons.s−1.nm−1) from 
the spectral light intensity of the excitation source that has passed through a 
blank sample (Iexc‐blank, in photons.s−1.nm−1), and by integrating over the 
excitation wavelength range λ3 to λ4, see Equation S.I.3. The blank sample 
resembled the upconverting sample in all ways, except that it did not contain 
any sensitizer, and thus did not absorb at the excitation wavelength. 
𝑞𝑝−𝑎𝑎𝑎 = � (𝐼𝑒𝑒𝑒−𝑎𝑡𝑎𝑎𝑘(𝜆)− 𝐼𝑒𝑒𝑒−𝑎𝑎𝑒𝑝𝑡𝑒(𝜆))𝑑𝜆
𝜆4
𝜆3
 Equation S.I.3 





∫ (𝐼𝑒𝑒𝑒−𝑎𝑡𝑎𝑎𝑘(𝜆) − 𝐼𝑒𝑒𝑒−𝑎𝑎𝑒𝑝𝑡𝑒(𝜆))𝑑𝜆
𝜆4
𝜆3
 Equation S.I.4 
The spectrometer and the integrating sphere were calibrated so that the 
observed intensities are directly proportional to the photon flux, i.e. 
𝐼(𝜆) ∝ [𝑛𝑜𝑙 𝑜𝑜 𝑢ℎ𝑜𝑑𝑜𝑛𝑜. 𝑜−1.𝑛𝑛−1]. Therefore, integrating these values over 
the relevant wavelength regions gave directly the flux of photons arriving at 
the spectrometer. 
Because the intensity of the upconverted light is relatively low compared to 
that of the exciting laser source the absorption and emission of the sample 
cannot be measured at the same time. In other words, the laser light saturates 
the spectrometer, which prevents upconversion to be measured. To 
circumvent this problem, the absorption was measured using a variable 
neutral density filter with known attenuation (typically Fattn ≈ 0.01, i.e., ~99% 
attenuation). This filter was placed between the integrating sphere and the 
spectrometer to measure the absorbed photon flux, whereas it was replaced 
for the measurement of the upconverted emission by a notch (533 nm) or by 
an OD4 short pass filter (< 575 nm) to remove the excitation wavelength. 
Thus, Equation S.I.4 was changed into Equation S.I.5. The attenuation factor 
Fattn was averaged over the wavelength range of the laser (520 − 540 nm or 
615 − 645 nm).  
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Additionally, during the research described in Chapter 4 and Chapter 9 it was 
realized a correction was necessary for Iannihilator to account for the secondary 
inner-filter effect, i.e. reabsorption of the upconverted light. This reabsorption 
occurred because the samples were relatively concentrated so that enough 
excitation light was absorbed to have an accurate value of qp-abs. To this end, 
the upconversion emission spectrum was recorded under highly diluted 
conditions in the temperature controlled cuvette holder setup (e.g. section 
4.4.5) and this spectrum was scaled at the second emission peak of the 
annihilator (i.e. 474 nm for perylene and 486 nm for 2,5,8,11-tetra(tert-
butyl)perylene), which cannot be reabsorbed, to match the photon flux value 
at 474 nm / 486 nm of Iannihilator. This corrected spectrum was called 
Iannihilator-corr. Note that this correction has not been applied for the quantum yield 
determination in Chapter 3, i.e. for those calculations Iannihilator-corr = Iannihilator.  
Finally, although at first the notch or short pass filter was assumed to only 
block the laser signal from reaching the spectrometer, in reality there was a 
small reduction of transmission for wavelengths situated in the upconversion 
range as well. This filtering can be corrected when calculating Φuc by dividing 
the upconversion luminescence intensity by the transmission curve T(λ) of 
the notch or short pass filter in the wavelength range of the upconverted light. 














 Equation S.I.5 
The boundary wavelengths that were used for determining Φuc, as well as the 
measured values for qp‐em and qp‐abs at 293 K, are given in Table S.I.1. 
Because the integrating sphere setup did not feature temperature control, ΦUC 
at 310 K was estimated from measuring the upconversion emission under 
highly diluted conditions in the temperature controlled cuvette holder setup 
at 293 K and at 310 K (e.g. Section 4.4.5) and scaling ΦUC at 293 K with the 
ratio of the upconversion emission at 293 K and 310 K by using Equation S.I.6: 
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𝛷𝑈𝑈310 𝐾 = 𝛷𝑈𝑈293 𝐾 ∗
∫ 𝐼𝑎𝑎𝑎𝑙ℎ𝑙𝑡𝑎𝑡𝑡𝑟310 𝐾 (𝜆)𝑑𝜆
𝜆2
𝜆1
∫ 𝐼𝑎𝑎𝑎𝑙ℎ𝑙𝑡𝑎𝑡𝑡𝑟293 𝐾 (𝜆)𝑑𝜆
𝜆2
𝜆1
 Equation S.I.6 
Table S.I.1. Values used throughout this thesis for Φuc determination at 293 K. See each chapter for 
the exact sample formulations. 

















Chapter 3 L1-2 390 525 520 545 0.0384 3.32 0.023 
 PtOEP & DPA 
in toluene[a] 
390 525 520 545 0.124 4.81 0.051 
 L3-4 400 575 615 645 0.0306 11.4 0.0054 
 PdTPTBP & 
perylene in 
toluene[b] 
400 600 615 645 0.0420 7.13 0.012 
Chapter 4 L12 400 575 615 645 0.705 30.0 0.024 
Chapter 9 P3-1-2 400 575 615 645 0.0925 45.3 0.0020 
 P4-1-2 400 575 615 645 0.103 49.7 0.0021 
[a] [PtOEP] = 3.5 µM, [DPA] = 100 µM. [b] [PdTPTBP] = 2.5 µM, [perylene] = 50 µM. PtOEP = 
platinum(II) octaethylporphyrin, DPA = 9,10-diphenylanthracene, PdTPTBP = palladium (II) 
tetraphenyltetrabenzoporphyrin 
 
For each measurement, two liposome or polymersome samples were 
prepared: one blank sample, containing only the annihilator but deprived of 
sensitizer. Since the concentration of the sensitizer is very small compared to 
the other sample constituents ([sensitizer] ≤ 0.05 mol%), we assume that 
removal of the sensitizer from the lipid or polymer mixture did not influence 
the physical properties of the vesicles (membrane fluidity, scattering 
properties of the sample, or others). The upconverting sample or the blank 
sample was loaded into specially designed measurement tubes that were 
made of a quartz EPR-tube bottom (± 7 cm length) fused to a NS-14 glass 
connector (± 2 cm length), at the top of which a septum was adapted. The tube 
fit precisely a hole made in the integrating sphere, and reached the center of 
the sphere, where it was hit by the excitation laser beam.  
In Chapter 3 and Chapter 4, deoxygenation of the sample was performed in a 
separate ice-cooled, pear-shaped flask, by bubbling the sample with argon for 
at least 30 minutes with a rate of 1 − 2 mL per second. The degassed sample 
was then transferred to the measurement tube by cannulation in the strict 
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absence of oxygen. Degassing in the tube was found to be impossible due to 
foam formation. In Chapter 9, the samples were 1:1 v/v mixed with a 50 mM 
Na2SO3 solution in PBS to chemically deoxygenate the samples and allow 
measurements to conveniently take place in air. For these measurements, the 
final concentrations were [PiB-PEG-Me polymer] = 5.0 mg/mL, [sensitizer] = 5 









Figure S.II.1. Absorbance (left axes, solid lines) and normalized emission (right axes, dashed lines) 
spectra of compounds 1-4 in toluene solution (red) and in liposome samples (black). Liposome 
samples were diluted 12 times with respect to the formulation given in Table 3.1, to keep 
absorbance values low enough. Absorbance spectra of liposome samples are uncorrected for 
scattering. Samples containing compound 1 or 3 were deoxygenated thoroughly before 
measurement by bubbling the sample with argon for 30 min with a rate of ~2 bubbles per second. 
All spectra were taken at room temperature. (a) Sample L1 ([1] = 0.3 μM) and 1 in toluene (7 μM). 
For emission, λexc = 532 nm. (b) Sample L2 ([2] = 8 μM) and 2 in toluene (20 μM). For emission λexc 
= 378 nm. (c) Sample L3 ([3] = 0.2 μM) and 3 in toluene (5 μM). For emission λexc = 630 nm. (d) 
Sample L4 ([4] = 4 μM) and 4 in toluene (20 μM). For emission, λexc = 416 nm.  
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Figure S.II.2. Transmission curve of the 633 nm notch filter used in this work (Thorlabs part no. 
NF633-25). The low transmission for λ ≤ 450 nm explains the difference between the emission of 4 
in Figure S.II.1d and the upconverted emission of 4 as observed in spectra acquired in 
upconversion experiments using the 633 nm notch filter (Figure 3.3). 
 
Figure S.II.3. (a) Emission spectra of couple 1-2 ([1] = 3.5 μM, [2] = 100 μM) in toluene at 288 K 
(black line), 293 K (red line), and 298 K (green line). (b) Emission spectra of couple 3-4 ([3] = 2.5 
μM, [4] = 50 μM) in toluene at 288 K (black line), 293 K (red line), and 298 K (green line). Asterisks 
indicate excitation wavelength: couple 1-2 and couple 3-4 were excited at 532 nm and 630 nm, 
respectively. Samples were thoroughly deoxygenated before measurement. The excitation power 
for both samples was 27 mW in a 2.6 mm diameter beam (light intensity: 0.51 W.cm−2). 
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APPENDIX III: SUPPORTING INFORMATION 
FOR CHAPTER 4 
 
III.1. Ru concentration in liposome samples by 
inductively coupled plasma optical emission 
spectroscopy 
 
Figure S.III.1. Bulk concentrations of 32+ experimentally found in PEGylated DMPC liposome 
samples, determined by inductively coupled plasma optical emission spectroscopy, versus 
theoretical concentrations. As best fit, a straight line was plotted through the origin with a slope of 
0.89 (R2 = 0.997). Error bars represent 5% instrumental error. 
The bulk concentration of 32+ in liposome samples was measured with 
inductively coupled plasma optical emission spectroscopy (ICP-OES), see 
Figure S.III.1. From the slope of a linear fit of the measured values plotted 
versus theoretical values it was determined that on average, 89% of the 
theoretical concentration 32+ was experimentally found. In all experiments 
when the determined value was too low with respect to the threshold of the 
ICP-OES machine, an extrapolated value was used from the theoretical 
concentration multiplied by 0.89. 
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III.2. Differential scanning calorimetry 
 
Figure S.III.2. Differential scanning calorimetry thermograms (in heating mode) for PEGylated (4 
mol%) DMPC liposomes without any chromophores (L0), with the TTA-UC dye couple (L12), and 
with the TTA-UC dye couple and various amounts of 32+ added (L123). Reported molar 
percentages of 32+ are based on ICP-OES measurements (see Chapter 4). Measurements were 
performed with a scanning rate of 1 K.min−1 at 3 atm. pressure. 
 
Table S.III.1. Differential scanning calorimetry data for PEGylated (4 mol%) DMPC liposomes 
without any chromophores (L0), with the TTA-UC dye couple (L12), and with the TTA-UC dye 
couple and various amounts of 32+ added (L123) , with Tm (in °C) as the main transition 
temperature and ΔH (in kJ.mol−1) as the molar change in enthalpy when heating from 10 to 35 °C. 
Reported molar percentages of 32+ are based on ICP-OES measurements (see Chapter 4). 
Measurements were performed with a scanning rate of 1 K.min−1 at 3 atm. pressure. 
Sample 32+ molar 
percentage 
Tm (°C) ΔH (kJ.mol−1) 
L0  25.1 25.1 
L12  25.0 23.1 
L123 0.8 24.5 23.8 
L123 1.6 24.2 22.4 
L123 2.4 23.8 21.6 
L123 3.1 23.5 21.7 





III.3. Photodissociation experiments using red light 
 
Figure S.III.3. Luminescence emission spectrum of L12 (black) and L123 with 3.3 mol% 32+ at t = 0 
of the irradiation experiment using red light (dashed). λexc = 630 nm. Irradiation conditions: power 
120 mW, beam diameter 4  mm, intensity 0.95 W.cm−2, T = 310 K, sample volume 1.5 ml. The 
liposome dispersion was diluted prior to measurement so that [2] = 2.5 µM and [1] = 0.25 µM, and 
in the case of L123, the concentration of 32+ = 18 µM. 
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III.4. Lifetime studies with time-correlated single photon 
counting and transient absorption spectroscopy 
III.4.1. Analysis of time-correlated single photon 
counting data 
Fluorescence lifetime measurements were performed using time-correlated 
single photon counting (TCSPC). The obtained histograms were fitted with 
Origin Pro software as the sum of single exponential decays, as described by 
Equation S.III.1: 




 Equation S.III.1 
where t is time, I(t) is the time-dependent observed emission intensity 
(photon counts), Ai is the decay amplitude, and τi is the decay constant. For 
each sample, fitting with a single exponential decay curve did not give 
satisfactory fits. In the case of liposomes  L2, this is attributed to the molecules 
being dissolved in a heterogeneous system (e.g. liposomes), and a small 
degree of self-energy transfer (homo-transfer) due to clustering of 2 in the 
membrane.[1] In the case of L23 or L123, the occurrence of energy transfer 
results in a multitude of donor excited state lifetimes, i.e. multi-exponential 
decays. To achieve a single lifetime value, required for further data processing, 
it was therefore necessary to use amplitude weighted average lifetimes (τ), as 









III.4.2. Time-correlated single photon counting data 
Table S.III.2. Fitting parameters to various decay functions for the fluorescence lifetime (in ns) of 
compound 2, as measured with TCSPC at 293 K (λexc = 440 nm, and λem = 474 nm), in PEGylated 
DMPC liposomes with a fixed amount (0.5 mol%) of 2 while varying the molar percentage of 32+ 
from 0 to 6%, as well as the calculated parameters τ as the amplitude averaged lifetime calculated 
from τ1, A1, τ2, A2, τ3, and A3 by Equation S.III.2, and EET as the efficiency of energy transfer 
calculated from Equation S.III.6. Goodness of fit expressed as R2 values. The bulk concentration of 
32+ was determined by ICP-OES. Bulk concentration of DMPC, DSPE-PEG-2000, and compound 2 
were 0.20 mM, 8 µM, and 1 µM, respectively.  
Decay function Concentration of 32+ in the membrane in mol% 
 0.0% 0.2% 0.5% 0.7% 0.9% 1.7% 
Multi-
exponential 
            
τ1 (A1 in %) 6.49 ± 0.01 
(93%) 
5.82 ± 0.01 
(77%) 
5.37 ± 0.01 
(83%) 
5.10 ± 0.13 
(44%) 
4.56 ± 0.08 
(36%) 
2.43 ± 0.03 
(37%) 
τ2 (A2 in %) 1.58 ± 0.06 
(7%) 
1.64 ± 0.02 
(23%) 
1.30 ± 0.02 
(17%) 
2.09 ± 0.16 
(38%) 
1.79 ± 0.08 
(42%) 
0.79 ± 0.05 
(40%) 
τ3 (A3 in %)    0.63 ± 0.04 
(19%) 
0.54 ± 0.03 
(23%) 
0.30 ± 0.03 
(23%) 
τ  6.17 ± 0.01 4.85 ± 0.01 4.67 ± 0.01 3.14 ± 0.08 2.50 ± 0.05 1.29 ± 0.02 
R2 0.9997 0.9996 0.9996 0.9996 0.9995 0.9994 
EET 0% 21% 24% 49% 60% 79% 
Förster 3D 
model 
            
γ 0.00 ± 0.00 0.23 ± 0.00 0.28 ± 0.00 0.74 ± 0.01 1.044 ± 0.01 1.82 ± 0.01 
R2 0.9995 0.9996 0.9996 0.9995 0.9995 0.999 
 
Decay function Concentration of 32+ in the membrane in mol% 
 
2.1% 2.4% 3.5% 5.0% 5.6% 
Multi-
exponential           
τ1 (A1 in %) 
2.85 ± 0.08 
(21%) 
3.35 ± 0.19 
(18%) 
2.12 ± 0.18 
(19%) 
   
τ2 (A2 in %) 
0.98 ± 0.06 
(42%) 
1.21  ± 0.08 
(41%) 
0.85 ± 0.14 
(33%) 
1.20 ± 0.01 
(24%) 
0.96 ± 0.01 
(41%) 
τ3 (A3 in %) 
0.32 ± 0.02 
(36%) 
0.37 ± 0.01 
(41%) 
0.33 ± 0.02 
(48%) 
0.31  ± 0.00 
(76%) 
0.29 ± 0.01 
(59%) 
τ 1.14 ± 0.03 1.25 ± 0.05 0.85 ± 0.06  0.53 ± 0.00 0.57 ± 0.01 
R2 0.9992 0.9993 0.9992 0.9991 0.9992 
EET 82% 80% 86% 91% 91% 
Förster 3D 
model           
γ 2.04 ± 0.01 1.93 ± 0.01 2.67 ± 0.02 3.99 ± 0.08 3.84 ± 0.08 
R2 0.9992 0.9993 0.9991 0.9991 0.9991 
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Table S.III.3. Fitting parameters to various decay functions for the fluorescence lifetime (in ns) of 
compound 2, as measured with TCSPC at 310 K (λexc = 440 nm, and λem = 474 nm), in PEGylated 
DMPC liposomes with a fixed amount (0.5 mol%) of 2 while varying the molar percentage of 32+ 
from 0 to 6%, as well as the calculated parameters τ as the amplitude averaged lifetime calculated 
from τ1, A1, τ2, A2, τ3, and A3 by Equation S.III.2, and EET as the efficiency of energy transfer 
calculated from Equation S.III.6. Goodness of fit expressed as R2 values. The bulk concentration of 
32+ was determined by ICP-OES. Bulk concentration of DMPC, DSPE-PEG-2000, and compound 2 
were 0.20 mM, 8 µM, and 1 µM, respectively. 
Decay function Concentration of 32+ in the membrane in mol% 
 0.0% 0.2% 0.5% 0.7% 0.9% 1.7% 
Multi-exponential             
τ1 (A1 in %) 5.94 ± 0.01 
(94%) 
5.33 ± 0.01 
(80%) 
4.79 ± 0.01 
(77%) 
4.01 ± 0.03 
(63%) 
4.06 ± 0.11 
(36%) 
 
τ2 (A2 in %) 2.01 ± 0.10 
(6%) 
1.72 ± 0.03 
(20%) 
1.35 ± 0.02 
(23%) 
1.38 ± 0.10 
(29%) 
1.86 ± 0.13 
(41%) 
1.85 ± 0.01 
(45%) 
τ3 (A3 in %)    0.49 ± 0.09 
(9%) 
0.64 ± 0.03 
(23%) 
0.54 ± 0.00 
(55%) 
τ 5.69 ± 0.01 4.60 ± 0.01 4.00 ± 0.01 2.96 ± 0.03 2.37 ± 0.07 1.14 ± 0.00 
R2 0.9997 0.9997 0.9996 0.9996 0.9996 0.9995 
EET 0% 19% 30% 52% 58% 80% 
Förster 3D model       
γ 0.00 ± 0.01 0.22 ± 0.00 0.36 ± 0.00 0.74 ± 0.01 1.15 ± 0.01 2.25 ± 0.02 
R2 0.9996 0.9997 0.9996 0.9996 0.9996 0.9994 
 
Decay function Concentration of 32+ in the membrane in mol% 
 2.1% 2.4% 3.5% 5.0% 5.6% 
Multi-exponential           
τ1 (A1 in %) 2.61 ± 0.20 
(7%) 
     
τ2 (A2 in %) 1.07 ± 0.08 
(32%) 
1.53 ± 0.01 
(38%) 
0.84 ± 0.01 
(29%) 
0.66 ± 0.01 
(13%) 
0.72 ± 0.01 
(17%) 
τ3 (A3 in %) 0.40 ± 0.02 
(61%) 
0.43 ± 0.00 
(62%) 
0.30 ± 0.00 
(71%) 
0.23 ± 0.00 
(87%) 
0.26 ± 0.00 
(83%) 
τ 0.77 ± 0.03 0.84 ± 0.00 0.45 ± 0.00 0.29 ± 0.00 0.34 ± 0.00 
R2 0.9993 0.9993 0.9994 0.9985 0.9990 
EET 87% 85% 92% 95% 94% 
Förster 3D model      
γ 2.86 ± 0.02 2.75 ± 0.01 5.49 ± 0.09 8.46 ± 0.19 7.25 ± 0.14 




III.4.3. Analysis of transient absorption data 
Data from transient absorption (TA) spectroscopy was fitted using the 
software package Glotaran, with which the user can conveniently analyze TA 
data and correct for experimental artefacts. The software features global 
fitting, with which different components that contribute to the data can be 
untangled and represented as separate datasets.[2] Each component i in the 
observed time-dependent transient absorption spectrum ΔOD(t,λ) is described 
with a non-normalized Decay-Associated transient absorption Spectrum 
DASi(λ) and a single exponential decay function with decay constant τi, see 
Equation S.III.3: 




 Equation S.III.3 
In the case of multi-exponential behavior of one of the species (i.e. 2 in 
presence of 32+), multiple components were identified with different τi, but 
with identical DASi(λ). The amplitude averaged lifetime (τ) was then 




 Equation S.III.4 
in which Bi represents the relative amplitude of DASi. For measurements on 
liposomes L2 and L23, i.e. experiments that were meant to probe the lifetime 
of 2, Bi was calculated from the average DAS value at 695 − 705 nm, at which 2 
has a very strong transient peak, while the influence of 32+ is negligible (see 
below). For measurements on liposomes with only 32+ (i.e. L3 liposomes), Ai 
was calculated from the average DAS value from 445 − 455 nm, where the 
transient absorption of 32+ is strongest (see below). 
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III.4.4. Transient absorption data 
Table S.III.4. Fitting parameters to various decay functions for the excited state lifetime (in ns) of 
compound 2, as measured with TA spectroscopy at 293 K (λexc = 400 nm), in PEGylated DMPC 
liposomes with a fixed amount (0.5 mol%) of 2 while varying the molar percentage of 32+ from 0 to 
3%, as well as the calculated parameters τ as the amplitude averaged lifetime calculated from τ3, 
B3, τ4, and B4 by Equation S.III.4, and EET as the efficiency of energy transfer calculated from 
Equation S.III.6. Goodness of fit expressed as R2 values. Bulk concentration of DMPC, DSPE-PEG-
2000, and compound 2 were 20 mM, 0.8 mM, and 0.1 mM, respectively. All experimental details can 
be found in the experimental section. 
Kinetic model Concentration of 32+ in the membrane in mol% 
 0 0.4% 0.8% 1.7% 2.5% 3.3% 
Multi-exponential 
(GLOTARAN) 
            
























τ3 (B3 in %) 2.30 ± 0.12 
(22.1%) 
0.45 ± 0.00 
(27.0%) 
0.26 ± 0.00 
(41.7%) 
0.19 ± 0.00 
(49.1%) 
0.11 ± 0.00 
(57.6%) 
0.07 ± 0.00 
(55.3%) 
τ4 (B4 in %) 7.05 ± 0.12 
(77.9%) 
3.99 ± 0.02 
(73.0%) 
2.43 ± 0.01 
(58.3%) 
1.85 ± 0.01 
(50.1%) 
0.79 ± 0.01 
(42.4%) 
0.56 ± 0.00 
(44.7%) 
τ5 118 ± 34 629 ± 78 916 ± 161 6380 ± 4160 1850 ± 359 613 ± 79 
τ 6.00 ± 0.10 3.03 ± 0.02 1.52 ± 0.01 1.04 ± 0.01 0.40 ± 0.00 0.29 ± 0.00 
EET 0% 49.5% 74.7% 82.7% 93.3% 95.1% 
Förster 3D model             
γ 0.02 ± 0.02 0.43 ± 0.02 1.00 ± 0.06 1.35 ± 0.05 2.43 ± 0.07 2.99 ± 0.09 
R2 0.9974 0.9991 0.9959 0.9975 0.9968 0.9969 
III.4.5. Transient absorption in liposomes L2 
The transient absorption spectrum of PEGylated DMPC liposomes bearing 0.5 
mol% 2 (liposomes L2), 1.0 ns after a 400 nm excitation pulse, is displayed in 
Figure S.III.4. The spectrum closely matches literature reports for perylene in 
cyclohexane, and features negative signals from 430 to 550 nm, due to ground 
state bleach and stimulated emission, and a strong positive band centered at 
700 nm, due to excited state absorption as the result of an S1-Sn transition.[3] 
The transient absorption data was analyzed with Glotaran and was best-fitted 
using 5 single-exponential decay functions (Table S.III.4). The fastest decay 
component (τ1 = 0.1 ps) is attributed to coherent artefacts due to spatial and 
temporal overlap of the pump and probe pulses around t = 0. The second 
decay component (τ2 = 8.3 ps) is attributed to vibrational relaxation of 
compound 2 and/or solvent relaxation of the phospholipid matrix. A 
component with a very long lifetime (τ5 > 100 ns) and almost negligible 
amplitude is attributed to either triplet state and/or excimer absorption. The 
nanosecond scale components with τ3 = 2.3 and τ4 = 7.1 ns have identical 
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spectra, which indicates that they originate from the same species. In this case, 
τ1, τ2, and τ5 were not taken into account for calculating τ by Equation S.III.4, 
so that τ = τ34 = 6.00 ± 0.10 ns, which corresponds to literature values of the 
excited state lifetime of 2.[1, 3] 
 
Figure S.III.4. Transient absorption spectra at 293 K of PEGylated DMPC liposomes with either 0.5 
mol% 2 (liposomes L2, solid line), 1.0 ns after the excitation pulse, and 3.3 mol% 32+ (liposomes L3, 
dashed line), 1.0 ps after the excitation pulse. Both samples were excited with 400 nm light (20-60 
nJ/pulse, 1 kHz repetition rate). Bulk DMPC concentration: 20 mM. 
III.4.6. Transient absorption in liposomes L3 
Next, the transient absorption of liposomes with 3.3 mol% of 32+ (liposomes 
L3) was evaluated. It was confirmed with UV-VIS spectroscopy before and 
after the experiment that negligible photodissociation occurred during the 
time-resolved spectroscopic analysis. The maximum amount of 
photodissociation, expressed as the total amount of mol 42+, can be estimated 
from the photon flux at 400 nm (Φ400 = 30 µW, i.e. = 1.0 x 10−10 einstein.s−1), 
measurement time (≤ 7200 s), quantum yield of photodissociation (0.52%),[4] 
and chance of absorption (A400 ≤ 0.60), see Equation S.III.5: 
𝑛𝟒 = (1 − 10−𝐴)𝛷400𝛷𝑅𝑅𝑑 Equation S.III.5 
The value of n4 for these experiments is ≤ 2.8 x 10-9 mol. With a sample volume 
of 200 µL and a 32+ concentration of 0.71 mM (as determined by ICP-OES), 
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n3 = 1.4 x 10-7 mol. The maximum amount of photodissociation reaction 
triggered during the measurement is therefore 2%.  
Figure S.III.4 shows the transient absorption spectrum of liposomes L3 1.0 ps 
after the excitation pulse at 400 nm. A negative band ranging from 400 to 500 
nm and a weaker positive band from 500 nm onwards are observed. The 
negative band from 400 to 500 nm coincides with the region of the MLCT 
absorption band in the steady state absorption spectrum (Figure 1c). Thus 
this band can be attributed to ground-state bleaching of the ruthenium 
complex. The broad positive band for λ > 500 nm are attributed to the 3MLCT 
excited state absorption, as the 1MLCT to 3MLCT intersystem crossing is 
known to be extremely fast (300 fs time scale).[5] The time evolution of the 
transient spectrum was best fitted with Glotaran using a model with two 
exponential decay curves using Glotaran. Two DAS were identified with 
identical spectra and with lifetimes of 0.17 (53%) and 0.92 ns (47%), hence 
the average 3MLCT lifetime τRu has a value of 0.52 ns.  
III.4.7. Transient absorption in liposomes L23 
For liposomes L23, i.e. samples containing both 2 and a varying amount of 32+, 
the time-dependent absorption data was consistently fitted using 5 single 
exponential decays, similar to as discussed above (Table S.III.4). Each time, it 
was most satisfactory to fit the decays in the nanosecond regime with a bi-
exponential decay. The decay associated spectra for these two components 
consistently featured the transient spectral characteristics of compound 2. For 
calculation of τ with Equation S.III.4, τ1, τ2, and τ5 were irrelevant, so that the 
reported τ for liposomes L23 is each time the average of τ3 and τ4, i.e. τ = τ34. 
The results of these experiments are discussed in the main text. 
III.5. Analysis and quantification of non-radiative energy 
transfer  
III.5.1. Calculation of energy transfer efficiency EET 
For liposomes L23, the energy transfer efficiency (EET) values were calculated 
by Equation S.III.6: 
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 Equation S.III.6 
where τ and τ0 are the amplitude-weighted averages of the excited state 
lifetime of compound 2 in presence and absence of 32+, respectively, and I and 
I0 are the integrated fluorescence intensity of compound 2 in presence and 
absence of 32+, respectively.[6] Stern-Volmer kinetics are generally applied to 
photochemical quenching based on collisional quenching, but are to known to 
may be applicable to FRET systems as well.[7] By rewriting the classical Stern-
Volmer equation, see Equation S.III.7, 
𝜏0
𝜏
= 1 + 𝐾𝐼𝑆[𝟑] = 1 + 𝑘𝐼𝑆𝜏0[𝟑] Equation S.III.7 
an expression for EET is obtained, see Equation S.III.8: 






 Equation S.III.8 
where KSV is the Stern-Volmer quenching constant (in L.mol−1), kSV is the Stern-
Volmer rate of quenching (L.mol−1.s−1), τ0 is the lifetime of the energy donor 
without any quencher present, and [3] is the bulk concentration of 32+. 
However, the volume in which the quenching occurs is much smaller than the 
sample volume, because both compound 2 and 32+ are only located within the 
membrane. Therefore, [3] was substituted with [3]local, i.e. the local 







 Equation S.III.9 
where n3 is the number of mol 32+, as calculated by ICP-OES, nDMPC is the 
number of mol DMPC, VM is the molar volume of DMPC in lipid bilayers at 293 
K (VM = 0.637 L.mol−1),[8] and x3 is the mol fraction of 32+ in the lipid bilayer. To 
simplify, we did not account for the volume of DSPE-PEG-2000, 2, and 32+, 
because no data was available, and we did not account for the fact that 32+ 
occupies a volume outside the lipid bilayer as well. Under these assumptions, 
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KSV was found to be 0.32 L.mol−1. With τ0 = 6.2 ns, the value of kSV is 5.2 x 107 
L.mol−1.s−1. 
III.5.2. Calculating the theoretical R0 distance 
One of the prerequisites for FRET is to have a good spectral overlap between 
the donor emission spectrum and acceptor absorption spectrum, as given by 
the overlap integral JDA (in M−1.cm−1.nm4) in Equation S.III.10, 
𝐽𝐷𝐴 = � 𝐹𝐷(𝜆)𝜀𝐴(𝜆)𝜆4𝑑𝜆
∞
0
 Equation S.III.10 
where FD(λ) is the area-normalized donor emission spectrum and εA(λ) is the 
molar absorption spectrum of the acceptor (in L.mol−1.cm−1). JDA = 2.8 x 1014 
nm4.M−1.cm−1 for 2 as FRET-donor and 32+ as FRET-acceptor (see Figure 1c). 
From JDA, the relative orientation factor κ, the refractive index of the medium n 
(1.334 for PBS buffer), and the fluorescence quantum yield of the donor φD, 
the Förster distance R0 (in Å) can be calculated, for which half the donor 
molecules decay by FRET, according to Equation S.III.11 below.[6] Assuming 
κ2 = 2/3 and using φD = 0.94 in cyclohexane,[9] R0 was predicted to be 41 Å.  
𝑅0 = 0.211 × (𝜅2𝑛−4𝜙𝐷𝐽𝐷𝐴)
1
6 Equation S.III.11 
III.5.3. Fitting lifetime data with a Förster decay 
model 
Besides the use of multi-exponential decays to calculate FRET efficiencies and 
Stern-Volmer parameters, the time-correlated single photon counting data 
and transient absorption spectroscopy data were also analyzed using a 
Förster decay model to derive different system parameters. This model has 
been used before for the analysis of energy transfer from perylene to various 









 Equation S.III.12 
where I(t) is the time-dependent fluorescence intensity, I0 is the fluorescence 
intensity directly after excitation, τ0 is the FRET donor lifetime in absence [1, 
10]of the FRET acceptor, d is the dimensionality of the system (d = 2 and d = 3 
for quenching in two and three dimensions, respectively), and γ is defined as 
[3]/C0, with [3] the bulk concentration 32+ (in M) and C0 the critical acceptor 
concentration for energy transfer (in M), which is the acceptor concentration 
needed for 72% energy transfer.[6] In this work, the lifetime data acquired 
from TCSPC were indeed fitted using the Förster decay model, see Table 
S.III.2-Table S.III.3. For the fitting, τ0 was fixed at 6.2 ns. Figure S.III.5 shows a 
fit of the three-dimensional model (d = 3) on lifetime decay data from TCSPC 
at 293 K acquired from a liposome sample (L23) with 0.5 mol% 2 and 0.9 
mol% 32+.  
 
Figure S.III.5. Time-correlated single photon counting decay curve (black) of PEGylated (4 mol%) 
DMPC liposomes L23, ([DMPC] = 0.2 mM) at 293 K with 0.5 mol% 2 and 0.9 mol% 32+ upon 
excitation with 440 nm (6 μW laser power, 0.6 pJ/pulse) and collecting emission at 474 nm. The 
red curve (top) represents a fit of the data according to a 3D FRET model (Equation S.III.12) with 
d = 3, τ = 6.2 ns, γ = 1.04, with the corresponding residual plot (bottom). The fit has an R2 value of 
0.9995. 
In the case of TA spectroscopy data, Equation S.III.12 was modified to 
Equation S.III.13: 
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 Equation S.III.13 
where ∆OD(t,λ) is the observed time-dependent transient absorption 
spectrum and ∆OD(λ)0 is the transient absorption spectrum at t = 0. It was 
most convenient to use a kinetic trace at a particular wavelength to fit the 
data. Preliminary experiments with TA spectroscopy on L2 and L3 alone 
showed that 400 nm light excites both molecules, but that at 700 nm 
compound 2 has a major transient absorption peak while there is negligible 
signal of 32+ (see above). Therefore the kinetic trace at 700 nm was therefore 
selected for fitting with Equation S.III.13, i.e. λ = 700 nm. Similar to the fitting 
of TCSPC data, the TA data was indeed fitted using the model (Table S.III.4). 
Figure S.III.6 shows a fit of the three-dimensional model (d = 3) on lifetime 
decay data from TA at 293 K acquired from a liposome sample L23 with 0.5 
mol% 2 and 0.8 mol% 32+. 
 
Figure S.III.6. Transient absorption decay curve at 700 nm (black) of PEGylated (4 mol%) DMPC 
liposomes L23 ([DMPC] = 20 mM) at 293 K with 0.5 mol% 2 and 0.8 mol% 32+ upon excitation with 
400 nm (20-60 nJ/pulse, 1 KHz repetition rate). The red curve (top) represents a fit of the data 
according to a 3D FRET model (Equation S.III.12) with d = 3, τ = 6.0 ns, γ = 0.99, with the 
corresponding residual plot (bottom). The fit has a R2 value of 0.997. 
The fitting parameters of the Förster three-dimensional decay model for both 
TCSPC and TA data, listed in Table S.III.2-Table S.III.4, show that for greater 
concentration of 32+, higher values of γ are obtained. In general, a three-
dimensional model fitted the data better than a two-dimensional model, as the 
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3D model produced fits with Χ2 values closer to 1. This agrees with the work of 
Holmes et al.[1, 10]  
III.5.4. Calculating the experimental R0 distance 
The critical acceptor concentration C0 (in M) is related to R0 (in dm) by 






 Equation S.III.14 
so that a plot of γ versus [3] provided a straight line, of which the slope 1/C0 
was used to evaluate R0 (in dm), see Figure S.III.7. Again, [3] was substituted 
with [3]local (see Equation S.III.9). In such conditions, R0 was calculated to be 
29 Å. 
 
Figure S.III.7. Plot of γ at 293 K, as determined from transient absorption data (black filled 
squares) or from time-correlated single photon counting data (empty squares), as a function of the 
local concentration of 32+, as defined by Equation S.III.9, in the lipid bilayer of PEGylated DMPC 
liposomes as determined by ICP-OES. Horizontal error bars represent 5% instrumental error from 
ICP-OES. Vertical error bars represent the fitting error of Equation S.III.12 on the data. The black 
line represents the best linear fit from the origin through the two combined data sets, and has a 
slope of 56.3 M−1 with R2 = 0.955. 
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III.6. Photodissociation experiments using red light 
 
Figure S.III.8. Setup used for photosubstitution experiments using red light. Legend: (1) 630 nm 
laser source, (2) optical fibers, (3) filter holder, (4) 630 nm band pass filter, (5) variable neutral 
density filter that can be installed or removed, (6) halogen-deuterium light source for UV-Vis 
absorption spectroscopy, (7) temperature controlled cuvette holder, (8) variable filter holder, and 
(9) CCD spectrometer. 
III.7. Definition and calculation of the total efficiency of 
TTA-UC, FRET and photodissociation 
When TTA-UC and FRET are combined within the same membrane to realize 
the photochemical conversion of 32+ to 42+, the relevant photophysical and 
photochemical steps are 
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where for clarity purposes PS is the photosensitizer (1), and A is the 
annihilator (2), ISC means intersystem crossing, TTET means triplet-triplet 
energy transfer, TTA means triplet-triplet annihilation, and ET means non-
















 is the rate of singlet state photosensitizer generated, φISC 
is the QY of ISC of the photosensitizer, φTETT is the QY of TTET, φTTA is the QY of 
TTA, EET is the energy transfer efficiency as defined in Equation S.III.8, and φRu 
is the quantum yield of photosubstitution in absence of 1 and 2, measured 
under blue light irradiation. The rate of singlet state photosensitizer generated 






= 𝛷630(1− 10−𝐴630) Equation S.III.16 
where Φ630 is the photon flux at 630 nm (einstein.s−1) and A630 is the 
absorbance of the photosensitizer at 630 nm. In addition, similarly to Equation 
S.III.8, the efficiency of non-radiative energy transfer, EET, is given by Equation 
S.III.17: 
𝛥𝑇𝑇 = 1 −
1




 Equation S.III.17 
where [3]local is the local concentration of 32+ in the membrane, defined by 
Equation S.III.9 ([𝟑]𝑡𝑡𝑒𝑎𝑡 =
𝑎𝟑
𝑎𝐷𝐷𝑃𝐼𝑆𝐷
), and KSV is the Stern-Volmer constant 
(L.mol−1) for the quenching of 1A* by 32+ in the lipid membrane. The quantum 
yield of TTA-UC is given by Equation S.III.18: 
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𝜙𝐼𝐼𝑈𝜙𝑇𝑇𝑇𝑇𝜙𝑇𝑇𝐴 =  𝜙𝑇𝑇𝐴−𝑈𝑈  Equation S.III.18 




= 𝛷630(1− 10−𝐴630)𝜙𝑇𝑇𝐴 −𝑈𝑈
𝐾𝐼𝑆[𝟑]𝑡𝑡𝑒𝑎𝑡
1 + 𝐾𝐼𝑆[𝟑]𝑡𝑡𝑒𝑎𝑡
𝜙𝑅𝑅 Equation S.III.19 
Equation S.III.19 shows that the rate of the photosubstitution reaction 
depends on the local concentration of 32+ and a non-zero order reaction rate 
can be expected. Realizing that KSV[3]local << 1, and that therefore EET can be 
approximated with 𝐾𝐼𝑆[𝟑]𝑡𝑡𝑒𝑎𝑡 ≡ 𝐾𝐼𝑆
𝑎𝟑
𝑎𝐷𝐷𝑃𝐼𝑆𝐷





= 𝛷630(1− 10−𝐴630)𝜙𝑇𝑇𝐴 −𝑈𝑈𝐾𝐼𝑆
𝑛𝟑
𝑛𝐷𝐷𝑃𝑈𝑉𝐷
𝜙𝑅𝑅 Equation S.III.20 
Integrating Equation S.III.20 yields a first-order expression for 𝑛𝟑(𝑑): 
𝑛𝟑(𝑑) = 𝑛𝟑(0) ∗ 𝑛−𝑘𝑡 Equation S.III.21 




(1 − 10−𝐴630)𝜙𝑇𝑇𝐴 −𝑈𝑈𝐾𝐼𝑆𝜙𝑅𝑅 Equation S.III.22 
The total efficiency of TTA-UC, FRET, and photodissociation of 32+ in 
liposomes L123 is defined by Equation S.III.23: 
𝛥𝑡𝑡𝑡𝑎𝑡 = 𝜙𝑇𝑇𝐴 −𝑈𝑈𝛥𝑇𝑇𝜙𝑅𝑅 ≈ 𝜙𝑇𝑇𝐴 −𝑈𝑈𝐾𝐼𝑆
𝑛𝟑
𝑛𝐷𝐷𝑃𝑈𝑉𝐷




Figure S.III.9. Plot of n3 as a function of the amount of photons absorbed during the 
photodissociation experiment with red light of L123. The black line represents a single exponential 
fit for the first 45 min of irradiation. 
For t = 0 − 45 min, i.e. when EET is more or less constant, Etotal can be 
experimentally determined from a plot of the amount of mol of 32+ as a 
function of the amount of absorbed photons, i.e.𝛷630 ∗ (1 − 10−𝐴630) ∗ 𝑑, see 
Figure S.III.9. Φ630 was estimated from measuring the optical power (120 mW 
at 630 nm, i.e. 0.632 µeinstein.s−1) and A630 was 0.025. Note that at t = 0, mostly 
1 absorbs at 630 nm. Some bleaching of 1 was observed during the reaction 
(Figure 4.3b), but it was neglected in this calculation. Therefore, the amount of 
absorbed photons per unit time was considered to be constant. Etotal at t = 0 
can be evaluated from the slope at t = 0 of the single exponential fit curve of 
the evolution of n3 versus the amount of red photons absorbed since t = 0 (see 
Figure S.III.9). From this, a value of 0.027% was determined. 
The amount of mol 32+ was determined from the UV-VIS absorbance data at 
490 nm by accounting for the contributions of both 32+ and 42+ to the 
absorption at this wavelength, as explained here. The total absorbance at 490 
nm is given by Equation S.III.24: 
𝐴490 = 𝜀𝟑490 × 𝑙 × [𝟑] + 𝜀𝟒490 × 𝑙 × [𝟒] Equation S.III.24 
where 𝜀𝟑490 is the molar absorption coefficient of 32+ at 490 nm (3760 M−1.cm−1 
in CHCl3), [3] is the bulk concentration of 32+, 𝜀𝟒490 is the molar absorption 
Appendix III: Supporting information for Chapter 4 
242 
coefficient of 42+ at 490 nm (8690 M−1.cm−1 in H2O), [4] is the bulk 
concentration of 42+, and l is the cuvette path length (i.e. 1 cm). At t = ∞, the 
photoreaction is complete and no more 32+ is present, which means that 
𝐴∞490 = 𝜀𝟒490 × 𝑙 × [𝟑]0 Equation S.III.25 
By replacing [4] with [3]0 − [3] in Equation S.III.24, [3] can be expressed as a 
function of A490 in Equation S.III.26: 
[𝟑] =
𝐴490 − 𝐴∞490
𝜀𝟑490 × 𝑙 − 𝜀𝟒490 × 𝑙
 Equation S.III.26 
Finally, the amount of mol 32+ is obtained by multiplying with the volume in 
the cuvette (V, i.e. 1.5 ml), see Equation S.III.27: 
𝑛𝟑 = 𝑉 ∗
𝐴490 − 𝐴∞490
𝜀𝟑490 − 𝜀𝟒490
 Equation S.III.27 
At t = 0, the value for n3 (2.95 x 10-8 ± 0.06 x 10-8 mol) was very comparable 
with the value for n3 determined by ICP-OES (2.82 x 10-8 ± 0.01 x 10-8) , which 
confirms the validity of this approach. 
III.8. Photodissociation experiments with lower red-light 
intensities 
Irradiation experiments on liposomes L123 were repeated with three 
different red light intensities of 30, 60, and 120 mW (0.24, 0.48, and 0.95 
W.cm−2, respectively). The course of the reaction was monitored by UV-Vis 
absorption spectroscopy following the absorbance of the aqua photoproduct 
at 490 nm (Figure S.III.10). As expected, a decrease in reaction rate was 
observed for lower irradiation intensities (Figure S.III.10d). To determine the 
total efficiency of the system (Etotal, see Equation S.III.23), the amount of 
ruthenium (n3) was plotted versus the amount Q of photons absorbed since 
t = 0 (Figure S.III.11). Etotal was calculated from the exponential fit of the data 
by multiplying the exponent with the amplitude, yielding values of 0.026% for 
0.24 W.cm−2, 0.024% for 0.48 W.cm−2, and 0.019% for 0.95 W.cm−2. The 
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somewhat lower quantum yield for the experiment using 0.95 W.cm−2 
irradiation is attributed to some bleaching of the photosensitizer (1) in this 
particular experiment (compare A630 at t = 180 between the three individual 
experiments in Figure S.III.10). The real amount of photons absorbed by 1 is 
therefore lower (i.e. the real quantum yield is higher), but the data is not 
corrected for this effect. Overall, all three efficiencies values Etotal were found 
very similar to that given in the main text (0.027% for 0.95 W.cm−2 red light 
irradiation), so it can be concluded that the quantum efficiency of red light-
induced photosubstitution in L123 is unaffected by light intensity and this 
range of intensities. 
 
Figure S.III.10. Absorption spectra of liposomes L123 during red light irradiation (630 nm) with 
(a) 30 mW (0.24 W.cm−2), (b) 60 mW (0.48 W.cm−2), and (c) 120 mW (0.95 W.cm−2). Blue line: 
spectrum at t = 0; red line: spectrum at t = 180 minutes; other spectra measured every 15 minutes. 
d) Difference in absorbance at 490 nm, after baseline correction, during red-light irradiation of 
L123 with 30 mW (white), 60 mW (grey), or 120 mW (black). T = 310 K, sample volume 1.5 ml, 8% 
of sample volume simultaneously irradiated. A single L123 liposome stock dispersion was used in 
these experiments and diluted with PBS buffer prior to measurement so that every time [1] = 0.25 
µM, and [2] = 2.5 µM. 
Appendix III: Supporting information for Chapter 4 
244 
 
Figure S.III.11. Evolution of the number of mol of 32+ (n3) as a function of the amount of red 
photons absorbed since t = 0 for liposome sample L123 irradiated with 30 mW (0.24 W.cm−2 white 
circles, purple fit curve), 60 mW (0.48 W.cm−2, grey circles, blue fit curve), or 120 mW    
(0.95 W.cm−2, black circles, red fit curve). The fit lines represent single exponential fits for the first 
45 min of irradiation for each dataset. The lower slope for the 120 mW experiment is attributed to 
more bleaching of the photosensitizer during irradiation. 
III.9. References 
[1] A. S. Holmes, D. J. S. Birch, T. Salthammer, J. Fluoresc. 1993, 3, 77-84. 
[2] S. L. Joris J. Snellenburg, Ralf Seger, Katharine M. Mullen, Ivo H. M. van Stokkum, J. Stat. 
Softw. 2012, 49, 1-22. 
[3] Y. H. Meyer, P. Plaza, Chem. Phys. 1995, 200, 235-243. 
[4] S. Bonnet, B. Limburg, J. D. Meeldijk, R. J. M. Klein Gebbink, J. A. Killian, J. Am. Chem. Soc. 
2010, 133, 252-261. 
[5] N. H. Damrauer, G. Cerullo, A. Yeh, T. R. Boussie, C. V. Shank, J. K. McCusker, Science 
1997, 275, 54-57. 
[6] J. R. Lakowicz, Principles of Fluorescence Spectroscopy, 3rd ed., Springer 
Science+Business Media, LLC, New York, NY, USA, 2006. 
[7] J. T. Buboltz, C. Bwalya, S. Reyes, D. Kamburov, J. Chem. Phys. 2007, 127, 215101. 
[8] D. Marsh, Handbook of Lipid Bilayers, 2nd ed., Taylor & Francis Group, LLC, Boca Raton, 
FL, USA, 2013. 
[9] I. B. Berlman, Handbook of fluorescence spectra of aromatic molecules, 2nd ed., 
Academic Press, New York, NY, USA, 1971. 
[10] A. S. Holmes, K. Suhling, D. J. S. Birch, Biophys. Chem. 1993, 48, 193-204. 
 
245 
APPENDIX IV: SUPPORTING INFORMATION 
FOR CHAPTER 5 
 
IV.1. Cryo transmission electron microscopy 
 
Figure S.IV.1. Cryo transmission electron micrographs of DMPC LUV12. 
IV.2. Emission spectroscopy on LUVs  
 
Figure S.IV.2. Emission spectra of DOPC (a) and DMPC (b) LUV12 samples ([lipid] = 1 mM, [DSPE-
PEG-2000] = 0.04 mM, [2] = 5 µM, [1] = 0.25 µM) under 630 nm excitation at 298 K. The samples 
were either deoxygenated by bubbling argon for 30 min prior to measurement (solid curves) or by 
addition of sodium sulfite at a concentration of 0.3 M to the buffer (dotted curves). Irradiation 
conditions: 3.0 mL sample volume in a macro fluorescence cuvette, with 30 mW 630 nm 
irradiation power (4 mm beam diameter, intensity 0.24 W.cm−2). Bubbling of argon through the 
sample inevitably results in the formation of small bubbles on the walls of the measurement 
cuvette, resulting in scattering of light in both the excitation and the detection pathway. These 
bubbles are absent in the case of deoxygenation using the sodium sulfite oxygen scavenger, which 
explains why the observed intensities are higher for samples deoxygenated with sulfite. 
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IV.3. Emission spectroscopy on GUVs 
 
Figure S.IV.3. Emission spectra of DOPC (a) and DMPC (b) LUV12 (solid curves) and GUV12 
(dotted curves) with 30 mW 630 nm excitation (0.24 W.cm2 intensity) at 298 K. In the case of LUVs, 
[DMPC] = 1 mM, [DSPE-PEG-2000] = 0.04 mM, [2] =  5 µM, [1] = 0.25 µM, whereas in the case of 
GUVs, the lipid concentration was not known, but the components in the membrane were 
introduced in the same molar ratio as for the LUV samples. In all cases, the buffer was 




IV.4. Power dependency measurements 
 
Figure S.IV.4. Luminescence emission spectra of DMPC LUV-12 (a) and DOPC LUV-12 (c) at 
various excitation intensities. Double logarithmic plot of the upconversion luminescence intensity 
(IUC) of DMPC LUV-12 (b) and DOPC LUV-12 (d), integrated from 420 to 575 nm, as a function of 
the excitation intensity P (in W.cm−2). The low power regime was fitted with straight lines with 
slopes 2.02 (R2 = 0.995) and 1.95 (R2 = 0.977) for DMPC and DOPC LUV-12, respectively (red solid 
lines), and the high power regime was fitted with straight lines with slopes 1.04 (R2 = 0.997) and 
1.15 for DMPC and DOPC LUV-12, respectively (blue solid lines). From the intersection of the 
extrapolated fits (red and blue dashed lines), the intensity threshold (Ith) was found to be 50 
mW.cm−2 for DMPC LUV-12 and 59 mW.cm−2 for DOPC LUV-12. Irradiation conditions: [lipid] = 1.0 
mM, T = 298 K, laser beam diameter 4 mM. 
  
Appendix IV: Supporting information for Chapter 5 
248 
IV.5. Microscopy imaging 
 
Figure S.IV.5. Transmission curves of the filter and dichroic beam splitter that were used for 
emission microscopy with violet light (405 nm), consisting of a Chroma ZT405/514/561rpc 
dichroic beam splitter (red) and a Chroma ZET442/514/568m emission filter (black). 
 
 
Figure S.IV.6. Transmission curves of the filters and dichroic beam splitter that were used for 
emission microscopy with red light (630 nm), consisting of a Thorlabs NF633-25 notch filter (red) 
and an Edmund Optics 575 nm OD4 short pass filter (black), a Thorlabs FB630-10 band pass filter 





Figure S.IV.7. Bright field (left) and upconversion emission (right) photographs of DOPC GUV2, i.e. 
GUVs similar to GUV12 but deprived of the photosensitizer 1, in buffer without sodium sulfite and 
under air atmosphere. 
 
Figure S.IV.8. Bright field (left) and upconversion emission (right) photographs of DOPC GUV12 in 












Figure S.V.1. Time dependence of IUC and IP at 20 °C of samples O12, L12, M12, PD12, and P12. All 
samples show an initial drop in phosphorescence, followed by stabilization. Considering that trace 
amounts of oxygen are still present at t = 0, we attribute this to the generation of singlet oxygen by 
the photosensitizer upon light excitation and reaction of singlet oxygen with the photosensitizer 
and/or annihilator.   
 
 
Figure S.V.2. Luminescence spectra of samples O12, L12, M12, PD12, and P12 at 5°C before 
(black) and after (red) heating from 5 °C to 50 °C and continuous red light irradiation. Spectra 
taken with 10 mW (80 mW.cm−2) 630 nm excitation. Only O12 shows significant bleach. 
 
Appendix V: Supporting information for Chapter 6 
252 
 
Figure S.V.3. Setup used for emission spectroscopy. Legend: (1) 630 nm laser source, (2) optical 
fibers, (3) filter holder, (4) 630 nm band pass filter, (5) variable neutral density filter that can be 
installed or removed, (6) halogen-deuterium light source for UV-Vis absorption spectroscopy, (7) 
temperature controlled cuvette holder, (8) variable filter holder, (9) CCD spectrometer, and (10) 




APPENDIX VI: SUPPORTING INFORMATION 




Figure S.VI.1. Temperature dependencies of upconversion (at 475 nm, blue circles) and 
phosphorescence (at 800 nm, red squares) for A-UL (a), ApT-UL (b), T-UL (c), and pTA-UL (d) in 
50 mM Na2SO3 PBS with 30 mW 630 nm (240 mW.cm−2). 
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Figure S.VI.2. Microscopy imaging in bright field mode (left column) and with 377 nm excitation 





Figure S.VI.3. 29Si-NMR spectra of samples A-UL-D (left) and ApT-UL-D (right). 
 
Figure S.VI.4. Emission spectrum of freeze-dried upconverting liposomes (UL-F) under 30 mW 630 
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VII.1. Hopping of perylene (compound 2) versus 2,5,8,11-
tetra(tert-butyl)perylene (compound 3) 
 
Figure S.VII.1. Hopping of compound 2 versus compound 3 by monitoring TTA-UC upon mixing M1 
with either M2 or M3. A diluted sample of M1 liposomes (0.25 mM DMPC) in 0.1 M Na2SO3 in PBS 
was placed in a stirred macro cuvette at 25 °C and the emission spectrum was acquired for 2 min 
with 10 mW 630 nm (80 mW.cm−2). At t = 2 min, 1 equivalent of either M2, M3, or only PBS (all 
containing 0.1 M Na2SO3) was added and spectra were continuously acquired. The upconversion 
intensity (IUC) at 474 nm (2) or 486 nm (3), and the phosphorescence intensity (Ip) at 800 nm (1) 
are plotted versus time. 
It is known in the literature that perylene (compound 2) partitions with the 
aqueous phase when dissolved in the lipid bilayer of liposomes.[1] To prevent 
perylene from escaping the vesicles, 2,5,8,11-tetra(tert-butyl)perylene 
(compound 3) was synthesized (see Chapter 9, section 9.4.2). In order to 
investigate whether tert-butylation made the compound more membrane-
bound, a “hopping” experiment was conducted as follows. Three different 
PEGylated DMPC liposome samples were prepared in 0.1 M Na2SO3 in PBS: 
one containing only photosensitizer 1 (M1), one containing only perylene 2 
(M2), and one containing only tert-butylated perylene 3 (M3). Then, M1 was 
placed in a stirred cuvette at 25 °C and the emission spectrum was 
continuously acquired under 10 mW 630 nm irradiation (80 mW.cm−2). After 
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2 min, M2 was added and the emission spectrum was acquired for 3 more 
min. The same experiment was also performed with using M3 instead of M2. 
As a control, the emission of M1 was monitored for 5 min without further 
liposome addition. In Figure S.VII.1, the upconversion intensity (IUC) and 
phosphorescence intensity of 1 (Ip) are plotted versus time. Upon addition of 
M2 to M1, upconversion was instantaneously observed and stabilized 1 min 
after mixing, while the phosphorescence was quenched and also stabilized 
after 1 min after mixing. Note that TTA-UC requires molecular contact, and 
that the liposomes do not fuse or come in close proximity of each other due 
their PEGylated surface. Thus, under the assumption that 1 does not hop, 
these results indicate that compound 2 had hopped from M2 to M1 within this 
time, which is consistent with the observations of Almgren.[1] For the mixture 
of M1 and M3, no phosphorescence quenching was observed and no 
upconversion was observed throughout the experiment. From this, it can be 
concluded that neither compound 3 nor compound 1 escapes DMPC 
membranes. Overall, these results demonstrate that four-fold t-butylation of 
perylene indeed prevents liposomal escape. 
VII.2. Fluorescence spectrum of LysoTracker Red 
 
Figure S.VII.2. Normalized excitation (solid) and emission spectrum (dashed) of LysoTracker Red 
DND-99. Data acquired from manufacturer ThermoFisher Scientific.  
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VII.3. Uptake of M1, M3, and M1-3 liposomes in cells 
 
Figure S.VII.3. Bright field and fluorescence micrographs (λexc = 377 nm) at 20x magnification of 
A549 (top row), MCF7 (middle row), and MRC5 cells (bottom row) that were incubated with no 
liposomes (left side) and M1-3 liposomes (right side) for 24h. 
 
Figure S.VII.4. Bright field and fluorescence micrographs (λexc = 377 nm) at 20x magnification of 
A549 (top row), MCF7 (middle row), and MRC5 cells (bottom row) that were incubated with M1 
liposomes (left side) and M3 liposomes (right side) for 24h. Note that M1 liposomes are not 
fluorescent and only autofluorescence is observed. 
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VII.4. Overlap between absorption of Ru-complexes 52+, 
62+, 72+ and 82+ and emission of compound 3 
 
Figure S.VII.5. Overlap between normalized absorption spectra of Ru-complexes 52+, 62+, 72+ and 
82+ and the normalized emission spectrum of compound 3.  
VII.5. Photosubstitution of Ru-complexes 52+, 62+, and 72+ 
with blue light 
 
Figure S.VII.6. Time-dependent UV-vis absorption spectroscopy of complex 52+ (0.1 mM) during 
blue light irradiation (450 nm, photon flux 0.17 µEinstein.s−1) in water at 25 °C. a) Absorption 
spectra, recorded every 1 min (blue to red evolution). b) Evolution of the absorbance at 400 nm 
(red squares) and 500 nm (black circles). The water was deoxygenated for 10 min by bubbling 
with argon and the solution was kept under an argon atmosphere during spectroscopy. The 
quantum yield of photosubstitution of converting 52+ to 82+ was calculated to be 0.70% according 




Figure S.VII.7. Time-dependent UV-vis absorption spectroscopy of complex 62+ (0.07 mM) during 
blue light irradiation (450 nm, photon flux 0.17 µEinstein.s−1) in water at 25 °C. a) Absorption 
spectra, recorded every 1 min (blue to red evolution). b) Evolution of the absorbance at 440 nm 
(red squares) and 500 nm (black circles). The water was deoxygenated for 10 min by bubbling 
with argon and the solution was kept under an argon atmosphere during spectroscopy. The 
spectral evolution upon reaction of 62+ to 92+ shows that the photoreaction proceeds via two 
distinct steps: it is proposed that the first step is fast and involves the release of one of the 
thioether-ruthenium bonds (see how the spectrum changes in the first minute), and the second 
step is slower and involves the release of the other thioether-ruthenium bond. 
 
Figure S.VII.8. Time-dependent UV-vis absorption spectroscopy of complex 72+ (0.070 mM) during 
blue light irradiation (450 nm, photon flux 0.17 µEinstein.s−1) in 9:1 v/v acetone:H2O at 25 °C. 
a) Absorption spectra, recorded every 1 min (blue to red evolution). b) Evolution of the absorbance 
at 450 nm (red squares) and 500 nm (black circles). The water was deoxygenated for 10 min by 
bubbling with argon and the solution was kept under an argon atmosphere during spectroscopy. 
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VII.6. Photosubstitution of Ru-complexes with blue light: 
estimation of reaction half-time 
Because the amount of [Ru] inside the cells was unknown, an estimation was 
based on a 10 µM aqueous solution. The reaction half-time for a prototypical 
Ru-complex photosubstitution ([Ru-L] + hν  [Ru-H2O] + L) was estimated 
using the following set of equations.  
𝑑𝑛𝑅𝑅𝑅𝑅2
𝑑𝑑
= 𝑘 × 𝑛𝑅𝑅𝑅 Equation S VII.1 
where 𝑛𝑅𝑅𝑅𝑅2is the amount of Ru-H2O molecules (mol), 𝑛𝑅𝑅𝑅is the amount of 
Ru-L molecules (mol), and k is the photosubstitution rate, defined by Equation 
S VII.2: 
𝑘 =  𝑊 × 𝜑454 × (1 − 10−𝐴454) × �
𝜀454 × 𝑙
𝐴454 × 𝑉
�× Φ𝑅𝑅 Equation S VII.2 
in which W is the surface area of a 96 well-plate well (0.3 cm2), φ454 is the 
photon flux at 454 nm (7.0 mW.cm−2, i.e. 2.7 × 10−8 mol.s−1.cm−2), A454 is the 
absorbance at 454 nm (0.042 for a complex with a molar absorption 
coefficient (ε454) of 6000 M−1cm−1), l is the light path length for a 200 µL work 
volume (V) in a 96 well-plate well (l = 0.7 cm), and ΦRu is the 
photosubstitution quantum yield (usually around 0.01 for such complexes).[3] 
Under these assumptions, k at t = 0 was estimated to be 3.6 × 10−3 s−1. Then, 




 Equation S VII.3 
The value of t1/2 was estimated to be 192 s (~ 3 min). 
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VII.7. UV-vis spectroscopy and mass spectrometry after 
red-light irradiation of M1-3-6 liposomes 
 
Figure S.VII.9. UV-vis absorption spectra of filtered solutions of red-light irradiated M1-3-6 
liposomes ([DMPC] = 1 mM) under argon (solid black) and in air in presence of 10 mM L-Asc and 
GSH (solid red). Irradiation was done for 60 min with 2 mL sample volume, 150 mW 630 nm light 
(1.2 W.cm−2 intensity, 4.3 kJ.cm−2), and at 37 °C, and then the solution was filtered with a 
centrifuge filter (MWCO = 100,000 Da); the UV-vis absorption spectrum of the filtrate is shown 
here. As controls, samples were kept in the dark and filtered in the same way (dashed lines): these 
spectra show neither absorption of the upconversion compounds 1 and 3, nor that of the Ru-
complex 62+, which indicates that no Ru photosubstitution has taken place and that the liposomes 
remain in the filter. 
Appendix VII: Supporting information for Chapter 8 
264 
 
Figure S.VII.10. Mass spectrometry after red light irradiation of M1-3-6 liposomes (DMPC = 20 
mM). After 60 min irradiation with 150 mW 630 nm light (1.2 W.cm−2) at 37 °C under argon, the 
liposome solution was filtered with a centrifuge filter (MWCO = 100,000 Da), the filtrate was 
lyophilized and redissolved in a minimal amount of acetone. Attribution of main peaks in m/z 
(calculated): 449.1 [Ru(bpy)2Cl]+ (449.0); 467.1 [Ru(bpy)2Cl(OH2)]+ (467.0); 490.1 





Figure S.VII.11. Mass spectrometry after red light irradiation of M1-3-6 liposomes (DMPC = 20 
mM) in presence of 10 mM L-Asc and GSH. After 60 min irradiation with 150 mW 630 nm light (1.2 
W.cm−2) at 37 °C under argon, the liposome solution was filtered with a centrifuge filter (MWCO = 
100,000 Da), the filtrate was lyophilized and redissolved in a minimal amount of methanol. 
Attribution of main peaks in m/z (calculated): 481.1 [Ru(bpy)2(MeOH)Cl]+ (481.0) or 
[Ru(bpy)2(OH2)2]2+(MeO−) (481.1); 490.0 [Ru(bpy)2(OH2)(OH)]+(MeCN) (490.1). The rest of the 
signals do not contain a ruthenium isotope pattern. 
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Scheme S.VIII.1. Synthesis of PiB-b-PEG-Me block copolymers 3 and 4 from polyisobutylene succinic 
anhydride (PiB1000-SA) and mono-methoxy ethylene glycol (PEG350-Me or PEG750-Me). 
VIII.1.2. Molecular weights 
Table S.VIII.1. Molecular weights of PiB1000-SA, PEG350-Me, PEG750-Me, and compounds 3 and 4 in 
weight averaged molecular weight (Mw) and number averaged molecular weight (Mn), according 
to the manufacturer, gel permeation chromatography (GPC), and NMR, see sections VIII.1.3 and 
VIII.1.4. Gel permeation chromatography was done in THF with molecular weights reported 
relative to polybutadiene standards.  
Polymer Manufacturer GPC 1H NMR 
 Mn (kg.mol−1) Mn (kg.mol−1) PDI 
(Mw/Mn) 
Mn (kg.mol−1) 
PiB1000-SA 1.05 0.95 1.71 1.11[a] 
PEG350-Me 0.35 N/A N/A 0.36[b] 
PEG750-Me 0.75 N/A N/A 0.80[b] 
3 - 1.32 1.50 1.25[b] 
4 - 1.18 1.54 2.11[b] 
[a] Based on normalization of the alkene signal at 4.6 − 5.3 ppm as 1 proton. [b] Based on 
normalization of the terminal methyl peak at 3.2 ppm as 3 protons. 
 
For the GPC results, we expected Mn of 4 to have a value in the range of 1.50 to 
2.00 kg/mol, but found a value of 1.18 kg/mol. We attribute this to the greater 
molecular weight of the hydrophilic fraction.  
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VIII.1.3. Gel Permeation Chromatography (GPC) 
 
Figure S.VIII.1. Elugram of monomethyl polyethylene glycol (PEG350-Me, red), 
polyisobutylene-succinic anhydride (PiB1000-SA, blue), and compound 3 (black). 
 
Figure S.VIII.2. Elugram of monomethyl polyethylene glycol (PEG750-Me, red), 
polyisobutylene-succinic anhydride (PiB1000-SA, blue), and compound 4 (black). 
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VIII.1.4. NMR Spectroscopy 
 
Figure S.VIII.3. 1H NMR spectrum of compound 3 (PiB1000-b-PEG350-Me) in CDCl3. Attribution: δ 
(ppm) 4.9 − 4.8 (1 H, C=C of PiB), 4.3 − 4.1 (2 H, alpha protons of the ester), 3.8 − 3.5 (30 H, PEG) 
3.4 (3 H, O-CH3 of PEG-Me), 3.1 − 2.9; 2.8 − 2.4; 2.3 − 2.1; 2.1 − 0.8 (111 H, methyl and methylene of 
PiB). The spectrum corresponds to literature data.[1] 
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Figure S.VIII.4. 1H NMR spectrum of compound 4 (PiB1000-b-PEG750-Me) in CDCl3. Attribution: δ 
(ppm) 4.9 − 4.8 (1 H, C=C of PiB), 4.3 − 4.1 (2 H, alpha protons of the ester), 3.8 − 3.5 (71 H, PEG) 
3.4 (3 H, O-CH3 of PEG-Me), 3.1 − 2.9; 2.8 − 2.4; 2.3 − 2.1; 2.1 − 0.8 (169 H, methyl and methylene of 





VIII.1.5. IR Spectroscopy 
 
Figure S.VIII.5. Infrared spectrum of 3 (PiB1000-b-PEG350-Me). Peak assignment (cm−1): 3467 (OH), 
2949, 2883 (C-H), 1734 (C=O), 1638 (C=C), 1470, 1389, 1366, 1231 (PiB skeleton), and 1104 (C-O 
of PEG). The spectrum corresponds to literature data.[1] 
 
Figure S.VIII.6. Infrared spectrum of 4 (PiB1000-b-PEG750-Me). Peak assignment (cm−1): 3487 (OH), 
2949, 2878 (C-H), 1737 (C=O), 1636 (C=C), 1470, 1388, 1366, 1230 (PiB skeleton), and 1107 (C-O 
of PEG). The spectrum corresponds to literature data.[1] 
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VIII.2. Transmission electron microscopy images of 
vesicles 
 
Figure S.VIII.7. TEM micrographs of P3 (a) and P4 (b) vesicles in intact state (left) and after 2 
minutes when the vesicles had collapsed and dried out under influence of the electron beam in the 
transmission electron microscope (right). Note the ring of salt around the vesicles after drying out, 
indicating the escape of salty water from the vesicles’ interior. No TEM-stain was needed to 
visualize the vesicles. 
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VIII.3. Upconversion with 1 and 2 in organic solvent 
 
Figure S.VIII.8. a) Emission spectroscopy of 1 and 2 in a 3:1 v/v chloroform/oleic acid mixture 
([1] = 7.5 µM, [2] = 150 µM) in air, irradiated with 50 mW 630 nm laser light (4 mm beam 
diameter, 0.4 W.cm−2) in a macro cuvette at 20 °C. No emission filters were used. b) Photograph of 
the same solution in a semi-micro cuvette, irradiated with a 50 mW 630 nm laser beam (4 mm 
beam diameter, 0.4 W.cm−2) from the left side. The photograph was taken without filtering the 
excitation source. 
VIII.4. Compounds 1 and 2 in organic solvent 
 
Figure S.VIII.9. UV-Vis absorbance (solid lines) and emission (dashed lines) spectroscopy of 1 and 2 
in chloroform. [1] = 0.5 µM, [2] = 10 µM.  λexc = 405 nm for compound 2 and λexc = 630 nm for 
compound 1. 
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VIII.5. Compounds 1 and 2 in polymersomes 
 
Figure S.VIII.10. a) Photograph of samples P3, P3-1, and P3-2. b) Photograph of samples P4, P4-1, 
and P4-2. c) UV-Vis absorbance (solid lines) and normalized emission (dashed lines) of samples 
P3-1 (red) and P3-2 (blue). d) UV-Vis absorbance (solid lines) and normalized emission (dashed 
lines) of samples P4-1 (red) and P4-2 (blue). Conditions: [3] = [4] = 0.5 mg/mL, [1] = 0.5 µM, 
[2] = 10 µM, T = 20 °C, λexc = 405 nm for P3-2 and P4-2 and λexc = 630 nm for P3-1 and P4-1. 
Spectra taken in air without anti-oxidants.  
VIII.6. Giant vesicles 
To investigate whether TTA-UC truly occurs in the polymer membrane, giant 
polymersomes with polymer 3 were prepared by following a procedure for 
self-assembly of phospholipid giant vesicles to make giant polymersomes 
GP3-1-2,[2] and imaged by bright field and emission spectroscopy. First, the 
vesicles were imaged in a regular fluorescence microscope at 20x 
magnification and  λexc = 377 nm (Figure S.VIII.11). The bright field images 
showed microscale spherical vesicles. When excited at 377 nm (i.e. direct 
excitation of 2), bright fluorescence was observed from the membrane, which 
proves that 2 was indeed located inside the membrane. Then, the vesicles 
were imaged with a laser microscopy setup (see experimental section) with 
405 and 635 nm excitation in presence of 0.1 M sodium sulfite (Figure 
S.VIII.12). The addition of the sulfite after GUV preparation caused the vesicles 
to shrink significantly (compare Figure S.VIII.11 with Figure S.VIII.12), but 
they could be imaged nonetheless. Again, bright fluorescence was observed 
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from the membrane when 2 was excited directly (λexc = 405 nm). The giant 
vesicles were also illuminated with 635 nm laser light, while selectively 
imaging between 450 − 575 nm: upconversion emission was indeed detected 
in the membrane, completely superimposable with the bright field and 405 
nm excitation images and ultimately proving that 1 and 2 were co-localized in 
the polymer membrane. In control experiments, in which 2 was omitted from 
the formulation (GP3-1), only very weak luminescence with 405 nm 
excitation was observed, due to phosphorescence of 1 at 800 nm that is not 
entirely blocked with the dichroic mirror and emission filter used for 405 nm 
excitation. However, no emission was observed with 635 nm excitation, due to 
strict blocking of everything but 450 − 575 nm. This confirmed that our 
microscopy setup was indeed selectively imaging upconversion emission 
under 635 nm excitation. 
 
Figure S.VIII.11. a) Bright field (left) and emission spectroscopy (right, λexc = 377 nm) of giant 
polymersomes GP3-1-2. The profile plot of the white arrow is given in (b).  
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Figure S.VIII.12. Bright field and emission microscopy images of giant polymersomes GP3-1-2 
(top) and GP3-1 (bottom). Left: Bright field image. The vesicles are indicated with arrows. Middle: 
fluorescence microscopy by directly exciting compound 2 with 405 nm light (6.7 µW, 60 µm spot 
size, intensity 0.24 W.cm−2). Right: upconversion microscopy by exciting compound 1 with 635 nm 
light (13 mW, 50 µm spot size, intensity 640 W.cm−2) and imaging from 450 to 575 nm. The images 
were acquired in air in presence of 0.1 M Na2SO3.   
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VIII.7. Temperature dependency of TTA-UC in 
polymersomes 
 
Figure S.VIII.13. Temperature dependency of phosphorescence (red) and upconversion emission 
(blue) in P4-1-2 vesicles (0.5 mg/mL compound 4) irradiated with 50 mW 630 nm (4 mm 
diameter, 0.4 W.cm−2) in presence of 50 mM sodium sulfite. Experiment with P3-1-2 vesicles 
yielded very similar results. 
VIII.8. Power dependency of TTA-UC in polymersomes 
 
Figure S.VIII.14. Power dependency of upconversion emission in P4-1-2 vesicles (0.5 mg/mL 
compound 4) at 20 °C. The red and blue lines are straight fit curves through the first and last data 
points, respectively, where the intersection of the two lines represent the intensity threshold (Ith). 
Experiment with P4-1-2 at 37 °C, and experiments with P3-1-2 at 20 °C and 37 °C yielded very 
similar results.  
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VIII.9. Time evolution of upconversion with P3-1-2 and 
P4-1-2 in air and dye bleaching 
VIII.9.1. P3-1-2 vesicles 
 
Figure S.VIII.15. Red-light irradiation of P3-1-2 vesicles at 5.0 (a, b), 7.5 (c, d), and 10 mg/mL (e, f) 
in air and in absence of added oxygen-scavenger. UV-Vis absorption spectra (a, c, e, 4 mm path 
length) before (black) and after (red) 30 min 630 nm irradiation (50 mW, 0.4 W.cm−2, 4 mm path 
length) showing dye bleaching. Emission time traces (b, d, f) during the irradiation experiment, 
showing IUC (blue, left axis) and Iphosphorescence (red, right axis). Conditions: 600 µL sample in a 




Figure S.VIII.16. Emission time traces of a 7.5 mg/mL P3-1-2 sample with addition of 75 mM 
Na2SO3 as oxygen scavenger, showing IUC (blue, left axis) and Iphosphorescence (red, right axis), during 
50 mW 630 nm (0.4 W.cm−2, 4 mm path length) irradiation.  
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VIII.9.2. P4-1-2 vesicles 
 
Figure S.VIII.17. Red light irradiation experiments with P4-1-2 vesicles at 7.5 (a, b), 8.8 (c, d), and 
10 mg/mL (e, f) in air without added anti-oxidants. UV-Vis absorption spectra (a, c, e, 4 mm path 
length) before (black) and after (red) 30 min 630 nm irradiation (50 mW, 0.4 W.cm−2, 4 mm path 
length) showing bleaching. Emission time traces (b, d, f) during the irradiation experiment, 
showing IUC (blue, left axis) and Iphosphorescence (red, right axis). Conditions: 600 µL sample in a 
semi-micro cuvette at 20 °C. 
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VIII.10. Oxygen consumption during red light irradiation 
of P3-1-2 and P4-1-2 in air 
 
Figure S.VIII.18. Upconversion intensity IUC (blue, data multiplied by 1000 for clarity, left axis), 
phosphorescence intensity Iphosphorescence (red, left axis), and dissolved oxygen concentration (black, 
right axis, measured using a submerged oxygen probe) during 50 mW 630 nm light irradiation (10 
mm path length, 4 mm beam diameter, 0.4 W.cm−2) of 2.0 mL samples of P3-1-2 (a) or P4-1-2 (b) 
at 10 mg/mL polymer concentration in a stirred macro cuvette at 20 °C. Laser was turned on at 
t = 0, as indicated by the dashed line, and IUC and Iphosphorescence were recorded at 486 and 800 nm, 
respectively. 
VIII.11. Oxygen and emission time traces of diluted 
samples of P4-1-2 without addition of oxygen scavengers 
 
Figure S.VIII.19. Oxygen measurement of a P4-1-2 sample without the addition of oxygen 
scavengers in the dark (left) and during 50 mW 630 nm (0.4 W.cm−2) excitation (right). Red and 
blue line represent photosensitizer phosphorescence at 800 nm and upconversion emission at 486 
nm, respectively. [4] = 0.5 mg/mL, [1] = 0.5 µM, [2] = 10 µM, T = 20 °C, 2 mL sample volume in a 
stirred macro cuvette. Laser was turned on at t = 0, as indicated by the dashed line. 
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VIII.12.  Cell imaging with upconverting polymersomes 
 
Figure S.VIII.20. a) Imaging of P4-1-2 upconverting polymersomes in A549 lung carcinoma cells in 
bright field mode (left column), with λexc = 405 nm (middle column), and with λexc = 635 nm (right 
column). Cells were incubated for 4 h with 1:1 v/v mixture of Opti-MEM and P4-1-2 vesicles (top 
row, [4] = 0.5 mg/mL), or with 1:1 v/v mixture of Opti-MEM and P4-1-2 vesicles ([4] = 0.5 mg/mL) 
and addition of 5 mM sodium L-ascorbate and 5 mM sodium glutathionate (bottom row). The cell 
nuclei were stained with Hoechst 33342 prior to imaging (1 µg/mL in PBS, incubated for 20 min). 
Imaging conditions: T = 37 °C, 7.0% CO2, 1.0% O2, 62 µW 405 nm laser power (60 µm spot 
diameter, 2.2 W.cm−2 intensity), 13 mW 635 nm laser power (50 µm spot diameter, 640 W.cm−2 
intensity), cells were allowed to equilibrate for 30 min before imaging. b/c) Profile plots of the red 
arrows in panel [a] in absence (b) or presence (c) of sodium L-ascorbate and sodium glutathionate, 




Figure S.VIII.21. Example images used for quantification of in vitro upconversion luminescence. 
Imaging of P4-1-2 upconverting polymersomes in A549 lung carcinoma cells in bright field mode 
(left column), with λexc = 405 nm (middle column), and with λexc = 635 nm (right column) with 40x 
magnification. Cells were incubated for 4 h with Opti-MEM only (top row),with 1:1 v/v mixture of 
Opti-MEM and P4-1-2 vesicles (middle row, [4] = 0.5 mg/mL), or with 1:1 v/v mixture of Opti-MEM 
and P4-1-2 vesicles ([4] = 0.5 mg/mL) and addition of 5 mM sodium L-ascorbate and 5 mM sodium 
glutathionate (bottom row). Imaging conditions: T = 37 °C, 7.0% CO2, 1.0% O2, 76 µW 405 nm 
laser power (150 µm spot diameter, 0.44 W.cm−2 intensity), 13 mW 635 nm laser power (131 µm 
spot diameter, 97 W.cm−2 intensity), cells were allowed to equilibrate for 30 min before imaging. 
For comparison, the image histograms for λexc = 405 nm are scaled from 0 − 8000 pixel values, and 
for λexc = 635 nm are scaled from 0 − 800 pixel values, as given by the calibration bars in the top 
row. In each image, the region of interest (ROI) is indicated with a white circle, and the total signal 
ST (in mean pixel value) within the ROI is given. 
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VIII.13. Emission spectroscopy setup 
 
Figure S.VIII.22. Setup used for photosubstitution experiments using red light. Legend: (1) 630 nm 
laser source, (2) optical fibers, (3) filter holder, (4) 630 nm band pass filter, (5) variable neutral 
density filter that can be installed or removed, (6) halogen-deuterium light source for UV-Vis 
absorption spectroscopy, (7) temperature controlled cuvette holder, (8) variable filter holder, and 
(9) CCD spectrometer. 
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Inleiding 
Chemotherapie is een van de voornaamste therapieën om kanker te genezen. 
De huidige chemotherapeutische geneesmiddelen die goedgekeurd zijn voor 
klinische toepassing veroorzaken echter ernstige bijwerkingen in patiënten 
omdat de drugs systemisch actief zijn in het lichaam en daardoor ook gezond 
weefsel aantasten. Een veelbelovende manier om het probleem van 
systemische giftigheid te omzeilen is het gebruik van lichtactiveerbare 
“prodrugs” in een therapie genaamd lichtgeactiveerde chemotherapie (PACT): 
een inactieve voorloper van het geneesmiddel wordt in het lichaam 
geïntroduceerd en wordt alleen in de tumor omgezet naar de giftige vorm van 
het geneesmiddel door het kankerweefsel te bestralen met zichtbaar licht. Op 
deze manier kan het gebruik van licht zorgen voor een uitstekende controle 
over waar en wanneer de prodrug geactiveerd wordt. Veelbelovende 
moleculen voor toepassing in PACT zijn lichtgevoelige ruthenium(II)-
polypyridylcomplexen met een ligand dat met licht afgesplitst kan worden 
(Hoofdstuk 1). Wanneer zulke verbindingen worden bestraald met licht, 
wordt het lichtafsplitsbare ligand vervangen door een zwakgebonden 
watermolecuul. Vervolgens kan het geactiveerde complex interactie aangaan 
met diverse biomoleculen aanwezig in het menselijk lichaam door het 
vervangen van het waterligand met stikstof of zwavelrijke liganden, zoals 
DNA-baseparen of cysteïneresiduen in eiwitten, wat uiteindelijk kan leiden tot 
celdood. Het grote voordeel van dit soort verbindingen is dat de giftigheid niet 
afhangt van de aanwezigheid van zuurstof, in tegenstelling tot fotodynamische 
therapie (PDT) wat werkt door reactieve zuurstofdeeltjes (ROS) te genereren. 
Het gebruik van lichtactiveerbare Ru complexen kan dus geschikt zijn voor het 
behandelen van tumorweefsel waarvoor PDT niet effectief is.  
De meeste Ru(II)-polypyridylcomplexen absorberen echter alleen blauw tot 
groen licht, wat slechts tot ongeveer een millimeter in menselijk weefsel 
doordringt. Idealiter gebruikt men rood tot nabij-infrarood licht, wat tot wel 
een centimeter doordringt: daardoor wordt dit deel van het lichtspectrum ook 
wel het “fototherapeutische venster” genoemd. Om de activatiegolflengte van 
Ru(II)-polypyridylcomplexen naar het fototherapeutische venster te 
verschuiven, wordt in dit proefschrift voorgesteld om “lichtopwaardering” te 
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gebruiken om laag-energetisch licht, zoals rood of nabij-infrarood licht, om te 
zetten naar hoog-energetisch licht, zoals blauw licht. Praktisch gezien 
betekent dit dat de tumor wordt bestraald met rood tot nabij-infrarood licht, 
wat lokaal wordt opgewaardeerd naar blauw licht, waarmee de prodrug kan 
worden geactiveerd. Onder de verscheidene vormen van lichtopwaardering is 
“triplet-triplet annihilatie upconversie” (TTA-UC) verkozen als meest 
veelbelovende methode omdat het gerealiseerd kan worden bij lage 
bestralingsintensiteit en met hoge efficiëntie.  
TTA-UC is gebaseerd op het samenspel van fotosensibilisator en annihilator 
kleurstoffen, zoals als volgt beschreven (zie ook Hoofdstuk 2). De 
fotosensibilisator absorbeert het laag-energetische licht, waarna 
intersysteemkruising leidt tot het molecuul in een langlevende triplet-
toestand. Wanneer deze triplet-fotosensibilisator botst met een 
annihilatormolecuul, wordt de triplet-toestand overgedragen aan de 
annihilator door middel van triplet-triplet energie overdracht (TTET); een 
opeenvolging van dit TTET proces zorgt voor een concentratieopbouw van 
langlevende triplet-toestand annihilatormoleculen. De botsing van twee 
triplet-toestand annihilatormoleculen resulteert vervolgens in triplet-triplet 
annihilatie (TTA), waarbij één van de annihilatormoleculen vertrekt met de 
gecombineerde energie van beide triplet-toestanden en een hoog-
energetische aangeslagen singlet-toestand bereikt. Deze singlet-toestand 
annihilator keert vervolgens terug naar de grondtoestand door uitstraling van 
een hoog-energetisch foton, waarbij de licht opwaardering tot stand is 
gebracht. In dit proefschrift wordt voorgesteld om rood-naar-blauw TTA-UC 
te gebruiken om een licht-gevoelig Ru(II)-polypyridylcomplex te activeren 
door de fotosensibilisator, annihilator, en Ru(II)-complex gezamenlijk te 
doteren in een nano-geneesmiddelafgiftesysteem zoals liposomen of 
polymeersomen. Dit heeft twee belangrijke voordelen: aan de ene kant zorgt 
deze supramoleculaire benadering voor een hogere selectiviteit voor tumoren 
door gebruik te maken van het feit dat het vaatstelsel van tumoren van nature 
meer doordringbaar is dan normale bloedvaten en tumoren geen 
lymfesysteem heeft (EPR effect). Aan de andere kant garandeert het gebruik 




TTA-UC in liposomen en polymeersomen 
Zoals beschreven in Hoofdstuk 3 zijn met succes liposomen vervaardigd die in 
staat zijn blauwe fotonen te genereren uit groen of rood licht door middel van 
TTA-UC met twee verschillende kleurstofparen (Figuur S.1). De 
lichtopwaarderingsefficiëntie in liposomen was hoog en zeer vergelijkbaar 
met dat in organisch oplosmiddel. Om te onderzoeken waar de 
lichtopwaardering plaatsvond, werden rood-naar-blauw opwaarderende 
“giant vesicles” (GUVs) vervaardigd en gefotografeerd door middel van 
lichtopwaardering luminescentie microscopie, zoals beschreven in Hoofdstuk 
5. De resultaten laten zien dat TTA-UC plaatsvond in de lipide dubbellaag van 
de GUVs en de hoge kwaliteit en stabiliteit van de afbeeldingen gaf 
gelegenheid tot het 3D-reconstrueren van de lichtopwaarderende GUVs. 
Omdat uiteindelijk de liposomen functioneel behoren te zijn bij menselijke 
lichaamstemperatuur (37 °C), werd de temperatuur-afhankelijkheid van TTA-
UC in liposomen getest in een reeks van neutrale fosfolipide liposomen, 
waarvan de resultaten beschreven zijn in Hoofstuk 6. Er werd vastgesteld dat 
de TTA-UC-intensiteit rond de hoofdtransitietemperatuur (Tm) 
maximaliseerde. Dit werd verklaard door het feit dat de moleculaire 
bewegingsvrijheid van de TTA-UC-kleurstoffen toeneemt met hogere 
temperatuur tot Tm, en daarmee TTA-UC-efficiëntie, terwijl bij nog hogere 
temperatuur het uitdoven van de fotosensibilisator resulteerde in een afname 
van TTA-UC-intensiteit boven Tm. De TTA-UC-efficiëntie bij 37 °C in DOPC, 
DLPC en DMPC liposomen was zeer vergelijkbaar. TTA-UC kan dus in het 
algemeen gerealiseerd worden in liposomen en de fosfolipide kan vrij worden 
gekozen om de liposoomformulering te optimaliseren wat betreft stabiliteit in 
medium, biologische compatibiliteit, verwijdering uit de bloedbaan en 
functionalisatie van het deeltjesoppervlakte.  
 
Figuur S.1. TTA-UC in liposomen met een fotosensibilisator (PS) en annihilator-kleurstof (A). 
Samenvatting in het Nederlands 
288 
Om op deze resultaten voort te bouwen was het belangrijk om vast te stellen 
of TTA-UC kon plaatsvinden in levende cellen. Inderdaad is vastgesteld dat 
lichtopwaarderende liposomen door kankercellen werden opgenomen en dat 
de rood-naar-blauwe opwaardering kon worden waargenomen en 
gefotografeerd onder zuurstofarme condities, zoals beschreven in Hoofdstuk 7 
en 8. De liposomen waren gelokaliseerd in endosomen en lysosomen en 
werden binnen 24 uur na opname door de cellen afgebroken. De 
lichtopwaardering verbleekte echter binnen een aantal seconden en de 
intensiteit was erg laag door uitdoving door de aanwezigheid van zuurstof in 
de cellen. Zoals beschreven in Hoofstuk 8 werd deze zuurstofgevoeligheid 
verminderd door de cellen ook te behandelen met een biologisch relevante 
hoeveelheid glutathion en L-ascorbinezuur waardoor de TTA-UC-intensiteit 
sterk verhoogd werd. Daarnaast werd vastgesteld dat de lichtopwaarderende 
liposomen niet toxisch waren in het donker en onder bestraling met rood 
licht; er werd geen PDT effect waargenomen ten gevolge van de singlet-
toestand zuurstof die werd gegenereerd door de fotosensibilisator.  
Afgezien van liposomen werd rood-naar-blauw TTA-UC ook gerealiseerd in 
het membraan van polymeersomen, die zelf-geassembleerd waren uit 
polyisobutyleen-polyethyleenglycol blokcopolymeren, zoals beschreven in 
Hoofdstuk 9. Alhoewel de rood-naar-blauw opwaardering enigszins minder 
efficiënt was dan in liposomen, werden de polymeersomen sneller opgenomen 
door levende cellen. Vervolgens konden de lichtopwaarderende 
polymeersomen gefotografeerd worden in de levende cellen, terwijl de 
toevoeging van glutathion en L-ascorbinezuur de in vitro prestaties sterk 
verbeterde. In vergelijking met liposomen kan het sterke rubberachtige 
membraan van polymeersomen beter bestendig zijn tegen afbraak door cellen 
of in het spijsverteringskanaal van zoogdieren, wat diverse mogelijkheden 
biedt voor toepassingen zoals medicijnafgifte. Alles samengenomen 
vertegenwoordigt TTA-UC in liposomen en polymeersomen interessante 
mogelijkheden in luminescentie biofotografie, omdat auto-fluorescentie en 





Figuur S.2.Cartoon ter illustratie van de drie verschillende strategieën die zijn nagestreefd in dit 
proefschrift om de zuurstofgevoeligheid van TTA-UC in nanodeeltjes te verlagen. a) Coating van 
het nanodeeltje met een materiaal als barrière voor zuurstof. b) Toevoeging van een antioxidant 
(A.O.) die reageert met grondtoestand zuurstof, wat leidt tot een geoxideerde antioxidant (Ox. 
A.O.). c) Toevoeging van een antioxidant die reageert met aangeslagen singlet-toestand zuurstof: 
wanneer de fotosensibilisator aangeslagen wordt ontstaat singlet-zuurstof, wat reageert met de 
antioxidant en leidt tot een zuurstofarme omgeving. 
Zuurstofgevoeligheid van TTA-UC 
Het mechanisme van TTA-UC hangt sterk af van langlevende triplet-toestand 
moleculen, die sterk kunnen worden uitgedoofd door zuurstof. Deze uitdoving 
leidt tot zeer lage TTA-UC-efficiëntie in aanwezigheid van zuurstof; in de 
literatuur zijn er tot op heden nog maar nauwelijks manieren gerapporteerd 
om dit probleem te verhelpen. Inderdaad werd tijdens het eerste werk voor 
Hoofdstuk 3 gerealiseerd dat TTA-UC in liposomen alleen goed werkte 
wanneer de oplossingen strikt zuurstofvrij waren gemaakt door een 
argonstroom door de oplossing te borrelen. Om dit grote nadeel tegen te gaan 
werden in opvolgende experimenten drie strategieën nagestreefd om de 
zuurstofgevoeligheid van TTA-UC in nanodeeltjes te verlagen (Figuur S.2). De 
eerste strategie was het aanbrengen van een zuurstof-ondoordringbare laag 
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rondom liposomen (Figuur S.2a). In Hoofdstuk 7 wordt beschreven hoe een 
nanometer-dikke (organo)silica-coating werd aangebracht rondom 
lichtopwaarderende liposomen. Alhoewel de resulterende nanodeeltjes 
gemakkelijk werden opgenomen in kankercellen zonder celdood te 
veroorzaken, zorgde de silica-coating helaas niet voor de beoogde 
zuurstofbescherming (noch in oplossing, noch in cellen), hoogstwaarschijnlijk 
door de porositeit van de silica-coating. Wanneer de silica-gecoate deeltjes 
werden gedroogd in een overmaat (organo)silica precursor werden echter 
interessante nano-composietmaterialen verkregen waarmee TTA-UC in lucht 
mogelijk was. Deze resultaten bevestigden dat (organo)silica onder bepaalde 
omstandigheden inderdaad TTA-UC materialen kan beschermen tegen 
zuurstof. Dit werk vertegenwoordigt een interessant voorbeeld van de 
combinatie van fosfolipiden, water, en silica voor het vervaardigen van 
lichtopwaarderende nanodeeltjes en materialen die eenvoudig kunnen 
worden afgestemd op de toepassing.  
In een tweede benadering werd gerealiseerd dat het verwijderen van zuurstof 
uit de oplossing door middel van een fysieke methode (bubbelen van argon) 
kon worden vervangen door het toevoegen van een antioxidant die reageert 
met grondtoestand zuurstof, zoals natriumsulfiet (Figuur S.2b). Sulfiet zorgt 
voor een sterke afname van opgeloste zuurstof, waardoor stabiele en 
efficiënte TTA-UC in oplossing kan plaatsvinden. Veel antioxidanten die met 
grondtoestand zuurstof kunnen reageren zijn echter niet compatibel met 
biologische systemen (bijv. hydrazine) en ze putten langzaam uit wanneer 
zuurstof in de samples lekt. Om deze benadering te verbeteren werd een 
derde benadering nagestreefd met antioxidanten die alleen met aangeslagen 
singlet-toestand zuurstof kunnen reageren, zoals ascorbinezuur of glutathion 
(Hoofdstuk 8). Dit werkt als volgt: wanneer het TTA-UC systeem continu 
wordt bestraald, produceert de fotosensibilisator aangeslagen singlet-
toestand zuurstof dat vervolgens reageert met de antioxidant totdat alle 
zuurstof in het monster is geconsumeerd. Deze strategie leidde tot zeer 
efficiënte en stabiele TTA-UC in lucht (> 80% stabiliteit gedurende het eerste 
uur bestraling). Zoals beschreven wordt in Hoofdstuk 9 kan de rol van 
antioxidant ook vervuld worden door histidine, trolox, of de antioxidanten die 
aanwezig zijn in celgroeimedium (bijv. bovien serum albumine of pyruvaat). 
Het gebruik van antioxidanten is dus een zeer algemene en krachtige strategie 
om de zuurstofgevoeligheid van vrijwel elk TTA-UC systeem te verminderen.  
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Activering van Ru prodrugs door middel van TTA-UC 
Het doel van dit proefschrift was de activering van Ru(II)-prodrugs met rood 
licht door middel van lichtopwaardering in een geneesmiddelafgiftesysteem. 
Dit doel werd voor het eerst behaald in Hoofdstuk 3, waarin wordt beschreven 
hoe de fotochemische afsplitsing van een Ru(II)-polypyridylcomplex van 
liposomen werd getriggerd door lichtopwaarderende liposomen in een 
mengsel van rood-naar-blauw opwaarderende liposomen en Ru-complex 
gedoteerde liposomen (Figuur S.3a). In dit eerste werk werd het blauwe 
opgewaardeerde licht naar het Ru-complex overgebracht door middel van 
radiatieve energieoverdracht, d.w.z. door tussenkomst van een foton. 
Wanneer het Ru-complex in hetzelfde membraan werd gedoteerd als de 
lichtopwaarderende kleurstoffen, werd de energie door middel van Förster 
resonantie-energieoverdracht (FRET) overgebracht met meer dan 85% 
efficiënte bij relatief lage Ru-complex hoeveelheden (4 mol% met betrekking 
tot de fosfolipiden), zoals beschreven in Hoofdstuk 4 en Figuur S.3b. Deze 
studies lieten zien dat Ru-prodrug activering door rood-naar-blauw TTA-UC 
veelbelovend is, maar werkte helaas nog niet in lucht vanwege het uitdoven 
van TTA-UC door zuurstof. Om het systeem in lucht te laten functioneren werd 
de fotoreactie succesvol uitgevoerd in aanwezigheid van ascorbinezuur en 
glutathion, zoals beschreven in Hoofdstuk 8. Er is ook geprobeerd om de 
liposomen met Ru-complex en TTA-UC-kleurstoffen te testen in cellen. De Ru 
complexen die werden gebruikt waren echter ook zeer giftig in het donker, en 
werden niet significant meer giftig onder bestraling van licht. Vanwege deze 
redenen kon de activatie door rood-naar-blauw TTA-UC in liposomen niet 
leiden tot een uitgesproken fotochemotherapeutisch effect, en de 
haalbaarheid van deze aanpak blijft dus nog onzeker. Op dit moment is meer 
onderzoek nodig naar het ontwerp van membraangebonden Ru-prodrugs met 
hoge giftigheid na bestraling en lage giftigheid in het donker om de activering-
door-lichtopwaardering benadering te valideren in biologische systemen.  
Algemene opmerkingen 
De resultaten beschreven in dit proefschrift verschaffen waardevolle inzichten 
voor het ontwikkelen van biologische TTA-UC toepassingen. Liposomen en 
polymeersomen werden succesvol gebruikt als multifunctionele rood-naar-
blauw opwaarderend platform voor biofotografie en activering van 
lichtgevoelige Ru-prodrugs. Het is duidelijk gedemonstreerd dat blauw-licht 
gevoelige Ru-polypyridylcomplexen, die normaal gesproken niet gevoelig zijn 
voor licht in het fototherapeutische venster, kunnen worden geactiveerd door 
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rood licht door middel van TTA-UC. De biologische evaluatie van deze 
activering-door-lichtopwaardering strategie vereist meer wetenschappelijke 
aandacht om te achterhalen welke parameters optimalisatie nodig hebben, 
zoals het ontwerp van het nanodeeltje, stabiliteit van TTA-UC, 
zuurstofgevoeligheid en aanwezigheid van antioxidanten, lichtdosis, 
doteringshoeveelheid van kleurstoffen en prodrugs in het nanodeeltje, en de 
foto-index van de Ru-prodrugs. We verwachten dat de resultaten van dit 
proefschrift zullen leiden tot interessante toepassingen in fotogeactiveerde 
chemotherapie dat een alternatief biedt voor fotodynamische therapie in 
zuurstofarme tumoren. 
 
Figuur S.3. Cartoon ter illustratie van de combinatie van TTA-UC in liposomen en 
lichtactiveerbare, membraangebonden Ru-polypyridylcomplexen. a) TTA-UC en Ru-complex zijn 
fysiek gescheiden op twee verschillende liposomen: het blauwe licht wat door TTA-UC wordt 
gegenereerd wordt aan het Ru-complex overgedragen door radiatieve energieoverdracht 
(Hoofdstuk 3), waarna het geactiveerde Ru-aqua complex vertrekt van het membraan. b) TTA-UC 
en Ru complex zijn gelokaliseerd op hetzelfde liposoom: het blauwe licht wat door TTA-UC wordt 
gegenereerd wordt via FRET aan het Ru complex overgedragen (Hoofdstuk 4). PS: 
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